1	Cancer	NNP	O	Cancer	nn	3	SENT_1	[p1l53t81r152b106],
2	Chemother	NNP	PERSON	Chemother	nn	3	SENT_1	[p1l162t81r318b106],
3	Pharmacol	NNP	PERSON	Pharmacol	dep	7	SENT_1	[p1l328t81r478b106],
4	(	CD	NUMBER	(	dep	3	SENT_1	[p1l489t81r581b111],
5	2010	CD	DATE	2010	dep	7	SENT_1	[p1l489t81r581b111],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l489t81r581b111],
7	66:765	CD	NUMBER	66:765	dep	11	SENT_1	[p1l592t81r757b106],
8	—	NN	O	—	nn	10	SENT_1	[p1l592t81r757b106],
9	771	CD	NUMBER	771	num	10	SENT_1	[p1l592t81r757b106],
10	DOI	NNP	O	DOI	dep	7	SENT_1	[p1l52t123r114b148],
11	10.1007	CD	NUMBER	10.1007	_	0	SENT_1	[p1l128t123r527b148],
12	/	:	O	/	punct	11	SENT_1	[p1l128t123r527b148],
13	s00280	CD	NUMBER	s00280	dep	11	SENT_1	[p1l128t123r527b148],
14	.	.	O	.	_	0	SENT_1	[p1l128t123r527b148],

1	—	NN	O	—	_	0	SENT_2	[p1l128t123r527b148],
2	.	.	O	.	_	0	SENT_2	[p1l128t123r527b148],

1	O09	NN	O	o09	_	0	SENT_3	[p1l128t123r527b148],
2	.	.	O	.	_	0	SENT_3	[p1l128t123r527b148],

1	—	NN	O	—	_	0	SENT_4	[p1l128t123r527b148],
2	.	.	O	.	_	0	SENT_4	[p1l128t123r527b148],

1	1221	CD	DATE	1221	_	0	SENT_5	[p1l128t123r527b148],
2	.	.	O	.	_	0	SENT_5	[p1l128t123r527b148],

1	—	NN	O	—	_	0	SENT_6	[p1l128t123r527b148],
2	.	.	O	.	_	0	SENT_6	[p1l128t123r527b148],

1	4	CD	NUMBER	4	_	0	SENT_7	[p1l128t123r527b148],

1	PXR-mediated	JJ	O	pxr-mediated	amod	2	SENT_8	[p1l53t340r473b387],
2	induction	NN	O	induction	_	0	SENT_8	[p1l492t340r760b387],
3	of	IN	O	of	_	0	SENT_8	[p1l779t340r837b387],
4	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_8	[p1l850t340r1267b400],
5	by	IN	O	by	dep	2	SENT_8	[p1l1285t341r1353b400],
6	anticancer	JJ	O	anticancer	amod	7	SENT_8	[p1l1372t340r1671b387],
7	drugs	NNS	O	drug	pobj	5	SENT_8	[p1l1689t341r1849b400],
8	in	IN	O	in	dep	2	SENT_8	[p1l53t414r107b460],
9	a	DT	O	a	det	14	SENT_8	[p1l125t428r156b461],
10	human	JJ	O	human	amod	14	SENT_8	[p1l174t415r373b461],
11	colon	NN	O	colon	nn	14	SENT_8	[p1l392t415r542b461],
12	adenocarcinoma-derived	JJ	O	adenocarcinoma-derived	amod	14	SENT_8	[p1l561t414r1265b461],
13	cell	NN	O	cell	nn	14	SENT_8	[p1l1285t415r1378b461],
14	line	NN	O	line	pobj	8	SENT_8	[p1l1397t414r1499b461],

1	Stefan	NNP	PERSON	Stefan	nn	16	SENT_9	[p1l53t536r164b566],
2	Harmsen	NNP	PERSON	Harmsen	nn	16	SENT_9	[p1l176t537r340b566],
3	-	:	O	-	_	0	SENT_9	[p1l352t548r360b555],
4	I.	NN	PERSON	i.	dep	16	SENT_9	[p1l372t537r397b566],
5	Meijerman	NNP	PERSON	Meijerman	dep	4	SENT_9	[p1l409t536r607b574],
6	-	:	O	-	_	0	SENT_9	[p1l619t548r627b555],
7	C.	NNP	PERSON	C.	nn	12	SENT_9	[p1l641t536r678b566],
8	L.	NNP	PERSON	L.	nn	12	SENT_9	[p1l690t537r726b566],
9	Febus	NNP	PERSON	Febus	nn	12	SENT_9	[p1l738t537r844b566],
10	R.	NNP	PERSON	R.	nn	12	SENT_9	[p1l856t548r864b555, p1l53t589r91b618],
11	F.	NNP	PERSON	F.	nn	12	SENT_9	[p1l103t589r137b618],
12	Maas-Bakker	NNP	PERSON	Maas-Bakker	dep	4	SENT_9	[p1l149t589r392b618],
13	-	:	O	-	_	0	SENT_9	[p1l404t600r411b607],
14	J.	NNP	PERSON	J.	nn	15	SENT_9	[p1l423t589r453b622],
15	H.	NNP	PERSON	H.	dep	12	SENT_9	[p1l465t589r506b618],
16	Beijnen	NNP	PERSON	Beijnen	_	0	SENT_9	[p1l518t588r654b626],
17	-	:	O	-	_	0	SENT_9	[p1l666t600r674b607],
18	J.	NNP	PERSON	J.	nn	21	SENT_9	[p1l686t589r715b622],
19	H.	NNP	PERSON	H.	nn	21	SENT_9	[p1l728t589r769b618],
20	M.	NNP	PERSON	M.	nn	21	SENT_9	[p1l781t589r829b618],
21	Schellens	NNP	PERSON	Schellens	dep	16	SENT_9	[p1l842t588r1005b618],

1	Received	VBN	O	receive	_	0	SENT_10	[p1l52t701r191b726],
2	:	:	O	:	_	0	SENT_10	[p1l52t701r191b726],
3	16	CD	DATE	16	num	4	SENT_10	[p1l206t701r237b726],
4	July	NNP	DATE	July	nsubj	13	SENT_10	[p1l247t701r305b733],
5	2009	CD	DATE	2009	num	4	SENT_10	[p1l316t701r404b726],
6	/	:	O	/	punct	7	SENT_10	[p1l316t701r404b726],
7	Accepted	JJ	O	accepted	dep	4	SENT_10	[p1l413t701r553b733],
8	:	:	O	:	_	0	SENT_10	[p1l413t701r553b733],
9	13	CD	DATE	13	num	10	SENT_10	[p1l569t701r598b726],
10	December	NNP	DATE	December	dep	7	SENT_10	[p1l610t701r756b726],
11	2009	CD	DATE	2009	num	10	SENT_10	[p1l765t701r854b726],
12	/	:	O	/	punct	7	SENT_10	[p1l765t701r854b726],
13	Published	VBN	O	publish	parataxis	1	SENT_10	[p1l863t701r1002b726],
14	online	NN	O	online	prep	13	SENT_10	[p1l1012t701r1107b726],
15	:	:	O	:	_	0	SENT_10	[p1l1012t701r1107b726],
16	30	CD	DATE	30	num	17	SENT_10	[p1l1120t701r1153b726],
17	December	NNP	DATE	December	tmod	25	SENT_10	[p1l1163t701r1308b726],
18	2009	CD	DATE	2009	num	19	SENT_10	[p1l1318t701r1387b726],
19	©	CD	NUMBER	©	nsubj	25	SENT_10	[p1l53t743r78b768],
20	The	DT	O	the	det	22	SENT_10	[p1l93t743r146b768],
21	Author	NN	O	author	nn	22	SENT_10	[p1l157t743r292b774],
22	(	NN	O	(	dep	19	SENT_10	[p1l157t743r292b774],
23	s	VBZ	O	s	cop	25	SENT_10	[p1l157t743r292b774],
24	)	CD	NUMBER	)	num	25	SENT_10	[p1l157t743r292b774],
25	2009	CD	DATE	2009	parataxis	1	SENT_10	[p1l304t743r380b768],
26	.	.	O	.	_	0	SENT_10	[p1l304t743r380b768],

1	This	DT	O	this	det	2	SENT_11	[p1l392t743r453b768],
2	article	NN	O	article	nsubjpass	4	SENT_11	[p1l464t743r551b768],
3	is	VBZ	O	be	auxpass	4	SENT_11	[p1l561t743r583b768],
4	published	VBN	O	publish	_	0	SENT_11	[p1l593t743r730b775],
5	with	IN	O	with	_	0	SENT_11	[p1l740t743r802b768],
6	open	JJ	O	open	amod	7	SENT_11	[p1l812t751r879b775],
7	access	NN	O	access	prep_with	4	SENT_11	[p1l890t751r978b768],
8	at	IN	O	at	_	0	SENT_11	[p1l990t747r1014b768],
9	Springerlink.com	NNP	O	Springerlink.com	prep_at	4	SENT_11	[p1l1024t743r1269b775],

1	Abstract	JJ	O	abstract	amod	2	SENT_12	[p1l8t938r342b1001],
2	Purpose	NN	O	purpose	nsubj	12	SENT_12	[p1l8t1053r305b1130],
3	The	DT	O	the	det	4	SENT_12	[p1l398t1050r534b1113],
4	development	NN	O	development	dep	2	SENT_12	[p1l630t1050r1092b1131],
5	of	IN	O	of	_	0	SENT_12	[p1l1185t1050r1262b1113],
6	multidrug	JJ	O	multidrug	amod	7	SENT_12	[p1l1350t1050r1700b1131],
7	resistance	NN	O	resistance	prep_of	4	SENT_12	[p1l1794t1050r2146b1113],
8	(	CD	NUMBER	(	num	10	SENT_12	[p1l12t1162r268b1239],
9	MDR	NN	ORGANIZATION	mdr	nn	10	SENT_12	[p1l12t1162r268b1239],
10	)	NN	O	)	dep	2	SENT_12	[p1l12t1162r268b1239],
11	is	VBZ	O	be	cop	12	SENT_12	[p1l305t1161r360b1224],
12	one	CD	NUMBER	one	_	0	SENT_12	[p1l398t1181r523b1224],
13	of	IN	O	of	_	0	SENT_12	[p1l558t1161r636b1224],
14	the	DT	O	the	det	16	SENT_12	[p1l664t1161r771b1224],
15	major	JJ	O	major	amod	16	SENT_12	[p1l805t1161r1013b1242],
16	limitations	NNS	O	limitation	prep_of	12	SENT_12	[p1l1046t1161r1425b1224],
17	in	IN	O	in	_	0	SENT_12	[p1l1461t1161r1529b1223],
18	the	DT	O	the	det	19	SENT_12	[p1l1562t1161r1669b1224],
19	treatment	NN	O	treatment	prep_in	16	SENT_12	[p1l1703t1171r2042b1224],
20	of	IN	O	of	_	0	SENT_12	[p1l2075t1161r2153b1224],
21	cancer	NN	O	cancer	prep_of	19	SENT_12	[p1l10t1292r258b1335],
22	.	.	O	.	_	0	SENT_12	[p1l10t1292r258b1335],

1	Induction	NN	O	induction	nsubj	22	SENT_13	[p1l339t1272r681b1335],
2	of	IN	O	of	_	0	SENT_13	[p1l759t1272r835b1335],
3	P	NN	O	p	nn	5	SENT_13	[p1l905t1272r1437b1353],
4	—	CD	NUMBER	—	num	5	SENT_13	[p1l905t1272r1437b1353],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_13	[p1l905t1272r1437b1353],
6	(	CD	NUMBER	(	num	5	SENT_13	[p1l1516t1273r1708b1353],
7	Pgp	NNP	O	Pgp	nn	8	SENT_13	[p1l1516t1273r1708b1353],
8	)	NNP	O	)	nsubjpass	11	SENT_13	[p1l1516t1273r1708b1353],
9	has	VBZ	O	have	aux	11	SENT_13	[p1l1786t1272r1901b1335],
10	been	VBN	O	be	auxpass	11	SENT_13	[p1l1978t1272r2147b1335],
11	regarded	VBN	O	regard	rcmod	1	SENT_13	[p1l8t1383r322b1464],
12	as	IN	O	as	_	0	SENT_13	[p1l357t1403r426b1446],
13	one	CD	NUMBER	one	prep_as	11	SENT_13	[p1l464t1403r589b1446],
14	of	IN	O	of	_	0	SENT_13	[p1l626t1383r703b1446],
15	the	DT	O	the	det	17	SENT_13	[p1l731t1383r838b1446],
16	main	JJ	O	main	amod	17	SENT_13	[p1l874t1383r1051b1446],
17	mechanisms	NNS	O	mechanism	prep_of	13	SENT_13	[p1l1086t1383r1525b1446],
18	underlying	VBG	O	underlie	xcomp	11	SENT_13	[p1l1562t1383r1947b1464],
19	anticancer	JJ	O	anticancer	amod	21	SENT_13	[p1l1986t1383r2143b1446, p1l10t1514r243b1557],
20	drug	NN	O	drug	nn	21	SENT_13	[p1l279t1494r755b1575],
21	—	NN	O	—	dobj	18	SENT_13	[p1l279t1494r755b1575],
22	induced	VBD	O	induce	_	0	SENT_13	[p1l279t1494r755b1575],
23	MDR	NN	O	mdr	dobj	22	SENT_13	[p1l790t1496r1010b1557],
24	.	.	O	.	_	0	SENT_13	[p1l790t1496r1010b1557],

1	Since	IN	O	since	mark	6	SENT_14	[p1l1055t1494r1249b1557],
2	the	DT	O	the	det	3	SENT_14	[p1l1287t1494r1394b1557],
3	induction	NN	O	induction	nsubj	6	SENT_14	[p1l1431t1494r1768b1557],
4	of	IN	O	of	_	0	SENT_14	[p1l1807t1494r1883b1557],
5	Pgp	NNP	ORGANIZATION	Pgp	prep_of	3	SENT_14	[p1l1915t1496r2051b1575],
6	is	VBZ	O	be	advcl	35	SENT_14	[p1l2089t1494r2144b1557],
7	(	RB	O	(	advmod	6	SENT_14	[p1l12t1605r107b1683],
8	in	IN	O	in	_	0	SENT_14	[p1l12t1605r107b1683],
9	part	NN	O	part	prep_in	6	SENT_14	[p1l140t1606r305b1686],
10	)	RB	O	)	advmod	11	SENT_14	[p1l140t1606r305b1686],
11	regulated	VBN	O	regulate	partmod	9	SENT_14	[p1l340t1605r675b1686],
12	by	IN	O	by	_	0	SENT_14	[p1l706t1605r793b1686],
13	the	DT	O	the	det	19	SENT_14	[p1l828t1605r935b1668],
14	pregnane	NN	O	pregnane	nn	19	SENT_14	[p1l969t1625r1294b1686],
15	X	NN	O	x	nn	19	SENT_14	[p1l1328t1607r1391b1667],
16	receptor	NN	O	receptor	nn	19	SENT_14	[p1l1424t1615r1719b1686],
17	(	NN	O	(	nn	19	SENT_14	[p1l1754t1606r2002b1683],
18	PXR	NN	O	pxr	nn	19	SENT_14	[p1l1754t1606r2002b1683],
19	)	NN	O	)	agent	11	SENT_14	[p1l1754t1606r2002b1683],
20	,	,	O	,	_	0	SENT_14	[p1l1754t1606r2002b1683],
21	the	DT	O	the	det	22	SENT_14	[p1l2040t1605r2146b1668],
22	ability	NN	O	ability	nsubjpass	35	SENT_14	[p1l11t1716r236b1797],
23	of	IN	O	of	_	0	SENT_14	[p1l272t1716r349b1779],
24	several	JJ	O	several	amod	28	SENT_14	[p1l381t1716r629b1779],
25	widely	RB	O	widely	advmod	26	SENT_14	[p1l664t1716r905b1797],
26	used	VBN	O	use	amod	28	SENT_14	[p1l940t1716r1103b1779],
27	anticancer	JJ	O	anticancer	amod	28	SENT_14	[p1l1138t1716r1504b1779],
28	drugs	NNS	O	drug	prep_of	22	SENT_14	[p1l1537t1716r1732b1797],
29	to	TO	O	to	aux	30	SENT_14	[p1l1768t1726r1834b1779],
30	activate	VB	O	activate	infmod	28	SENT_14	[p1l1871t1716r2146b1779],
31	PXR-mediated	JJ	O	pxr-mediated	amod	33	SENT_14	[p1l9t1827r541b1890],
32	Pgp	NN	O	pgp	nn	33	SENT_14	[p1l565t1829r702b1908],
33	induction	NN	O	induction	dobj	30	SENT_14	[p1l727t1827r1064b1890],
34	was	VBD	O	be	auxpass	35	SENT_14	[p1l1090t1847r1224b1890],
35	investigated	VBN	O	investigate	_	0	SENT_14	[p1l1251t1827r1701b1908],
36	.	.	O	.	_	0	SENT_14	[p1l1251t1827r1701b1908],

1	Methods	NNS	O	method	nsubjpass	9	SENT_15	[p1l6t1938r315b2001],
2	A	DT	O	a	det	7	SENT_15	[p1l408t1939r470b2000],
3	Pgp	NN	O	pgp	nn	7	SENT_15	[p1l522t1940r976b2019],
4	—	NN	O	—	nn	7	SENT_15	[p1l522t1940r976b2019],
5	reporter	NN	O	reporter	nn	7	SENT_15	[p1l522t1940r976b2019],
6	gene	NN	O	gene	nn	7	SENT_15	[p1l1026t1958r1191b2019],
7	assay	NN	O	assay	dep	1	SENT_15	[p1l1246t1958r1436b2019],
8	was	VBD	O	be	auxpass	9	SENT_15	[p1l1488t1958r1623b2001],
9	employed	VBN	O	employ	_	0	SENT_15	[p1l1677t1938r2028b2019],
10	to	TO	O	to	aux	11	SENT_15	[p1l2078t1948r2146b2001],
11	determine	VB	O	determine	xcomp	9	SENT_15	[p1l10t2049r365b2112],
12	the	DT	O	the	det	13	SENT_15	[p1l399t2049r507b2112],
13	ability	NN	O	ability	dobj	11	SENT_15	[p1l542t2049r767b2130],
14	of	IN	O	of	_	0	SENT_15	[p1l802t2049r880b2112],
15	a	DT	O	a	det	16	SENT_15	[p1l908t2069r945b2112],
16	panel	NN	O	panel	prep_of	13	SENT_15	[p1l977t2049r1169b2130],
17	of	IN	O	of	_	0	SENT_15	[p1l1204t2049r1282b2112],
18	widely	RB	O	widely	advmod	19	SENT_15	[p1l1310t2049r1550b2130],
19	used	VBN	O	use	amod	21	SENT_15	[p1l1585t2049r1748b2112],
20	anticancer	JJ	O	anticancer	amod	21	SENT_15	[p1l1782t2049r2149b2112],
21	drugs	NNS	O	drug	prep_of	16	SENT_15	[p1l10t2160r204b2241],
22	to	TO	O	to	aux	23	SENT_15	[p1l235t2170r301b2223],
23	induce	VB	O	induce	xcomp	11	SENT_15	[p1l333t2160r568b2223],
24	Pgp	NNP	O	Pgp	dobj	23	SENT_15	[p1l599t2162r753b2241],
25	.	.	O	.	_	0	SENT_15	[p1l599t2162r753b2241],

1	To	TO	O	to	aux	3	SENT_16	[p1l788t2162r884b2223],
2	further	RB	O	further	advmod	3	SENT_16	[p1l914t2160r1157b2223],
3	assess	VB	O	assess	purpcl	37	SENT_16	[p1l1187t2180r1400b2223],
4	whether	IN	O	whether	complm	8	SENT_16	[p1l1432t2160r1721b2223],
5	PXR	NN	O	pxr	nsubjpass	8	SENT_16	[p1l1748t2162r1921b2222],
6	could	MD	O	could	aux	8	SENT_16	[p1l1950t2160r2148b2223],
7	be	VB	O	be	auxpass	8	SENT_16	[p1l8t2271r91b2334],
8	involved	VBN	O	involve	ccomp	3	SENT_16	[p1l130t2271r443b2334],
9	in	IN	O	in	_	0	SENT_16	[p1l480t2271r548b2333],
10	the	DT	O	the	det	11	SENT_16	[p1l587t2271r694b2334],
11	induction	NN	O	induction	prep_in	8	SENT_16	[p1l733t2271r1070b2334],
12	of	IN	O	of	_	0	SENT_16	[p1l1109t2271r1187b2334],
13	Pgp	NN	ORGANIZATION	pgp	prep_of	11	SENT_16	[p1l1219t2273r1355b2352],
14	by	IN	O	by	_	0	SENT_16	[p1l1394t2271r1481b2352],
15	anticancer	JJ	O	anticancer	amod	16	SENT_16	[p1l1523t2271r1890b2334],
16	drugs	NNS	O	drug	agent	8	SENT_16	[p1l1928t2271r2143b2352],
17	,	,	O	,	_	0	SENT_16	[p1l1928t2271r2143b2352],
18	Pgp	NN	ORGANIZATION	pgp	nn	20	SENT_16	[p1l9t2384r145b2463],
19	protein	NN	O	protein	nn	20	SENT_16	[p1l179t2382r432b2463],
20	expression	NN	O	expression	nsubj	37	SENT_16	[p1l467t2382r847b2463],
21	after	IN	O	after	mark	28	SENT_16	[p1l884t2382r1046b2445],
22	treatment	NN	O	treatment	nsubjpass	28	SENT_16	[p1l1077t2392r1415b2445],
23	with	IN	O	with	_	0	SENT_16	[p1l1448t2382r1606b2445],
24	the	DT	O	the	det	26	SENT_16	[p1l1638t2382r1746b2445],
25	anticancer	JJ	O	anticancer	amod	26	SENT_16	[p1l1782t2382r2149b2445],
26	drugs	NNS	O	drug	prep_with	22	SENT_16	[p1l10t2493r204b2574],
27	was	VBD	O	be	auxpass	28	SENT_16	[p1l235t2513r370b2556],
28	determined	VBN	O	determine	dep	20	SENT_16	[p1l401t2493r803b2556],
29	in	IN	O	in	_	0	SENT_16	[p1l831t2493r899b2555],
30	both	CC	O	both	preconj	33	SENT_16	[p1l927t2493r1085b2556],
31	wild	JJ	O	wild	amod	33	SENT_16	[p1l1114t2493r1454b2574],
32	—	NN	O	—	nn	33	SENT_16	[p1l1114t2493r1454b2574],
33	type	NN	O	type	prep_in	28	SENT_16	[p1l1114t2493r1454b2574],
34	and	CC	O	and	_	0	SENT_16	[p1l1486t2493r1612b2556],
35	PXR	NN	O	pxr	prep_in	28	SENT_16	[p1l1640t2493r2148b2556],
36	—	CD	NUMBER	—	num	35	SENT_16	[p1l1640t2493r2148b2556],
37	knocked	VBD	O	knock	_	0	SENT_16	[p1l1640t2493r2148b2556],
38	down	RP	O	down	prt	37	SENT_16	[p1l10t2604r206b2667],
39	LS	NN	O	l	dobj	37	SENT_16	[p1l231t2605r329b2667],
40	180	CD	NUMBER	180	num	41	SENT_16	[p1l345t2605r468b2667],
41	cells	NNS	O	cell	dep	39	SENT_16	[p1l494t2604r675b2667],
42	.	.	O	.	_	0	SENT_16	[p1l494t2604r675b2667],

1	Furthermore	RB	O	furthermore	advmod	21	SENT_17	[p1l704t2604r1170b2679],
2	,	,	O	,	_	0	SENT_17	[p1l704t2604r1170b2679],
3	the	DT	O	the	det	4	SENT_17	[p1l1198t2604r1306b2667],
4	effect	NN	O	effect	nsubjpass	21	SENT_17	[p1l1333t2602r1526b2667],
5	of	IN	O	of	_	0	SENT_17	[p1l1550t2604r1628b2667],
6	the	DT	O	the	det	8	SENT_17	[p1l1647t2604r1754b2667],
7	anticancer	JJ	O	anticancer	amod	8	SENT_17	[p1l1782t2604r2149b2667],
8	drugs	NNS	O	drug	prep_of	4	SENT_17	[p1l10t2716r204b2797],
9	on	IN	O	on	_	0	SENT_17	[p1l241t2736r328b2779],
10	the	DT	O	the	det	12	SENT_17	[p1l363t2716r470b2779],
11	intracellular	JJ	O	intracellular	amod	12	SENT_17	[p1l505t2716r941b2779],
12	accumulation	NN	O	accumulation	prep_on	8	SENT_17	[p1l975t2716r1456b2779],
13	of	IN	O	of	_	0	SENT_17	[p1l1492t2716r1570b2779],
14	the	DT	O	the	det	16	SENT_17	[p1l1599t2716r1706b2779],
15	Pgp-probes	JJ	MISC	pgp-probes	amod	16	SENT_17	[p1l1741t2716r2146b2797],
16	rhodamine	NN	O	rhodamine	prep_of	12	SENT_17	[p1l8t2827r390b2890],
17	123	CD	NUMBER	123	num	16	SENT_17	[p1l424t2828r543b2890],
18	and	CC	O	and	_	0	SENT_17	[p1l575t2827r701b2890],
19	doxorubicin	NN	O	doxorubicin	prep_of	12	SENT_17	[p1l726t2827r1157b2890],
20	was	VBD	O	be	auxpass	21	SENT_17	[p1l1182t2847r1316b2890],
21	determined	VBN	O	determine	_	0	SENT_17	[p1l1345t2827r1763b2890],
22	.	.	O	.	_	0	SENT_17	[p1l1345t2827r1763b2890],

1	S.	NNP	PERSON	S.	nn	2	SENT_18	[p1l11t3109r64b3161],
2	Harmsen	NNP	PERSON	Harmsen	_	0	SENT_18	[p1l90t3110r363b3161],
3	(	CD	NUMBER	(	num	2	SENT_18	[p1l387t3105r517b3173],
4	)	SYM	O	)	dep	2	SENT_18	[p1l387t3105r517b3173],
5	-	:	O	-	_	0	SENT_18	[p1l545t3136r554b3145],
6	I.	NN	PERSON	i.	dep	2	SENT_18	[p1l578t3110r617b3161],
7	Meijerman	NNP	PERSON	Meijerman	dep	6	SENT_18	[p1l641t3108r976b3176],
8	-	:	O	-	_	0	SENT_18	[p1l1000t3136r1009b3145],
9	C.	NNP	PERSON	C.	nn	11	SENT_18	[p1l1035t3109r1099b3161],
10	L.	NNP	PERSON	L.	nn	11	SENT_18	[p1l1123t3110r1183b3161],
11	Febus	NNP	PERSON	Febus	dep	7	SENT_18	[p1l1209t3108r1387b3161],
12	R.	NNP	PERSON	R.	nn	14	SENT_18	[p1l1415t3136r1424b3145, p1l9t3199r73b3251],
13	F.	NNP	PERSON	F.	nn	14	SENT_18	[p1l97t3199r154b3251],
14	Maas-Bakker	NNP	PERSON	Maas-Bakker	dep	11	SENT_18	[p1l178t3198r589b3251],
15	-	:	O	-	_	0	SENT_18	[p1l613t3226r622b3235],
16	J.	NNP	PERSON	J.	nn	18	SENT_18	[p1l647t3199r689b3251],
17	H.	NNP	PERSON	H.	nn	18	SENT_18	[p1l715t3199r784b3251],
18	Beijnen	NNP	PERSON	Beijnen	dep	11	SENT_18	[p1l808t3198r1044b3266],
19	-	:	O	-	_	0	SENT_18	[p1l1069t3226r1078b3235],
20	J.	NNP	PERSON	J.	nn	24	SENT_18	[p1l1103t3199r1146b3251],
21	H.	NNP	PERSON	H.	nn	24	SENT_18	[p1l1172t3199r1240b3251],
22	M.	NNP	PERSON	M.	nn	24	SENT_18	[p1l1264t3199r1345b3251],
23	Schellens	NNP	PERSON	Schellens	nn	24	SENT_18	[p1l1373t3198r1660b3251],
24	Division	NNP	O	Division	dep	18	SENT_18	[p1l9t3288r269b3341],
25	of	IN	O	of	_	0	SENT_18	[p1l292t3288r358b3341],
26	Biomedical	NNP	O	Biomedical	nn	27	SENT_18	[p1l374t3288r723b3341],
27	Analysis	NNP	O	Analysis	prep_of	24	SENT_18	[p1l744t3288r1026b3356],
28	,	,	O	,	_	0	SENT_18	[p1l744t3288r1026b3356],
29	Department	NNP	ORGANIZATION	Department	appos	27	SENT_18	[p1l9t3379r367b3446],
30	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l390t3378r455b3431],
31	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	32	SENT_18	[p1l472t3378r940b3431],
32	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	29	SENT_18	[p1l963t3378r1243b3441],
33	,	,	O	,	_	0	SENT_18	[p1l963t3378r1243b3441],
34	Faculty	NNP	O	Faculty	appos	32	SENT_18	[p1l1266t3378r1492b3446],
35	of	IN	O	of	_	0	SENT_18	[p1l1515t3378r1581b3431],
36	Science	NNP	O	Science	prep_of	34	SENT_18	[p1l1599t3378r1849b3441],
37	,	,	O	,	_	0	SENT_18	[p1l1599t3378r1849b3441],
38	Utrecht	NNP	ORGANIZATION	Utrecht	nn	39	SENT_18	[p1l9t3468r236b3521],
39	University	NNP	ORGANIZATION	University	appos	32	SENT_18	[p1l257t3468r594b3536],
40	,	,	O	,	_	0	SENT_18	[p1l257t3468r594b3536],
41	Sorbonnelaan	NNP	ORGANIZATION	Sorbonnelaan	appos	32	SENT_18	[p1l620t3468r1036b3521],
42	16	CD	NUMBER	16	num	41	SENT_18	[p1l1065t3468r1147b3531],
43	,	,	O	,	_	0	SENT_18	[p1l1065t3468r1147b3531],
44	3584	CD	NUMBER	3584	num	46	SENT_18	[p1l1174t3468r1321b3521],
45	CA	NNP	O	CA	nn	46	SENT_18	[p1l1344t3468r1446b3521],
46	Utrecht	NNP	O	Utrecht	appos	32	SENT_18	[p1l1468t3468r1712b3530],
47	,	,	O	,	_	0	SENT_18	[p1l1468t3468r1712b3530],
48	The	DT	LOCATION	the	det	49	SENT_18	[p1l9t3558r125b3611],
49	Netherlands	NNP	LOCATION	Netherlands	appos	32	SENT_18	[p1l147t3558r511b3611],
50	e	SYM	O	e	dep	52	SENT_18	[p1l9t3648r218b3701],
51	—	CD	NUMBER	—	num	52	SENT_18	[p1l9t3648r218b3701],
52	mail	NN	O	mail	dep	29	SENT_18	[p1l9t3648r218b3701],
53	:	:	O	:	_	0	SENT_18	[p1l9t3648r218b3701],
54	s.harmsen@uu.nl	NN	O	s.harmsen@uu.nl	dep	18	SENT_18	[p1l247t3648r775b3701],

1	J.	NNP	PERSON	J.	nn	4	SENT_19	[p2l8t71r51b123],
2	H.	NNP	PERSON	H.	nn	4	SENT_19	[p2l77t71r145b123],
3	Beijnen	NNP	PERSON	Beijnen	nn	4	SENT_19	[p2l170t70r405b138],
4	Department	NNP	ORGANIZATION	Department	_	0	SENT_19	[p2l9t161r367b228],
5	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l390t160r455b213],
6	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	4	SENT_19	[p2l472t160r773b228],
7	and	CC	ORGANIZATION	and	_	0	SENT_19	[p2l797t160r903b213],
8	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	4	SENT_19	[p2l924t160r1381b228],
9	,	,	O	,	_	0	SENT_19	[p2l924t160r1381b228],
10	Slotervaart	NNP	LOCATION	Slotervaart	nn	11	SENT_19	[p2l11t249r343b302],
11	Hospital	NNP	LOCATION	Hospital	appos	4	SENT_19	[p2l363t249r636b317],
12	,	,	O	,	_	0	SENT_19	[p2l363t249r636b317],
13	Louwesweg	NNP	ORGANIZATION	Louwesweg	appos	11	SENT_19	[p2l660t250r1026b317],
14	6	CD	NUMBER	6	num	13	SENT_19	[p2l1050t249r1101b312],
15	,	,	O	,	_	0	SENT_19	[p2l1050t249r1101b312],
16	1066	CD	DATE	1066	num	13	SENT_19	[p2l16t338r158b391],
17	EC	NNP	ORGANIZATION	EC	nn	18	SENT_19	[p2l180t338r273b391],
18	Amsterdam	NNP	ORGANIZATION	Amsterdam	dep	4	SENT_19	[p2l296t338r668b401],
19	,	,	O	,	_	0	SENT_19	[p2l296t338r668b401],
20	The	DT	LOCATION	the	det	21	SENT_19	[p2l692t338r808b391],
21	Netherlands	NNPS	LOCATION	Netherlands	appos	18	SENT_19	[p2l829t338r1195b391],

1	J.	NNP	PERSON	J.	nn	5	SENT_20	[p2l8t519r51b571],
2	H.	NNP	PERSON	H.	nn	5	SENT_20	[p2l77t519r145b571],
3	M.	NNP	PERSON	M.	nn	5	SENT_20	[p2l169t519r251b571],
4	Schellens	NNP	PERSON	Schellens	nn	5	SENT_20	[p2l279t518r565b571],
5	Department	NNP	ORGANIZATION	Department	nsubj	27	SENT_20	[p2l9t608r367b675],
6	of	IN	ORGANIZATION	of	_	0	SENT_20	[p2l390t607r455b660],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_20	[p2l471t607r719b660],
8	Oncology	NNP	ORGANIZATION	Oncology	prep_of	5	SENT_20	[p2l741t607r1056b675],
9	,	,	O	,	_	0	SENT_20	[p2l741t607r1056b675],
10	The	DT	O	the	det	13	SENT_20	[p2l9t697r125b750],
11	Netherlands	NNP	ORGANIZATION	Netherlands	nn	13	SENT_20	[p2l147t697r512b750],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_20	[p2l536t697r751b750],
13	Institute	NNP	ORGANIZATION	Institute	appos	8	SENT_20	[p2l770t697r1035b760],
14	,	,	O	,	_	0	SENT_20	[p2l770t697r1035b760],
15	Plesmanlaan	NNP	O	Plesmanlaan	appos	8	SENT_20	[p2l1058t697r1443b750],
16	121	CD	NUMBER	121	num	15	SENT_20	[p2l1471t698r1592b760],
17	,	,	O	,	_	0	SENT_20	[p2l1471t698r1592b760],
18	1066	CD	DATE	1066	num	15	SENT_20	[p2l16t786r158b839],
19	CX	NNP	O	CX	nn	20	SENT_20	[p2l182t786r283b839],
20	Amsterdam	NNP	LOCATION	Amsterdam	dep	15	SENT_20	[p2l305t786r676b847],
21	,	,	O	,	_	0	SENT_20	[p2l305t786r676b847],
22	The	DT	LOCATION	the	det	24	SENT_20	[p2l700t786r816b839],
23	Netherlands	NNP	LOCATION	Netherlands	nn	24	SENT_20	[p2l838t786r1204b839],
24	Results	NNS	O	result	appos	8	SENT_20	[p2l8t887r266b950],
25	Our	PRP$	O	we	poss	26	SENT_20	[p2l362t888r500b950],
26	study	NN	O	study	dep	24	SENT_20	[p2l554t887r743b968],
27	showed	VBD	O	show	_	0	SENT_20	[p2l801t887r1071b950],
28	that	IN	O	that	complm	44	SENT_20	[p2l1124t887r1259b950],
29	vincristine	NN	O	vincristine	nsubj	44	SENT_20	[p2l1312t887r1708b961],
30	,	,	O	,	_	0	SENT_20	[p2l1312t887r1708b961],
31	tamoxifen	NN	O	tamoxifen	appos	29	SENT_20	[p2l1766t887r2149b962],
32	,	,	O	,	_	0	SENT_20	[p2l1766t887r2149b962],
33	Vinblastine	NNP	O	Vinblastine	appos	29	SENT_20	[p2l10t997r410b1071],
34	,	,	O	,	_	0	SENT_20	[p2l10t997r410b1071],
35	docetaxel	NN	O	docetaxel	appos	29	SENT_20	[p2l445t997r797b1071],
36	,	,	O	,	_	0	SENT_20	[p2l445t997r797b1071],
37	cyclophosphamide	NN	O	cyclophosphamide	appos	29	SENT_20	[p2l833t997r1506b1078],
38	,	,	O	,	_	0	SENT_20	[p2l833t997r1506b1078],
39	ﬂutamide	NN	O	ﬂutamide	appos	29	SENT_20	[p2l1543t994r1888b1071],
40	,	,	O	,	_	0	SENT_20	[p2l1543t994r1888b1071],
41	ifosfamide	NN	O	ifosfamide	conj_and	35	SENT_20	[p2l1923t997r2149b1060, p2l10t1109r187b1172],
42	and	CC	O	and	_	0	SENT_20	[p2l219t1109r346b1172],
43	paclitaxel	NN	O	paclitaxel	conj_and	35	SENT_20	[p2l374t1109r722b1190],
44	activate	VBP	O	activate	ccomp	27	SENT_20	[p2l755t1109r1030b1172],
45	PXR	NN	O	pxr	nn	46	SENT_20	[p2l1061t1109r1593b1172],
46	—	NN	O	—	nsubjpass	54	SENT_20	[p2l1061t1109r1593b1172],
47	mediated	VBD	O	mediate	ccomp	44	SENT_20	[p2l1061t1109r1593b1172],
48	Pgp	NNP	O	Pgp	nn	49	SENT_20	[p2l1623t1111r1759b1190],
49	induction	NN	O	induction	dobj	47	SENT_20	[p2l1791t1109r2148b1183],
50	,	,	O	,	_	0	SENT_20	[p2l1791t1109r2148b1183],
51	and	CC	O	and	_	0	SENT_20	[p2l12t1219r139b1282],
52	were	VBD	O	be	auxpass	54	SENT_20	[p2l162t1239r333b1282],
53	additionally	RB	O	additionally	advmod	54	SENT_20	[p2l358t1219r784b1300],
54	shown	VBN	O	show	ccomp	44	SENT_20	[p2l811t1219r1041b1282],
55	to	TO	O	to	aux	56	SENT_20	[p2l1064t1229r1130b1282],
56	affect	VB	O	affect	xcomp	54	SENT_20	[p2l1158t1217r1350b1282],
57	the	DT	O	the	det	59	SENT_20	[p2l1371t1219r1478b1282],
58	intracellular	JJ	O	intracellular	amod	59	SENT_20	[p2l1503t1219r1937b1282],
59	accumulation	NN	O	accumulation	dobj	56	SENT_20	[p2l1961t1239r2149b1282, p2l10t1331r328b1394],
60	of	IN	O	of	_	0	SENT_20	[p2l356t1331r434b1394],
61	the	DT	O	the	det	64	SENT_20	[p2l455t1331r562b1394],
62	Pgp	NNP	ORGANIZATION	Pgp	nn	64	SENT_20	[p2l590t1333r726b1412],
63	probe	NN	O	probe	nn	64	SENT_20	[p2l753t1331r956b1412],
64	rhodamine	NN	O	rhodamine	prep_of	59	SENT_20	[p2l983t1331r1366b1394],
65	123	CD	NUMBER	123	dep	64	SENT_20	[p2l1402t1332r1544b1394],
66	.	.	O	.	_	0	SENT_20	[p2l1402t1332r1544b1394],

1	Moreover	RB	O	moreover	advmod	7	SENT_21	[p2l1576t1333r1948b1406],
2	,	,	O	,	_	0	SENT_21	[p2l1576t1333r1948b1406],
3	PXR	NN	O	pxr	nn	4	SENT_21	[p2l1979t1333r2152b1393],
4	activation	NN	O	activation	nsubjpass	7	SENT_21	[p2l12t1442r363b1505],
5	was	VBD	O	be	auxpass	7	SENT_21	[p2l397t1462r531b1505],
6	also	RB	O	also	advmod	7	SENT_21	[p2l569t1442r708b1505],
7	shown	VBN	O	show	_	0	SENT_21	[p2l745t1442r974b1505],
8	to	TO	O	to	aux	9	SENT_21	[p2l1007t1452r1073b1505],
9	reduce	VB	O	reduce	xcomp	7	SENT_21	[p2l1106t1442r1343b1505],
10	the	DT	O	the	det	12	SENT_21	[p2l1377t1442r1484b1505],
11	cytotoxic	JJ	O	cytotoxic	amod	12	SENT_21	[p2l1518t1442r1848b1523],
12	activity	NN	O	activity	dobj	9	SENT_21	[p2l1884t1442r2150b1523],
13	of	IN	O	of	_	0	SENT_21	[p2l11t1553r89b1616],
14	the	DT	O	the	det	17	SENT_21	[p2l107t1553r214b1616],
15	Pgp	NNP	O	Pgp	nn	17	SENT_21	[p2l240t1555r377b1634],
16	substrate	NN	O	substrate	nn	17	SENT_21	[p2l405t1553r719b1616],
17	doxorubicin	NN	O	doxorubicin	prep_of	12	SENT_21	[p2l746t1553r1177b1616],
18	in	IN	O	in	_	0	SENT_21	[p2l1203t1553r1270b1615],
19	colon	NN	O	colon	nn	21	SENT_21	[p2l1295t1553r1493b1616],
20	cancer	NN	O	cancer	nn	21	SENT_21	[p2l1518t1573r1751b1616],
21	cells	NNS	O	cell	prep_in	9	SENT_21	[p2l1775t1553r1954b1616],
22	.	.	O	.	_	0	SENT_21	[p2l1775t1553r1954b1616],

1	Conclusion	NN	O	conclusion	nsubj	13	SENT_22	[p2l14t1664r417b1728],
2	Our	PRP$	O	we	poss	3	SENT_22	[p2l512t1665r649b1727],
3	results	NNS	O	result	nsubj	4	SENT_22	[p2l694t1664r925b1727],
4	indicate	VBP	O	indicate	rcmod	1	SENT_22	[p2l975t1664r1257b1727],
5	that	IN	O	that	complm	10	SENT_22	[p2l1304t1664r1438b1727],
6	several	JJ	O	several	amod	8	SENT_22	[p2l1488t1664r1735b1727],
7	anticancer	JJ	O	anticancer	amod	8	SENT_22	[p2l1786t1664r2153b1727],
8	drugs	NNS	O	drug	nsubj	10	SENT_22	[p2l11t1776r205b1857],
9	can	MD	O	can	aux	10	SENT_22	[p2l255t1796r377b1839],
10	activate	VB	O	activate	ccomp	4	SENT_22	[p2l427t1776r703b1839],
11	PXR	NN	O	pxr	nn	12	SENT_22	[p2l751t1776r1286b1839],
12	—	NN	O	—	dobj	10	SENT_22	[p2l751t1776r1286b1839],
13	mediated	VBD	O	mediate	_	0	SENT_22	[p2l751t1776r1286b1839],
14	induction	NN	O	induction	dobj	13	SENT_22	[p2l1333t1776r1671b1839],
15	of	IN	O	of	_	0	SENT_22	[p2l1720t1776r1797b1839],
16	Pgp	NNP	ORGANIZATION	Pgp	prep_of	14	SENT_22	[p2l1839t1778r1975b1857],
17	and	CC	O	and	_	0	SENT_22	[p2l2026t1776r2152b1839],
18	affect	VB	O	affect	conj_and	13	SENT_22	[p2l12t1884r204b1949],
19	the	DT	O	the	det	20	SENT_22	[p2l227t1886r335b1949],
20	accumulation	NN	O	accumulation	dobj	18	SENT_22	[p2l362t1886r843b1949],
21	of	IN	O	of	_	0	SENT_22	[p2l868t1886r946b1949],
22	Pgp	NNP	ORGANIZATION	Pgp	nn	23	SENT_22	[p2l964t1888r1100b1967],
23	substrates	NNS	O	substrate	prep_of	20	SENT_22	[p2l1130t1886r1497b1949],
24	.	.	O	.	_	0	SENT_22	[p2l1130t1886r1497b1949],

1	Keywords	NNPS	O	Keywords	_	0	SENT_23	[p2l11t2111r397b2190],
2	PXR	SYM	O	pxr	dep	1	SENT_23	[p2l491t2112r665b2172],
3	-	:	O	-	_	0	SENT_23	[p2l694t2143r704b2154],
4	Induction	NN	O	induction	nn	6	SENT_23	[p2l734t2110r1076b2173],
5	~	NN	O	~	nn	6	SENT_23	[p2l1106t2143r1117b2154],
6	P-glycoprotein	NN	O	p-glycoprotein	dep	1	SENT_23	[p2l1145t2110r1679b2191],
7	-	:	O	-	_	0	SENT_23	[p2l1708t2143r1718b2154],
8	Multidrug	JJ	O	multidrug	amod	9	SENT_23	[p2l1748t2110r2109b2191],
9	resistance	NN	O	resistance	dep	6	SENT_23	[p2l9t2221r361b2284],
10	-	:	O	-	_	0	SENT_23	[p2l392t2254r402b2265],
11	Anticancer	NN	O	anticancer	nn	12	SENT_23	[p2l432t2221r827b2284],
12	drugs	NNS	O	drug	dep	9	SENT_23	[p2l850t2221r1045b2302],

1	Abbreviations	NNS	O	abbreviation	dep	12	SENT_24	[p2l9t2445r552b2509],
2	ABC	NNP	O	ABC	nn	5	SENT_24	[p2l10t2559r191b2621],
3	ATP	NN	O	atp	nn	5	SENT_24	[p2l334t2558r805b2639],
4	—	NN	O	—	nn	5	SENT_24	[p2l334t2558r805b2639],
5	binding	NN	O	binding	dep	1	SENT_24	[p2l334t2558r805b2639],
6	cassette	NN	O	cassette	nn	7	SENT_24	[p2l832t2568r1109b2621],
7	ATP	NN	O	atp	dep	12	SENT_24	[p2l10t2670r178b2731],
8	Adenosine	NN	LOCATION	adenosine	nn	12	SENT_24	[p2l334t2669r716b2732],
9	triphosphate	NN	O	triphosphate	nn	12	SENT_24	[p2l741t2669r1183b2750],
10	DMSO	NN	ORGANIZATION	dmso	nn	12	SENT_24	[p2l10t2781r266b2843],
11	Dimethylsulfoxide	NN	O	dimethylsulfoxide	nn	12	SENT_24	[p2l334t2780r1006b2861],
12	HBSS	NN	O	hbss	dep	26	SENT_24	[p2l10t2892r228b2954],
13	Hank	NN	PERSON	hank	poss	17	SENT_24	[p2l334t2891r588b2954],
14	’s	POS	O	’s	_	0	SENT_24	[p2l334t2891r588b2954],
15	Balanced	JJ	O	balanced	amod	17	SENT_24	[p2l616t2891r949b2954],
16	Salt	NNP	O	Salt	amod	15	SENT_24	[p2l975t2891r1112b2954],
17	Solution	NN	O	solution	dep	12	SENT_24	[p2l1139t2891r1439b2954],
18	HRP	NNP	O	HRP	nn	21	SENT_24	[p2l10t3005r183b3065],
19	Horse	NNP	O	Horse	nn	21	SENT_24	[p2l334t3005r546b3066],
20	radish	JJ	O	radish	amod	21	SENT_24	[p2l571t3003r789b3066],
21	peroxidise	NN	O	peroxidise	dep	17	SENT_24	[p2l812t3003r1185b3084],
22	MDR	NNP	ORGANIZATION	MDR	nn	26	SENT_24	[p2l10t3116r213b3176],
23	Multidrug	NNP	O	Multidrug	nn	26	SENT_24	[p2l333t3114r695b3195],
24	resistance	NN	O	resistance	nn	26	SENT_24	[p2l721t3114r1073b3177],
25	NR	NNP	MISC	NR	nn	26	SENT_24	[p2l10t3227r133b3288],
26	Nuclear	NNP	MISC	Nuclear	dep	27	SENT_24	[p2l334t3225r618b3288],
27	receptor	NN	O	receptor	dep	31	SENT_24	[p2l640t3235r936b3306],
28	PBS	NNP	O	PBS	nn	31	SENT_24	[p2l10t3336r163b3398],
29	phosphate	NN	O	phosphate	nn	31	SENT_24	[p2l333t3335r696b3416],
30	buffer	NN	O	buffer	nn	31	SENT_24	[p2l721t3333r930b3398],
31	saline	NN	O	saline	dep	35	SENT_24	[p2l956t3335r1161b3398],
32	Pgp	NN	O	pgp	nn	33	SENT_24	[p2l10t3449r147b3528],
33	P	NN	O	p	dep	31	SENT_24	[p2l334t3447r866b3528],
34	—	CD	NUMBER	—	num	35	SENT_24	[p2l334t3447r866b3528],
35	glycoprotein	NN	O	glycoprotein	dep	39	SENT_24	[p2l334t3447r866b3528],
36	PXR	NN	O	pxr	nn	39	SENT_24	[p2l10t3561r183b3621],
37	Pregnane	NN	O	pregnane	nn	39	SENT_24	[p2l335t3561r666b3640],
38	X	NN	O	x	nn	39	SENT_24	[p2l691t3561r754b3621],
39	receptor	NN	O	receptor	_	0	SENT_24	[p2l778t3569r1073b3640],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p3l10t88r498b152],

1	A	DT	O	a	det	3	SENT_26	[p3l10t315r73b376],
2	major	JJ	O	major	amod	3	SENT_26	[p3l102t314r312b395],
3	drawback	NN	O	drawback	nsubj	13	SENT_26	[p3l339t314r687b377],
4	in	IN	O	in	_	0	SENT_26	[p3l715t314r783b376],
5	the	DT	O	the	det	7	SENT_26	[p3l811t314r918b377],
6	successful	JJ	O	successful	amod	7	SENT_26	[p3l951t314r1315b377],
7	treatment	NN	O	treatment	prep_in	3	SENT_26	[p3l1345t324r1684b377],
8	of	IN	O	of	_	0	SENT_26	[p3l1713t314r1790b377],
9	advanced	JJ	O	advanced	amod	10	SENT_26	[p3l1816t314r2152b377],
10	malignancies	NNS	O	malignancy	prep_of	7	SENT_26	[p3l10t425r480b506],
11	is	VBZ	O	be	cop	13	SENT_26	[p3l526t425r582b488],
12	the	DT	O	the	det	13	SENT_26	[p3l628t425r735b488],
13	development	NN	O	development	_	0	SENT_26	[p3l780t425r1243b506],
14	of	IN	O	of	_	0	SENT_26	[p3l1287t425r1365b488],
15	multidrug	JJ	O	multidrug	amod	16	SENT_26	[p3l1402t425r1754b506],
16	resistance	NN	O	resistance	prep_of	13	SENT_26	[p3l1798t425r2150b488],
17	(	CD	NUMBER	(	num	19	SENT_26	[p3l13t537r290b614],
18	MDR	NN	O	mdr	nn	19	SENT_26	[p3l13t537r290b614],
19	)	NN	O	)	dep	16	SENT_26	[p3l13t537r290b614],
20	.	.	O	.	_	0	SENT_26	[p3l13t537r290b614],

1	One	CD	NUMBER	one	nsubj	21	SENT_27	[p3l343t537r489b599],
2	of	IN	O	of	_	0	SENT_27	[p3l537t536r614b599],
3	the	DT	O	the	det	5	SENT_27	[p3l655t536r762b599],
4	main	JJ	O	main	amod	5	SENT_27	[p3l808t536r986b599],
5	causes	NNS	O	cause	prep_of	1	SENT_27	[p3l1033t556r1263b599],
6	by	IN	O	by	_	0	SENT_27	[p3l1310t536r1398b617],
7	which	WDT	O	which	rel	10	SENT_27	[p3l1445t536r1663b599],
8	cancer	NN	O	cancer	nn	9	SENT_27	[p3l1710t556r1943b599],
9	cells	NNS	O	cell	nsubj	10	SENT_27	[p3l1989t536r2149b599],
10	acquire	VBP	O	acquire	rcmod	5	SENT_27	[p3l12t647r271b728],
11	the	DT	O	the	det	14	SENT_27	[p3l316t647r423b710],
12	multidrug	JJ	O	multidrug	amod	13	SENT_27	[p3l466t647r817b728],
13	resistant	JJ	O	resistant	amod	14	SENT_27	[p3l860t647r1161b710],
14	phenotype	NN	O	phenotype	dobj	10	SENT_27	[p3l1202t647r1574b728],
15	in	IN	O	in	_	0	SENT_27	[p3l1617t647r1685b709],
16	response	NN	O	response	prep_in	14	SENT_27	[p3l1728t667r2040b728],
17	to	TO	O	to	_	0	SENT_27	[p3l2084t657r2150b710],
18	chemotherapy	NN	O	chemotherapy	prep_to	10	SENT_27	[p3l11t758r542b839],
19	is	VBZ	O	be	cop	21	SENT_27	[p3l581t758r637b821],
20	the	DT	O	the	det	21	SENT_27	[p3l676t758r787b821],
21	induction	NN	O	induction	_	0	SENT_27	[p3l826t758r1180b821],
22	of	IN	O	of	_	0	SENT_27	[p3l1218t758r1297b821],
23	ATP	NN	O	atp	nn	25	SENT_27	[p3l1328t758r1819b839],
24	—	NN	O	—	nn	25	SENT_27	[p3l1328t758r1819b839],
25	binding	NN	O	binding	prep_of	21	SENT_27	[p3l1328t758r1819b839],
26	cassette	NN	O	cassette	nn	28	SENT_27	[p3l1858t767r2149b821],
27	(	CD	NUMBER	(	num	28	SENT_27	[p3l13t869r257b946],
28	ABC	NNP	ORGANIZATION	ABC	dep	25	SENT_27	[p3l13t869r257b946],
29	)	CD	NUMBER	)	num	33	SENT_27	[p3l13t869r257b946],
30	drug	NN	O	drug	nn	33	SENT_27	[p3l312t868r478b949],
31	eﬂlux	NN	O	eﬂlux	nn	33	SENT_27	[p3l532t866r737b931],
32	transporter	NN	O	transporter	nn	33	SENT_27	[p3l789t878r1197b949],
33	proteins	NNS	O	protein	dep	28	SENT_27	[p3l1245t868r1569b949],
34	.	.	O	.	_	0	SENT_27	[p3l1245t868r1569b949],

1	An	DT	O	a	npadvmod	2	SENT_28	[p3l1625t869r1734b930],
2	important	JJ	O	important	_	0	SENT_28	[p3l1786t868r2151b949],

1	@	IN	O	@	_	0	SENT_29	[p3l1773t1111r1851b1207],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_29	[p3l1879t1134r2143b1209],

1	766	CD	NUMBER	766	num	4	SENT_30	[p3l53t1284r104b1309],
2	Cancer	NN	O	cancer	nn	4	SENT_30	[p3l1400t1284r1500b1309],
3	Chemother	NN	PERSON	chemother	nn	4	SENT_30	[p3l1509t1284r1666b1309],
4	Pharmacol	NN	PERSON	pharmacol	_	0	SENT_30	[p3l1675t1284r1826b1309],
5	(	CD	NUMBER	(	num	6	SENT_30	[p3l1836t1284r1928b1314],
6	2010	CD	DATE	2010	nsubj	30	SENT_30	[p3l1836t1284r1928b1314],
7	)	CD	NUMBER	)	number	8	SENT_30	[p3l1836t1284r1928b1314],
8	66:765	CD	NUMBER	66:765	num	9	SENT_30	[p3l1939t1284r2104b1309],
9	—	NN	O	—	dep	6	SENT_30	[p3l1939t1284r2104b1309],
10	77l	CD	NUMBER	77l	num	11	SENT_30	[p3l1939t1284r2104b1309],
11	mediator	NN	O	mediator	dep	6	SENT_30	[p3l9t1453r343b1516],
12	of	IN	O	of	_	0	SENT_30	[p3l390t1453r470b1516],
13	MDR	NN	ORGANIZATION	mdr	prep_of	11	SENT_30	[p3l509t1455r717b1515],
14	that	WDT	O	that	nsubjpass	17	SENT_30	[p3l763t1453r902b1516],
15	has	VBZ	O	have	aux	17	SENT_30	[p3l946t1453r1066b1516],
16	been	VBN	O	be	auxpass	17	SENT_30	[p3l1113t1453r1287b1516],
17	associated	VBN	O	associate	rcmod	6	SENT_30	[p3l1336t1453r1722b1516],
18	with	IN	O	with	_	0	SENT_30	[p3l1769t1453r1931b1516],
19	poor	JJ	O	poor	amod	21	SENT_30	[p3l1976t1473r2147b1534],
20	treatment	NN	O	treatment	nn	21	SENT_30	[p3l9t1574r331b1627],
21	response	NN	O	response	prep_with	17	SENT_30	[p3l354t1584r652b1645],
22	in	IN	O	in	_	0	SENT_30	[p3l677t1564r743b1626],
23	various	JJ	O	various	amod	24	SENT_30	[p3l767t1564r1012b1627],
24	malignancies	NNS	O	malignancy	prep_in	21	SENT_30	[p3l1037t1564r1484b1645],
25	is	VBZ	O	be	cop	30	SENT_30	[p3l1510t1564r1564b1627],
26	the	DT	O	the	det	30	SENT_30	[p3l1590t1564r1693b1627],
27	ABC	NNP	ORGANIZATION	ABC	nn	30	SENT_30	[p3l1717t1564r2146b1645],
28	—	NN	O	—	nn	30	SENT_30	[p3l1717t1564r2146b1645],
29	family	NN	O	family	nn	30	SENT_30	[p3l1717t1564r2146b1645],
30	member	NN	O	member	rcmod	4	SENT_30	[p3l9t1675r303b1738],
31	P	NN	O	p	nn	33	SENT_30	[p3l332t1675r863b1756],
32	—	CD	NUMBER	—	num	33	SENT_30	[p3l332t1675r863b1756],
33	glycoprotein	NN	O	glycoprotein	dep	4	SENT_30	[p3l332t1675r863b1756],
34	(	CD	NUMBER	(	num	35	SENT_30	[p3l896t1676r1082b1756],
35	Pgp	NN	O	pgp	dep	33	SENT_30	[p3l896t1676r1082b1756],
36	;	:	O	;	_	0	SENT_30	[p3l896t1676r1082b1756],
37	ABCBl	NN	O	abcbl	dep	4	SENT_30	[p3l1116t1676r1424b1749],
38	;	:	O	;	_	0	SENT_30	[p3l1116t1676r1424b1749],
39	MDRl	NN	O	mdrl	nn	42	SENT_30	[p3l1457t1676r1732b1753],
40	)	CD	NUMBER	)	num	42	SENT_30	[p3l1457t1676r1732b1753],
41	[	NN	O	[	nn	42	SENT_30	[p3l1772t1676r1975b1751],
42	l	NN	O	l	dep	37	SENT_30	[p3l1772t1676r1975b1751],
43	—	CD	NUMBER	—	number	44	SENT_30	[p3l1772t1676r1975b1751],
44	3	CD	NUMBER	3	num	45	SENT_30	[p3l1772t1676r1975b1751],
45	]	NN	O	]	dep	42	SENT_30	[p3l1772t1676r1975b1751],
46	.	.	O	.	_	0	SENT_30	[p3l1772t1676r1975b1751],

1	Pgp	NNP	PERSON	Pgp	nsubj	5	SENT_31	[p3l2010t1677r2147b1756],
2	is	VBZ	O	be	cop	5	SENT_31	[p3l9t1786r64b1849],
3	a	DT	O	a	det	5	SENT_31	[p3l93t1806r130b1849],
4	transmembrane	JJ	O	transmembrane	amod	5	SENT_31	[p3l153t1786r702b1849],
5	protein	NN	O	protein	_	0	SENT_31	[p3l726t1786r979b1867],
6	that	WDT	O	that	nsubj	7	SENT_31	[p3l1003t1786r1137b1849],
7	protects	VBZ	O	protect	rcmod	5	SENT_31	[p3l1159t1796r1439b1867],
8	the	DT	O	the	det	9	SENT_31	[p3l1466t1786r1572b1849],
9	cell	NN	O	cell	dobj	7	SENT_31	[p3l1598t1786r1725b1849],
10	from	IN	O	from	_	0	SENT_31	[p3l1750t1786r1922b1849],
11	xenobiotic	JJ	O	xenobiotic	amod	12	SENT_31	[p3l1946t1806r2144b1849, p3l8t1897r210b1960],
12	stress	NN	O	stress	prep_from	9	SENT_31	[p3l251t1907r443b1960],
13	by	IN	O	by	_	0	SENT_31	[p3l479t1897r567b1978],
14	facilitating	VBG	O	facilitate	prepc_by	7	SENT_31	[p3l605t1897r990b1978],
15	the	DT	O	the	det	16	SENT_31	[p3l1027t1897r1134b1960],
16	extrusion	NN	O	extrusion	dobj	14	SENT_31	[p3l1171t1897r1503b1960],
17	of	IN	O	of	_	0	SENT_31	[p3l1540t1897r1617b1960],
18	a	DT	O	a	det	20	SENT_31	[p3l1649t1917r1686b1960],
19	broad	JJ	O	broad	amod	20	SENT_31	[p3l1720t1897r1924b1960],
20	spectrum	NN	O	spectrum	prep_of	16	SENT_31	[p3l1963t1917r2144b1978, p3l9t2018r177b2071],
21	of	IN	O	of	_	0	SENT_31	[p3l213t2008r290b2071],
22	substrates	NNS	O	substrate	prep_of	20	SENT_31	[p3l322t2008r690b2083],
23	,	,	O	,	_	0	SENT_31	[p3l322t2008r690b2083],
24	including	VBG	O	include	_	0	SENT_31	[p3l729t2008r1064b2089],
25	anticancer	JJ	O	anticancer	amod	26	SENT_31	[p3l1102t2008r1469b2071],
26	drugs	NNS	O	drug	prep_including	7	SENT_31	[p3l1503t2008r1697b2089],
27	such	JJ	O	such	_	0	SENT_31	[p3l1738t2008r1897b2071],
28	as	IN	O	as	_	0	SENT_31	[p3l1934t2028r2002b2071],
29	the	DT	O	the	det	35	SENT_31	[p3l2040t2008r2146b2071],
30	anthracyclines	NNS	O	anthracycline	nn	35	SENT_31	[p3l11t2119r545b2200],
31	,	,	O	,	_	0	SENT_31	[p3l11t2119r545b2200],
32	epipodophyllotoxins	NNS	O	epipodophyllotoxin	conj_and	35	SENT_31	[p3l595t2119r1349b2200],
33	,	,	O	,	_	0	SENT_31	[p3l595t2119r1349b2200],
34	Vinca	NNP	PERSON	Vinca	conj_and	35	SENT_31	[p3l1404t2122r1605b2183],
35	alkaloids	NNS	O	alkaloid	prep_such_as	26	SENT_31	[p3l1653t2119r1971b2182],
36	and	CC	O	and	_	0	SENT_31	[p3l2021t2119r2147b2182],
37	taxanes	NNS	O	taxane	conj_and	35	SENT_31	[p3l9t2239r294b2292],
38	.	.	O	.	_	0	SENT_31	[p3l9t2239r294b2292],

1	As	IN	O	as	_	0	SENT_32	[p3l342t2230r437b2292],
2	a	DT	O	a	det	3	SENT_32	[p3l487t2249r524b2292],
3	consequence	NN	O	consequence	prep_as	8	SENT_32	[p3l567t2249r1042b2310],
4	,	,	O	,	_	0	SENT_32	[p3l567t2249r1042b2310],
5	induction	NN	O	induction	nsubj	8	SENT_32	[p3l1090t2229r1426b2292],
6	of	IN	O	of	_	0	SENT_32	[p3l1472t2229r1548b2292],
7	Pgp	NNP	ORGANIZATION	Pgp	prep_of	5	SENT_32	[p3l1587t2231r1723b2310],
8	affects	VBZ	O	affect	_	0	SENT_32	[p3l1770t2227r1993b2292],
9	the	DT	O	the	det	10	SENT_32	[p3l2041t2229r2147b2292],
10	eﬂicacy	NN	O	eﬂicacy	dobj	8	SENT_32	[p3l10t2338r285b2421],
11	of	IN	O	of	_	0	SENT_32	[p3l333t2340r409b2403],
12	these	DT	O	these	det	13	SENT_32	[p3l449t2340r630b2403],
13	agents	NNS	O	agent	prep_of	10	SENT_32	[p3l679t2350r901b2421],
14	by	IN	O	by	_	0	SENT_32	[p3l947t2340r1036b2421],
15	decreasing	VBG	O	decrease	prepc_by	8	SENT_32	[p3l1082t2340r1462b2421],
16	their	PRP$	O	they	poss	18	SENT_32	[p3l1508t2340r1672b2403],
17	intracellular	JJ	O	intracellular	amod	18	SENT_32	[p3l1716t2340r2150b2403],
18	accumulation	NN	O	accumulation	dobj	15	SENT_32	[p3l11t2452r491b2515],
19	in	IN	O	in	_	0	SENT_32	[p3l516t2452r584b2514],
20	cancer	NN	O	cancer	nn	21	SENT_32	[p3l609t2472r842b2515],
21	cells	NNS	O	cell	prep_in	15	SENT_32	[p3l865t2452r1045b2515],
22	.	.	O	.	_	0	SENT_32	[p3l865t2452r1045b2515],

1	The	DT	O	the	det	6	SENT_33	[p3l111t2564r251b2627],
2	pregnane	NN	O	pregnane	nn	6	SENT_33	[p3l277t2584r611b2645],
3	X	NN	O	x	nn	6	SENT_33	[p3l639t2566r702b2626],
4	receptor	NN	O	receptor	nn	6	SENT_33	[p3l728t2574r1030b2645],
5	(	NN	O	(	nn	6	SENT_33	[p3l1058t2565r1283b2642],
6	PXR	NN	O	pxr	nsubjpass	38	SENT_33	[p3l1058t2565r1283b2642],
7	;	:	O	;	_	0	SENT_33	[p3l1058t2565r1283b2642],
8	NRlI2	NN	O	nrli2	nn	9	SENT_33	[p3l1314t2565r1588b2642],
9	)	NN	O	)	dep	6	SENT_33	[p3l1314t2565r1588b2642],
10	has	VBZ	O	have	aux	12	SENT_33	[p3l1617t2564r1735b2627],
11	been	VBN	O	be	auxpass	12	SENT_33	[p3l1763t2564r1933b2627],
12	identiﬁed	VBN	O	identiﬁed	rcmod	9	SENT_33	[p3l1961t2564r2144b2627, p3l10t2672r198b2737],
13	as	IN	O	as	_	0	SENT_33	[p3l227t2694r296b2737],
14	a	DT	O	a	det	16	SENT_33	[p3l328t2694r365b2737],
15	major	JJ	O	major	amod	16	SENT_33	[p3l392t2674r604b2755],
16	regulator	NN	O	regulator	prep_as	12	SENT_33	[p3l629t2674r964b2755],
17	of	IN	O	of	_	0	SENT_33	[p3l990t2674r1069b2737],
18	Pgp	NN	O	pgp	nn	19	SENT_33	[p3l1091t2676r1229b2755],
19	induction	NN	O	induction	prep_of	16	SENT_33	[p3l1258t2674r1603b2737],
20	[	CD	NUMBER	[	number	21	SENT_33	[p3l1638t2675r1753b2750],
21	4	CD	NUMBER	4	num	22	SENT_33	[p3l1638t2675r1753b2750],
22	]	NN	O	]	dep	19	SENT_33	[p3l1638t2675r1753b2750],
23	,	,	O	,	_	0	SENT_33	[p3l1638t2675r1753b2750],
24	and	CC	O	and	cc	12	SENT_33	[p3l1786t2674r1933b2748],
25	,	,	O	,	_	0	SENT_33	[p3l1786t2674r1933b2748],
26	apart	RB	O	apart	advmod	12	SENT_33	[p3l1967t2684r2147b2755],
27	from	IN	O	from	dep	12	SENT_33	[p3l9t2786r185b2849],
28	expression	NN	O	expression	pobj	27	SENT_33	[p3l212t2786r602b2867],
29	in	IN	O	in	_	0	SENT_33	[p3l629t2786r698b2848],
30	the	DT	O	the	det	31	SENT_33	[p3l724t2786r833b2849],
31	liver	NN	O	liver	prep_in	12	SENT_33	[p3l862t2786r1029b2849],
32	and	CC	O	and	_	0	SENT_33	[p3l1056t2786r1184b2849],
33	small	JJ	O	small	amod	34	SENT_33	[p3l1214t2786r1406b2849],
34	intestines	NNS	O	intestine	prep_in	12	SENT_33	[p3l1434t2786r1800b2860],
35	,	,	O	,	_	0	SENT_33	[p3l1434t2786r1800b2860],
36	has	VBZ	O	have	aux	38	SENT_33	[p3l1830t2786r1947b2849],
37	been	VBN	O	be	auxpass	38	SENT_33	[p3l1976t2786r2147b2849],
38	shown	VBN	O	show	dep	58	SENT_33	[p3l12t2897r244b2960],
39	to	TO	O	to	aux	41	SENT_33	[p3l281t2907r348b2960],
40	be	VB	O	be	auxpass	41	SENT_33	[p3l384t2897r468b2960],
41	expressed	VBN	O	express	xcomp	38	SENT_33	[p3l505t2897r864b2978],
42	in	IN	O	in	_	0	SENT_33	[p3l899t2897r968b2959],
43	several	JJ	O	several	amod	45	SENT_33	[p3l1007t2897r1262b2960],
44	cancerous	JJ	O	cancerous	amod	45	SENT_33	[p3l1299t2917r1662b2960],
45	tissues	NNS	O	tissue	prep_in	41	SENT_33	[p3l1700t2897r1943b2960],
46	such	JJ	O	such	_	0	SENT_33	[p3l1984t2897r2146b2960],
47	as	IN	O	as	_	0	SENT_33	[p3l11t3028r80b3071],
48	breast	NN	O	breast	nn	54	SENT_33	[p3l120t3008r359b3082],
49	,	,	O	,	_	0	SENT_33	[p3l120t3008r359b3082],
50	colon	NN	O	colon	nn	57	SENT_33	[p3l402t3008r621b3083],
51	,	,	O	,	_	0	SENT_33	[p3l402t3008r621b3083],
52	bone	NN	O	bone	nn	57	SENT_33	[p3l662t3008r859b3082],
53	,	,	O	,	_	0	SENT_33	[p3l662t3008r859b3082],
54	prostate	NN	O	prostate	nn	57	SENT_33	[p3l899t3018r1189b3089],
55	and	CC	O	and	_	0	SENT_33	[p3l1230t3008r1358b3071],
56	endometrial	JJ	O	endometrial	nn	57	SENT_33	[p3l1397t3008r1834b3071],
57	cancers	NNS	O	cancer	prep_such_as	45	SENT_33	[p3l1874t3028r2143b3071],
58	[	VBP	O	[	_	0	SENT_33	[p3l15t3119r224b3195],
59	5	CD	NUMBER	5	num	60	SENT_33	[p3l15t3119r224b3195],
60	—	CD	NUMBER	—	dobj	58	SENT_33	[p3l15t3119r224b3195],
61	9	CD	NUMBER	9	num	62	SENT_33	[p3l15t3119r224b3195],
62	]	NN	O	]	nsubj	58	SENT_33	[p3l15t3119r224b3195],
63	.	.	O	.	_	0	SENT_33	[p3l15t3119r224b3195],

1	PXR	NN	O	pxr	nsubj	6	SENT_34	[p3l269t3121r444b3181],
2	is	VBZ	O	be	cop	6	SENT_34	[p3l484t3119r540b3182],
3	a	DT	O	a	det	6	SENT_34	[p3l585t3139r622b3182],
4	very	RB	O	very	advmod	5	SENT_34	[p3l661t3139r820b3200],
5	promiscuous	JJ	O	promiscuous	amod	6	SENT_34	[p3l861t3119r1327b3200],
6	receptor	NN	O	receptor	_	0	SENT_34	[p3l1369t3129r1671b3200],
7	that	WDT	O	that	nsubjpass	9	SENT_34	[p3l1710t3119r1847b3182],
8	is	VBZ	O	be	auxpass	9	SENT_34	[p3l1885t3119r1942b3182],
9	activated	VBN	O	activate	rcmod	6	SENT_34	[p3l1987t3119r2143b3182, p3l10t3230r206b3293],
10	by	IN	O	by	_	0	SENT_34	[p3l241t3230r330b3311],
11	a	DT	O	a	det	13	SENT_34	[p3l369t3250r406b3293],
12	wide	JJ	O	wide	amod	13	SENT_34	[p3l441t3230r615b3293],
13	variety	NN	O	variety	agent	9	SENT_34	[p3l652t3230r905b3311],
14	of	IN	O	of	_	0	SENT_34	[p3l943t3230r1022b3293],
15	structurally	RB	O	structurally	advmod	16	SENT_34	[p3l1055t3230r1470b3311],
16	unrelated	JJ	O	unrelated	amod	17	SENT_34	[p3l1506t3230r1848b3293],
17	ligands	NNS	O	ligand	prep_of	13	SENT_34	[p3l1883t3230r2143b3311],
18	including	VBG	O	include	_	0	SENT_34	[p3l9t3341r353b3422],
19	rifampicin	NN	O	rifampicin	prep_including	17	SENT_34	[p3l391t3341r793b3422],
20	,	,	O	,	_	0	SENT_34	[p3l391t3341r793b3422],
21	hyperforin	NN	O	hyperforin	conj_and	19	SENT_34	[p3l833t3341r1221b3422],
22	and	CC	O	and	_	0	SENT_34	[p3l1259t3341r1387b3404],
23	the	DT	O	the	det	26	SENT_34	[p3l1422t3341r1531b3404],
24	anticancer	JJ	O	anticancer	amod	26	SENT_34	[p3l1569t3341r1947b3404],
25	drug	NN	O	drug	nn	26	SENT_34	[p3l1982t3341r2145b3422],
26	paclitaxel	NN	O	paclitaxel	prep_including	17	SENT_34	[p3l8t3452r385b3533],
27	.	.	O	.	_	0	SENT_34	[p3l8t3452r385b3533],

1	Due	JJ	O	due	_	0	SENT_35	[p3l418t3454r566b3515],
2	to	TO	O	to	_	0	SENT_35	[p3l595t3462r663b3515],
3	the	DT	O	the	det	4	SENT_35	[p3l693t3452r801b3515],
4	promiscuity	NN	O	promiscuity	prep_due_to	9	SENT_35	[p3l830t3452r1268b3533],
5	of	IN	O	of	_	0	SENT_35	[p3l1299t3452r1377b3515],
6	PXR	NN	O	pxr	prep_of	4	SENT_35	[p3l1400t3454r1594b3526],
7	,	,	O	,	_	0	SENT_35	[p3l1400t3454r1594b3526],
8	possibly	RB	O	possibly	advmod	9	SENT_35	[p3l1624t3452r1930b3533],
9	other	JJ	O	other	_	0	SENT_35	[p3l1961t3452r2148b3515],
10	widely	RB	O	widely	advmod	11	SENT_35	[p3l9t3563r255b3644],
11	used	VBN	O	use	partmod	9	SENT_35	[p3l300t3563r466b3626],
12	anticancer	JJ	O	anticancer	amod	13	SENT_35	[p3l511t3563r888b3626],
13	drugs	NNS	O	drug	nsubj	16	SENT_35	[p3l932t3563r1129b3644],
14	could	MD	O	could	aux	16	SENT_35	[p3l1177t3563r1378b3626],
15	also	RB	O	also	advmod	16	SENT_35	[p3l1423t3563r1565b3626],
16	activate	VB	O	activate	dep	11	SENT_35	[p3l1613t3563r1895b3626],
17	PXRmediated	JJ	O	pxrmediated	amod	19	SENT_35	[p3l1941t3565r2144b3625, p3l9t3674r345b3737],
18	Pgp	NN	O	pgp	nn	19	SENT_35	[p3l393t3676r531b3755],
19	induction	NN	O	induction	dobj	16	SENT_35	[p3l582t3674r947b3748],
20	,	,	O	,	_	0	SENT_35	[p3l582t3674r947b3748],
21	and	CC	O	and	_	0	SENT_35	[p3l1001t3674r1130b3737],
22	as	IN	O	as	mark	25	SENT_35	[p3l1180t3694r1249b3737],
23	a	DT	O	a	det	24	SENT_35	[p3l1303t3694r1340b3737],
24	consequence	NN	O	consequence	nsubj	25	SENT_35	[p3l1388t3694r1854b3755],
25	induce	VBP	O	induce	dep	11	SENT_35	[p3l1904t3674r2144b3737],

1	MDR	NN	O	mdr	_	0	SENT_36	[p4l9t24r214b84],
2	in	IN	O	in	_	0	SENT_36	[p4l240t22r309b84],
3	cancer	NN	O	cancer	nn	4	SENT_36	[p4l336t42r573b85],
4	cells	NNS	O	cell	prep_in	1	SENT_36	[p4l599t22r784b85],
5	.	.	O	.	_	0	SENT_36	[p4l599t22r784b85],

1	In	IN	O	in	_	0	SENT_37	[p4l111t136r184b196],
2	the	DT	O	the	det	4	SENT_37	[p4l219t134r326b197],
3	current	JJ	DATE	current	amod	4	SENT_37	[p4l363t144r615b197],
4	study	NN	O	study	prep_in	14	SENT_37	[p4l653t134r860b215],
5	,	,	O	,	_	0	SENT_37	[p4l653t134r860b215],
6	a	DT	O	a	det	7	SENT_37	[p4l900t154r937b197],
7	panel	NN	O	panel	nsubjpass	14	SENT_37	[p4l971t134r1163b215],
8	of	IN	O	of	_	0	SENT_37	[p4l1200t134r1277b197],
9	widely	RB	O	widely	advmod	10	SENT_37	[p4l1307t134r1548b215],
10	used	VBN	O	use	amod	12	SENT_37	[p4l1583t134r1746b197],
11	anticancer	JJ	O	anticancer	amod	12	SENT_37	[p4l1782t134r2150b197],
12	drugs	NNS	O	drug	prep_of	7	SENT_37	[p4l10t245r211b326],
13	was	VBD	O	be	auxpass	14	SENT_37	[p4l257t265r395b308],
14	evaluated	VBN	O	evaluate	_	0	SENT_37	[p4l442t245r802b308],
15	for	IN	O	for	_	0	SENT_37	[p4l846t245r952b308],
16	their	PRP$	O	they	poss	17	SENT_37	[p4l994t245r1165b308],
17	ability	NN	O	ability	prep_for	14	SENT_37	[p4l1208t245r1446b326],
18	to	TO	O	to	aux	19	SENT_37	[p4l1490t255r1558b308],
19	activate	VB	O	activate	infmod	17	SENT_37	[p4l1604t245r1893b308],
20	PXR	NN	O	pxr	nn	21	SENT_37	[p4l1937t247r2142b307],
21	—	NN	O	—	nsubj	22	SENT_37	[p4l1937t247r2142b307],
22	mediated	VBD	O	mediate	ccomp	19	SENT_37	[p4l9t356r345b419],
23	Pgp	NNP	O	Pgp	nn	24	SENT_37	[p4l401t358r538b437],
24	induction	NN	O	induction	dobj	22	SENT_37	[p4l596t356r932b419],
25	in	IN	O	in	_	0	SENT_37	[p4l989t356r1056b418],
26	the	DT	O	the	det	29	SENT_37	[p4l1113t356r1219b419],
27	colon	NN	O	colon	nn	29	SENT_37	[p4l1277t356r1474b419],
28	adenocarcinoma	NN	O	adenocarcinoma	nn	29	SENT_37	[p4l1533t356r2144b419],
29	—	NN	O	—	prep_in	22	SENT_37	[p4l1533t356r2144b419],
30	derived	VBN	O	derive	partmod	29	SENT_37	[p4l10t467r287b530],
31	cell	NN	O	cell	nn	33	SENT_37	[p4l327t467r458b530],
32	line	NN	O	line	nn	33	SENT_37	[p4l499t467r635b530],
33	LSl80	NN	O	lsl80	dobj	30	SENT_37	[p4l675t468r938b530],
34	.	.	O	.	_	0	SENT_37	[p4l675t468r938b530],

1	In	IN	O	in	_	0	SENT_38	[p4l982t469r1057b529],
2	addition	NN	O	addition	prep_in	17	SENT_38	[p4l1098t467r1424b542],
3	,	,	O	,	_	0	SENT_38	[p4l1098t467r1424b542],
4	the	DT	O	the	det	5	SENT_38	[p4l1466t467r1577b530],
5	effect	NN	O	effect	nsubjpass	17	SENT_38	[p4l1618t465r1819b530],
6	of	IN	O	of	_	0	SENT_38	[p4l1857t467r1936b530],
7	PXR	NN	O	pxr	nn	8	SENT_38	[p4l1969t469r2147b529],
8	activation	NN	O	activation	prep_of	5	SENT_38	[p4l11t579r368b642],
9	on	IN	O	on	_	0	SENT_38	[p4l414t599r500b642],
10	the	DT	O	the	det	12	SENT_38	[p4l544t579r650b642],
11	intracellular	JJ	O	intracellular	amod	12	SENT_38	[p4l696t579r1130b642],
12	accumulation	NN	O	accumulation	prep_on	8	SENT_38	[p4l1174t579r1653b642],
13	of	IN	O	of	_	0	SENT_38	[p4l1699t579r1776b642],
14	Pgp	NNP	O	Pgp	nn	15	SENT_38	[p4l1814t581r1950b660],
15	substrates	NNS	O	substrate	prep_of	12	SENT_38	[p4l1999t579r2145b642, p4l12t700r234b753],
16	was	VBD	O	be	auxpass	17	SENT_38	[p4l260t710r394b753],
17	determined	VBN	O	determine	_	0	SENT_38	[p4l420t690r839b753],
18	.	.	O	.	_	0	SENT_38	[p4l420t690r839b753],

1	Our	PRP$	O	we	poss	2	SENT_39	[p4l867t691r1005b753],
2	results	NNS	O	result	nsubj	3	SENT_39	[p4l1025t690r1256b753],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_39	[p4l1282t690r1716b753],
4	that	IN	O	that	complm	14	SENT_39	[p4l1740t690r1872b753],
5	several	JJ	O	several	nsubj	14	SENT_39	[p4l1897t690r2146b753],
6	widely	RB	O	widely	advmod	7	SENT_39	[p4l9t802r251b883],
7	used	VBN	O	use	amod	9	SENT_39	[p4l290t802r453b865],
8	anticancer	JJ	O	anticancer	amod	9	SENT_39	[p4l495t802r861b865],
9	drugs	NNS	O	drug	nsubj	11	SENT_39	[p4l901t802r1094b883],
10	can	MD	O	can	aux	11	SENT_39	[p4l1137t822r1258b865],
11	activate	VB	O	activate	rcmod	5	SENT_39	[p4l1300t802r1575b865],
12	PXR	NN	O	pxr	nn	13	SENT_39	[p4l1615t802r2148b865],
13	—	NN	O	—	dobj	11	SENT_39	[p4l1615t802r2148b865],
14	mediated	VBD	O	mediate	ccomp	3	SENT_39	[p4l1615t802r2148b865],
15	induction	NN	O	induction	dobj	14	SENT_39	[p4l9t913r362b976],
16	of	IN	O	of	_	0	SENT_39	[p4l416t913r494b976],
17	Pgp	NNP	ORGANIZATION	Pgp	prep_of	15	SENT_39	[p4l541t915r680b994],
18	and	CC	O	and	_	0	SENT_39	[p4l735t913r865b976],
19	as	IN	O	as	mark	22	SENT_39	[p4l918t933r988b976],
20	a	DT	O	a	det	21	SENT_39	[p4l1045t933r1082b976],
21	consequence	NN	O	consequence	nsubj	22	SENT_39	[p4l1134t933r1610b994],
22	decrease	VB	O	decrease	ccomp	3	SENT_39	[p4l1663t913r1981b976],
23	the	DT	O	the	det	25	SENT_39	[p4l2034t913r2144b976],
24	intracellular	JJ	O	intracellular	amod	25	SENT_39	[p4l9t1024r451b1087],
25	accumulation	NN	O	accumulation	dobj	22	SENT_39	[p4l492t1024r971b1087],
26	of	IN	O	of	_	0	SENT_39	[p4l1013t1024r1090b1087],
27	Pgp	NNP	ORGANIZATION	Pgp	nn	28	SENT_39	[p4l1125t1026r1261b1105],
28	substrates	NNS	O	substrate	prep_of	25	SENT_39	[p4l1307t1024r1673b1087],
29	.	.	O	.	_	0	SENT_39	[p4l1307t1024r1673b1087],

1	In	IN	O	in	_	0	SENT_40	[p4l1719t1026r1791b1086],
2	addition	NN	O	addition	prep_in	6	SENT_40	[p4l1833t1024r2143b1098],
3	,	,	O	,	_	0	SENT_40	[p4l1833t1024r2143b1098],
4	evidence	NN	O	evidence	nsubjpass	6	SENT_40	[p4l10t1135r324b1198],
5	is	VBZ	O	be	auxpass	6	SENT_40	[p4l354t1135r409b1198],
6	presented	VBN	O	present	_	0	SENT_40	[p4l439t1135r783b1216],
7	that	IN	O	that	complm	16	SENT_40	[p4l809t1135r943b1198],
8	the	DT	O	the	det	10	SENT_40	[p4l971t1135r1078b1198],
9	cytotoxic	JJ	O	cytotoxic	amod	10	SENT_40	[p4l1109t1135r1438b1216],
10	activity	NN	O	activity	nsubjpass	16	SENT_40	[p4l1470t1135r1734b1216],
11	of	IN	O	of	_	0	SENT_40	[p4l1765t1135r1842b1198],
12	doXoru	NN	O	doxoru	nn	14	SENT_40	[p4l1866t1135r2144b1198],
13	—	CD	NUMBER	—	num	14	SENT_40	[p4l1866t1135r2144b1198],
14	bicin	NN	O	bicin	prep_of	10	SENT_40	[p4l8t1246r186b1309],
15	is	VBZ	O	be	auxpass	16	SENT_40	[p4l227t1246r282b1309],
16	reduced	VBN	O	reduce	ccomp	6	SENT_40	[p4l324t1246r608b1309],
17	when	WRB	O	when	advmod	20	SENT_40	[p4l647t1246r839b1309],
18	cells	NNS	O	cell	nsubjpass	20	SENT_40	[p4l880t1246r1040b1309],
19	are	VBP	O	be	auxpass	20	SENT_40	[p4l1085t1266r1190b1309],
20	pretreated	VBN	O	pretreat	advcl	16	SENT_40	[p4l1230t1246r1588b1327],
21	with	IN	O	with	_	0	SENT_40	[p4l1629t1246r1786b1309],
22	the	DT	O	the	det	25	SENT_40	[p4l1826t1246r1933b1309],
23	PXR	NN	O	pxr	nn	25	SENT_40	[p4l1974t1248r2148b1308],
24	activator	NN	O	activator	nn	25	SENT_40	[p4l11t1357r323b1420],
25	rifampicin	NN	O	rifampicin	prep_with	20	SENT_40	[p4l345t1357r735b1438],
26	.	.	O	.	_	0	SENT_40	[p4l345t1357r735b1438],

1	Materials	NNPS	O	Materials	_	0	SENT_41	[p4l9t1600r375b1664],
2	and	CC	O	and	_	0	SENT_41	[p4l401t1602r542b1664],
3	methods	NNS	O	method	conj_and	1	SENT_41	[p4l567t1602r889b1664],

1	Materials	NNPS	O	Materials	_	0	SENT_42	[p4l9t1825r344b1888],

1	All	DT	O	all	det	4	SENT_43	[p4l9t2050r120b2112],
2	cell	NN	O	cell	nn	4	SENT_43	[p4l168t2050r294b2113],
3	culture	NN	O	culture	nn	4	SENT_43	[p4l343t2050r588b2113],
4	media	NNS	O	media	nsubjpass	8	SENT_43	[p4l636t2050r854b2113],
5	and	CC	O	and	_	0	SENT_43	[p4l901t2050r1027b2113],
6	supplements	NNS	O	supplement	conj_and	4	SENT_43	[p4l1076t2050r1518b2131],
7	were	VBD	O	be	auxpass	8	SENT_43	[p4l1567t2070r1738b2113],
8	purchased	VBN	O	purchase	_	0	SENT_43	[p4l1784t2050r2148b2131],
9	from	IN	O	from	_	0	SENT_43	[p4l9t2161r182b2224],
10	Invitrogen	NNP	ORGANIZATION	Invitrogen	nn	12	SENT_43	[p4l234t2161r606b2242],
11	(	NNP	O	(	nn	12	SENT_43	[p4l661t2161r920b2239],
12	Breda	NNP	PERSON	Breda	prep_from	8	SENT_43	[p4l661t2161r920b2239],
13	,	,	O	,	_	0	SENT_43	[p4l661t2161r920b2239],
14	The	DT	LOCATION	the	det	16	SENT_43	[p4l975t2161r1112b2224],
15	Netherlands	NNP	LOCATION	Netherlands	nn	16	SENT_43	[p4l1165t2161r1645b2239],
16	)	NN	O	)	appos	12	SENT_43	[p4l1165t2161r1645b2239],
17	.	.	O	.	_	0	SENT_43	[p4l1165t2161r1645b2239],

1	Carboplatin	NNP	MISC	Carboplatin	nsubjpass	10	SENT_44	[p4l1703t2161r2142b2242],
2	,	,	O	,	_	0	SENT_44	[p4l1703t2161r2142b2242],
3	ifosfamide	NN	O	ifosfamide	conj_and	1	SENT_44	[p4l9t2272r410b2346],
4	,	,	O	,	_	0	SENT_44	[p4l9t2272r410b2346],
5	tamoxifen	NN	O	tamoxifen	nn	6	SENT_44	[p4l447t2272r809b2335],
6	citrate	NN	O	citrate	conj_and	1	SENT_44	[p4l842t2272r1064b2335],
7	and	CC	O	and	_	0	SENT_44	[p4l1099t2272r1226b2335],
8	etoposide	NN	O	etoposide	conj_and	1	SENT_44	[p4l1260t2272r1600b2353],
9	were	VBD	O	be	auxpass	10	SENT_44	[p4l1635t2292r1806b2335],
10	obtained	VBN	O	obtain	_	0	SENT_44	[p4l1840t2272r2148b2335],
11	from	IN	O	from	_	0	SENT_44	[p4l9t2383r177b2446],
12	Axxora	NNP	LOCATION	Axxora	nn	15	SENT_44	[p4l197t2384r455b2446],
13	(	NNP	O	(	nn	15	SENT_44	[p4l477t2384r631b2461],
14	San	NNP	LOCATION	San	nn	15	SENT_44	[p4l477t2384r631b2461],
15	Diego	NNP	LOCATION	Diego	prep_from	10	SENT_44	[p4l652t2383r880b2464],
16	,	,	O	,	_	0	SENT_44	[p4l652t2383r880b2464],
17	CA	NNP	O	CA	nn	19	SENT_44	[p4l905t2384r1041b2457],
18	,	,	O	,	_	0	SENT_44	[p4l905t2384r1041b2457],
19	USA	NNP	LOCATION	USA	appos	15	SENT_44	[p4l1066t2384r1284b2460],
20	)	CD	NUMBER	)	num	19	SENT_44	[p4l1066t2384r1284b2460],
21	.	.	O	.	_	0	SENT_44	[p4l1066t2384r1284b2460],

1	Zosuquidar	NNP	O	Zosuquidar	nsubjpass	6	SENT_45	[p4l1309t2383r1697b2464],
2	(	CD	NUMBER	(	num	4	SENT_45	[p4l1719t2383r2144b2461],
3	LY335979	NN	O	ly335979	nn	4	SENT_45	[p4l1719t2383r2144b2461],
4	)	NN	O	)	dep	1	SENT_45	[p4l1719t2383r2144b2461],
5	was	VBD	O	be	auxpass	6	SENT_45	[p4l9t2514r144b2557],
6	obtained	VBN	O	obtain	_	0	SENT_45	[p4l179t2494r485b2557],
7	through	IN	O	through	_	0	SENT_45	[p4l515t2494r792b2575],
8	Kanisa	NNP	ORGANIZATION	Kanisa	nn	10	SENT_45	[p4l823t2494r1070b2557],
9	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	10	SENT_45	[p4l1099t2494r1684b2557],
10	Inc.	NNP	ORGANIZATION	Inc.	prep_through	6	SENT_45	[p4l1717t2496r1847b2557],
11	(	CD	NUMBER	(	dep	10	SENT_45	[p4l1885t2494r2142b2571],
12	Irvine	NNP	LOCATION	Irvine	nn	16	SENT_45	[p4l1885t2494r2142b2571],
13	,	,	O	,	_	0	SENT_45	[p4l1885t2494r2142b2571],
14	CA	NNP	LOCATION	CA	appos	16	SENT_45	[p4l10t2606r154b2679],
15	,	,	O	,	_	0	SENT_45	[p4l10t2606r154b2679],
16	USA	NNP	LOCATION	USA	dep	11	SENT_45	[p4l205t2606r438b2683],
17	)	CD	NUMBER	)	num	16	SENT_45	[p4l205t2606r438b2683],
18	.	.	O	.	_	0	SENT_45	[p4l205t2606r438b2683],

1	All	DT	O	all	det	3	SENT_46	[p4l491t2605r606b2667],
2	other	JJ	O	other	amod	3	SENT_46	[p4l657t2605r846b2668],
3	chemicals	NNS	O	chemical	nsubjpass	5	SENT_46	[p4l893t2605r1265b2668],
4	were	VBD	O	be	auxpass	5	SENT_46	[p4l1316t2625r1492b2668],
5	purchased	VBN	O	purchase	_	0	SENT_46	[p4l1541t2605r1920b2686],
6	from	IN	O	from	_	0	SENT_46	[p4l1968t2605r2146b2668],
7	Sigma	NNP	O	Sigma	prep_from	5	SENT_46	[p4l11t2716r556b2797],
8	.	.	O	.	_	0	SENT_46	[p4l11t2716r556b2797],

1	—	NN	O	—	_	0	SENT_47	[p4l11t2716r556b2797],
2	.	.	O	.	_	0	SENT_47	[p4l11t2716r556b2797],

1	Aldrich	NNP	PERSON	Aldrich	nn	3	SENT_48	[p4l11t2716r556b2797],
2	(	NNP	O	(	nn	3	SENT_48	[p4l584t2716r1067b2797],
3	Zwijndrecht	NNP	O	Zwijndrecht	_	0	SENT_48	[p4l584t2716r1067b2797],
4	,	,	O	,	_	0	SENT_48	[p4l584t2716r1067b2797],
5	The	DT	LOCATION	the	det	7	SENT_48	[p4l1095t2716r1231b2779],
6	Netherlands	NNP	LOCATION	Netherlands	nn	7	SENT_48	[p4l1257t2716r1736b2793],
7	)	NN	O	)	appos	3	SENT_48	[p4l1257t2716r1736b2793],
8	.	.	O	.	_	0	SENT_48	[p4l1257t2716r1736b2793],

1	Plasmids	NNS	O	plasmid	_	0	SENT_49	[p4l9t2940r328b3003],

1	The	DT	O	the	det	7	SENT_50	[p4l9t3164r145b3227],
2	pGL3-MDR1	NN	O	pgl3-mdr1	nn	7	SENT_50	[p4l186t3165r665b3245],
3	(	NN	O	(	nn	7	SENT_50	[p4l716t3165r1066b3245],
4	p	NN	O	p	nn	7	SENT_50	[p4l716t3165r1066b3245],
5	—	CD	NUMBER	—	num	7	SENT_50	[p4l716t3165r1066b3245],
6	l0224	NN	O	l0224	nn	7	SENT_50	[p4l716t3165r1066b3245],
7	)	NN	O	)	nsubjpass	13	SENT_50	[p4l716t3165r1066b3245],
8	luciferase	NN	O	luciferase	nn	10	SENT_50	[p4l1110t3164r1456b3227],
9	reporter	NN	O	reporter	nn	10	SENT_50	[p4l1496t3174r1781b3245],
10	construct	NN	O	construct	dep	7	SENT_50	[p4l1821t3174r2148b3227],
11	was	VBD	O	be	auxpass	13	SENT_50	[p4l9t3295r144b3338],
12	generously	RB	O	generously	advmod	13	SENT_50	[p4l184t3275r574b3356],
13	provided	VBN	O	provide	_	0	SENT_50	[p4l610t3275r928b3356],
14	by	IN	O	by	_	0	SENT_50	[p4l962t3275r1050b3356],
15	Dr.	NNP	O	Dr.	nn	19	SENT_50	[p4l1087t3277r1198b3338],
16	Oliver	NNP	PERSON	Oliver	nn	19	SENT_50	[p4l1240t3275r1467b3338],
17	Burk	NNP	PERSON	Burk	nn	19	SENT_50	[p4l1503t3275r1682b3338],
18	(	NNP	O	(	nn	19	SENT_50	[p4l1719t3275r2037b3353],
19	Institute	NNP	O	Institute	agent	13	SENT_50	[p4l1719t3275r2037b3353],
20	of	IN	O	of	_	0	SENT_50	[p4l2076t3275r2153b3338],
21	Clinical	JJ	O	clinical	amod	22	SENT_50	[p4l10t3386r275b3449],
22	Pharmacology	NN	O	pharmacology	prep_of	19	SENT_50	[p4l303t3386r811b3467],
23	,	,	O	,	_	0	SENT_50	[p4l303t3386r811b3467],
24	Eberhard	NNP	PERSON	Eberhard	appos	22	SENT_50	[p4l843t3386r1364b3449],
25	.	.	O	.	_	0	SENT_50	[p4l843t3386r1364b3449],

1	—	NN	O	—	_	0	SENT_51	[p4l843t3386r1364b3449],
2	.	.	O	.	_	0	SENT_51	[p4l843t3386r1364b3449],

1	Karls	NNP	ORGANIZATION	Karls	nn	2	SENT_52	[p4l843t3386r1364b3449],
2	University	NNP	ORGANIZATION	University	_	0	SENT_52	[p4l1395t3386r1769b3467],
3	,	,	O	,	_	0	SENT_52	[p4l1395t3386r1769b3467],
4	Tiibingen	NNP	PERSON	Tiibingen	dep	2	SENT_52	[p4l1802t3386r2144b3467],
5	,	,	O	,	_	0	SENT_52	[p4l1802t3386r2144b3467],

1	Q	NNP	O	Q	nn	2	SENT_53	[p4l7t3626r85b3722],
2	Springer	NNP	O	Springer	_	0	SENT_53	[p4l113t3649r376b3724],

1	Germany	NNP	LOCATION	Germany	nn	2	SENT_54	[p5l8t21r404b101],
2	)	NNP	O	)	_	0	SENT_54	[p5l8t21r404b101],
3	.	.	O	.	_	0	SENT_54	[p5l8t21r404b101],

1	The	DT	O	the	det	6	SENT_55	[p5l474t20r614b83],
2	pCDG	NN	O	pcdg	nn	6	SENT_55	[p5l679t20r1178b101],
3	—	CD	NUMBER	—	num	6	SENT_55	[p5l679t20r1178b101],
4	hPXR	NN	O	hpxr	nn	6	SENT_55	[p5l679t20r1178b101],
5	expression	NN	O	expression	nn	6	SENT_55	[p5l1244t20r1644b101],
6	vector	NN	O	vector	nsubjpass	9	SENT_55	[p5l1710t30r1944b83],
7	was	VBD	O	be	auxpass	9	SENT_55	[p5l2008t40r2147b83],
8	generously	RB	O	generously	advmod	9	SENT_55	[p5l8t131r410b212],
9	provided	VBN	O	provide	_	0	SENT_55	[p5l444t131r764b212],
10	by	IN	O	by	_	0	SENT_55	[p5l796t131r884b212],
11	Dr.	NNP	O	Dr.	nn	16	SENT_55	[p5l920t133r1030b194],
12	Ron	NNP	PERSON	Ron	nn	16	SENT_55	[p5l1069t133r1216b194],
13	Evans	NNP	PERSON	Evans	nn	16	SENT_55	[p5l1251t133r1467b194],
14	(	NNP	O	(	nn	16	SENT_55	[p5l1506t131r1693b209],
15	Salk	NNP	PERSON	Salk	nn	16	SENT_55	[p5l1506t131r1693b209],
16	institute	NN	O	institute	agent	9	SENT_55	[p5l1725t131r2014b194],
17	for	IN	O	for	_	0	SENT_55	[p5l2048t131r2153b194],
18	biological	JJ	O	biological	amod	19	SENT_55	[p5l6t242r365b323],
19	studies	NNS	O	study	prep_for	9	SENT_55	[p5l400t242r664b317],
20	,	,	O	,	_	0	SENT_55	[p5l400t242r664b317],
21	La	NNP	PERSON	La	nn	26	SENT_55	[p5l698t244r793b305],
22	Jolla	NNP	PERSON	Jolla	nn	26	SENT_55	[p5l823t242r1010b317],
23	,	,	O	,	_	0	SENT_55	[p5l823t242r1010b317],
24	CA	NNP	O	CA	appos	26	SENT_55	[p5l1046t243r1187b316],
25	,	,	O	,	_	0	SENT_55	[p5l1046t243r1187b316],
26	USA	NNP	LOCATION	USA	appos	19	SENT_55	[p5l1222t243r1448b319],
27	)	CD	NUMBER	)	num	26	SENT_55	[p5l1222t243r1448b319],
28	.	.	O	.	_	0	SENT_55	[p5l1222t243r1448b319],

1	The	DT	O	the	det	2	SENT_56	[p5l1484t242r1621b305],
2	pRL	NN	O	prl	_	0	SENT_56	[p5l1652t244r1963b323],
3	.	.	O	.	_	0	SENT_56	[p5l1652t244r1963b323],

1	—	NN	O	—	_	0	SENT_57	[p5l1652t244r1963b323],
2	.	.	O	.	_	0	SENT_57	[p5l1652t244r1963b323],

1	TK	NN	O	tk	nn	3	SENT_58	[p5l1652t244r1963b323],
2	control	NN	O	control	nn	3	SENT_58	[p5l1994t262r2149b305, p5l7t353r130b416],
3	plasmid	NN	O	plasmid	nsubjpass	5	SENT_58	[p5l171t353r456b434],
4	was	VBD	O	be	auxpass	5	SENT_58	[p5l500t373r635b416],
5	obtained	VBN	O	obtain	_	0	SENT_58	[p5l681t353r989b416],
6	from	IN	O	from	_	0	SENT_58	[p5l1031t353r1204b416],
7	Promega	NNP	O	Promega	nn	9	SENT_58	[p5l1247t355r1566b434],
8	(	NNP	O	(	nn	9	SENT_58	[p5l1610t353r1969b430],
9	Madison	NNP	PERSON	Madison	prep_from	5	SENT_58	[p5l1610t353r1969b430],
10	,	,	O	,	_	0	SENT_58	[p5l1610t353r1969b430],
11	WI	NNP	O	WI	nn	13	SENT_58	[p5l2014t355r2148b427],
12	,	,	O	,	_	0	SENT_58	[p5l2014t355r2148b427],
13	USA	NNP	LOCATION	USA	appos	9	SENT_58	[p5l7t465r233b542],
14	)	CD	NUMBER	)	num	13	SENT_58	[p5l7t465r233b542],
15	.	.	O	.	_	0	SENT_58	[p5l7t465r233b542],

1	Plasmids	NNS	MISC	plasmid	nsubjpass	12	SENT_59	[p5l276t464r597b527],
2	were	VBD	O	be	auxpass	3	SENT_59	[p5l639t484r810b527],
3	checked	VBN	O	check	_	0	SENT_59	[p5l850t464r1142b527],
4	by	IN	O	by	_	0	SENT_59	[p5l1178t464r1266b545],
5	enzyme	NN	O	enzyme	nn	6	SENT_59	[p5l1307t484r1583b545],
6	restriction	NN	O	restriction	agent	3	SENT_59	[p5l1621t464r1985b527],
7	and	CC	O	and	_	0	SENT_59	[p5l2025t464r2152b527],
8	agarose	NN	O	agarose	nn	10	SENT_59	[p5l9t594r278b655],
9	gel	NN	O	gel	nn	10	SENT_59	[p5l321t574r427b655],
10	electrophoresis	NN	O	electrophoresis	agent	3	SENT_59	[p5l469t574r1009b655],
11	and	CC	O	and	_	0	SENT_59	[p5l1053t574r1179b637],
12	puriﬁed	VBN	O	puriﬁed	conj_and	3	SENT_59	[p5l1217t572r1497b655],
13	using	VBG	O	use	xcomp	12	SENT_59	[p5l1535t574r1727b655],
14	Promega	NNP	O	Promega	poss	19	SENT_59	[p5l1768t575r2149b655],
15	’s	POS	O	’s	_	0	SENT_59	[p5l1768t575r2149b655],
16	Pureyield	NN	O	pureyield	nn	19	SENT_59	[p5l7t686r351b767],
17	Midi	NN	O	midi	nn	19	SENT_59	[p5l379t686r740b767],
18	—	CD	NUMBER	—	num	19	SENT_59	[p5l379t686r740b767],
19	prep	NN	O	prep	nsubj	20	SENT_59	[p5l379t686r740b767],
20	(	CD	NUMBER	(	xcomp	13	SENT_59	[p5l773t686r1132b763],
21	Madison	NNP	PERSON	Madison	nn	25	SENT_59	[p5l773t686r1132b763],
22	,	,	O	,	_	0	SENT_59	[p5l773t686r1132b763],
23	WI	NNP	O	WI	appos	25	SENT_59	[p5l1163t688r1296b760],
24	,	,	O	,	_	0	SENT_59	[p5l1163t688r1296b760],
25	USA	NNP	LOCATION	USA	dep	20	SENT_59	[p5l1328t687r1533b763],
26	)	CD	NUMBER	)	num	25	SENT_59	[p5l1328t687r1533b763],
27	according	VBG	O	accord	_	0	SENT_59	[p5l1568t686r1916b767],
28	to	TO	O	to	prepc_according_to	3	SENT_59	[p5l1946t696r2013b749],
29	the	DT	O	the	det	30	SENT_59	[p5l2043t686r2150b749],
30	instructions	NNS	O	instruction	pobj	3	SENT_59	[p5l7t797r423b860],
31	of	IN	O	of	_	0	SENT_59	[p5l452t797r529b860],
32	the	DT	O	the	det	33	SENT_59	[p5l548t797r655b860],
33	manufacturer	NN	O	manufacturer	prep_of	30	SENT_59	[p5l680t797r1175b860],
34	.	.	O	.	_	0	SENT_59	[p5l680t797r1175b860],

1	Cell	NN	O	cell	nn	2	SENT_60	[p5l8t1022r155b1085],
2	culture	NN	O	culture	_	0	SENT_60	[p5l181t1022r427b1085],

1	The	DT	O	the	det	7	SENT_61	[p5l7t1247r146b1310],
2	human	JJ	O	human	amod	7	SENT_61	[p5l221t1247r469b1310],
3	colon	NN	O	colon	nn	7	SENT_61	[p5l545t1247r746b1310],
4	adenocarcinoma-derived	JJ	O	adenocarcinoma-derived	amod	7	SENT_61	[p5l823t1247r1732b1310],
5	cell	NN	O	cell	nn	7	SENT_61	[p5l1808t1247r1938b1310],
6	line	NN	O	line	nn	7	SENT_61	[p5l2014t1247r2150b1310],
7	LSl80	NN	O	lsl80	nsubjpass	9	SENT_61	[p5l7t1360r248b1422],
8	was	VBD	O	be	auxpass	9	SENT_61	[p5l292t1379r429b1422],
9	purchased	VBN	O	purchase	_	0	SENT_61	[p5l474t1359r846b1440],
10	from	IN	O	from	_	0	SENT_61	[p5l889t1359r1065b1422],
11	the	DT	O	the	det	12	SENT_61	[p5l1108t1359r1217b1422],
12	ATCC	NN	ORGANIZATION	atcc	prep_from	9	SENT_61	[p5l1261t1360r1500b1422],
13	(	CD	NUMBER	(	num	12	SENT_61	[p5l1548t1360r1951b1436],
14	Manassas	NNP	LOCATION	Manassas	nn	18	SENT_61	[p5l1548t1360r1951b1436],
15	,	,	O	,	_	0	SENT_61	[p5l1548t1360r1951b1436],
16	VA	NNP	ORGANIZATION	VA	appos	18	SENT_61	[p5l1998t1360r2147b1433],
17	,	,	O	,	_	0	SENT_61	[p5l1998t1360r2147b1433],
18	USA	NNP	LOCATION	USA	dep	12	SENT_61	[p5l7t1471r237b1548],
19	)	CD	NUMBER	)	num	18	SENT_61	[p5l7t1471r237b1548],
20	.	.	O	.	_	0	SENT_61	[p5l7t1471r237b1548],

1	The	DT	O	the	det	2	SENT_62	[p5l297t1470r436b1533],
2	cell-line	JJ	O	cell-line	nsubjpass	4	SENT_62	[p5l492t1470r791b1533],
3	was	VBD	O	be	auxpass	4	SENT_62	[p5l847t1490r984b1533],
4	maintained	VBN	O	maintain	_	0	SENT_62	[p5l1043t1470r1449b1533],
5	in	IN	O	in	_	0	SENT_62	[p5l1505t1470r1573b1532],
6	Roswell	NNP	ORGANIZATION	Roswell	nn	9	SENT_62	[p5l1629t1470r1928b1533],
7	Park	NNP	ORGANIZATION	Park	nn	9	SENT_62	[p5l1984t1470r2152b1533],
8	Memorial	NNP	ORGANIZATION	Memorial	nn	9	SENT_62	[p5l7t1582r367b1645],
9	Institute	NNP	ORGANIZATION	Institute	prep_in	4	SENT_62	[p5l413t1582r713b1645],
10	(	CD	NUMBER	(	num	11	SENT_62	[p5l760t1583r1037b1660],
11	RPMI	NN	O	rpmus	dep	9	SENT_62	[p5l760t1583r1037b1660],
12	)	CD	NUMBER	)	number	13	SENT_62	[p5l760t1583r1037b1660],
13	1640	CD	DATE	1640	dep	14	SENT_62	[p5l1092t1582r1264b1645],
14	medium	NN	O	medium	dep	15	SENT_62	[p5l1308t1582r1608b1645],
15	(	NN	O	(	dep	11	SENT_62	[p5l1653t1582r1843b1660],
16	with	IN	O	with	_	0	SENT_62	[p5l1653t1582r1843b1660],
17	25	CD	NUMBER	25	num	19	SENT_62	[p5l1887t1582r1971b1645],
18	mM	NN	O	mm	nn	19	SENT_62	[p5l2002t1584r2149b1644],
19	HEPES	NN	O	hepe	prep_with	4	SENT_62	[p5l7t1695r279b1757],
20	and	CC	O	and	_	0	SENT_62	[p5l330t1694r458b1757],
21	L	NN	O	l	conj_and	4	SENT_62	[p5l501t1694r958b1775],
22	—	CD	NUMBER	—	num	23	SENT_62	[p5l501t1694r958b1775],
23	glutamine	NN	O	glutamine	dobj	21	SENT_62	[p5l501t1694r958b1775],
24	,	,	O	,	_	0	SENT_62	[p5l501t1694r958b1775],
25	supplemented	VBN	O	supplement	conj_and	4	SENT_62	[p5l1010t1694r1517b1775],
26	with	IN	O	with	_	0	SENT_62	[p5l1561t1694r1721b1757],
27	10	CD	PERCENT	10	num	28	SENT_62	[p5l1773t1695r1925b1757],
28	%	NN	PERCENT	%	prep_with	25	SENT_62	[p5l1773t1695r1925b1757],
29	(	CD	NUMBER	(	num	30	SENT_62	[p5l1976t1695r2148b1772],
30	v/v	NN	O	v/v	tmod	25	SENT_62	[p5l1976t1695r2148b1772],
31	)	CD	NUMBER	)	num	32	SENT_62	[p5l1976t1695r2148b1772],
32	heat	NN	O	heat	nsubj	34	SENT_62	[p5l6t1805r596b1868],
33	—	RB	O	—	advmod	34	SENT_62	[p5l6t1805r596b1868],
34	inactivated	VBD	O	inactivate	rcmod	30	SENT_62	[p5l6t1805r596b1868],
35	fetal	JJ	O	fetal	amod	37	SENT_62	[p5l636t1805r797b1868],
36	bovine	JJ	O	bovine	amod	37	SENT_62	[p5l837t1805r1085b1868],
37	serum	NN	O	serum	dobj	34	SENT_62	[p5l1130t1825r1369b1880],
38	,	,	O	,	_	0	SENT_62	[p5l1130t1825r1369b1880],
39	100	CD	NUMBER	100	num	41	SENT_62	[p5l1421t1806r1546b1868],
40	U/ml	NN	O	u/ml	nn	41	SENT_62	[p5l1573t1805r1759b1868],
41	penicillin	NN	O	penicillin	dobj	34	SENT_62	[p5l1800t1805r2150b1886],
42	and	CC	O	and	_	0	SENT_62	[p5l9t1915r137b1978],
43	100	CD	NUMBER	100	num	46	SENT_62	[p5l176t1916r300b1978],
44	ug/ml	JJ	O	ug/ml	amod	46	SENT_62	[p5l333t1915r545b1996],
45	streptomycin	NN	O	streptomycin	nn	46	SENT_62	[p5l578t1915r1106b1996],
46	)	NN	O	)	dobj	34	SENT_62	[p5l578t1915r1106b1996],
47	,	,	O	,	_	0	SENT_62	[p5l578t1915r1106b1996],
48	at	IN	O	at	_	0	SENT_62	[p5l1143t1925r1205b1978],
49	37	CD	NUMBER	37	number	50	SENT_62	[p5l1236t1916r1418b1978],
50	°	CD	NUMBER	°	num	51	SENT_62	[p5l1236t1916r1418b1978],
51	C	NN	O	c	prep_at	34	SENT_62	[p5l1236t1916r1418b1978],
52	under	IN	O	under	_	0	SENT_62	[p5l1450t1915r1659b1978],
53	a	DT	O	a	det	55	SENT_62	[p5l1689t1935r1726b1978],
54	humidiﬁed	JJ	O	humidiﬁed	amod	55	SENT_62	[p5l1755t1913r2151b1978],
55	atmosphere	NN	O	atmosphere	prep_under	34	SENT_62	[p5l9t2027r428b2108],
56	of	IN	O	of	_	0	SENT_62	[p5l457t2027r535b2090],
57	5	CD	PERCENT	5	number	58	SENT_62	[p5l558t2027r671b2090],
58	%	NN	PERCENT	%	amod	59	SENT_62	[p5l558t2027r671b2090],
59	CO2	NN	O	co2	prep_of	55	SENT_62	[p5l702t2028r876b2111],
60	.	.	O	.	_	0	SENT_62	[p5l702t2028r876b2111],

1	Cell	NN	O	cell	nn	2	SENT_63	[p5l8t2251r155b2314],
2	viability	NN	O	viability	_	0	SENT_63	[p5l180t2251r477b2332],

1	Cell	NN	O	cell	nn	2	SENT_64	[p5l8t2475r155b2538],
2	viability	NN	O	viability	nsubj	3	SENT_64	[p5l185t2475r482b2556],
3	was	VBD	O	be	_	0	SENT_64	[p5l513t2495r648b2538],
4	after	IN	O	after	_	0	SENT_64	[p5l682t2475r844b2538],
5	48	CD	NUMBER	48	num	6	SENT_64	[p5l871t2476r956b2538],
6	h	NN	O	h	prep_after	3	SENT_64	[p5l984t2475r1046b2549],
7	,	,	O	,	_	0	SENT_64	[p5l984t2475r1046b2549],
8	and	CC	O	and	_	0	SENT_64	[p5l1081t2475r1208b2538],
9	the	DT	O	the	det	12	SENT_64	[p5l1236t2475r1343b2538],
10	anticancer	JJ	O	anticancer	amod	12	SENT_64	[p5l1375t2475r1743b2538],
11	drug	NN	O	drug	nn	12	SENT_64	[p5l1772t2475r1933b2556],
12	treatment	NN	O	treatment	nsubjpass	14	SENT_64	[p5l1964t2485r2149b2538, p5l7t2596r186b2649],
13	was	VBD	O	be	auxpass	14	SENT_64	[p5l214t2606r349b2649],
14	assessed	VBN	O	assess	conj_and	3	SENT_64	[p5l381t2586r683b2649],
15	with	IN	O	with	_	0	SENT_64	[p5l711t2586r869b2649],
16	a	DT	O	a	det	17	SENT_64	[p5l899t2606r936b2649],
17	3	CD	NUMBER	3	prep_with	14	SENT_64	[p5l965t2586r2149b2667],
18	.	.	O	.	_	0	SENT_64	[p5l965t2586r2149b2667],

1	—	NN	O	—	_	0	SENT_65	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_65	[p5l965t2586r2149b2667],

1	(	NN	O	(	_	0	SENT_66	[p5l965t2586r2149b2667],
2	4,5	CD	NUMBER	4,5	dep	1	SENT_66	[p5l965t2586r2149b2667],
3	.	.	O	.	_	0	SENT_66	[p5l965t2586r2149b2667],

1	—	NN	O	—	_	0	SENT_67	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_67	[p5l965t2586r2149b2667],

1	dimethylthiazol	NN	O	dimethylthiazol	_	0	SENT_68	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_68	[p5l965t2586r2149b2667],

1	—	NN	O	—	_	0	SENT_69	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_69	[p5l965t2586r2149b2667],

1	2	LS	NUMBER	2	_	0	SENT_70	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_70	[p5l965t2586r2149b2667],

1	—	NN	O	—	_	0	SENT_71	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_71	[p5l965t2586r2149b2667],

1	yl	NN	O	yl	_	0	SENT_72	[p5l965t2586r2149b2667],
2	)	NN	O	)	dep	1	SENT_72	[p5l965t2586r2149b2667],
3	.	.	O	.	_	0	SENT_72	[p5l965t2586r2149b2667],

1	—	NN	O	—	_	0	SENT_73	[p5l965t2586r2149b2667],
2	.	.	O	.	_	0	SENT_73	[p5l965t2586r2149b2667],

1	2,5	CD	NUMBER	2,5	num	4	SENT_74	[p5l965t2586r2149b2667],
2	diphenyl	NN	O	diphenyl	nn	4	SENT_74	[p5l8t2697r319b2778],
3	tetrazolium	NN	O	tetrazolium	nn	4	SENT_74	[p5l344t2697r755b2760],
4	bromide	NN	O	bromide	_	0	SENT_74	[p5l777t2697r1075b2760],
5	(	CD	NUMBER	(	num	6	SENT_74	[p5l1104t2698r1591b2778],
6	MTT	NNP	O	MTT	dep	4	SENT_74	[p5l1104t2698r1591b2778],
7	)	CD	NUMBER	)	num	6	SENT_74	[p5l1104t2698r1591b2778],
8	.	.	O	.	_	0	SENT_74	[p5l1104t2698r1591b2778],

1	—	NN	O	—	_	0	SENT_75	[p5l1104t2698r1591b2778],
2	.	.	O	.	_	0	SENT_75	[p5l1104t2698r1591b2778],

1	assay	NN	O	assay	_	0	SENT_76	[p5l1104t2698r1591b2778],
2	.	.	O	.	_	0	SENT_76	[p5l1104t2698r1591b2778],

1	Pgp	NN	ORGANIZATION	pgp	nn	4	SENT_77	[p5l7t2924r144b3003],
2	reporter	NN	O	reporter	nn	4	SENT_77	[p5l168t2932r454b3003],
3	gene	NN	O	gene	nn	4	SENT_77	[p5l479t2942r644b3003],
4	assay	NN	O	assay	_	0	SENT_77	[p5l672t2942r862b3003],

1	The	DT	O	the	det	5	SENT_78	[p5l7t3146r148b3209],
2	Pgp	NNP	ORGANIZATION	Pgp	nn	5	SENT_78	[p5l181t3148r321b3227],
3	reporter	NN	O	reporter	nn	5	SENT_78	[p5l353t3156r652b3227],
4	gene	NN	O	gene	nn	5	SENT_78	[p5l683t3166r854b3227],
5	assay	NN	O	assay	nsubjpass	7	SENT_78	[p5l889t3166r1087b3227],
6	was	VBD	O	be	auxpass	7	SENT_78	[p5l1120t3166r1258b3209],
7	performed	VBN	O	perform	_	0	SENT_78	[p5l1293t3146r1684b3227],
8	in	IN	O	in	_	0	SENT_78	[p5l1715t3146r1784b3208],
9	a	DT	O	a	det	11	SENT_78	[p5l1819t3166r1856b3209],
10	similar	JJ	O	similar	amod	11	SENT_78	[p5l1890t3146r2151b3209],
11	manner	NN	O	manner	prep_in	7	SENT_78	[p5l7t3277r287b3320],
12	as	IN	O	as	mark	13	SENT_78	[p5l336t3277r406b3320],
13	described	VBN	O	describe	advcl	7	SENT_78	[p5l458t3257r815b3320],
14	previously	RB	DATE	previously	advmod	13	SENT_78	[p5l861t3257r1259b3338],
15	[	CD	NUMBER	[	number	16	SENT_78	[p5l1315t3258r1480b3333],
16	10	CD	NUMBER	10	num	17	SENT_78	[p5l1315t3258r1480b3333],
17	]	NN	O	]	pobj	14	SENT_78	[p5l1315t3258r1480b3333],
18	.	.	O	.	_	0	SENT_78	[p5l1315t3258r1480b3333],

1	In	IN	O	in	_	0	SENT_79	[p5l1534t3259r1608b3319],
2	brief	NN	O	brief	prep_in	7	SENT_79	[p5l1655t3257r1853b3331],
3	,	,	O	,	_	0	SENT_79	[p5l1655t3257r1853b3331],
4	LSl8O	NN	O	lsl8o	nn	5	SENT_79	[p5l1904t3258r2148b3320],
5	cells	NNS	O	cell	nsubjpass	7	SENT_79	[p5l8t3368r175b3431],
6	were	VBD	O	be	auxpass	7	SENT_79	[p5l224t3388r401b3431],
7	transfected	VBN	O	transfect	_	0	SENT_79	[p5l448t3368r864b3431],
8	with	IN	O	with	_	0	SENT_79	[p5l911t3368r1073b3431],
9	a	DT	O	a	det	14	SENT_79	[p5l1122t3388r1159b3431],
10	pCDG	NN	O	pcdg	nn	14	SENT_79	[p5l1203t3368r1702b3449],
11	—	CD	NUMBER	—	num	14	SENT_79	[p5l1203t3368r1702b3449],
12	hPXR	NN	O	hpxr	nn	14	SENT_79	[p5l1203t3368r1702b3449],
13	expression	NN	O	expression	nn	14	SENT_79	[p5l1749t3368r2150b3449],
14	vector	NN	O	vector	prep_with	7	SENT_79	[p5l7t3489r261b3553],
15	,	,	O	,	_	0	SENT_79	[p5l7t3489r261b3553],
16	a	DT	O	a	det	17	SENT_79	[p5l297t3499r334b3542],
17	pGL3	NN	O	pgl3	appos	14	SENT_79	[p5l362t3480r857b3560],
18	.	.	O	.	_	0	SENT_79	[p5l362t3480r857b3560],

1	—	NN	O	—	_	0	SENT_80	[p5l362t3480r857b3560],
2	.	.	O	.	_	0	SENT_80	[p5l362t3480r857b3560],

1	MDR1	NN	O	mdr1	nn	2	SENT_81	[p5l362t3480r857b3560],
2	luciferase	NN	O	luciferase	_	0	SENT_81	[p5l896t3479r1263b3542],
3	reporter	NN	O	reporter	nn	4	SENT_81	[p5l1292t3489r1591b3560],
4	construct	NN	O	construct	dep	2	SENT_81	[p5l1621t3489r1985b3553],
5	,	,	O	,	_	0	SENT_81	[p5l1621t3489r1985b3553],
6	and	CC	O	and	_	0	SENT_81	[p5l2020t3479r2150b3542],
7	a	DT	O	a	det	8	SENT_81	[p5l9t3610r46b3653],
8	pRL	NN	O	prl	dep	2	SENT_81	[p5l81t3592r401b3671],
9	.	.	O	.	_	0	SENT_81	[p5l81t3592r401b3671],

1	—	NN	O	—	_	0	SENT_82	[p5l81t3592r401b3671],
2	.	.	O	.	_	0	SENT_82	[p5l81t3592r401b3671],

1	TK	NN	O	tk	nn	3	SENT_83	[p5l81t3592r401b3671],
2	control	NN	O	control	nn	3	SENT_83	[p5l440t3590r704b3653],
3	plasmid	NN	O	plasmid	nsubjpass	16	SENT_83	[p5l741t3590r1039b3671],
4	for	IN	O	for	_	0	SENT_83	[p5l1077t3590r1185b3653],
5	24	CD	NUMBER	24	num	6	SENT_83	[p5l1223t3591r1310b3652],
6	h.	NN	O	h.	prep_for	3	SENT_83	[p5l1339t3590r1401b3653],
7	After	IN	O	after	_	0	SENT_83	[p5l1445t3590r1641b3653],
8	transfection	NN	O	transfection	prep_after	16	SENT_83	[p5l1677t3590r2146b3664],
9	,	,	O	,	_	0	SENT_83	[p5l1677t3590r2146b3664],
10	the	DT	O	the	det	14	SENT_83	[p5l7t3701r118b3764],
11	transiently	RB	O	transiently	amod	14	SENT_83	[p5l149t3701r546b3782],
12	transfected	VBN	O	transfect	dep	11	SENT_83	[p5l576t3701r991b3764],
13	LSl8O	NN	O	lsl8o	nn	14	SENT_83	[p5l1020t3702r1265b3764],
14	cells	NNS	O	cell	appos	8	SENT_83	[p5l1296t3701r1463b3764],
15	were	VBD	O	be	auxpass	16	SENT_83	[p5l1495t3721r1672b3764],
16	treated	VBN	O	treat	_	0	SENT_83	[p5l1703t3701r1957b3764],
17	with	IN	O	with	_	0	SENT_83	[p5l1987t3701r2150b3764],
18	the	DT	O	the	det	23	SENT_83	[p6l7t22r118b85],
19	highest	JJS	O	highest	amod	23	SENT_83	[p6l161t22r433b103],
20	non	JJ	O	non	amod	23	SENT_83	[p6l474t22r830b85],
21	—	NN	O	—	nn	23	SENT_83	[p6l474t22r830b85],
22	toxic	JJ	O	toxic	amod	23	SENT_83	[p6l474t22r830b85],
23	concentration	NN	O	concentration	prep_with	16	SENT_83	[p6l877t22r1391b85],
24	of	IN	O	of	_	0	SENT_83	[p6l1434t22r1514b85],
25	each	DT	O	each	det	27	SENT_83	[p6l1551t22r1718b85],
26	anticancer	JJ	O	anticancer	amod	27	SENT_83	[p6l1763t22r2151b85],
27	drug	NN	O	drug	prep_of	23	SENT_83	[p6l8t133r194b214],
28	.	.	O	.	_	0	SENT_83	[p6l8t133r194b214],

1	After	IN	O	after	_	0	SENT_84	[p6l248t133r445b196],
2	48	CD	NUMBER	48	num	4	SENT_84	[p6l491t134r578b196],
3	h	NN	O	h	nn	4	SENT_84	[p6l610t133r653b195],
4	incubation	NN	O	incubation	prep_after	10	SENT_84	[p6l701t133r1120b207],
5	,	,	O	,	_	0	SENT_84	[p6l701t133r1120b207],
6	the	DT	O	the	det	8	SENT_84	[p6l1171t133r1283b196],
7	reporter	NN	O	reporter	nn	8	SENT_84	[p6l1332t143r1629b214],
8	activity	NN	O	activity	nsubjpass	10	SENT_84	[p6l1679t133r1958b214],
9	was	VBD	O	be	auxpass	10	SENT_84	[p6l2008t153r2147b196],
10	determined	VBN	O	determine	_	0	SENT_84	[p6l8t244r447b307],
11	.	.	O	.	_	0	SENT_84	[p6l8t244r447b307],

1	Cell	NN	O	cell	nn	2	SENT_85	[p6l8t469r155b532],
2	treatment	NN	O	treatment	_	0	SENT_85	[p6l180t479r519b532],

1	LS180	NN	O	ls180	nn	2	SENT_86	[p6l7t696r244b758],
2	cells	NNS	O	cell	nsubjpass	4	SENT_86	[p6l268t695r429b758],
3	were	VBD	O	be	auxpass	4	SENT_86	[p6l454t715r626b758],
4	plated	VBN	O	plate	dep	35	SENT_86	[p6l648t695r869b776],
5	at	IN	O	at	_	0	SENT_86	[p6l893t705r955b758],
6	a	DT	O	a	det	7	SENT_86	[p6l979t715r1016b758],
7	density	NN	O	density	prep_at	4	SENT_86	[p6l1040t695r1295b776],
8	of	IN	O	of	_	0	SENT_86	[p6l1320t695r1397b758],
9	5	CD	NUMBER	5	prep_of	7	SENT_86	[p6l1416t695r1453b758],
10	x	CC	O	x	_	0	SENT_86	[p6l1493t715r1539b756],
11	104	CD	NUMBER	104	num	12	SENT_86	[p6l1584t678r1694b758],
12	cells/well	NNS	O	cells/well	npadvmod	15	SENT_86	[p6l1718t695r2059b758],
13	in	IN	O	in	_	0	SENT_86	[p6l2084t695r2151b757],
14	96	CD	NUMBER	96	prep_in	12	SENT_86	[p6l8t807r94b872],
15	well	RB	O	well	advmod	16	SENT_86	[p6l123t807r275b871],
16	plates	VBZ	O	plate	conj_x	4	SENT_86	[p6l302t807r508b889],
17	(	CD	NUMBER	(	num	20	SENT_86	[p6l541t808r705b889],
18	Pgp	NN	O	pgp	nn	20	SENT_86	[p6l541t808r705b889],
19	protein	NN	O	protein	nn	20	SENT_86	[p6l733t807r986b889],
20	level	NN	O	level	dobj	16	SENT_86	[p6l1014t808r1186b871],
21	determination	NN	O	determination	dep	20	SENT_86	[p6l1216t807r1740b886],
22	)	CD	NUMBER	)	num	21	SENT_86	[p6l1216t807r1740b886],
23	or	CC	O	or	_	0	SENT_86	[p6l1772t828r1845b871],
24	1	CD	NUMBER	1	num	27	SENT_86	[p6l1879t808r1905b870],
25	X	NN	O	x	nn	27	SENT_86	[p6l1950t827r1996b869],
26	105	CD	NUMBER	105	num	27	SENT_86	[p6l2040t789r2149b871],
27	cells/well	NNS	O	cells/well	dobj	16	SENT_86	[p6l8t919r349b982],
28	in	IN	O	in	_	0	SENT_86	[p6l389t919r457b981],
29	1	CD	NUMBER	1	num	31	SENT_86	[p6l504t920r530b981],
30	ml	NN	O	ml	nn	31	SENT_86	[p6l564t919r656b981],
31	RMPI	NN	ORGANIZATION	rmpus	prep_in	27	SENT_86	[p6l696t921r914b981],
32	in	IN	O	in	_	0	SENT_86	[p6l953t919r1021b981],
33	24	CD	NUMBER	24	prep_in	31	SENT_86	[p6l1061t920r1146b981],
34	well	RB	O	well	advmod	35	SENT_86	[p6l1187t919r1339b982],
35	plates	VBZ	O	plate	_	0	SENT_86	[p6l1377t919r1583b1000],
36	(	CD	NUMBER	(	num	39	SENT_86	[p6l1628t920r1793b1000],
37	Pgp	NN	O	pgp	nn	39	SENT_86	[p6l1628t920r1793b1000],
38	transport	NN	O	transport	nn	39	SENT_86	[p6l1832t929r2152b1000],
39	activity	NN	O	activity	dobj	35	SENT_86	[p6l9t1029r324b1110],
40	)	CD	NUMBER	)	nsubj	35	SENT_86	[p6l9t1029r324b1110],
41	.	.	O	.	_	0	SENT_86	[p6l9t1029r324b1110],

1	After	IN	O	after	_	0	SENT_87	[p6l359t1029r549b1092],
2	reaching	VBG	O	reach	prepc_after	9	SENT_87	[p6l577t1029r885b1110],
3	80-90	CD	PERCENT	80-90	num	4	SENT_87	[p6l920t1030r1209b1093],
4	%	NN	PERCENT	%	dobj	2	SENT_87	[p6l920t1030r1209b1093],
5	conﬂuency	NN	O	conﬂuency	dep	2	SENT_87	[p6l1244t1026r1656b1110],
6	,	,	O	,	_	0	SENT_87	[p6l1244t1026r1656b1110],
7	medium	NN	O	medium	nsubjpass	9	SENT_87	[p6l1690t1029r1984b1092],
8	was	VBD	O	be	auxpass	9	SENT_87	[p6l2014t1049r2149b1092],
9	replaced	VBN	O	replace	_	0	SENT_87	[p6l6t1140r310b1221],
10	with	IN	O	with	_	0	SENT_87	[p6l351t1140r508b1203],
11	medium	NN	O	medium	prep_with	9	SENT_87	[p6l549t1140r841b1203],
12	containing	VBG	O	contain	partmod	11	SENT_87	[p6l881t1140r1257b1221],
13	the	DT	O	the	det	16	SENT_87	[p6l1298t1140r1405b1203],
14	different	JJ	O	different	amod	16	SENT_87	[p6l1447t1138r1744b1203],
15	anticancer	JJ	O	anticancer	amod	16	SENT_87	[p6l1785t1140r2153b1203],
16	drugs	NNS	O	drug	dobj	12	SENT_87	[p6l8t1252r223b1333],
17	:	:	O	:	_	0	SENT_87	[p6l8t1252r223b1333],
18	carboplatin	NN	O	carboplatin	dep	16	SENT_87	[p6l269t1252r672b1333],
19	(	CD	NUMBER	(	number	20	SENT_87	[p6l713t1253r827b1330],
20	10	CD	NUMBER	10	num	22	SENT_87	[p6l713t1253r827b1330],
21	uM	NN	O	um	nn	22	SENT_87	[p6l857t1253r1030b1332],
22	)	NN	O	)	dep	18	SENT_87	[p6l857t1253r1030b1332],
23	,	,	O	,	_	0	SENT_87	[p6l857t1253r1030b1332],
24	cyclophosphamide	NN	O	cyclophosphamide	nn	25	SENT_87	[p6l1072t1252r1744b1333],
25	(	NN	O	(	appos	16	SENT_87	[p6l1786t1253r1945b1330],
26	100	CD	NUMBER	100	num	28	SENT_87	[p6l1786t1253r1945b1330],
27	uM	NN	O	um	nn	28	SENT_87	[p6l1976t1253r2148b1332],
28	)	NN	O	)	dep	25	SENT_87	[p6l1976t1253r2148b1332],
29	,	,	O	,	_	0	SENT_87	[p6l1976t1253r2148b1332],
30	ifosfamide	NN	O	ifosfamide	nn	31	SENT_87	[p6l7t1363r389b1426],
31	(	NN	O	(	appos	16	SENT_87	[p6l488t1364r647b1440],
32	100	CD	NUMBER	100	num	34	SENT_87	[p6l488t1364r647b1440],
33	uM	NN	O	um	nn	34	SENT_87	[p6l678t1364r850b1443],
34	)	NN	O	)	dep	31	SENT_87	[p6l678t1364r850b1443],
35	,	,	O	,	_	0	SENT_87	[p6l678t1364r850b1443],
36	docetaxel	NN	O	docetaxel	appos	16	SENT_87	[p6l950t1363r1291b1426],
37	(	CD	NUMBER	(	number	38	SENT_87	[p6l1389t1364r1504b1441],
38	10	CD	NUMBER	10	num	40	SENT_87	[p6l1389t1364r1504b1441],
39	uM	NN	O	um	nn	40	SENT_87	[p6l1533t1364r1705b1443],
40	)	NN	O	)	dep	36	SENT_87	[p6l1533t1364r1705b1443],
41	,	,	O	,	_	0	SENT_87	[p6l1533t1364r1705b1443],
42	paclitaxel	NN	O	paclitaxel	appos	16	SENT_87	[p6l1803t1363r2151b1444],
43	(	CD	NUMBER	(	number	44	SENT_87	[p6l10t1474r123b1551],
44	10	CD	NUMBER	10	num	46	SENT_87	[p6l10t1474r123b1551],
45	uM	NN	O	um	nn	46	SENT_87	[p6l154t1474r326b1553],
46	)	NN	O	)	dep	42	SENT_87	[p6l154t1474r326b1553],
47	,	,	O	,	_	0	SENT_87	[p6l154t1474r326b1553],
48	ﬂutamide	NN	O	ﬂutamide	appos	16	SENT_87	[p6l369t1470r706b1536],
49	(	CD	NUMBER	(	number	50	SENT_87	[p6l748t1474r861b1550],
50	10	CD	NUMBER	10	num	51	SENT_87	[p6l748t1474r861b1550],
51	]	NN	O	]	dep	48	SENT_87	[p6l891t1474r1041b1553],
52	.	.	O	.	_	0	SENT_87	[p6l891t1474r1041b1553],

1	LM	NNP	O	LM	nn	2	SENT_88	[p6l891t1474r1041b1553],
2	)	NNP	O	)	_	0	SENT_88	[p6l891t1474r1041b1553],
3	and	CC	O	and	_	0	SENT_88	[p6l1084t1473r1211b1536],
4	tamoxifen	NN	O	tamoxifen	conj_and	2	SENT_88	[p6l1247t1473r1610b1536],
5	(	CD	NUMBER	(	number	6	SENT_88	[p6l1652t1474r1765b1551],
6	10	CD	NUMBER	10	dep	2	SENT_88	[p6l1652t1474r1765b1551],
7	uM	NN	O	um	nn	8	SENT_88	[p6l1795t1474r1965b1553],
8	)	NN	O	)	dep	6	SENT_88	[p6l1795t1474r1965b1553],
9	.	.	O	.	_	0	SENT_88	[p6l1795t1474r1965b1553],

1	Rifampicin	NNP	O	Rifampicin	nsubjpass	7	SENT_89	[p6l2008t1473r2149b1535, p6l9t1585r296b1666],
2	(	CD	NUMBER	(	num	1	SENT_89	[p6l323t1586r437b1662],
3	10	CD	NUMBER	10	num	5	SENT_89	[p6l323t1586r437b1662],
4	uM	NN	O	um	nn	5	SENT_89	[p6l467t1586r617b1665],
5	)	NN	O	)	dep	1	SENT_89	[p6l467t1586r617b1665],
6	was	VBD	O	be	auxpass	7	SENT_89	[p6l645t1605r780b1648],
7	used	VBN	O	use	_	0	SENT_89	[p6l807t1585r971b1648],
8	as	IN	O	as	_	0	SENT_89	[p6l997t1605r1065b1648],
9	a	DT	O	a	det	11	SENT_89	[p6l1095t1605r1132b1648],
10	positive	JJ	O	positive	amod	11	SENT_89	[p6l1153t1585r1437b1666],
11	control	NN	O	control	prep_as	7	SENT_89	[p6l1464t1585r1715b1648],
12	and	CC	O	and	_	0	SENT_89	[p6l1743t1585r1869b1648],
13	DMSO	NN	ORGANIZATION	dmso	prep_as	7	SENT_89	[p6l1893t1586r2149b1648],
14	(	CD	PERCENT	(	number	15	SENT_89	[p6l10t1697r249b1774],
15	0.1	CD	PERCENT	0.1	num	16	SENT_89	[p6l10t1697r249b1774],
16	%	NN	PERCENT	%	dep	11	SENT_89	[p6l10t1697r249b1774],
17	)	CD	NUMBER	)	dep	16	SENT_89	[p6l10t1697r249b1774],
18	as	IN	O	as	_	0	SENT_89	[p6l278t1716r347b1759],
19	a	DT	O	a	det	21	SENT_89	[p6l374t1716r411b1759],
20	negative	JJ	O	negative	amod	21	SENT_89	[p6l433t1696r735b1777],
21	control	NN	O	control	prep_as	7	SENT_89	[p6l760t1696r1030b1759],
22	.	.	O	.	_	0	SENT_89	[p6l760t1696r1030b1759],

1	The	DT	O	the	det	2	SENT_90	[p6l1058t1696r1195b1759],
2	cells	NNS	O	cell	nsubjpass	4	SENT_90	[p6l1221t1696r1381b1759],
3	were	VBD	O	be	auxpass	4	SENT_90	[p6l1407t1716r1578b1759],
4	treated	VBN	O	treat	_	0	SENT_90	[p6l1603t1696r1847b1759],
5	for	IN	O	for	_	0	SENT_90	[p6l1870t1696r1973b1759],
6	48	CD	NUMBER	48	num	7	SENT_90	[p6l1996t1697r2080b1759],
7	h	NN	O	h	prep_for	4	SENT_90	[p6l2108t1696r2151b1758],
8	with	IN	O	with	_	0	SENT_90	[p6l7t1807r165b1870],
9	the	DT	O	the	det	10	SENT_90	[p6l201t1807r308b1870],
10	drugs	NNS	O	drug	prep_with	4	SENT_90	[p6l345t1807r538b1888],
11	and	CC	O	and	_	0	SENT_90	[p6l578t1807r705b1870],
12	the	DT	O	the	det	13	SENT_90	[p6l739t1807r846b1870],
13	controls	NNS	O	control	prep_with	4	SENT_90	[p6l883t1807r1188b1870],
14	.	.	O	.	_	0	SENT_90	[p6l883t1807r1188b1870],

1	At	IN	O	at	_	0	SENT_91	[p6l1228t1808r1317b1870],
2	the	DT	O	the	det	3	SENT_91	[p6l1351t1807r1459b1870],
3	end	NN	O	end	prep_at	11	SENT_91	[p6l1495t1807r1623b1870],
4	of	IN	O	of	_	0	SENT_91	[p6l1659t1807r1735b1870],
5	each	DT	O	each	det	6	SENT_91	[p6l1767t1807r1928b1870],
6	treatment	NN	O	treatment	prep_of	3	SENT_91	[p6l1963t1817r2149b1870, p6l7t1928r204b1992],
7	,	,	O	,	_	0	SENT_91	[p6l1963t1817r2149b1870, p6l7t1928r204b1992],
8	the	DT	O	the	det	9	SENT_91	[p6l238t1918r345b1981],
9	cells	NNS	O	cell	nsubjpass	11	SENT_91	[p6l378t1918r538b1981],
10	were	VBD	O	be	auxpass	11	SENT_91	[p6l572t1938r744b1981],
11	processed	VBN	O	process	_	0	SENT_91	[p6l774t1918r1129b1999],
12	for	IN	O	for	_	0	SENT_91	[p6l1159t1918r1263b1981],
13	immunoblotting	NN	O	immunoblotting	nn	17	SENT_91	[p6l1292t1918r1868b1999],
14	or	CC	O	or	_	0	SENT_91	[p6l1902t1938r1975b1981],
15	rhodamine	NN	O	rhodamine	nn	17	SENT_91	[p6l2003t1918r2149b1981, p6l8t2029r269b2092],
16	l23	NN	O	l23	nn	17	SENT_91	[p6l303t2029r664b2092],
17	—	NN	O	—	prep_for	11	SENT_91	[p6l303t2029r664b2092],
18	based	VBN	O	base	partmod	17	SENT_91	[p6l303t2029r664b2092],
19	Pgp	NN	ORGANIZATION	pgp	nn	21	SENT_91	[p6l687t2031r824b2110],
20	activity	NN	O	activity	nn	21	SENT_91	[p6l853t2029r1118b2110],
21	assays	NNS	O	assay	dobj	18	SENT_91	[p6l1145t2049r1389b2110],
22	.	.	O	.	_	0	SENT_91	[p6l1145t2049r1389b2110],

1	Cancer	NNP	O	Cancer	nn	3	SENT_92	[p6l53t2185r152b2210],
2	Chemother	NNP	PERSON	Chemother	nn	3	SENT_92	[p6l162t2185r318b2210],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_92	[p6l328t2185r478b2210],
4	(	CD	NUMBER	(	num	5	SENT_92	[p6l489t2185r581b2215],
5	2010	CD	DATE	2010	dep	3	SENT_92	[p6l489t2185r581b2215],
6	)	CD	NUMBER	)	number	7	SENT_92	[p6l489t2185r581b2215],
7	66:765	CD	NUMBER	66:765	dep	5	SENT_92	[p6l592t2185r757b2210],
8	—	CD	NUMBER	—	num	9	SENT_92	[p6l592t2185r757b2210],
9	77l	NN	O	77l	dep	7	SENT_92	[p6l592t2185r757b2210],
10	767	CD	NUMBER	767	dep	3	SENT_92	[p6l2055t2185r2106b2210],

1	RNA	NN	O	rna	nn	2	SENT_93	[p6l8t2355r196b2417],
2	interference	NN	O	interference	_	0	SENT_93	[p6l221t2354r647b2417],
3	of	IN	O	of	_	0	SENT_93	[p6l674t2354r751b2417],
4	PXR	NN	O	pxr	prep_of	2	SENT_93	[p6l769t2356r943b2416],

1	The	DT	O	the	det	3	SENT_94	[p6l8t2579r144b2642],
2	siRNA	NN	O	sirna	nn	3	SENT_94	[p6l178t2579r422b2642],
3	sequence	NN	O	sequence	nsubjpass	33	SENT_94	[p6l455t2599r777b2660],
4	targeting	VBG	O	target	partmod	3	SENT_94	[p6l806t2579r1124b2660],
5	human	JJ	O	human	amod	8	SENT_94	[p6l1153t2579r1396b2642],
6	PXR	NN	O	pxr	nn	8	SENT_94	[p6l1425t2581r1598b2641],
7	(	NN	O	(	nn	8	SENT_94	[p6l1629t2580r1867b2657],
8	sense	NN	O	sense	dobj	4	SENT_94	[p6l1629t2580r1867b2657],
9	:	:	O	:	_	0	SENT_94	[p6l1629t2580r1867b2657],
10	cguuu	FW	O	cguuu	nn	12	SENT_94	[p6l1903t2599r2147b2660],
11	—	FW	O	—	nn	12	SENT_94	[p6l1903t2599r2147b2660],
12	guucgcuuccugagtt	NN	O	guucgcuuccugagtt	dobj	4	SENT_94	[p6l9t2698r681b2769],
13	;	:	O	;	_	0	SENT_94	[p6l9t2698r681b2769],
14	antisense	NN	O	antisense	dobj	4	SENT_94	[p6l720t2688r1065b2751],
15	:	:	O	:	_	0	SENT_94	[p6l720t2688r1065b2751],
16	cucaggaagcgaacaaacgtg	NN	O	cucaggaagcgaacaaacgtg	nn	17	SENT_94	[p6l1104t2689r1987b2769],
17	)	NN	O	)	dobj	4	SENT_94	[p6l1104t2689r1987b2769],
18	and	CC	O	and	_	0	SENT_94	[p6l2024t2688r2150b2751],
19	the	DT	O	the	det	21	SENT_94	[p6l8t2801r111b2864],
20	negative	JJ	O	negative	amod	21	SENT_94	[p6l136t2801r422b2882],
21	control	NN	O	control	conj_and	8	SENT_94	[p6l447t2801r704b2875],
22	,	,	O	,	_	0	SENT_94	[p6l447t2801r704b2875],
23	which	WDT	O	which	nsubj	24	SENT_94	[p6l732t2801r942b2864],
24	consisted	VBD	O	consist	rcmod	3	SENT_94	[p6l967t2801r1283b2864],
25	of	IN	O	of	_	0	SENT_94	[p6l1307t2801r1382b2864],
26	a	DT	O	a	det	30	SENT_94	[p6l1403t2821r1440b2864],
27	non	JJ	O	non	amod	30	SENT_94	[p6l1463t2801r2149b2882],
28	—	NN	O	—	nn	30	SENT_94	[p6l1463t2801r2149b2882],
29	complementary	JJ	O	complementary	amod	30	SENT_94	[p6l1463t2801r2149b2882],
30	sequence	NN	O	sequence	prep_of	24	SENT_94	[p6l11t2932r354b2993],
31	,	,	O	,	_	0	SENT_94	[p6l11t2932r354b2993],
32	were	VBD	O	be	auxpass	33	SENT_94	[p6l419t2932r590b2975],
33	purchased	VBN	O	purchase	_	0	SENT_94	[p6l650t2912r1014b2993],
34	from	IN	O	from	_	0	SENT_94	[p6l1074t2912r1247b2975],
35	Ambion	NNP	ORGANIZATION	Ambion	nn	37	SENT_94	[p6l1307t2912r1599b2975],
36	(	NNP	O	(	nn	37	SENT_94	[p6l1661t2912r1945b2990],
37	Austin	NNP	LOCATION	Austin	prep_from	33	SENT_94	[p6l1661t2912r1945b2990],
38	,	,	O	,	_	0	SENT_94	[p6l1661t2912r1945b2990],
39	TX	NNP	LOCATION	TX	nn	41	SENT_94	[p6l2009t2914r2145b2986],
40	,	,	O	,	_	0	SENT_94	[p6l2009t2914r2145b2986],
41	USA	NNP	LOCATION	USA	appos	37	SENT_94	[p6l8t3024r233b3100],
42	)	CD	NUMBER	)	num	41	SENT_94	[p6l8t3024r233b3100],
43	.	.	O	.	_	0	SENT_94	[p6l8t3024r233b3100],

1	LS180	NN	O	ls180	nn	2	SENT_95	[p6l266t3024r502b3086],
2	cells	NNS	O	cell	nsubjpass	5	SENT_95	[p6l532t3023r692b3086],
3	were	VBD	O	be	auxpass	5	SENT_95	[p6l723t3043r894b3086],
4	reversely	RB	O	reversely	advmod	5	SENT_95	[p6l921t3023r1249b3104],
5	transfected	VBN	O	transfect	_	0	SENT_95	[p6l1277t3023r1671b3086],
6	48	CD	NUMBER	48	num	7	SENT_95	[p6l1698t3024r1783b3086],
7	h	NN	O	h	npadvmod	5	SENT_95	[p6l1811t3023r1854b3085],
8	prior	RB	O	prior	_	0	SENT_95	[p6l1881t3023r2055b3104],
9	to	TO	O	to	_	0	SENT_95	[p6l2081t3033r2148b3086],
10	the	DT	O	the	det	13	SENT_95	[p6l8t3134r115b3197],
11	Pgp	NNP	O	Pgp	nn	13	SENT_95	[p6l148t3136r285b3215],
12	induction	NN	O	induction	nn	13	SENT_95	[p6l319t3134r656b3197],
13	experiment	NN	O	experiment	prep_prior_to	5	SENT_95	[p6l690t3134r1093b3215],
14	with	IN	O	with	_	0	SENT_95	[p6l1125t3134r1282b3197],
15	50	CD	NUMBER	50	num	18	SENT_95	[p6l1316t3134r1401b3197],
16	nM	NN	O	nm	nn	18	SENT_95	[p6l1435t3136r1557b3196],
17	siRNA	NN	O	sirna	nn	18	SENT_95	[p6l1593t3134r1838b3197],
18	PXR	NN	O	pxr	prep_with	13	SENT_95	[p6l1871t3136r2044b3196],
19	or	CC	O	or	_	0	SENT_95	[p6l2077t3154r2151b3197],
20	50	CD	NUMBER	50	num	21	SENT_95	[p6l9t3245r95b3308],
21	nM	NN	O	nm	conj_or	13	SENT_95	[p6l125t3247r246b3307],
22	negative	JJ	O	negative	amod	24	SENT_95	[p6l276t3245r577b3326],
23	control	NN	O	control	nn	24	SENT_95	[p6l607t3245r859b3308],
24	siRNA	NN	O	sirna	dep	21	SENT_95	[p6l891t3245r1135b3308],
25	using	VBG	O	use	xcomp	5	SENT_95	[p6l1163t3245r1355b3326],
26	Lipofectamine	NNP	O	Lipofectamine	nn	30	SENT_95	[p6l1384t3245r1907b3326],
27	RNAi	NNP	O	RNAi	nn	30	SENT_95	[p6l1936t3245r2148b3308],
28	Max	NNP	O	Max	nn	30	SENT_95	[p6l8t3358r170b3419],
29	(	NNP	O	(	nn	30	SENT_95	[p6l212t3356r630b3437],
30	Invitrogen	NNP	ORGANIZATION	Invitrogen	dobj	25	SENT_95	[p6l212t3356r630b3437],
31	,	,	O	,	_	0	SENT_95	[p6l212t3356r630b3437],
32	Breda	NNP	PERSON	Breda	appos	30	SENT_95	[p6l672t3356r903b3430],
33	,	,	O	,	_	0	SENT_95	[p6l672t3356r903b3430],
34	The	DT	LOCATION	the	det	36	SENT_95	[p6l945t3356r1081b3419],
35	Netherlands	NNP	LOCATION	Netherlands	nn	36	SENT_95	[p6l1119t3356r1601b3433],
36	)	NN	O	)	appos	32	SENT_95	[p6l1119t3356r1601b3433],
37	.	.	O	.	_	0	SENT_95	[p6l1119t3356r1601b3433],

1	Subsequently	RB	O	subsequently	advmod	10	SENT_96	[p6l1646t3356r2145b3437],
2	,	,	O	,	_	0	SENT_96	[p6l1646t3356r2145b3437],
3	PXR	NN	O	pxr	nn	4	SENT_96	[p6l8t3469r181b3529],
4	knockdown	NN	O	knockdown	nsubjpass	10	SENT_96	[p6l205t3467r623b3530],
5	and	CC	O	and	_	0	SENT_96	[p6l648t3467r775b3530],
6	control	NN	O	control	nn	8	SENT_96	[p6l800t3467r1051b3530],
7	LS180	NN	O	ls180	nn	8	SENT_96	[p6l1076t3468r1313b3530],
8	cells	NNS	O	cell	nsubjpass	10	SENT_96	[p6l1339t3467r1499b3530],
9	were	VBD	O	be	auxpass	10	SENT_96	[p6l1526t3487r1698b3530],
10	treated	VBN	O	treat	_	0	SENT_96	[p6l1723t3467r1967b3530],
11	with	IN	O	with	_	0	SENT_96	[p6l1991t3467r2150b3530],
12	different	JJ	O	different	amod	14	SENT_96	[p6l9t3576r306b3641],
13	anticancer	JJ	O	anticancer	amod	14	SENT_96	[p6l332t3578r701b3641],
14	drugs	NNS	O	drug	prep_with	10	SENT_96	[p6l724t3578r918b3659],
15	for	IN	O	for	_	0	SENT_96	[p6l945t3578r1049b3641],
16	48	CD	NUMBER	48	num	17	SENT_96	[p6l1072t3579r1156b3641],
17	h.	NN	O	h.	prep_for	14	SENT_96	[p6l1184t3578r1245b3641],

1	Immunoblot	NN	O	immunoblot	nn	2	SENT_97	[p7l8t78r452b141],
2	analysis	NN	O	analysis	_	0	SENT_97	[p7l477t78r761b159],

1	After	IN	O	after	_	0	SENT_98	[p7l8t302r197b365],
2	48	CD	NUMBER	48	num	3	SENT_98	[p7l234t303r317b365],
3	h	NN	O	h	prep_after	9	SENT_98	[p7l346t302r389b364],
4	of	IN	O	of	_	0	SENT_98	[p7l427t302r505b365],
5	culture	NN	O	culture	prep_of	3	SENT_98	[p7l538t302r803b376],
6	,	,	O	,	_	0	SENT_98	[p7l538t302r803b376],
7	cells	NNS	O	cell	nsubjpass	18	SENT_98	[p7l846t302r1006b365],
8	were	VBD	O	be	auxpass	9	SENT_98	[p7l1046t322r1218b365],
9	washed	VBN	O	wash	_	0	SENT_98	[p7l1257t302r1524b365],
10	with	IN	O	with	_	0	SENT_98	[p7l1562t302r1720b365],
11	phosphatebuffered	JJ	O	phosphatebuffered	amod	14	SENT_98	[p7l1757t302r2147b383, p7l7t410r301b475],
12	saline	NN	O	saline	nn	14	SENT_98	[p7l334t412r537b475],
13	(	NN	O	(	nn	14	SENT_98	[p7l571t413r805b490],
14	PBS	NNP	O	PBS	prep_with	9	SENT_98	[p7l571t413r805b490],
15	)	CD	NUMBER	)	num	14	SENT_98	[p7l571t413r805b490],
16	,	,	O	,	_	0	SENT_98	[p7l571t413r805b490],
17	and	CC	O	and	_	0	SENT_98	[p7l841t412r966b475],
18	lysed	VBN	O	lyse	conj_and	9	SENT_98	[p7l996t412r1183b493],
19	in	IN	O	in	_	0	SENT_98	[p7l1213t412r1281b474],
20	1	CD	NUMBER	1	num	23	SENT_98	[p7l1319t413r1345b474],
21	ml/well	NN	O	ml/well	nn	23	SENT_98	[p7l1378t412r1651b475],
22	MilliQ	NN	O	milliq	nn	23	SENT_98	[p7l1680t412r1923b490],
23	water	NN	O	water	prep_in	18	SENT_98	[p7l1953t422r2152b475],
24	that	WDT	O	that	nsubj	25	SENT_98	[p7l8t524r137b587],
25	contained	VBD	O	contain	rcmod	23	SENT_98	[p7l160t524r492b587],
26	protease	NN	O	protease	nn	27	SENT_98	[p7l514t534r795b605],
27	inhibitors	NNS	O	inhibitor	nsubj	28	SENT_98	[p7l820t524r1140b587],
28	(	VBP	O	(	ccomp	25	SENT_98	[p7l1169t524r1432b601],
29	Roche	NNP	PERSON	Roche	dobj	28	SENT_98	[p7l1169t524r1432b601],
30	,	,	O	,	_	0	SENT_98	[p7l1169t524r1432b601],
31	Basal	JJ	O	basal	appos	29	SENT_98	[p7l1460t524r1666b598],
32	,	,	O	,	_	0	SENT_98	[p7l1460t524r1666b598],
33	Switzerland	NNP	LOCATION	Switzerland	appos	31	SENT_98	[p7l1696t524r2145b601],
34	)	CD	NUMBER	)	num	33	SENT_98	[p7l1696t524r2145b601],
35	.	.	O	.	_	0	SENT_98	[p7l1696t524r2145b601],

1	The	DT	O	the	det	2	SENT_99	[p7l8t635r144b698],
2	lysate	NN	O	lysate	nsubjpass	4	SENT_99	[p7l187t635r393b716],
3	was	VBD	O	be	auxpass	4	SENT_99	[p7l436t655r571b698],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_99	[p7l614t635r1021b716],
5	(	RB	O	(	advmod	4	SENT_99	[p7l1065t635r1290b713],
6	5,000	CD	NUMBER	5,000	num	7	SENT_99	[p7l1065t635r1290b713],
7	rpm	NN	O	rpm	nsubjpass	22	SENT_99	[p7l1316t655r1478b716],
8	,	,	O	,	_	0	SENT_99	[p7l1316t655r1478b716],
9	5	CD	DURATION	5	num	10	SENT_99	[p7l1523t635r1560b698],
10	min	NN	DURATION	min	appos	7	SENT_99	[p7l1590t635r1745b709],
11	,	,	O	,	_	0	SENT_99	[p7l1590t635r1745b709],
12	4	CD	NUMBER	4	num	15	SENT_99	[p7l1789t636r1978b713],
13	°	NN	O	°	nn	15	SENT_99	[p7l1789t636r1978b713],
14	C	NN	O	c	nn	15	SENT_99	[p7l1789t636r1978b713],
15	)	NN	O	)	conj_and	10	SENT_99	[p7l1789t636r1978b713],
16	,	,	O	,	_	0	SENT_99	[p7l1789t636r1978b713],
17	and	CC	O	and	_	0	SENT_99	[p7l2024t635r2150b698],
18	the	DT	O	the	det	20	SENT_99	[p7l8t746r115b809],
19	remaining	VBG	O	remain	amod	20	SENT_99	[p7l163t746r526b827],
20	pellet	NN	O	pellet	conj_and	10	SENT_99	[p7l574t746r774b827],
21	was	VBD	O	be	auxpass	22	SENT_99	[p7l821t766r956b809],
22	resuspended	VBN	O	resuspend	ccomp	4	SENT_99	[p7l1006t746r1450b827],
23	in	IN	O	in	_	0	SENT_99	[p7l1498t746r1566b808],
24	100	CD	NUMBER	100	num	27	SENT_99	[p7l1622t747r1746b809],
25	uL	NN	O	ul	nn	27	SENT_99	[p7l1800t748r1897b826],
26	RIPA	NN	O	ripa	nn	27	SENT_99	[p7l1947t747r2148b808],
27	buffer	NN	O	buffer	prep_in	22	SENT_99	[p7l7t854r234b919],
28	.	.	O	.	_	0	SENT_99	[p7l7t854r234b919],

1	The	DT	O	the	det	2	SENT_100	[p7l262t856r398b919],
2	lysate	NN	O	lysate	nsubjpass	4	SENT_100	[p7l422t856r629b937],
3	was	VBD	O	be	auxpass	4	SENT_100	[p7l654t876r788b919],
4	centrifuged	VBN	O	centrifuge	ccomp	20	SENT_100	[p7l814t856r1222b937],
5	(	CD	NUMBER	(	number	6	SENT_100	[p7l1248t857r1518b933],
6	10,000	CD	NUMBER	10,000	num	7	SENT_100	[p7l1248t857r1518b933],
7	rpm	NN	O	rpm	dobj	4	SENT_100	[p7l1542t876r1704b937],
8	,	,	O	,	_	0	SENT_100	[p7l1542t876r1704b937],
9	5	CD	DURATION	5	num	10	SENT_100	[p7l1732t856r1769b919],
10	min	NN	DURATION	min	nsubjpass	20	SENT_100	[p7l1799t856r1955b930],
11	,	,	O	,	_	0	SENT_100	[p7l1799t856r1955b930],
12	4	CD	NUMBER	4	num	15	SENT_100	[p7l1981t857r2148b934],
13	°	NN	O	°	nn	15	SENT_100	[p7l1981t857r2148b934],
14	C	NN	O	c	nn	15	SENT_100	[p7l1981t857r2148b934],
15	)	NN	O	)	nsubjpass	20	SENT_100	[p7l1981t857r2148b934],
16	and	CC	O	and	_	0	SENT_100	[p7l10t968r136b1031],
17	the	DT	O	the	det	18	SENT_100	[p7l181t968r288b1031],
18	supernatant	NN	O	supernatant	conj_and	10	SENT_100	[p7l337t978r747b1049],
19	was	VBD	O	be	auxpass	20	SENT_100	[p7l792t988r927b1031],
20	transferred	VBN	O	transfer	_	0	SENT_100	[p7l974t968r1362b1031],
21	to	TO	O	to	_	0	SENT_100	[p7l1407t978r1474b1031],
22	a	DT	O	a	det	25	SENT_100	[p7l1522t988r1559b1031],
23	new	JJ	O	new	amod	25	SENT_100	[p7l1603t988r1749b1031],
24	collection	NN	O	collection	nn	25	SENT_100	[p7l1797t968r2149b1031],
25	tube	NN	O	tube	prep_to	20	SENT_100	[p7l8t1079r178b1142],
26	.	.	O	.	_	0	SENT_100	[p7l8t1079r178b1142],

1	Protein	NN	O	protein	nn	2	SENT_101	[p7l221t1079r479b1142],
2	concentrations	NNS	O	concentration	nsubjpass	4	SENT_101	[p7l517t1079r1036b1142],
3	were	VBD	O	be	auxpass	4	SENT_101	[p7l1077t1099r1247b1142],
4	determined	VBN	O	determine	_	0	SENT_101	[p7l1287t1079r1689b1142],
5	by	IN	O	by	_	0	SENT_101	[p7l1725t1079r1812b1160],
6	a	DT	O	a	det	9	SENT_101	[p7l1853t1099r1890b1142],
7	Pierce	NNP	ORGANIZATION	Pierce	nn	9	SENT_101	[p7l1926t1079r2148b1142],
8	BCA	NNP	ORGANIZATION	BCA	nn	9	SENT_101	[p7l8t1191r194b1253],
9	protein	NN	O	protein	agent	4	SENT_101	[p7l241t1190r507b1271],
10	assay	NN	O	assay	nn	12	SENT_101	[p7l558t1210r754b1271],
11	(	CD	NUMBER	(	num	12	SENT_101	[p7l806t1190r1088b1268],
12	Pierce	NNP	PERSON	Pierce	dep	4	SENT_101	[p7l806t1190r1088b1268],
13	,	,	O	,	_	0	SENT_101	[p7l806t1190r1088b1268],
14	Rockford	NNP	LOCATION	Rockford	appos	12	SENT_101	[p7l1140t1190r1513b1264],
15	,	,	O	,	_	0	SENT_101	[p7l1140t1190r1513b1264],
16	IL	NN	O	il	appos	12	SENT_101	[p7l1564t1192r1669b1264],
17	,	,	O	,	_	0	SENT_101	[p7l1564t1192r1669b1264],
18	USA	NNP	LOCATION	USA	appos	12	SENT_101	[p7l1721t1191r1954b1267],
19	)	CD	NUMBER	)	num	18	SENT_101	[p7l1721t1191r1954b1267],
20	.	.	O	.	_	0	SENT_101	[p7l1721t1191r1954b1267],

1	Ten	CD	NUMBER	ten	num	2	SENT_102	[p7l2007t1192r2149b1253],
2	micrograms	NNS	O	microgram	nsubjpass	7	SENT_102	[p7l8t1301r451b1382],
3	of	IN	O	of	_	0	SENT_102	[p7l511t1301r589b1364],
4	total	JJ	O	total	amod	5	SENT_102	[p7l640t1301r804b1364],
5	protein	NN	O	protein	prep_of	2	SENT_102	[p7l860t1301r1126b1382],
6	was	VBD	O	be	auxpass	7	SENT_102	[p7l1182t1321r1320b1364],
7	separated	VBN	O	separate	dep	26	SENT_102	[p7l1382t1301r1734b1382],
8	by	IN	O	by	_	0	SENT_102	[p7l1789t1301r1878b1382],
9	SDS	NN	O	sd	nn	13	SENT_102	[p7l1937t1302r2149b1364],
10	—	CD	NUMBER	—	num	13	SENT_102	[p7l1937t1302r2149b1364],
11	polyacrylamide	NN	O	polyacrylamide	nn	13	SENT_102	[p7l7t1412r592b1493],
12	gel	NN	O	gel	nn	13	SENT_102	[p7l624t1412r733b1493],
13	electrophoresis	NN	O	electrophoresis	agent	7	SENT_102	[p7l764t1412r1336b1493],
14	using	VBG	O	use	xcomp	7	SENT_102	[p7l1368t1412r1566b1493],
15	NuPage	NN	O	nupage	nn	16	SENT_102	[p7l1598t1414r1890b1493],
16	novex	NN	O	novex	iobj	14	SENT_102	[p7l1921t1432r2146b1475],
17	4	CD	PERCENT	4	number	18	SENT_102	[p7l8t1524r263b1586],
18	—	CD	PERCENT	—	amod	16	SENT_102	[p7l8t1524r263b1586],
19	l2	CD	PERCENT	l2	num	20	SENT_102	[p7l8t1524r263b1586],
20	%	NN	PERCENT	%	dep	18	SENT_102	[p7l8t1524r263b1586],
21	bis	FW	O	bis	nn	23	SENT_102	[p7l318t1523r592b1586],
22	—	FW	O	—	nn	23	SENT_102	[p7l318t1523r592b1586],
23	tris	FW	O	tris	dobj	14	SENT_102	[p7l318t1523r592b1586],
24	gradient	NN	O	gradient	nn	25	SENT_102	[p7l648t1523r957b1604],
25	gels	NNS	O	gel	dobj	14	SENT_102	[p7l1008t1523r1153b1604],
26	(	VBP	O	(	_	0	SENT_102	[p7l1211t1523r1653b1604],
27	InVitrogen	NNP	ORGANIZATION	InVitrogen	nsubj	26	SENT_102	[p7l1211t1523r1653b1604],
28	,	,	O	,	_	0	SENT_102	[p7l1211t1523r1653b1604],
29	Breda	NNP	PERSON	Breda	appos	27	SENT_102	[p7l1709t1523r1950b1597],
30	,	,	O	,	_	0	SENT_102	[p7l1709t1523r1950b1597],
31	The	DT	LOCATION	the	det	33	SENT_102	[p7l2006t1523r2146b1586],
32	Netherlands	NNP	LOCATION	Netherlands	nn	33	SENT_102	[p7l8t1634r495b1712],
33	)	NN	O	)	appos	29	SENT_102	[p7l8t1634r495b1712],
34	.	.	O	.	_	0	SENT_102	[p7l8t1634r495b1712],

1	Proteins	NNS	O	protein	nsubjpass	3	SENT_103	[p7l527t1634r817b1697],
2	were	VBD	O	be	auxpass	3	SENT_103	[p7l848t1654r1019b1697],
3	electroblotted	VBN	O	electroblot	dep	8	SENT_103	[p7l1048t1634r1540b1697],
4	onto	IN	O	onto	_	0	SENT_103	[p7l1568t1644r1722b1697],
5	Immobilon	NN	O	immobilon	nn	7	SENT_103	[p7l1751t1634r2149b1697],
6	P	NN	O	p	nn	7	SENT_103	[p7l8t1748r56b1808],
7	membranes	NNS	O	membrane	prep_onto	3	SENT_103	[p7l79t1746r490b1809],
8	(	VBP	O	(	_	0	SENT_103	[p7l519t1746r902b1827],
9	Millipore	NNP	ORGANIZATION	Millipore	nsubj	8	SENT_103	[p7l519t1746r902b1827],
10	,	,	O	,	_	0	SENT_103	[p7l519t1746r902b1827],
11	Bedford	NNP	LOCATION	Bedford	nn	15	SENT_103	[p7l930t1746r1242b1820],
12	,	,	O	,	_	0	SENT_103	[p7l930t1746r1242b1820],
13	MA	NNP	O	MA	appos	15	SENT_103	[p7l1268t1747r1429b1820],
14	,	,	O	,	_	0	SENT_103	[p7l1268t1747r1429b1820],
15	USA	NNP	LOCATION	USA	appos	9	SENT_103	[p7l1456t1747r1681b1824],
16	)	CD	NUMBER	)	num	15	SENT_103	[p7l1456t1747r1681b1824],
17	.	.	O	.	_	0	SENT_103	[p7l1456t1747r1681b1824],

1	After	IN	O	after	_	0	SENT_104	[p7l1710t1746r1899b1809],
2	blocking	VBG	O	block	prepc_after	26	SENT_104	[p7l1920t1746r2147b1809, p7l8t1856r120b1937],
3	(	NN	O	(	nn	5	SENT_104	[p7l147t1857r209b1934],
4	1	CD	NUMBER	1	num	5	SENT_104	[p7l147t1857r209b1934],
5	h	NN	O	h	dobj	2	SENT_104	[p7l241t1856r284b1918],
6	at	IN	O	at	_	0	SENT_104	[p7l310t1866r372b1919],
7	RT	NN	O	rt	nn	8	SENT_104	[p7l394t1857r534b1933],
8	)	NN	O	)	prep_at	2	SENT_104	[p7l394t1857r534b1933],
9	in	IN	O	in	_	0	SENT_104	[p7l560t1856r627b1918],
10	3	CD	PERCENT	3	number	11	SENT_104	[p7l654t1857r764b1919],
11	%	NN	PERCENT	%	amod	12	SENT_104	[p7l654t1857r764b1919],
12	BSA	NN	O	bsa	prep_in	8	SENT_104	[p7l792t1857r965b1919],
13	in	IN	O	in	_	0	SENT_104	[p7l989t1856r1056b1918],
14	tris-buffered	JJ	O	tris-buffered	amod	15	SENT_104	[p7l1079t1854r1517b1919],
15	saline	NN	O	saline	prep_in	2	SENT_104	[p7l1544t1856r1747b1919],
16	containing	VBG	O	contain	partmod	15	SENT_104	[p7l1773t1856r2148b1937],
17	0.1	CD	PERCENT	0.1	num	18	SENT_104	[p7l9t1969r189b2031],
18	%	NN	PERCENT	%	dobj	16	SENT_104	[p7l9t1969r189b2031],
19	Tween	NNP	O	Tween	dep	18	SENT_104	[p7l224t1969r606b2042],
20	—	CD	NUMBER	—	number	21	SENT_104	[p7l224t1969r606b2042],
21	20	CD	NUMBER	20	dep	19	SENT_104	[p7l224t1969r606b2042],
22	,	,	O	,	_	0	SENT_104	[p7l224t1969r606b2042],
23	the	DT	O	the	det	24	SENT_104	[p7l641t1968r748b2031],
24	membranes	NNS	O	membrane	nsubjpass	26	SENT_104	[p7l781t1968r1191b2031],
25	were	VBD	O	be	auxpass	26	SENT_104	[p7l1224t1988r1395b2031],
26	incubated	VBN	O	incubate	_	0	SENT_104	[p7l1427t1968r1775b2031],
27	overnight	RB	TIME	overnight	advmod	26	SENT_104	[p7l1808t1968r2151b2049],
28	at	IN	O	at	_	0	SENT_104	[p7l10t2089r72b2142],
29	4	CD	NUMBER	4	number	30	SENT_104	[p7l111t2080r248b2142],
30	°	CD	NUMBER	°	num	31	SENT_104	[p7l111t2080r248b2142],
31	C	NN	O	c	prep_at	26	SENT_104	[p7l111t2080r248b2142],
32	with	IN	O	with	_	0	SENT_104	[p7l291t2079r448b2142],
33	a	DT	O	a	det	36	SENT_104	[p7l491t2099r528b2142],
34	murine	JJ	O	murine	amod	36	SENT_104	[p7l566t2079r817b2142],
35	monoclonal	JJ	O	monoclonal	amod	36	SENT_104	[p7l859t2079r1279b2142],
36	anti	JJ	O	anti	prep_with	26	SENT_104	[p7l1322t2079r1623b2160],
37	.	.	O	.	_	0	SENT_104	[p7l1322t2079r1623b2160],

1	—	NN	O	—	_	0	SENT_105	[p7l1322t2079r1623b2160],
2	.	.	O	.	_	0	SENT_105	[p7l1322t2079r1623b2160],

1	Pgp	NNP	O	Pgp	nn	3	SENT_106	[p7l1322t2079r1623b2160],
2	primary	JJ	O	primary	amod	3	SENT_106	[p7l1663t2079r1946b2160],
3	antibody	NN	O	antibody	_	0	SENT_106	[p7l1989t2079r2147b2142, p7l7t2190r184b2271],
4	(	CD	NUMBER	(	num	5	SENT_106	[p7l221t2191r460b2267],
5	C219	NN	O	c219	dep	3	SENT_106	[p7l221t2191r460b2267],
6	,	,	O	,	_	0	SENT_106	[p7l221t2191r460b2267],
7	1:500	CD	NUMBER	1:500	appos	5	SENT_106	[p7l504t2190r718b2264],
8	;	:	O	;	_	0	SENT_106	[p7l504t2190r718b2264],
9	Abcam	NNP	PERSON	Abcam	dep	3	SENT_106	[p7l755t2190r1032b2264],
10	,	,	O	,	_	0	SENT_106	[p7l755t2190r1032b2264],
11	Cambridge	NNP	LOCATION	Cambridge	appos	9	SENT_106	[p7l1070t2190r1485b2271],
12	,	,	O	,	_	0	SENT_106	[p7l1070t2190r1485b2271],
13	UK	NNP	LOCATION	UK	nn	14	SENT_106	[p7l1521t2191r1676b2268],
14	)	NN	O	)	appos	9	SENT_106	[p7l1521t2191r1676b2268],
15	followed	VBN	O	follow	partmod	14	SENT_106	[p7l1712t2190r2029b2253],
16	by	IN	O	by	_	0	SENT_106	[p7l2060t2190r2149b2271],
17	incubation	NN	O	incubation	agent	15	SENT_106	[p7l8t2301r385b2364],
18	with	IN	O	with	_	0	SENT_106	[p7l428t2301r585b2364],
19	a	DT	O	a	det	22	SENT_106	[p7l630t2321r667b2364],
20	goat	NN	O	goat	nn	22	SENT_106	[p7l709t2311r862b2382],
21	anti-mouse	JJ	O	anti-mouse	amod	22	SENT_106	[p7l904t2301r1299b2364],
22	IgG	NN	O	igg	prep_with	15	SENT_106	[p7l1342t2302r1479b2382],
23	coupled	VBN	O	couple	prep	22	SENT_106	[p7l1522t2301r1805b2382],
24	to	TO	O	to	pcomp	23	SENT_106	[p7l1846t2311r1912b2364],
25	horse	NN	O	horse	nn	30	SENT_106	[p7l1956t2301r2148b2364],
26	radish	NN	O	radish	nn	30	SENT_106	[p7l7t2412r226b2475],
27	peroxidase	NN	O	peroxidase	nn	30	SENT_106	[p7l285t2412r672b2493],
28	(	CD	NUMBER	(	num	30	SENT_106	[p7l737t2413r963b2489],
29	HRP	NN	O	hrp	nn	30	SENT_106	[p7l737t2413r963b2489],
30	)	NN	O	)	pobj	24	SENT_106	[p7l737t2413r963b2489],
31	secondary	JJ	O	secondary	amod	32	SENT_106	[p7l1031t2412r1389b2493],
32	antibody	NN	O	antibody	dep	30	SENT_106	[p7l1453t2412r1763b2493],
33	(	CD	NUMBER	(	number	34	SENT_106	[p7l1827t2413r2145b2489],
34	1:1,000	CD	NUMBER	1:1,000	dep	32	SENT_106	[p7l1827t2413r2145b2489],
35	;	:	O	;	_	0	SENT_106	[p7l1827t2413r2145b2489],
36	ImmunoPure	NNP	O	ImmunoPure	nn	39	SENT_106	[p7l8t2525r474b2586],
37	Peroxidase	NNP	O	Peroxidase	nn	39	SENT_106	[p7l506t2523r897b2586],
38	Conjugated	NNP	O	Conjugated	nn	39	SENT_106	[p7l929t2523r1340b2604],
39	Goat	NNP	O	Goat	dep	9	SENT_106	[p7l1372t2524r1545b2586],
40	anti	JJ	O	anti	dep	39	SENT_106	[p7l1576t2523r1980b2586],
41	.	.	O	.	_	0	SENT_106	[p7l1576t2523r1980b2586],

1	—	NN	O	—	_	0	SENT_107	[p7l1576t2523r1980b2586],
2	.	.	O	.	_	0	SENT_107	[p7l1576t2523r1980b2586],

1	Mouse	NN	O	mouse	nn	2	SENT_108	[p7l1576t2523r1980b2586],
2	IgG	NN	O	igg	_	0	SENT_108	[p7l2012t2524r2149b2604],
3	(	CD	NUMBER	(	num	5	SENT_108	[p7l11t2634r302b2710],
4	H+L	NN	O	h+l	nn	5	SENT_108	[p7l11t2634r302b2710],
5	)	NN	O	)	dep	2	SENT_108	[p7l11t2634r302b2710],
6	;	:	O	;	_	0	SENT_108	[p7l11t2634r302b2710],
7	Pierce	NNP	PERSON	Pierce	dep	11	SENT_108	[p7l331t2633r573b2707],
8	,	,	O	,	_	0	SENT_108	[p7l331t2633r573b2707],
9	Rockford	NNP	LOCATION	Rockford	dep	7	SENT_108	[p7l628t2633r984b2707],
10	,	,	O	,	_	0	SENT_108	[p7l628t2633r984b2707],
11	IL	NN	O	il	dep	2	SENT_108	[p7l1038t2635r1139b2707],
12	,	,	O	,	_	0	SENT_108	[p7l1038t2635r1139b2707],
13	USA	NNP	LOCATION	USA	appos	11	SENT_108	[p7l1194t2634r1420b2710],
14	)	CD	NUMBER	)	num	13	SENT_108	[p7l1194t2634r1420b2710],
15	.	.	O	.	_	0	SENT_108	[p7l1194t2634r1420b2710],

1	ﬂ-actin	NN	O	ﬂ-actin	nsubjpass	16	SENT_109	[p7l1477t2631r1728b2714],
2	(	CD	NUMBER	(	number	3	SENT_109	[p7l1782t2634r2145b2710],
3	1:10,000	CD	TIME	1:10,000	dep	1	SENT_109	[p7l1782t2634r2145b2710],
4	;	:	O	;	_	0	SENT_109	[p7l1782t2634r2145b2710],
5	AC	NN	O	ac	dep	1	SENT_109	[p7l8t2745r272b2819],
6	—	CD	NUMBER	—	number	7	SENT_109	[p7l8t2745r272b2819],
7	15	CD	NUMBER	15	dep	5	SENT_109	[p7l8t2745r272b2819],
8	;	:	O	;	_	0	SENT_109	[p7l8t2745r272b2819],
9	Abcam	NNP	PERSON	Abcam	dep	1	SENT_109	[p7l318t2745r594b2819],
10	,	,	O	,	_	0	SENT_109	[p7l318t2745r594b2819],
11	Cambridge	NNP	LOCATION	Cambridge	appos	9	SENT_109	[p7l641t2745r1056b2826],
12	,	,	O	,	_	0	SENT_109	[p7l641t2745r1056b2826],
13	UK	NNP	LOCATION	UK	nn	14	SENT_109	[p7l1101t2746r1256b2822],
14	)	NNP	O	)	appos	1	SENT_109	[p7l1101t2746r1256b2822],
15	was	VBD	O	be	auxpass	16	SENT_109	[p7l1302t2765r1437b2808],
16	used	VBN	O	use	_	0	SENT_109	[p7l1482t2745r1645b2808],
17	as	IN	O	as	_	0	SENT_109	[p7l1688t2765r1757b2808],
18	a	DT	O	a	det	20	SENT_109	[p7l1803t2765r1840b2808],
19	loading	VBG	O	load	amod	20	SENT_109	[p7l1881t2745r2148b2826],
20	control	NN	O	control	prep_as	16	SENT_109	[p7l9t2856r278b2919],
21	.	.	O	.	_	0	SENT_109	[p7l9t2856r278b2919],

1	The	DT	O	the	det	2	SENT_110	[p7l318t2856r455b2919],
2	proteins	NNS	O	protein	nsubjpass	4	SENT_110	[p7l491t2856r777b2937],
3	were	VBD	O	be	auxpass	4	SENT_110	[p7l815t2876r987b2919],
4	Visualized	VBN	O	visualize	_	0	SENT_110	[p7l1022t2856r1385b2919],
5	by	IN	O	by	_	0	SENT_110	[p7l1420t2856r1507b2937],
6	a	DT	O	a	det	8	SENT_110	[p7l1546t2876r1583b2919],
7	chemiluminescence	NN	O	chemiluminescence	nn	8	SENT_110	[p7l1617t2856r2147b2919, p7l9t2967r446b3030],
8	—	NN	O	—	agent	4	SENT_110	[p7l1617t2856r2147b2919, p7l9t2967r446b3030],
9	based	VBN	O	base	partmod	8	SENT_110	[p7l1617t2856r2147b2919, p7l9t2967r446b3030],
10	detection	NN	O	detection	nn	11	SENT_110	[p7l489t2967r816b3030],
11	reagent	NN	O	reagent	dobj	9	SENT_110	[p7l857t2977r1122b3048],
12	(	CD	NUMBER	(	num	15	SENT_110	[p7l1166t2967r1629b3048],
13	SuperSignal	NNP	O	SuperSignal	nn	15	SENT_110	[p7l1166t2967r1629b3048],
14	West	NNP	O	West	nn	15	SENT_110	[p7l1671t2969r1856b3030],
15	Femto	NNP	O	Femto	dep	11	SENT_110	[p7l1896t2969r2145b3041],
16	;	:	O	;	_	0	SENT_110	[p7l1896t2969r2145b3041],
17	Pierce	NNP	PERSON	Pierce	dep	21	SENT_110	[p7l8t3078r250b3152],
18	,	,	O	,	_	0	SENT_110	[p7l8t3078r250b3152],
19	Rockford	NNP	LOCATION	Rockford	dep	17	SENT_110	[p7l285t3078r641b3152],
20	,	,	O	,	_	0	SENT_110	[p7l285t3078r641b3152],
21	IL	NN	O	il	dep	11	SENT_110	[p7l677t3080r777b3152],
22	,	,	O	,	_	0	SENT_110	[p7l677t3080r777b3152],
23	USA	NNP	LOCATION	USA	appos	21	SENT_110	[p7l812t3079r1040b3156],
24	)	CD	NUMBER	)	num	23	SENT_110	[p7l812t3079r1040b3156],
25	,	,	O	,	_	0	SENT_110	[p7l812t3079r1040b3156],
26	and	CC	O	and	_	0	SENT_110	[p7l1077t3078r1203b3141],
27	the	DT	O	the	det	28	SENT_110	[p7l1234t3078r1341b3141],
28	intensities	NNS	O	intensity	nsubjpass	34	SENT_110	[p7l1373t3078r1733b3141],
29	of	IN	O	of	_	0	SENT_110	[p7l1768t3078r1846b3141],
30	the	DT	O	the	det	32	SENT_110	[p7l1872t3078r1979b3141],
31	Pgp	NNP	O	Pgp	nn	32	SENT_110	[p7l2011t3080r2148b3159],
32	bands	NNS	O	band	prep_of	28	SENT_110	[p7l7t3189r213b3252],
33	were	VBD	O	be	auxpass	34	SENT_110	[p7l243t3209r414b3252],
34	determined	VBN	O	determine	conj_and	4	SENT_110	[p7l442t3189r843b3252],
35	on	IN	O	on	_	0	SENT_110	[p7l871t3209r957b3252],
36	a	DT	O	a	det	41	SENT_110	[p7l985t3209r1022b3252],
37	Gel	NN	O	gel	nn	41	SENT_110	[p7l1049t3189r1175b3252],
38	Doc	NNP	O	Doc	nn	41	SENT_110	[p7l1202t3191r1348b3252],
39	XRS	NNP	O	XRS	nn	41	SENT_110	[p7l1375t3190r1544b3252],
40	Imaging	NNP	O	Imaging	nn	41	SENT_110	[p7l1576t3189r1872b3270],
41	system	NN	O	system	prep_on	34	SENT_110	[p7l1903t3199r2149b3270],
42	with	IN	O	with	_	0	SENT_110	[p7l8t3300r165b3363],
43	Quantity	NNP	O	Quantity	nn	45	SENT_110	[p7l206t3300r516b3381],
44	One	CD	NUMBER	one	num	45	SENT_110	[p7l558t3301r703b3363],
45	analysis	NN	O	analysis	prep_with	41	SENT_110	[p7l744t3300r1028b3381],
46	software	NN	O	software	nn	48	SENT_110	[p7l1072t3300r1376b3363],
47	(	CD	NUMBER	(	num	48	SENT_110	[p7l1418t3300r1767b3377],
48	Bio	NNP	O	Bio	dep	45	SENT_110	[p7l1418t3300r1767b3377],
49	.	.	O	.	_	0	SENT_110	[p7l1418t3300r1767b3377],

1	—	NN	O	—	_	0	SENT_111	[p7l1418t3300r1767b3377],
2	.	.	O	.	_	0	SENT_111	[p7l1418t3300r1767b3377],

1	Rad	NN	O	rad	_	0	SENT_112	[p7l1418t3300r1767b3377],
2	,	,	O	,	_	0	SENT_112	[p7l1418t3300r1767b3377],
3	Hercules	NNP	O	Hercules	nn	7	SENT_112	[p7l1809t3300r2145b3374],
4	,	,	O	,	_	0	SENT_112	[p7l1809t3300r2145b3374],
5	CA	NNP	O	CA	appos	7	SENT_112	[p7l9t3411r145b3484],
6	,	,	O	,	_	0	SENT_112	[p7l9t3411r145b3484],
7	USA	NNP	LOCATION	USA	appos	1	SENT_112	[p7l177t3411r396b3487],
8	)	CD	NUMBER	)	num	7	SENT_112	[p7l177t3411r396b3487],
9	.	.	O	.	_	0	SENT_112	[p7l177t3411r396b3487],

1	The	DT	O	the	det	2	SENT_113	[p7l428t3410r561b3473],
2	ratio	NN	O	ratio	_	0	SENT_113	[p7l589t3410r744b3473],
3	of	IN	O	of	_	0	SENT_113	[p7l775t3410r851b3473],
4	the	DT	O	the	det	6	SENT_113	[p7l872t3410r976b3473],
5	Pgp	NN	O	pgp	nn	6	SENT_113	[p7l1004t3412r1137b3491],
6	signal	NN	O	signal	prep_of	2	SENT_113	[p7l1169t3410r1367b3491],
7	and	CC	O	and	_	0	SENT_113	[p7l1397t3410r1520b3473],
8	the	DT	O	the	det	9	SENT_113	[p7l1546t3410r1650b3473],
9	ﬂ	NN	O	ﬂ	prep_of	2	SENT_113	[p7l1682t3408r1921b3491],
10	.	.	O	.	_	0	SENT_113	[p7l1682t3408r1921b3491],

1	—	NN	O	—	_	0	SENT_114	[p7l1682t3408r1921b3491],
2	.	.	O	.	_	0	SENT_114	[p7l1682t3408r1921b3491],

1	actin	NN	O	actin	nn	2	SENT_115	[p7l1682t3408r1921b3491],
2	signal	NN	O	signal	nsubj	4	SENT_115	[p7l1952t3410r2150b3491],
3	were	VBD	O	be	cop	4	SENT_115	[p7l8t3542r180b3585],
4	indicative	JJ	O	indicative	_	0	SENT_115	[p7l206t3522r558b3585],
5	for	IN	O	for	_	0	SENT_115	[p7l584t3522r687b3585],
6	Pgp	NN	O	pgp	nn	8	SENT_115	[p7l711t3524r847b3603],
7	protein	NN	O	protein	nn	8	SENT_115	[p7l872t3522r1126b3603],
8	expression	NN	O	expression	prep_for	4	SENT_115	[p7l1151t3522r1550b3603],
9	.	.	O	.	_	0	SENT_115	[p7l1151t3522r1550b3603],

1	Rhodamine	NN	O	rhodamine	_	0	SENT_116	[p8l8t79r419b142],
2	123	CD	NUMBER	123	num	4	SENT_116	[p8l454t80r572b142],
3	accumulation	NN	O	accumulation	nn	4	SENT_116	[p8l604t79r1085b142],
4	assay	NN	O	assay	dep	1	SENT_116	[p8l1112t99r1302b160],

1	The	DT	O	the	det	3	SENT_117	[p8l8t303r144b366],
2	eﬂiux	NN	O	eﬂiux	nn	3	SENT_117	[p8l171t301r371b366],
3	activity	NN	O	activity	nsubjpass	7	SENT_117	[p8l397t303r663b384],
4	of	IN	O	of	_	0	SENT_117	[p8l688t303r765b366],
5	Pgp	NNP	ORGANIZATION	Pgp	prep_of	3	SENT_117	[p8l784t305r920b384],
6	was	VBD	O	be	auxpass	7	SENT_117	[p8l946t323r1081b366],
7	determined	VBN	O	determine	_	0	SENT_117	[p8l1107t303r1510b366],
8	by	IN	O	by	_	0	SENT_117	[p8l1532t303r1620b384],
9	measuring	VBG	O	measure	agent	7	SENT_117	[p8l1644t303r2016b384],
10	the	DT	O	the	det	11	SENT_117	[p8l2042t303r2148b366],
11	accumulation	NN	O	accumulation	dobj	9	SENT_117	[p8l10t414r491b477],
12	of	IN	O	of	_	0	SENT_117	[p8l525t414r602b477],
13	the	DT	O	the	det	17	SENT_117	[p8l629t414r736b477],
14	ﬂuorescent	JJ	O	ﬂuorescent	amod	17	SENT_117	[p8l770t411r1163b477],
15	Pgp	NN	ORGANIZATION	pgp	nn	17	SENT_117	[p8l1195t416r1332b495],
16	probe	NN	O	probe	nn	17	SENT_117	[p8l1365t414r1567b495],
17	rhodamine	NN	O	rhodamine	prep_of	11	SENT_117	[p8l1600t414r1983b477],
18	123	CD	NUMBER	123	npadvmod	19	SENT_117	[p8l2025t415r2145b477],
19	as	IN	O	as	advmod	20	SENT_117	[p8l10t546r78b589],
20	described	VBN	O	describe	partmod	17	SENT_117	[p8l125t526r467b589],
21	by	IN	O	by	_	0	SENT_117	[p8l508t526r596b607],
22	Collett	NNP	PERSON	Collett	agent	20	SENT_117	[p8l642t526r884b589],
23	et	FW	O	et	nn	25	SENT_117	[p8l927t536r991b589],
24	al.	FW	O	al.	nn	25	SENT_117	[p8l1016t526r1091b589],
25	[	FW	O	[	dobj	20	SENT_117	[p8l1150t527r1308b602],
26	11	CD	NUMBER	11	num	27	SENT_117	[p8l1150t527r1308b602],
27	]	NN	O	]	dep	11	SENT_117	[p8l1150t527r1308b602],
28	.	.	O	.	_	0	SENT_117	[p8l1150t527r1308b602],

1	In	IN	O	in	_	0	SENT_118	[p8l1356t528r1429b588],
2	brief	NN	O	brief	prep_in	7	SENT_118	[p8l1470t526r1659b600],
3	,	,	O	,	_	0	SENT_118	[p8l1470t526r1659b600],
4	LSl80	NN	O	lsl80	nn	5	SENT_118	[p8l1704t527r1942b589],
5	cells	NNS	O	cell	nsubjpass	7	SENT_118	[p8l1987t526r2147b589],
6	were	VBD	O	be	auxpass	7	SENT_118	[p8l8t657r185b700],
7	pretreated	VBN	O	pretreat	_	0	SENT_118	[p8l226t637r603b718],
8	with	IN	O	with	_	0	SENT_118	[p8l643t637r807b700],
9	the	DT	O	the	det	11	SENT_118	[p8l848t637r959b700],
10	anticancer	JJ	O	anticancer	amod	11	SENT_118	[p8l1003t637r1390b700],
11	drugs	NNS	O	drug	prep_with	7	SENT_118	[p8l1430t637r1632b718],
12	as	IN	O	as	mark	13	SENT_118	[p8l1677t657r1747b700],
13	described	VBN	O	describe	advcl	7	SENT_118	[p8l1791t637r2148b700],
14	earlier	RBR	O	earlier	advmod	13	SENT_118	[p8l9t748r267b810],
15	.	.	O	.	_	0	SENT_118	[p8l9t748r267b810],

1	After	IN	O	after	_	0	SENT_119	[p8l313t748r510b810],
2	48	CD	NUMBER	48	num	3	SENT_119	[p8l548t749r636b811],
3	h	NN	O	h	prep_after	8	SENT_119	[p8l667t748r731b821],
4	,	,	O	,	_	0	SENT_119	[p8l667t748r731b821],
5	the	DT	O	the	det	6	SENT_119	[p8l776t748r886b810],
6	cells	NNS	O	cell	nsubjpass	19	SENT_119	[p8l929t748r1096b810],
7	were	VBD	O	be	auxpass	8	SENT_119	[p8l1140t768r1316b811],
8	washed	VBN	O	wash	_	0	SENT_119	[p8l1358t748r1636b810],
9	with	IN	O	with	_	0	SENT_119	[p8l1677t748r1840b811],
10	Hank	NN	PERSON	hank	poss	17	SENT_119	[p8l1881t748r2145b810],
11	’s	POS	O	’s	_	0	SENT_119	[p8l1881t748r2145b810],
12	Balanced	JJ	O	balanced	amod	17	SENT_119	[p8l8t859r345b922],
13	Salt	NNP	O	Salt	dep	14	SENT_119	[p8l379t859r516b922],
14	Solution	NN	O	solution	amod	17	SENT_119	[p8l549t859r849b922],
15	(	CD	NUMBER	(	num	17	SENT_119	[p8l884t860r1161b937],
16	HBSS	NN	O	hbss	nn	17	SENT_119	[p8l884t860r1161b937],
17	)	NN	O	)	prep_with	8	SENT_119	[p8l884t860r1161b937],
18	and	CC	O	and	_	0	SENT_119	[p8l1197t859r1323b922],
19	incubated	VBN	O	incubate	conj_and	8	SENT_119	[p8l1355t859r1702b922],
20	at	IN	O	at	advmod	33	SENT_119	[p8l1735t869r1797b922],
21	37	CD	NUMBER	37	number	22	SENT_119	[p8l1830t860r2009b922],
22	°	CD	NUMBER	°	num	23	SENT_119	[p8l1830t860r2009b922],
23	C	NN	O	c	pobj	20	SENT_119	[p8l1830t860r2009b922],
24	for	IN	O	for	_	0	SENT_119	[p8l2043t859r2147b922],
25	1	CD	NUMBER	1	num	26	SENT_119	[p8l17t972r42b1033],
26	h	NN	O	h	prep_for	20	SENT_119	[p8l74t971r117b1033],
27	with	IN	O	with	_	0	SENT_119	[p8l142t971r300b1034],
28	rhodamine	NN	O	rhodamine	prep_with	26	SENT_119	[p8l323t971r705b1034],
29	123	CD	NUMBER	123	num	28	SENT_119	[p8l739t972r857b1034],
30	(	NN	O	(	nn	33	SENT_119	[p8l889t972r1002b1048],
31	10	CD	NUMBER	10	num	33	SENT_119	[p8l889t972r1002b1048],
32	uM	NN	O	um	nn	33	SENT_119	[p8l1032t972r1182b1051],
33	)	NN	O	)	dobj	19	SENT_119	[p8l1032t972r1182b1051],
34	in	IN	O	in	_	0	SENT_119	[p8l1209t971r1277b1033],
35	the	DT	O	the	det	36	SENT_119	[p8l1301t971r1408b1034],
36	presence	NN	O	presence	prep_in	33	SENT_119	[p8l1431t991r1743b1052],
37	or	CC	O	or	_	0	SENT_119	[p8l1769t991r1842b1034],
38	absence	NN	O	absence	conj_or	36	SENT_119	[p8l1867t971r2146b1034],
39	of	IN	O	of	_	0	SENT_119	[p8l9t1081r87b1144],
40	the	DT	O	the	det	45	SENT_119	[p8l106t1081r213b1144],
41	Pgp-speciﬁc	JJ	MISC	pgp-speciﬁc	amod	45	SENT_119	[p8l240t1079r680b1162],
42	inhibitor	NN	O	inhibitor	nn	45	SENT_119	[p8l708t1081r1017b1144],
43	zosuquidar	NN	O	zosuquidar	nn	45	SENT_119	[p8l1041t1081r1434b1162],
44	(	CD	NUMBER	(	num	45	SENT_119	[p8l1462t1081r1897b1158],
45	LY335979	NN	O	ly335979	prep_of	36	SENT_119	[p8l1462t1081r1897b1158],
46	;	:	O	;	_	0	SENT_119	[p8l1462t1081r1897b1158],
47	5	CD	NUMBER	5	num	48	SENT_119	[p8l1928t1081r1965b1144],
48	uM	NN	O	um	dep	33	SENT_119	[p8l1999t1083r2141b1161],
49	;	:	O	;	_	0	SENT_119	[p8l1999t1083r2141b1161],
50	[	CD	NUMBER	[	number	51	SENT_119	[p8l14t1194r183b1270],
51	12	CD	NUMBER	12	dep	33	SENT_119	[p8l14t1194r183b1270],
52	]	CD	NUMBER	]	num	53	SENT_119	[p8l14t1194r183b1270],
53	)	NN	O	)	dep	51	SENT_119	[p8l14t1194r183b1270],
54	in	IN	O	in	_	0	SENT_119	[p8l236t1193r303b1255],
55	phenol	NN	O	phenol	nn	57	SENT_119	[p8l352t1193r595b1274],
56	red	JJ	O	red	amod	57	SENT_119	[p8l646t1193r927b1256],
57	—	NN	O	—	nn	60	SENT_119	[p8l646t1193r927b1256],
58	free	JJ	O	free	amod	60	SENT_119	[p8l646t1193r927b1256],
59	RPMI	NN	O	rpmus	nn	60	SENT_119	[p8l979t1195r1196b1255],
60	medium	NN	O	medium	prep_in	19	SENT_119	[p8l1246t1193r1556b1256],
61	.	.	O	.	_	0	SENT_119	[p8l1246t1193r1556b1256],

1	After	IN	O	after	_	0	SENT_120	[p8l1610t1193r1799b1256],
2	washing	VBG	O	wash	prepc_after	13	SENT_120	[p8l1849t1193r2145b1274],
3	thrice	NN	O	thrice	dobj	2	SENT_120	[p8l8t1304r210b1367],
4	with	IN	O	with	_	0	SENT_120	[p8l237t1304r394b1367],
5	ice	NN	O	ice	prep_with	2	SENT_120	[p8l420t1304r708b1367],
6	—	CD	NUMBER	—	num	8	SENT_120	[p8l420t1304r708b1367],
7	cold	JJ	O	cold	amod	8	SENT_120	[p8l420t1304r708b1367],
8	HBSS	NNS	O	hbss	dep	5	SENT_120	[p8l734t1305r975b1378],
9	,	,	O	,	_	0	SENT_120	[p8l734t1305r975b1378],
10	the	DT	O	the	det	11	SENT_120	[p8l1004t1304r1111b1367],
11	cells	NNS	O	cell	nsubjpass	13	SENT_120	[p8l1139t1304r1299b1367],
12	were	VBD	O	be	auxpass	13	SENT_120	[p8l1328t1324r1499b1367],
13	lysed	VBN	O	lyse	_	0	SENT_120	[p8l1527t1304r1714b1385],
14	with	IN	O	with	_	0	SENT_120	[p8l1741t1304r1897b1367],
15	Triton	NNP	ORGANIZATION	Triton	nn	16	SENT_120	[p8l1924t1304r2146b1367],
16	X-100	NN	O	x-100	prep_with	13	SENT_120	[p8l7t1416r234b1478],
17	(	CD	PERCENT	(	num	16	SENT_120	[p8l279t1416r518b1492],
18	0.1	CD	PERCENT	0.1	number	19	SENT_120	[p8l279t1416r518b1492],
19	%	NN	PERCENT	%	amod	16	SENT_120	[p8l279t1416r518b1492],
20	)	CD	NUMBER	)	dobj	13	SENT_120	[p8l279t1416r518b1492],
21	in	IN	O	in	_	0	SENT_120	[p8l562t1415r631b1477],
22	MilliQ	NNP	O	MilliQ	nn	23	SENT_120	[p8l671t1415r914b1493],
23	water	NN	O	water	prep_in	20	SENT_120	[p8l957t1425r1155b1478],
24	(	CD	NUMBER	(	num	23	SENT_120	[p8l1197t1415r1580b1496],
25	Millipore	NNP	ORGANIZATION	Millipore	nn	31	SENT_120	[p8l1197t1415r1580b1496],
26	,	,	O	,	_	0	SENT_120	[p8l1197t1415r1580b1496],
27	Bedford	NNP	LOCATION	Bedford	appos	31	SENT_120	[p8l1625t1415r1936b1489],
28	,	,	O	,	_	0	SENT_120	[p8l1625t1415r1936b1489],
29	MA	NNP	O	MA	appos	31	SENT_120	[p8l1980t1416r2143b1489],
30	,	,	O	,	_	0	SENT_120	[p8l1980t1416r2143b1489],
31	USA	NNP	LOCATION	USA	dep	23	SENT_120	[p8l8t1527r233b1604],
32	)	CD	NUMBER	)	num	31	SENT_120	[p8l8t1527r233b1604],
33	.	.	O	.	_	0	SENT_120	[p8l8t1527r233b1604],

1	The	DT	O	the	det	2	SENT_121	[p8l268t1526r405b1589],
2	ratio	NN	O	ratio	nsubj	18	SENT_121	[p8l435t1526r597b1589],
3	of	IN	O	of	_	0	SENT_121	[p8l630t1526r707b1589],
4	intracellular	JJ	O	intracellular	amod	7	SENT_121	[p8l732t1526r1165b1589],
5	rhodamine	NN	O	rhodamine	nn	7	SENT_121	[p8l1194t1526r1576b1589],
6	123	CD	NUMBER	123	num	7	SENT_121	[p8l1615t1527r1734b1589],
7	concentrations	NNS	O	concentration	prep_of	2	SENT_121	[p8l1770t1536r2143b1589, p8l8t1638r179b1701],
8	in	IN	O	in	_	0	SENT_121	[p8l219t1638r287b1700],
9	the	DT	O	the	det	10	SENT_121	[p8l326t1638r433b1701],
10	absence	NN	O	absence	prep_in	7	SENT_121	[p8l475t1638r755b1701],
11	and	CC	O	and	_	0	SENT_121	[p8l796t1638r923b1701],
12	presence	NN	O	presence	conj_and	10	SENT_121	[p8l959t1658r1272b1719],
13	of	IN	O	of	_	0	SENT_121	[p8l1313t1638r1391b1701],
14	5	CD	NUMBER	5	num	16	SENT_121	[p8l1424t1638r1461b1701],
15	uM	NN	O	um	nn	16	SENT_121	[p8l1495t1640r1617b1718],
16	zosuquidar	NN	O	zosuquidar	prep_of	10	SENT_121	[p8l1658t1638r2050b1719],
17	is	VBZ	O	be	cop	18	SENT_121	[p8l2088t1638r2143b1701],
18	indicative	JJ	O	indicative	_	0	SENT_121	[p8l8t1748r360b1811],
19	for	IN	O	for	_	0	SENT_121	[p8l385t1748r489b1811],
20	the	DT	O	the	det	22	SENT_121	[p8l511t1748r619b1811],
21	efflux	NN	O	efflux	nn	22	SENT_121	[p8l645t1746r846b1811],
22	activity	NN	O	activity	prep_for	18	SENT_121	[p8l874t1748r1138b1829],
23	of	IN	O	of	_	0	SENT_121	[p8l1165t1748r1242b1811],
24	Pgp	NNP	O	Pgp	prep_of	22	SENT_121	[p8l1261t1750r1416b1829],
25	.	.	O	.	_	0	SENT_121	[p8l1261t1750r1416b1829],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_122	[p8l8t1972r460b2035],
2	accumulation	NN	O	accumulation	_	0	SENT_122	[p8l487t1972r967b2035],

1	LS180	NN	O	ls180	nn	2	SENT_123	[p8l8t2198r245b2260],
2	cells	NNS	O	cell	nsubj	3	SENT_123	[p8l289t2197r449b2260],
3	(	VBP	O	(	_	0	SENT_123	[p8l497t2197r629b2274],
4	0.5	CD	NUMBER	0.5	num	5	SENT_123	[p8l497t2197r629b2274],
5	X	NN	O	x	dobj	3	SENT_123	[p8l670t2217r716b2258],
6	106	CD	NUMBER	106	num	8	SENT_123	[p8l761t2179r871b2260],
7	c/well	NN	O	c/well	nn	8	SENT_123	[p8l917t2197r1161b2274],
8	)	NN	O	)	nsubjpass	10	SENT_123	[p8l917t2197r1161b2274],
9	were	VBD	O	be	auxpass	10	SENT_123	[p8l1207t2217r1379b2260],
10	plated	VBN	O	plate	rcmod	5	SENT_123	[p8l1422t2197r1641b2278],
11	in	IN	O	in	_	0	SENT_123	[p8l1684t2197r1751b2259],
12	a	DT	O	a	det	14	SENT_123	[p8l1796t2217r1833b2260],
13	24-well	JJ	O	24-well	amod	14	SENT_123	[p8l1877t2197r2146b2260],
14	plate	NN	O	plate	prep_in	10	SENT_123	[p8l7t2309r198b2390],
15	.	.	O	.	_	0	SENT_123	[p8l7t2309r198b2390],

1	After	IN	O	after	_	0	SENT_124	[p8l233t2309r422b2372],
2	a	DT	O	a	det	5	SENT_124	[p8l453t2329r490b2372],
3	48	CD	NUMBER	48	num	5	SENT_124	[p8l519t2310r604b2372],
4	h	NN	O	h	nn	5	SENT_124	[p8l631t2309r675b2371],
5	incubation	NN	O	incubation	prep_after	17	SENT_124	[p8l705t2309r1082b2372],
6	with	IN	O	with	_	0	SENT_124	[p8l1113t2309r1270b2372],
7	0.1	CD	PERCENT	0.1	number	8	SENT_124	[p8l1301t2310r1481b2372],
8	%	NN	PERCENT	%	amod	9	SENT_124	[p8l1301t2310r1481b2372],
9	DMSO	NN	O	dmso	prep_with	5	SENT_124	[p8l1516t2310r1771b2372],
10	or	CC	O	or	_	0	SENT_124	[p8l1805t2329r1877b2372],
11	10	CD	NUMBER	10	num	13	SENT_124	[p8l1915t2310r1993b2372],
12	uM	NN	O	um	nn	13	SENT_124	[p8l2024t2311r2145b2389],
13	rifampicin	NN	O	rifampicin	prep_with	5	SENT_124	[p8l7t2420r399b2501],
14	,	,	O	,	_	0	SENT_124	[p8l7t2420r399b2501],
15	cells	NNS	O	cell	nsubjpass	17	SENT_124	[p8l444t2420r602b2483],
16	were	VBD	O	be	auxpass	17	SENT_124	[p8l646t2440r816b2483],
17	treated	VBN	O	treat	_	0	SENT_124	[p8l857t2420r1099b2483],
18	with	IN	O	with	_	0	SENT_124	[p8l1140t2420r1298b2483],
19	5	CD	NUMBER	5	num	21	SENT_124	[p8l1338t2420r1375b2483],
20	uM	NN	O	um	nn	21	SENT_124	[p8l1409t2422r1531b2500],
21	doxorubicin	NN	O	doxorubicin	prep_with	17	SENT_124	[p8l1573t2420r2003b2483],
22	for	IN	O	for	_	0	SENT_124	[p8l2043t2420r2148b2483],
23	90	CD	DURATION	90	num	24	SENT_124	[p8l9t2532r95b2595],
24	min	NN	DURATION	min	prep_for	21	SENT_124	[p8l120t2531r276b2594],
25	.	.	O	.	_	0	SENT_124	[p8l120t2531r276b2594],

1	Cells	NNS	O	cell	nsubjpass	11	SENT_125	[p8l310t2531r489b2594],
2	were	VBD	O	be	auxpass	3	SENT_125	[p8l521t2551r692b2594],
3	washed	VBN	O	wash	_	0	SENT_125	[p8l722t2531r988b2594],
4	thrice	RB	O	thrice	advmod	3	SENT_125	[p8l1016t2531r1218b2594],
5	with	IN	O	with	_	0	SENT_125	[p8l1248t2531r1405b2594],
6	ice	NN	O	ice	npadvmod	8	SENT_125	[p8l1434t2531r1721b2594],
7	—	CD	NUMBER	—	num	6	SENT_125	[p8l1434t2531r1721b2594],
8	cold	JJ	O	cold	amod	9	SENT_125	[p8l1434t2531r1721b2594],
9	PBS	NNP	ORGANIZATION	PBS	prep_with	3	SENT_125	[p8l1749t2532r1926b2605],
10	,	,	O	,	_	0	SENT_125	[p8l1749t2532r1926b2605],
11	lysed	VBN	O	lyse	conj_and	3	SENT_125	[p8l1959t2531r2147b2612],
12	in	IN	O	in	_	0	SENT_125	[p8l8t2641r75b2703],
13	250	CD	NUMBER	250	num	16	SENT_125	[p8l107t2641r237b2704],
14	pl	NN	O	pl	nn	16	SENT_125	[p8l268t2641r335b2721],
15	MilliQ	NN	O	milliq	nn	16	SENT_125	[p8l366t2641r608b2719],
16	water	NN	O	water	prep_in	11	SENT_125	[p8l640t2651r855b2715],
17	,	,	O	,	_	0	SENT_125	[p8l640t2651r855b2715],
18	and	CC	O	and	_	0	SENT_125	[p8l890t2641r1017b2704],
19	homogenized	VBN	O	homogenize	conj_and	3	SENT_125	[p8l1046t2641r1529b2722],
20	by	IN	O	by	_	0	SENT_125	[p8l1557t2641r1645b2722],
21	ultrasoniﬁcation	NN	O	ultrasoniﬁcation	nn	23	SENT_125	[p8l1675t2639r2143b2704, p8l8t2753r146b2816],
22	Labsonic	JJ	O	labsonic	amod	23	SENT_125	[p8l172t2753r498b2816],
23	P	NN	O	p	prep_by	19	SENT_125	[p8l527t2755r574b2815],
24	(	CD	NUMBER	(	num	25	SENT_125	[p8l604t2754r869b2831],
25	Braun	NNP	PERSON	Braun	dep	23	SENT_125	[p8l604t2754r869b2831],
26	;	:	O	;	_	0	SENT_125	[p8l604t2754r869b2831],
27	cycle	NN	O	cycle	nn	29	SENT_125	[p8l901t2753r1087b2834],
28	0.2	CD	DURATION	0.2	num	29	SENT_125	[p8l1114t2754r1222b2816],
29	min	NN	DURATION	min	dep	23	SENT_125	[p8l1248t2753r1385b2815],
30	en	IN	O	en	_	0	SENT_125	[p8l1414t2773r1495b2816],
31	Amplitude	NNP	O	Amplitude	prep_en	29	SENT_125	[p8l1522t2753r1903b2834],
32	60	CD	PERCENT	60	number	33	SENT_125	[p8l1933t2753r2141b2831],
33	%	NN	PERCENT	%	amod	31	SENT_125	[p8l1933t2753r2141b2831],
34	)	CD	NUMBER	)	dobj	3	SENT_125	[p8l1933t2753r2141b2831],
35	.	.	O	.	_	0	SENT_125	[p8l1933t2753r2141b2831],

1	Hundred	NNP	NUMBER	Hundred	nn	2	SENT_126	[p8l8t2864r321b2927],
2	microliters	NNS	O	microliter	nsubjpass	7	SENT_126	[p8l353t2864r738b2927],
3	of	IN	O	of	_	0	SENT_126	[p8l774t2864r852b2927],
4	the	DT	O	the	det	5	SENT_126	[p8l878t2864r985b2927],
5	homogenate	NN	O	homogenate	prep_of	2	SENT_126	[p8l1018t2864r1455b2945],
6	was	VBD	O	be	auxpass	7	SENT_126	[p8l1490t2884r1624b2927],
7	processed	VBN	O	process	_	0	SENT_126	[p8l1657t2864r2011b2945],
8	for	IN	O	for	_	0	SENT_126	[p8l2044t2864r2148b2927],
9	HPLC	NN	O	hplc	nn	10	SENT_126	[p8l8t2976r233b3038],
10	analysis	NN	O	analysis	prep_for	7	SENT_126	[p8l263t2975r566b3056],
11	.	.	O	.	_	0	SENT_126	[p8l263t2975r566b3056],

1	Daunorubicin	NN	PERSON	daunorubicin	nsubjpass	3	SENT_127	[p8l598t2975r1089b3038],
2	was	VBD	O	be	auxpass	3	SENT_127	[p8l1116t2995r1251b3038],
3	used	VBN	O	use	_	0	SENT_127	[p8l1278t2975r1442b3038],
4	as	IN	O	as	_	0	SENT_127	[p8l1469t2995r1537b3038],
5	an	DT	O	a	det	7	SENT_127	[p8l1568t2995r1649b3038],
6	intemal	JJ	O	intemal	amod	7	SENT_127	[p8l1675t2975r1946b3038],
7	standard	NN	O	standard	prep_as	3	SENT_127	[p8l1976t2985r2143b3038, p8l9t3086r183b3149],
8	.	.	O	.	_	0	SENT_127	[p8l1976t2985r2143b3038, p8l9t3086r183b3149],

1	The	DT	O	the	det	2	SENT_128	[p8l216t3086r352b3149],
2	samples	NNS	O	sample	nsubj	9	SENT_128	[p8l384t3086r666b3167],
3	and	CC	O	and	_	0	SENT_128	[p8l699t3086r825b3149],
4	standard	JJ	O	standard	amod	5	SENT_128	[p8l856t3086r1154b3149],
5	solutions	NNS	O	solution	conj_and	2	SENT_128	[p8l1185t3086r1502b3149],
6	were	VBD	O	be	aux	7	SENT_128	[p8l1534t3106r1705b3149],
7	prepared	VBN	O	prepare	_	0	SENT_128	[p8l1733t3086r2045b3167],
8	as	IN	O	as	_	0	SENT_128	[p8l2075t3106r2144b3149],
9	described	VBN	O	describe	conj_as	7	SENT_128	[p8l9t3197r351b3260],
10	by	IN	O	by	_	0	SENT_128	[p8l374t3197r461b3278],
11	van	NN	O	van	nn	12	SENT_128	[p8l487t3217r614b3260],
12	Asperen	NNP	O	Asperen	prep_by	9	SENT_128	[p8l639t3198r936b3278],
13	et	FW	O	et	nn	15	SENT_128	[p8l962t3207r1025b3260],
14	al.	FW	O	al.	nn	15	SENT_128	[p8l1051t3197r1129b3260],
15	[	FW	O	[	dobj	9	SENT_128	[p8l1164t3198r1324b3273],
16	13	CD	NUMBER	13	num	17	SENT_128	[p8l1164t3198r1324b3273],
17	]	NN	O	]	dobj	7	SENT_128	[p8l1164t3198r1324b3273],
18	.	.	O	.	_	0	SENT_128	[p8l1164t3198r1324b3273],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_129	[p8l8t3422r459b3485],
2	HPLC	NN	O	hplc	nn	3	SENT_129	[p8l485t3423r710b3485],
3	analysis	NN	O	analysis	dep	1	SENT_129	[p8l739t3422r1023b3503],

1	Doxorubicin	NN	O	doxorubicin	nsubj	9	SENT_130	[p8l8t3646r459b3709],
2	was	VBD	O	be	aux	3	SENT_130	[p8l495t3666r630b3709],
3	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_130	[p8l668t3644r1025b3727],
4	using	VBG	O	use	xcomp	3	SENT_130	[p8l1059t3646r1250b3727],
5	a	DT	O	a	det	6	SENT_130	[p8l1288t3666r1325b3709],
6	method	NN	O	method	dobj	4	SENT_130	[p8l1360t3646r1626b3709],
7	as	IN	O	as	_	0	SENT_130	[p8l1662t3666r1731b3709],
8	previously	RB	DATE	previously	advmod	9	SENT_130	[p8l1768t3646r2145b3727],
9	described	VBN	O	describe	conj_as	3	SENT_130	[p9l9t22r351b85],
10	by	IN	O	by	_	0	SENT_130	[p9l376t22r463b103],
11	DeGregorio	NNP	PERSON	DeGregorio	prep_by	9	SENT_130	[p9l492t22r916b103],
12	et	FW	O	et	nn	14	SENT_130	[p9l946t31r1010b85],
13	al.	FW	O	al.	nn	14	SENT_130	[p9l1035t22r1113b85],
14	[	FW	O	[	dobj	9	SENT_130	[p9l1152t23r1310b98],
15	14	CD	NUMBER	14	num	16	SENT_130	[p9l1152t23r1310b98],
16	]	NN	O	]	dobj	3	SENT_130	[p9l1152t23r1310b98],
17	.	.	O	.	_	0	SENT_130	[p9l1152t23r1310b98],

1	In	IN	O	in	_	0	SENT_131	[p9l1342t24r1415b84],
2	brief	NN	O	brief	prep_in	6	SENT_131	[p9l1441t22r1628b96],
3	,	,	O	,	_	0	SENT_131	[p9l1441t22r1628b96],
4	samples	NNS	O	sample	nsubjpass	6	SENT_131	[p9l1662t22r1944b103],
5	were	VBD	O	be	auxpass	6	SENT_131	[p9l1975t42r2144b85],
6	eluted	VBN	O	elute	_	0	SENT_131	[p9l9t133r226b196],
7	isocratically	RB	O	isocratically	advmod	6	SENT_131	[p9l263t133r699b214],
8	with	IN	O	with	_	0	SENT_131	[p9l739t133r896b196],
9	a	DT	O	a	det	11	SENT_131	[p9l936t153r972b196],
10	mobile	JJ	O	mobile	amod	11	SENT_131	[p9l1008t133r1255b196],
11	phase	NN	O	phase	prep_with	6	SENT_131	[p9l1293t133r1494b214],
12	that	WDT	O	that	nsubj	13	SENT_131	[p9l1533t133r1667b196],
13	consisted	VBD	O	consist	rcmod	11	SENT_131	[p9l1705t133r2037b196],
14	of	IN	O	of	_	0	SENT_131	[p9l2075t133r2152b196],
15	28	CD	PERCENT	28	number	16	SENT_131	[p9l9t245r166b307],
16	%	NN	PERCENT	%	amod	17	SENT_131	[p9l9t245r166b307],
17	acetonitrile	NN	O	acetonitrile	prep_of	13	SENT_131	[p9l224t244r624b307],
18	in	IN	O	in	_	0	SENT_131	[p9l677t244r745b306],
19	60	CD	NUMBER	60	num	20	SENT_131	[p9l798t244r883b307],
20	mM	NN	O	mm	npadvmod	21	SENT_131	[p9l909t246r1055b306],
21	phosphoric	JJ	O	phosphoric	amod	22	SENT_131	[p9l1108t244r1503b325],
22	acid	NN	O	acid	prep_in	13	SENT_131	[p9l1559t244r1722b307],
23	.	.	O	.	_	0	SENT_131	[p9l1559t244r1722b307],

1	A	DT	O	a	det	6	SENT_132	[p9l1779t245r1841b306],
2	Waters	NNP	O	Waters	nn	6	SENT_132	[p9l1892t246r2144b307],
3	Symmetry	NNP	O	Symmetry	nn	6	SENT_132	[p9l10t356r379b436],
4	C18	NN	O	c18	nn	6	SENT_132	[p9l421t356r564b418],
5	3.5	CD	NUMBER	3.5	num	6	SENT_132	[p9l609t355r712b418],
6	uM	NN	O	um	nsubjpass	18	SENT_132	[p9l746t357r887b435],
7	,	,	O	,	_	0	SENT_132	[p9l746t357r887b435],
8	4.6	CD	NUMBER	4.6	num	10	SENT_132	[p9l930t355r1039b418],
9	mm	NN	O	mm	nn	10	SENT_132	[p9l1065t375r1203b417],
10	X	NN	O	x	appos	6	SENT_132	[p9l1239t375r1285b416],
11	100	CD	NUMBER	100	num	12	SENT_132	[p9l1329t356r1452b418],
12	mm	NN	O	mm	dep	10	SENT_132	[p9l1477t375r1615b417],
13	reVerse	NN	O	reverse	nn	16	SENT_132	[p9l1654t355r2145b436],
14	—	CD	NUMBER	—	num	16	SENT_132	[p9l1654t355r2145b436],
15	phase	NN	O	phase	nn	16	SENT_132	[p9l1654t355r2145b436],
16	column	NN	O	column	dep	10	SENT_132	[p9l9t466r275b529],
17	was	VBD	O	be	auxpass	18	SENT_132	[p9l334t486r470b529],
18	used	VBN	O	use	_	0	SENT_132	[p9l529t466r710b529],
19	.	.	O	.	_	0	SENT_132	[p9l529t466r710b529],

1	Fluorescence	NN	O	fluorescence	nsubjpass	3	SENT_133	[p9l773t466r1244b529],
2	was	VBD	O	be	auxpass	3	SENT_133	[p9l1304t486r1439b529],
3	detected	VBN	O	detect	_	0	SENT_133	[p9l1501t466r1799b529],
4	using	VBG	O	use	_	0	SENT_133	[p9l1857t466r2048b547],
5	a	DT	O	a	det	8	SENT_133	[p9l2110t486r2147b529],
6	JASCO	NNP	ORGANIZATION	JASCO	nn	8	SENT_133	[p9l7t577r278b639],
7	FP-920	NN	O	fp-920	nn	8	SENT_133	[p9l309t577r570b640],
8	ﬂuorometer	NN	O	ﬂuorometer	prep_using	3	SENT_133	[p9l601t573r1018b639],
9	(	CD	NUMBER	(	num	10	SENT_133	[p9l1048t576r1447b654],
10	excitation	NN	O	excitation	dep	8	SENT_133	[p9l1048t576r1447b654],
11	:	:	O	:	_	0	SENT_133	[p9l1048t576r1447b654],
12	455	CD	NUMBER	455	num	13	SENT_133	[p9l1480t576r1610b639],
13	nm	NN	O	nm	dep	8	SENT_133	[p9l1638t596r1771b650],
14	;	:	O	;	_	0	SENT_133	[p9l1638t596r1771b650],
15	emission	NN	O	emission	dep	8	SENT_133	[p9l1805t576r2140b639],
16	:	:	O	:	_	0	SENT_133	[p9l1805t576r2140b639],
17	550	CD	NUMBER	550	num	19	SENT_133	[p9l9t688r139b751],
18	nm	NN	O	nm	nn	19	SENT_133	[p9l165t689r326b766],
19	)	NN	O	)	dep	8	SENT_133	[p9l165t689r326b766],
20	,	,	O	,	_	0	SENT_133	[p9l165t689r326b766],
21	Shimadzu	NNP	ORGANIZATION	Shimadzu	nn	22	SENT_133	[p9l372t688r726b751],
22	LC10AT	NNP	O	LC10AT	appos	8	SENT_133	[p9l765t689r1232b751],
23	.	.	O	.	_	0	SENT_133	[p9l765t689r1232b751],

1	—	NN	O	—	_	0	SENT_134	[p9l765t689r1232b751],
2	.	.	O	.	_	0	SENT_134	[p9l765t689r1232b751],

1	VP	NN	O	vp	_	0	SENT_135	[p9l765t689r1232b751],
2	pumps	NNS	O	pump	dep	1	SENT_135	[p9l1269t708r1505b769],
3	and	CC	O	and	_	0	SENT_135	[p9l1548t688r1674b751],
4	a	DT	O	a	det	7	SENT_135	[p9l1714t708r1751b751],
5	Shimadzu	NNP	O	Shimadzu	nn	7	SENT_135	[p9l1791t688r2146b751],
6	SCL10A-VP	NN	O	scl10a-vp	nn	7	SENT_135	[p9l10t800r470b862],
7	controller	NN	O	controller	conj_and	2	SENT_135	[p9l513t799r875b862],
8	.	.	O	.	_	0	SENT_135	[p9l513t799r875b862],

1	The	DT	O	the	det	3	SENT_136	[p9l921t799r1059b862],
2	ﬂow	NN	O	ﬂow	nn	3	SENT_136	[p9l1101t796r1257b862],
3	rate	NN	O	rate	nsubjpass	5	SENT_136	[p9l1298t809r1431b862],
4	was	VBD	O	be	auxpass	5	SENT_136	[p9l1473t819r1607b862],
5	set	VBN	O	set	_	0	SENT_136	[p9l1653t809r1750b862],
6	at	IN	O	at	_	0	SENT_136	[p9l1791t809r1853b862],
7	1.0	CD	NUMBER	1.0	num	8	SENT_136	[p9l1901t800r2002b862],
8	ml	NN	O	ml	prep_at	5	SENT_136	[p9l2028t799r2147b862],
9	]	CD	NUMBER	]	num	10	SENT_136	[p9l2028t799r2147b862],
10	min	NN	DURATION	min	dep	8	SENT_136	[p9l8t911r163b974],
11	.	.	O	.	_	0	SENT_136	[p9l8t911r163b974],

1	Doxorubicin	NN	O	doxorubicin	nn	5	SENT_137	[p9l208t911r661b974],
2	and	CC	O	and	_	0	SENT_137	[p9l703t911r830b974],
3	daunorubicin	NN	O	daunorubicin	conj_and	1	SENT_137	[p9l871t911r1342b974],
4	retention	NN	O	retention	nn	5	SENT_137	[p9l1381t911r1700b974],
5	times	NNS	O	time	nsubj	10	SENT_137	[p9l1740t911r1930b974],
6	were	VBD	O	be	cop	10	SENT_137	[p9l1975t931r2145b974],
7	2.38	CD	NUMBER	2.38	num	10	SENT_137	[p9l9t1024r159b1086],
8	and	CC	O	and	_	0	SENT_137	[p9l192t1023r319b1086],
9	5.01	CD	DURATION	5.01	num	10	SENT_137	[p9l347t1023r492b1086],
10	min	NN	DURATION	min	_	0	SENT_137	[p9l524t1023r681b1097],
11	,	,	O	,	_	0	SENT_137	[p9l524t1023r681b1097],
12	respectively	RB	O	respectively	advmod	10	SENT_137	[p9l711t1023r1163b1104],
13	.	.	O	.	_	0	SENT_137	[p9l711t1023r1163b1104],

1	A	DT	O	a	det	3	SENT_138	[p9l1195t1024r1257b1085],
2	standard	JJ	O	standard	amod	3	SENT_138	[p9l1288t1023r1587b1086],
3	curve	NN	O	curve	nsubjpass	21	SENT_138	[p9l1615t1043r1811b1086],
4	of	IN	O	of	_	0	SENT_138	[p9l1840t1023r1917b1086],
5	doxo	NN	O	doxo	nn	7	SENT_138	[p9l1940t1023r2144b1086],
6	—	NN	O	—	nn	7	SENT_138	[p9l1940t1023r2144b1086],
7	rubicin	NN	O	rubicin	prep_of	3	SENT_138	[p9l7t1134r260b1197],
8	(	CD	NUMBER	(	number	9	SENT_138	[p9l288t1135r488b1212],
9	0.08	CD	NUMBER	0.08	dep	7	SENT_138	[p9l288t1135r488b1212],
10	,	,	O	,	_	0	SENT_138	[p9l288t1135r488b1212],
11	0.4	CD	NUMBER	0.4	appos	7	SENT_138	[p9l518t1135r646b1208],
12	,	,	O	,	_	0	SENT_138	[p9l518t1135r646b1208],
13	2	CD	NUMBER	2	conj_and	11	SENT_138	[p9l676t1135r735b1208],
14	,	,	O	,	_	0	SENT_138	[p9l676t1135r735b1208],
15	10	CD	NUMBER	10	conj_and	11	SENT_138	[p9l773t1135r851b1197],
16	and	CC	O	and	_	0	SENT_138	[p9l878t1134r1004b1197],
17	50	CD	NUMBER	50	num	19	SENT_138	[p9l1029t1134r1115b1197],
18	14M	NN	O	14m	nn	19	SENT_138	[p9l1146t1135r1295b1214],
19	)	NN	O	)	conj_and	11	SENT_138	[p9l1146t1135r1295b1214],
20	was	VBD	O	be	auxpass	21	SENT_138	[p9l1323t1154r1457b1197],
21	prepared	VBN	O	prepare	_	0	SENT_138	[p9l1483t1134r1797b1215],
22	in	IN	O	in	_	0	SENT_138	[p9l1821t1134r1888b1196],
23	milliQ	JJ	O	milliq	amod	24	SENT_138	[p9l1914t1134r2146b1212],
24	water	NN	O	water	prep_in	21	SENT_138	[p9l8t1236r223b1289],
25	.	.	O	.	_	0	SENT_138	[p9l8t1236r223b1289],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_139	[p9l8t1450r459b1513],
2	cytotoxicity	NN	O	cytotoxicity	nn	3	SENT_139	[p9l486t1450r910b1531],
3	assay	NN	O	assay	dep	1	SENT_139	[p9l938t1470r1127b1531],

1	LS180	NN	O	ls180	nn	2	SENT_140	[p9l8t1676r245b1738],
2	cells	NNS	O	cell	nsubjpass	4	SENT_140	[p9l271t1675r430b1738],
3	were	VBD	O	be	auxpass	4	SENT_140	[p9l458t1695r628b1738],
4	plated	VBN	O	plate	_	0	SENT_140	[p9l652t1675r871b1756],
5	(	RB	O	(	advmod	6	SENT_140	[p9l898t1676r966b1753],
6	2	CD	NUMBER	2	dobj	4	SENT_140	[p9l898t1676r966b1753],
7	x	CC	O	x	_	0	SENT_140	[p9l1003t1695r1049b1736],
8	104	CD	NUMBER	104	num	9	SENT_140	[p9l1094t1658r1203b1738],
9	cells/well	NNS	O	cells/well	dobj	4	SENT_140	[p9l1230t1675r1592b1749],
10	;	:	O	;	_	0	SENT_140	[p9l1230t1675r1592b1749],
11	96	CD	NUMBER	96	nsubj	13	SENT_140	[p9l1622t1675r1706b1739],
12	well	RB	O	well	advmod	13	SENT_140	[p9l1732t1675r1884b1738],
13	plates	VBZ	O	plate	parataxis	4	SENT_140	[p9l1907t1675r2144b1756],
14	)	NN	O	)	dobj	13	SENT_140	[p9l1907t1675r2144b1756],
15	and	CC	O	and	_	0	SENT_140	[p9l10t1787r136b1850],
16	treated	VBN	O	treat	conj_and	13	SENT_140	[p9l158t1787r401b1850],
17	with	IN	O	with	_	0	SENT_140	[p9l423t1787r581b1850],
18	10	CD	NUMBER	10	num	20	SENT_140	[p9l611t1788r690b1850],
19	uM	NN	O	um	nn	20	SENT_140	[p9l720t1789r842b1867],
20	rifampicin	NN	O	rifampicin	prep_with	16	SENT_140	[p9l864t1787r1238b1868],
21	or	CC	O	or	_	0	SENT_140	[p9l1261t1807r1334b1850],
22	0.1	CD	PERCENT	0.1	number	23	SENT_140	[p9l1355t1788r1535b1850],
23	%	NN	PERCENT	%	amod	24	SENT_140	[p9l1355t1788r1535b1850],
24	DMSO	NN	O	dmso	conj_or	20	SENT_140	[p9l1562t1788r1837b1850],
25	.	.	O	.	_	0	SENT_140	[p9l1562t1788r1837b1850],

1	Following	VBG	O	follow	_	0	SENT_141	[p9l1864t1787r2145b1850, p9l8t1898r119b1979],
2	72	CD	NUMBER	72	num	4	SENT_141	[p9l171t1899r256b1961],
3	h	NN	O	h	nn	4	SENT_141	[p9l282t1898r325b1960],
4	incubation	NN	O	incubation	prep_following	8	SENT_141	[p9l374t1898r770b1972],
5	,	,	O	,	_	0	SENT_141	[p9l374t1898r770b1972],
6	cells	NNS	O	cell	appos	4	SENT_141	[p9l823t1898r983b1961],
7	were	VBD	O	be	auxpass	8	SENT_141	[p9l1035t1918r1205b1961],
8	exposed	VBN	O	expose	_	0	SENT_141	[p9l1257t1898r1548b1979],
9	to	TO	O	to	_	0	SENT_141	[p9l1596t1908r1664b1961],
10	doxorubicin	NN	O	doxorubicin	prep_to	8	SENT_141	[p9l1715t1898r2146b1961],
11	(	CD	NUMBER	(	num	10	SENT_141	[p9l11t2009r299b2090],
12	serially	RB	O	serially	advmod	13	SENT_141	[p9l11t2009r299b2090],
13	diluted	VBN	O	dilute	amod	10	SENT_141	[p9l332t2009r580b2072],
14	0-20	CD	NUMBER	0-20	num	15	SENT_141	[p9l611t2010r786b2072],
15	uM	NN	O	um	nsubjpass	8	SENT_141	[p9l817t2011r960b2089],
16	;	:	O	;	_	0	SENT_141	[p9l817t2011r960b2089],
17	dilution	NN	O	dilution	nn	18	SENT_141	[p9l997t2009r1273b2072],
18	factor	NN	O	factor	dep	15	SENT_141	[p9l1305t2009r1514b2072],
19	2	CD	NUMBER	2	num	20	SENT_141	[p9l1545t2010r1633b2086],
20	)	NN	O	)	dep	18	SENT_141	[p9l1545t2010r1633b2086],
21	.	.	O	.	_	0	SENT_141	[p9l1545t2010r1633b2086],

1	Cell	NN	O	cell	nn	2	SENT_142	[p9l1671t2009r1816b2072],
2	Viability	NN	O	viability	nsubjpass	9	SENT_142	[p9l1849t2009r2145b2090],
3	after	IN	O	after	_	0	SENT_142	[p9l10t2120r172b2183],
4	48	CD	NUMBER	48	num	7	SENT_142	[p9l200t2121r284b2183],
5	h	NN	O	h	nn	7	SENT_142	[p9l312t2120r355b2182],
6	doxorubicin	NN	O	doxorubicin	nn	7	SENT_142	[p9l386t2120r817b2183],
7	exposure	NN	O	exposure	prep_after	2	SENT_142	[p9l848t2140r1169b2201],
8	was	VBD	O	be	auxpass	9	SENT_142	[p9l1200t2140r1335b2183],
9	assessed	VBN	O	assess	_	0	SENT_142	[p9l1369t2120r1669b2183],
10	using	VBG	O	use	xcomp	9	SENT_142	[p9l1698t2120r1889b2201],
11	a	DT	O	a	det	17	SENT_142	[p9l1923t2140r1960b2183],
12	neutral	JJ	O	neutral	amod	17	SENT_142	[p9l1988t2140r2144b2183, p9l8t2231r125b2294],
13	red	JJ	O	red	amod	17	SENT_142	[p9l150t2231r264b2294],
14	assay	NN	O	assay	nn	17	SENT_142	[p9l289t2251r479b2312],
15	[	CD	NUMBER	[	number	16	SENT_142	[p9l511t2231r670b2307],
16	15	CD	NUMBER	15	num	17	SENT_142	[p9l511t2231r670b2307],
17	]	NN	O	]	dobj	10	SENT_142	[p9l511t2231r670b2307],
18	.	.	O	.	_	0	SENT_142	[p9l511t2231r670b2307],

1	Statistical	JJ	O	statistical	amod	2	SENT_143	[p9l10t2455r360b2518],
2	analysis	NN	O	analysis	_	0	SENT_143	[p9l387t2455r669b2536],

1	One	CD	NUMBER	one	num	4	SENT_144	[p9l9t2680r334b2760],
2	—	NN	O	—	nn	4	SENT_144	[p9l9t2680r334b2760],
3	way	NN	O	way	nn	4	SENT_144	[p9l9t2680r334b2760],
4	ANOVA	NN	O	anova	dep	8	SENT_144	[p9l376t2680r697b2742],
5	with	IN	O	with	_	0	SENT_144	[p9l740t2679r897b2742],
6	Bonferroni	NNP	PERSON	Bonferroni	prep_with	4	SENT_144	[p9l939t2679r1328b2742],
7	post	NN	O	post	dep	8	SENT_144	[p9l1370t2688r1520b2760],
8	hoc	FW	O	hoc	dep	11	SENT_144	[p9l1560t2679r1685b2742],
9	testing	NN	O	testing	dep	8	SENT_144	[p9l1728t2679r1966b2760],
10	was	VBD	O	be	auxpass	11	SENT_144	[p9l2009t2699r2143b2742],
11	performed	VBN	O	perform	_	0	SENT_144	[p9l7t2790r380b2871],
12	for	IN	O	for	_	0	SENT_144	[p9l421t2790r524b2853],
13	statistical	JJ	O	statistical	amod	14	SENT_144	[p9l567t2790r900b2853],
14	comparison	NN	O	comparison	prep_for	11	SENT_144	[p9l943t2790r1359b2871],
15	of	IN	O	of	_	0	SENT_144	[p9l1401t2790r1478b2853],
16	the	DT	O	the	det	20	SENT_144	[p9l1512t2790r1619b2853],
17	obtained	VBN	O	obtain	amod	20	SENT_144	[p9l1662t2790r1968b2853],
18	Pgp	NN	ORGANIZATION	pgp	nn	20	SENT_144	[p9l2008t2792r2145b2871],
19	reporter	NN	O	reporter	nn	20	SENT_144	[p9l7t2911r279b2982],
20	gene	NN	O	gene	prep_of	14	SENT_144	[p9l313t2921r473b2982],
21	and	CC	O	and	_	0	SENT_144	[p9l509t2901r632b2964],
22	activity	NN	O	activity	nn	23	SENT_144	[p9l668t2901r918b2982],
23	results	NNS	O	result	prep_of	14	SENT_144	[p9l952t2901r1172b2964],
24	and	CC	O	and	_	0	SENT_144	[p9l1209t2901r1332b2964],
25	considered	VBN	O	consider	conj_and	11	SENT_144	[p9l1366t2901r1733b2964],
26	statistically	RB	O	statistically	advmod	25	SENT_144	[p9l1771t2901r2147b2982],

1	@	IN	O	@	dep	12	SENT_145	[p9l1768t3141r1846b3237],
2	Springer	NNP	PERSON	Springer	nn	6	SENT_145	[p9l1875t3164r2137b3239],
3	768	CD	NUMBER	768	num	6	SENT_145	[p9l53t3314r103b3339],
4	Cancer	NNP	O	Cancer	nn	6	SENT_145	[p9l1400t3314r1500b3339],
5	Chemother	NNP	PERSON	Chemother	nn	6	SENT_145	[p9l1509t3314r1666b3339],
6	Pharmacol	NNP	PERSON	Pharmacol	pobj	1	SENT_145	[p9l1675t3314r1826b3339],
7	(	CD	NUMBER	(	num	8	SENT_145	[p9l1836t3314r1928b3344],
8	2010	CD	DATE	2010	dep	6	SENT_145	[p9l1836t3314r1928b3344],
9	)	CD	NUMBER	)	number	10	SENT_145	[p9l1836t3314r1928b3344],
10	66:765	CD	NUMBER	66:765	num	11	SENT_145	[p9l1939t3314r2104b3339],
11	—	NN	O	—	dep	8	SENT_145	[p9l1939t3314r2104b3339],
12	771	CD	NUMBER	771	_	0	SENT_145	[p9l1939t3314r2104b3339],

1	cell	NN	O	cell	nn	2	SENT_146	[p10l46t655r95b754],
2	Viability	NN	O	viability	_	0	SENT_146	[p10l46t402r110b635],

1	U1	NN	O	u1	nn	4	SENT_147	[p10l168t735r193b779],
2	\	CD	NUMBER	\	num	4	SENT_147	[p10l167t569r194b612],
3	]	NN	O	]	nn	4	SENT_147	[p10l167t569r194b612],
4	o	NN	O	o	_	0	SENT_147	[p10l198t736r227b779],
5	U1	NN	O	u1	nn	6	SENT_147	[p10l199t568r225b612],
6	o	NN	O	o	dep	4	SENT_147	[p10l232t734r279b779],
7	\	CD	NUMBER	\	number	8	SENT_147	[p10l232t734r279b779],
8	°	CD	NUMBER	°	num	9	SENT_147	[p10l232t734r279b779],
9	8	CD	NUMBER	8	dep	6	SENT_147	[p10l232t567r279b612],

1	N	NN	O	n	nn	3	SENT_148	[p10l168t898r196b941],
2	U1	NN	O	u1	nn	3	SENT_148	[p10l199t897r225b941],
3	o	NN	O	o	_	0	SENT_148	[p10l232t896r279b942],
4	\	CD	NUMBER	\	num	5	SENT_148	[p10l232t896r279b942],
5	°	NN	O	°	dep	3	SENT_148	[p10l232t896r279b942],

1	OSIAIG	CD	PERCENT	osiaig	num	2	SENT_149	[p10l383t1277r426b1453],
2	%	NN	PERCENT	%	_	0	SENT_149	[p10l383t1210r428b1257],
3	I	PRP	O	I	dep	2	SENT_149	[p10l384t1182r426b1200],
4	'	''	O	'	_	0	SENT_149	[p10l383t1130r426b1171],
5	o	NN	O	o	dep	3	SENT_149	[p10l383t1130r426b1171],

1	9p	NN	O	9p	nn	4	SENT_150	[p10l520t1313r576b1547],
2	§	CD	NUMBER	§	num	4	SENT_150	[p10l520t1313r576b1547],
3	sodo19	NN	O	sodo19	nn	4	SENT_150	[p10l520t1313r576b1547],
4	W11	NN	O	w11	_	0	SENT_150	[p10l520t1208r575b1295],
5	(	CD	NUMBER	(	num	6	SENT_150	[p10l533t1136r576b1189],
6	)	NN	O	)	dep	4	SENT_150	[p10l533t1136r576b1189],
7	1	CD	NUMBER	1	num	8	SENT_150	[p10l533t1136r576b1189],
8	ur112	NN	O	ur112	dep	6	SENT_150	[p10l669t1313r725b1589],
9	[	CD	NUMBER	[	num	11	SENT_150	[p10l669t1313r725b1589],
10	doq112o	NN	O	doq112o	nn	11	SENT_150	[p10l669t1313r725b1589],
11	W11	NN	O	w11	dep	6	SENT_150	[p10l669t1208r724b1295],
12	(	CD	NUMBER	(	num	13	SENT_150	[p10l682t1136r725b1189],
13	)	NN	O	)	dep	4	SENT_150	[p10l682t1136r725b1189],
14	1	CD	NUMBER	1	dep	13	SENT_150	[p10l682t1136r725b1189],
15	ounspoupx	NN	O	ounspoupx	nn	19	SENT_150	[p10l835t1328r879b1587],
16	W11	NN	O	w11	nn	19	SENT_150	[p10l823t1223r878b1311],
17	{	NN	O	{	nn	19	SENT_150	[p10l835t1130r879b1200],
18	'	''	O	'	_	0	SENT_150	[p10l835t1130r879b1200],
19	o	NN	O	o	dep	4	SENT_150	[p10l835t1130r879b1200],
20	9U	NN	O	9u	nn	22	SENT_150	[p10l985t1328r1028b1597],
21	¥	NN	O	¥	nn	22	SENT_150	[p10l985t1328r1028b1597],
22	1S9Iq11	NN	O	1s9iq11	dep	19	SENT_150	[p10l985t1328r1028b1597],
23	!	.	O	!	_	0	SENT_150	[p10l985t1328r1028b1597],

1	A	DT	O	a	det	2	SENT_151	[p10l985t1328r1028b1597],
2	wﬁ	NN	O	wﬁ	dep	8	SENT_151	[p10l972t1223r1027b1311],
3	1	CD	NUMBER	1	dep	2	SENT_151	[p10l985t1130r1028b1200],
4	'	''	O	'	_	0	SENT_151	[p10l985t1130r1028b1200],
5	0	CD	NUMBER	0	dep	3	SENT_151	[p10l985t1130r1028b1200],
6	II9	NN	O	ii9	dep	8	SENT_151	[p10l1122t1208r1178b1562],
7	}	CD	NUMBER	}	num	6	SENT_151	[p10l1122t1208r1178b1562],
8	[	CD	NUMBER	[	dep	14	SENT_151	[p10l1122t1208r1178b1562],
9	XOIJ	NN	O	xoij	dep	8	SENT_151	[p10l1122t1208r1178b1562],
10	,	,	O	,	_	0	SENT_151	[p10l1122t1208r1178b1562],
11	I13	NN	O	i13	appos	9	SENT_151	[p10l1122t1208r1178b1562],
12	'	''	O	'	_	0	SENT_151	[p10l1122t1208r1178b1562],
13	1	CD	NUMBER	1	num	14	SENT_151	[p10l1122t1208r1178b1562],
14	]	CD	NUMBER	]	_	0	SENT_151	[p10l1122t1208r1178b1562],
15	/	:	O	/	punct	14	SENT_151	[p10l1122t1208r1178b1562],
16	\	CD	NUMBER	\	num	18	SENT_151	[p10l1122t1208r1178b1562],
17	[	CD	NUMBER	[	num	18	SENT_151	[p10l1122t1208r1178b1562],
18	Tl	NN	O	tl	dep	26	SENT_151	[p10l1122t1208r1178b1562],
19	(	CD	NUMBER	(	num	20	SENT_151	[p10l1134t1135r1178b1189],
20	)	NN	O	)	dep	18	SENT_151	[p10l1134t1135r1178b1189],
21	1	CD	NUMBER	1	num	22	SENT_151	[p10l1134t1135r1178b1189],
22	soqdopzio	NN	O	soqdopzio	dep	26	SENT_151	[p10l1270t1344r1327b1590],
23	N11	NN	O	n11	nn	26	SENT_151	[p10l1270t1239r1326b1326],
24	001	CD	NUMBER	001	num	26	SENT_151	[p10l1283t1136r1327b1221],
25	Iexmooop	NN	O	iexmooop	nn	26	SENT_151	[p10l1432t1313r1476b1547],
26	W11	NN	O	w11	dep	33	SENT_151	[p10l1419t1208r1475b1295],
27	(	CD	NUMBER	(	num	28	SENT_151	[p10l1432t1136r1476b1189],
28	)	NN	O	)	dep	26	SENT_151	[p10l1432t1136r1476b1189],
29	1	CD	NUMBER	1	num	31	SENT_151	[p10l1432t1136r1476b1189],
30	epuumnu	NN	O	epuumnu	nn	31	SENT_151	[p10l1582t1313r1625b1547],
31	W11	NN	O	w11	dep	28	SENT_151	[p10l1569t1208r1624b1295],
32	01	CD	NUMBER	01	num	33	SENT_151	[p10l1582t1136r1625b1189],
33	9P	NN	O	9p	dep	14	SENT_151	[p10l1718t1239r1775b1605],
34	!	.	O	!	_	0	SENT_151	[p10l1718t1239r1775b1605],

1	U11	NN	O	u11	_	0	SENT_152	[p10l1718t1239r1775b1605],
2	?	.	O	?	_	0	SENT_152	[p10l1718t1239r1775b1605],

1	JS0J	NN	O	js0j	_	0	SENT_153	[p10l1718t1239r1775b1605],
2	!	.	O	!	_	0	SENT_153	[p10l1718t1239r1775b1605],

1	I	PRP	O	I	_	0	SENT_154	[p10l1718t1239r1775b1605],
2	/	:	O	/	punct	4	SENT_154	[p10l1718t1239r1775b1605],
3	\	CD	NUMBER	\	num	4	SENT_154	[p10l1718t1239r1775b1605],
4	ITl	NN	O	itl	dep	1	SENT_154	[p10l1718t1239r1775b1605],
5	001	CD	NUMBER	001	num	6	SENT_154	[p10l1731t1136r1775b1221],
6	19Xm	NN	O	19xm	dep	4	SENT_154	[p10l1872t1312r1928b1551],
7	,1	CD	NUMBER	,1	number	8	SENT_154	[p10l1872t1312r1928b1551],
8	[	CD	NUMBER	[	num	12	SENT_154	[p10l1872t1312r1928b1551],
9	o13d	NN	O	o13d	nn	12	SENT_154	[p10l1872t1312r1928b1551],
10	W11	NN	O	w11	nn	12	SENT_154	[p10l1872t1208r1927b1295],
11	(	CD	NUMBER	(	num	12	SENT_154	[p10l1885t1136r1928b1189],
12	)	NN	O	)	dep	6	SENT_154	[p10l1885t1136r1928b1189],
13	1	CD	NUMBER	1	num	15	SENT_154	[p10l1885t1136r1928b1189],
14	UIOICIHJOXOP	NN	O	uioicihjoxop	nn	15	SENT_154	[p10l2034t1313r2078b1610],
15	W11	NN	O	w11	dep	6	SENT_154	[p10l2021t1208r2076b1295],
16	01	CD	NUMBER	01	dep	1	SENT_154	[p10l2034t1136r2077b1189],

1	Fig	NN	O	fig	_	0	SENT_155	[p10l8t1699r129b1768],
2	.	.	O	.	_	0	SENT_155	[p10l8t1699r129b1768],

1	1	CD	NUMBER	1	num	3	SENT_156	[p10l156t1700r186b1752],
2	Cell	NN	O	cell	nn	3	SENT_156	[p10l243t1700r369b1753],
3	viability	NN	O	viability	_	0	SENT_156	[p10l400t1700r652b1768],
4	after	IN	O	after	_	0	SENT_156	[p10l685t1700r824b1753],
5	treatment	NN	O	treatment	prep_after	3	SENT_156	[p10l854t1708r1142b1753],
6	with	IN	O	with	_	0	SENT_156	[p10l1172t1700r1306b1753],
7	different	JJ	O	different	amod	9	SENT_156	[p10l1338t1698r1591b1753],
8	anticancer	JJ	O	anticancer	amod	9	SENT_156	[p10l1623t1700r1935b1753],
9	drugs	NNS	O	drug	prep_with	3	SENT_156	[p10l1966t1700r2149b1768],
10	.	.	O	.	_	0	SENT_156	[p10l1966t1700r2149b1768],

1	LSl8O	NN	O	lsl8o	nn	2	SENT_157	[p10l7t1788r209b1841],
2	cells	NNS	O	cell	nsubjpass	4	SENT_157	[p10l232t1788r368b1841],
3	were	VBD	O	be	auxpass	4	SENT_157	[p10l392t1805r538b1841],
4	treated	VBN	O	treat	_	0	SENT_157	[p10l561t1788r767b1841],
5	for	IN	O	for	_	0	SENT_157	[p10l789t1788r878b1841],
6	48	CD	NUMBER	48	num	7	SENT_157	[p10l898t1788r969b1841],
7	h	NN	O	h	prep_for	4	SENT_157	[p10l993t1788r1031b1840],
8	with	IN	O	with	_	0	SENT_157	[p10l1052t1788r1186b1841],
9	diﬂerent	JJ	O	diﬂerent	amod	11	SENT_157	[p10l1208t1786r1462b1841],
10	anticancer	JJ	O	anticancer	amod	11	SENT_157	[p10l1483t1788r1796b1841],
11	drugs	NNS	O	drug	prep_with	7	SENT_157	[p10l1818t1788r2000b1856],
12	.	.	O	.	_	0	SENT_157	[p10l1818t1788r2000b1856],

1	Cell	NN	O	cell	nn	2	SENT_158	[p10l2027t1788r2151b1841],
2	Viability	NN	O	viability	nsubjpass	4	SENT_158	[p10l8t1878r260b1946],
3	was	VBD	O	be	auxpass	4	SENT_158	[p10l283t1895r398b1931],
4	assessed	VBN	O	assess	_	0	SENT_158	[p10l421t1878r678b1931],
5	with	IN	O	with	_	0	SENT_158	[p10l699t1878r834b1931],
6	a	DT	O	a	det	8	SENT_158	[p10l857t1895r888b1931],
7	MTT-assay	JJ	O	mtt-assay	amod	8	SENT_158	[p10l908t1879r1258b1946],
8	signiﬁcant	NN	O	signiﬁcant	prep_with	4	SENT_158	[p10l11t2072r382b2155],
9	when	WRB	O	when	advmod	11	SENT_158	[p10l414t2074r606b2137],
10	P	NN	O	p	dep	11	SENT_158	[p10l638t2077r693b2136],
11	<	JJR	O	<	dep	8	SENT_158	[p10l718t2089r765b2137],
12	0.05	CD	NUMBER	0.05	advmod	4	SENT_158	[p10l791t2074r963b2137],
13	.	.	O	.	_	0	SENT_158	[p10l791t2074r963b2137],

1	All	DT	O	all	det	3	SENT_159	[p10l1000t2074r1114b2136],
2	statistical	JJ	O	statistical	amod	3	SENT_159	[p10l1150t2074r1485b2137],
3	calculations	NNS	O	calculation	nsubjpass	5	SENT_159	[p10l1519t2074r1944b2137],
4	were	VBD	O	be	auxpass	5	SENT_159	[p10l1979t2094r2151b2137],
5	done	VBN	O	do	_	0	SENT_159	[p10l9t2186r180b2249],
6	in	IN	O	in	_	0	SENT_159	[p10l206t2186r274b2248],
7	SPSS	NNP	ORGANIZATION	SPSS	prep_in	5	SENT_159	[p10l300t2187r492b2249],
8	(	CD	NUMBER	(	num	7	SENT_159	[p10l524t2187r704b2264],
9	V14	NNP	O	V14	tmod	5	SENT_159	[p10l524t2187r704b2264],
10	,	,	O	,	_	0	SENT_159	[p10l524t2187r704b2264],
11	SPSS	NNP	ORGANIZATION	SPSS	nn	12	SENT_159	[p10l735t2187r926b2249],
12	Inc.	NNP	ORGANIZATION	Inc.	appos	9	SENT_159	[p10l955t2188r1086b2249],
13	.	.	O	.	_	0	SENT_159	[p10l955t2188r1086b2249],

1	Chicago	NNP	LOCATION	Chicago	_	0	SENT_160	[p10l1116t2186r1432b2267],
2	,	,	O	,	_	0	SENT_160	[p10l1116t2186r1432b2267],
3	IL	NN	O	il	appos	1	SENT_160	[p10l1460t2188r1562b2260],
4	,	,	O	,	_	0	SENT_160	[p10l1460t2188r1562b2260],
5	USA	NNP	LOCATION	USA	appos	3	SENT_160	[p10l1589t2187r1816b2264],
6	)	CD	NUMBER	)	num	5	SENT_160	[p10l1589t2187r1816b2264],
7	.	.	O	.	_	0	SENT_160	[p10l1589t2187r1816b2264],

1	Results	NNS	O	result	_	0	SENT_161	[p10l9t2429r285b2491],

1	Cell	NN	O	cell	nn	2	SENT_162	[p10l9t2653r156b2716],
2	Viability	NN	O	viability	_	0	SENT_162	[p10l181t2653r478b2734],

1	Cell	NN	O	cell	nn	2	SENT_163	[p10l9t2878r156b2941],
2	Viability	NN	O	viability	nsubjpass	4	SENT_163	[p10l184t2878r481b2959],
3	was	VBD	O	be	auxpass	4	SENT_163	[p10l510t2898r646b2941],
4	assessed	VBN	O	assess	_	0	SENT_163	[p10l678t2878r980b2941],
5	after	IN	O	after	_	0	SENT_163	[p10l1010t2878r1172b2941],
6	48	CD	NUMBER	48	num	8	SENT_163	[p10l1199t2879r1283b2941],
7	h	NN	O	h	nn	8	SENT_163	[p10l1311t2878r1355b2940],
8	treatment	NN	O	treatment	prep_after	4	SENT_163	[p10l1382t2888r1722b2941],
9	with	IN	O	with	_	0	SENT_163	[p10l1748t2878r1906b2941],
10	different	JJ	O	different	amod	11	SENT_163	[p10l1935t2876r2150b2941, p10l9t3000r118b3053],
11	concentrations	NNS	O	concentration	prep_with	8	SENT_163	[p10l160t2990r680b3053],
12	of	IN	O	of	_	0	SENT_163	[p10l727t2990r804b3053],
13	the	DT	O	the	det	15	SENT_163	[p10l841t2990r948b3053],
14	anticancer	JJ	O	anticancer	amod	15	SENT_163	[p10l994t2990r1364b3053],
15	drugs	NNS	O	drug	prep_of	11	SENT_163	[p10l1405t2990r1619b3071],
16	.	.	O	.	_	0	SENT_163	[p10l1405t2990r1619b3071],

1	As	IN	O	as	mark	2	SENT_164	[p10l1667t2991r1763b3053],
2	shown	VBN	O	show	_	0	SENT_164	[p10l1811t2990r2042b3053],
3	in	IN	O	in	_	0	SENT_164	[p10l2084t2990r2152b3052],
4	Fig	NN	O	fig	prep_in	2	SENT_164	[p10l8t3100r143b3181],
5	.	.	O	.	_	0	SENT_164	[p10l8t3100r143b3181],

1	1	CD	NUMBER	1	nsubj	9	SENT_165	[p10l182t3101r235b3174],
2	,	,	O	,	_	0	SENT_165	[p10l182t3101r235b3174],
3	the	DT	O	the	det	5	SENT_165	[p10l273t3100r380b3163],
4	anticancer	JJ	O	anticancer	amod	5	SENT_165	[p10l417t3100r786b3163],
5	drugs	NNS	O	drug	appos	1	SENT_165	[p10l819t3100r1014b3181],
6	did	VBD	O	do	aux	9	SENT_165	[p10l1051t3100r1163b3163],
7	not	RB	O	not	neg	9	SENT_165	[p10l1197t3110r1311b3163],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_165	[p10l1346t3098r1784b3181],
9	affect	VB	O	affect	_	0	SENT_165	[p10l1821t3098r2013b3163],
10	the	DT	O	the	det	13	SENT_165	[p10l2046t3100r2152b3163],
11	LS18O	NN	O	ls18o	nn	13	SENT_165	[p10l7t3212r245b3274],
12	cell	NN	O	cell	nn	13	SENT_165	[p10l283t3211r409b3274],
13	Viability	NN	O	viability	dobj	9	SENT_165	[p10l446t3211r745b3292],
14	at	IN	O	at	_	0	SENT_165	[p10l783t3221r846b3274],
15	the	DT	O	the	det	16	SENT_165	[p10l881t3211r988b3274],
16	concentrations	NNS	O	concentration	prep_at	9	SENT_165	[p10l1027t3211r1547b3274],
17	used	VBN	O	use	partmod	16	SENT_165	[p10l1585t3211r1768b3285],
18	,	,	O	,	_	0	SENT_165	[p10l1585t3211r1768b3285],
19	while	IN	O	while	mark	27	SENT_165	[p10l1808t3211r2006b3274],
20	the	DT	O	the	det	25	SENT_165	[p10l2043t3211r2150b3274],
21	doxorubicin	NN	O	doxorubicin	nn	25	SENT_165	[p10l8t3320r440b3383],
22	(	NN	O	(	nn	25	SENT_165	[p10l467t3321r582b3397],
23	10	CD	NUMBER	10	num	25	SENT_165	[p10l467t3321r582b3397],
24	uM	NN	O	um	nn	25	SENT_165	[p10l613t3321r763b3400],
25	)	NN	O	)	nsubj	27	SENT_165	[p10l613t3321r763b3400],
26	did	VBD	O	do	aux	27	SENT_165	[p10l792t3320r905b3383],
27	affect	VB	O	affect	advcl	17	SENT_165	[p10l930t3318r1121b3383],
28	cell	NN	O	cell	nn	29	SENT_165	[p10l1146t3320r1272b3383],
29	Viability	NN	O	viability	dobj	27	SENT_165	[p10l1297t3320r1614b3401],
30	.	.	O	.	_	0	SENT_165	[p10l1297t3320r1614b3401],

1	PXR	NN	O	pxr	nn	2	SENT_166	[p10l7t3544r541b3607],
2	—	NN	O	—	nsubj	3	SENT_166	[p10l7t3544r541b3607],
3	mediated	VBD	O	mediate	_	0	SENT_166	[p10l7t3544r541b3607],
4	Pgp	NNP	ORGANIZATION	Pgp	nn	6	SENT_166	[p10l566t3546r703b3625],
5	reporter	NN	O	reporter	nn	6	SENT_166	[p10l727t3554r1012b3625],
6	activation	NN	O	activation	dobj	3	SENT_166	[p10l1038t3544r1390b3607],
7	by	IN	O	by	_	0	SENT_166	[p10l1413t3544r1501b3625],
8	anticancer	JJ	O	anticancer	amod	9	SENT_166	[p10l1528t3544r1897b3607],
9	drugs	NNS	O	drug	prep_by	3	SENT_166	[p10l1920t3544r2114b3625],

1	The	DT	O	the	det	2	SENT_167	[p11l7t79r144b142],
2	ability	NN	O	ability	nsubjpass	19	SENT_167	[p11l182t79r408b160],
3	of	IN	O	of	_	0	SENT_167	[p11l445t79r523b142],
4	widely	RB	O	widely	advmod	5	SENT_167	[p11l552t79r794b160],
5	used	VBN	O	use	amod	7	SENT_167	[p11l831t79r995b142],
6	anticancer	JJ	O	anticancer	amod	7	SENT_167	[p11l1031t79r1398b142],
7	drugs	NNS	O	drug	prep_of	2	SENT_167	[p11l1433t79r1628b160],
8	to	TO	O	to	aux	9	SENT_167	[p11l1666t89r1732b142],
9	induce	VB	O	induce	infmod	7	SENT_167	[p11l1770t79r2007b142],
10	the	DT	O	the	det	11	SENT_167	[p11l2044t79r2150b142],
11	expression	NN	O	expression	dobj	9	SENT_167	[p11l8t190r391b271],
12	of	IN	O	of	_	0	SENT_167	[p11l427t190r504b253],
13	Pgp	NNP	O	Pgp	prep_of	11	SENT_167	[p11l533t192r669b271],
14	via	IN	O	via	_	0	SENT_167	[p11l706t190r815b253],
15	activation	NN	O	activation	prep_via	13	SENT_167	[p11l851t190r1202b253],
16	of	IN	O	of	_	0	SENT_167	[p11l1239t190r1317b253],
17	PXR	NN	O	pxr	prep_of	15	SENT_167	[p11l1346t192r1519b252],
18	was	VBD	O	be	auxpass	19	SENT_167	[p11l1554t210r1689b253],
19	determined	VBN	O	determine	_	0	SENT_167	[p11l1727t190r2148b253],
20	.	.	O	.	_	0	SENT_167	[p11l1727t190r2148b253],

1	LSl8O	NN	O	lsl8o	nn	2	SENT_168	[p11l7t302r244b364],
2	cells	NNS	O	cell	nsubjpass	4	SENT_168	[p11l275t301r435b364],
3	were	VBD	O	be	auxpass	4	SENT_168	[p11l468t321r638b364],
4	transfected	VBN	O	transfect	_	0	SENT_168	[p11l668t301r1063b364],
5	with	IN	O	with	_	0	SENT_168	[p11l1091t301r1249b364],
6	a	DT	O	a	det	9	SENT_168	[p11l1280t321r1317b364],
7	Pgp	NN	ORGANIZATION	pgp	nn	9	SENT_168	[p11l1345t303r1482b382],
8	reporter	NN	O	reporter	nn	9	SENT_168	[p11l1512t311r1796b382],
9	construct	NN	O	construct	prep_with	4	SENT_168	[p11l1825t310r2153b364],
10	as	RB	O	as	_	0	SENT_168	[p11l9t432r78b475],
11	well	RB	O	well	_	0	SENT_168	[p11l104t412r256b475],
12	as	IN	O	as	_	0	SENT_168	[p11l281t432r350b475],
13	a	DT	O	a	det	16	SENT_168	[p11l377t432r414b475],
14	PXR	NN	O	pxr	nn	16	SENT_168	[p11l436t414r610b474],
15	expression	NN	O	expression	nn	16	SENT_168	[p11l633t412r1015b493],
16	plasmid	NN	O	plasmid	conj_and	9	SENT_168	[p11l1036t412r1338b493],
17	.	.	O	.	_	0	SENT_168	[p11l1036t412r1338b493],

1	Treatment	NN	O	treatment	nsubj	46	SENT_169	[p11l1366t414r1735b475],
2	of	IN	O	of	_	0	SENT_169	[p11l1758t412r1835b475],
3	the	DT	O	the	det	45	SENT_169	[p11l1852t412r1960b475],
4	transiently	RB	O	transiently	amod	45	SENT_169	[p11l1983t422r2149b475, p11l10t523r245b604],
5	transfected	VBN	O	transfect	dep	4	SENT_169	[p11l297t523r691b586],
6	LSl8O	NN	O	lsl8o	nn	7	SENT_169	[p11l741t524r978b586],
7	cells	NNS	O	cell	dobj	5	SENT_169	[p11l1032t523r1192b586],
8	with	IN	O	with	_	0	SENT_169	[p11l1246t523r1404b586],
9	cyclophosphamide	NN	O	cyclophosphamide	prep_with	5	SENT_169	[p11l1456t523r2148b604],
10	,	,	O	,	_	0	SENT_169	[p11l1456t523r2148b604],
11	ifosfamide	NN	O	ifosfamide	conj_and	9	SENT_169	[p11l7t633r409b707],
12	,	,	O	,	_	0	SENT_169	[p11l7t633r409b707],
13	docetaxel	NN	O	docetaxel	conj_and	9	SENT_169	[p11l444t633r805b707],
14	,	,	O	,	_	0	SENT_169	[p11l444t633r805b707],
15	paclitaxel	NN	O	paclitaxel	conj_and	9	SENT_169	[p11l838t633r1207b714],
16	,	,	O	,	_	0	SENT_169	[p11l838t633r1207b714],
17	ﬂutamide	NN	O	ﬂutamide	conj_and	9	SENT_169	[p11l1241t630r1598b707],
18	,	,	O	,	_	0	SENT_169	[p11l1241t630r1598b707],
19	and	CC	O	and	_	0	SENT_169	[p11l1633t633r1760b696],
20	tamoxifen	NN	O	tamoxifen	conj_and	9	SENT_169	[p11l1789t633r2153b696],
21	resulted	VBD	O	result	rcmod	9	SENT_169	[p11l6t745r291b808],
22	in	IN	O	in	_	0	SENT_169	[p11l320t745r389b807],
23	dose	NN	O	dose	nn	26	SENT_169	[p11l419t745r983b826],
24	—	NN	O	—	nn	26	SENT_169	[p11l419t745r983b826],
25	dependent	JJ	O	dependent	amod	26	SENT_169	[p11l419t745r983b826],
26	increases	NNS	O	increase	prep_in	21	SENT_169	[p11l1011t745r1337b808],
27	in	IN	O	in	_	0	SENT_169	[p11l1369t745r1438b807],
28	Pgp	NNP	ORGANIZATION	Pgp	nn	30	SENT_169	[p11l1467t747r1604b826],
29	reporter	NN	O	reporter	nn	30	SENT_169	[p11l1634t755r1920b826],
30	activity	NN	O	activity	prep_in	21	SENT_169	[p11l1951t745r2150b808, p11l7t855r119b936],
31	,	,	O	,	_	0	SENT_169	[p11l1951t745r2150b808, p11l7t855r119b936],
32	while	IN	O	while	mark	43	SENT_169	[p11l169t855r365b918],
33	exposure	NN	O	exposure	nsubj	43	SENT_169	[p11l413t875r734b936],
34	to	TO	O	to	_	0	SENT_169	[p11l780t865r847b918],
35	different	JJ	O	different	amod	36	SENT_169	[p11l894t853r1192b918],
36	concentrations	NNS	O	concentration	prep_to	33	SENT_169	[p11l1238t855r1758b918],
37	of	IN	O	of	_	0	SENT_169	[p11l1807t855r1884b918],
38	carboplatin	NN	O	carboplatin	prep_of	36	SENT_169	[p11l1925t855r2149b918, p11l6t967r210b1048],
39	and	CC	O	and	_	0	SENT_169	[p11l253t967r378b1030],
40	etoposide	NN	O	etoposide	prep_of	36	SENT_169	[p11l419t967r760b1048],
41	did	VBD	O	do	aux	43	SENT_169	[p11l802t967r914b1030],
42	not	RB	O	not	neg	43	SENT_169	[p11l954t977r1068b1030],
43	increase	VB	O	increase	advcl	21	SENT_169	[p11l1107t967r1399b1030],
44	PXR	NN	O	pxr	dobj	43	SENT_169	[p11l1440t967r1974b1030],
45	—	NN	O	—	prep_of	1	SENT_169	[p11l1440t967r1974b1030],
46	mediated	VBD	O	mediate	_	0	SENT_169	[p11l1440t967r1974b1030],
47	Pgp	NNP	ORGANIZATION	Pgp	nn	49	SENT_169	[p11l2014t969r2151b1048],
48	reporter	NN	O	reporter	nn	49	SENT_169	[p11l6t1088r292b1159],
49	activity	NN	O	activity	nsubj	51	SENT_169	[p11l315t1078r580b1159],
50	(	CD	NUMBER	(	num	51	SENT_169	[p11l608t1078r771b1159],
51	Fig	NN	O	fig	xcomp	46	SENT_169	[p11l608t1078r771b1159],
52	.	.	O	.	_	0	SENT_169	[p11l608t1078r771b1159],

1	2	CD	NUMBER	2	num	2	SENT_170	[p11l802t1079r891b1155],
2	)	CD	NUMBER	)	_	0	SENT_170	[p11l802t1079r891b1155],
3	.	.	O	.	_	0	SENT_170	[p11l802t1079r891b1155],

1	As	IN	O	as	_	0	SENT_171	[p11l919t1079r1014b1141],
2	a	DT	O	a	det	3	SENT_171	[p11l1042t1098r1079b1141],
3	control	NN	O	control	prep_as	9	SENT_171	[p11l1103t1078r1374b1152],
4	,	,	O	,	_	0	SENT_171	[p11l1103t1078r1374b1152],
5	the	DT	O	the	det	7	SENT_171	[p11l1401t1078r1508b1141],
6	same	JJ	O	same	amod	7	SENT_171	[p11l1536t1098r1715b1141],
7	compounds	NNS	O	compound	nsubjpass	9	SENT_171	[p11l1740t1078r2149b1159],
8	were	VBD	O	be	auxpass	9	SENT_171	[p11l7t1209r179b1252],
9	tested	VBN	O	test	_	0	SENT_171	[p11l211t1189r419b1252],
10	in	IN	O	in	_	0	SENT_171	[p11l450t1189r518b1251],
11	LSl8O	NN	O	lsl8o	nn	12	SENT_171	[p11l549t1190r786b1252],
12	cells	NNS	O	cell	prep_in	9	SENT_171	[p11l818t1189r978b1252],
13	that	WDT	O	that	nsubjpass	16	SENT_171	[p11l1012t1189r1146b1252],
14	were	VBD	O	be	auxpass	16	SENT_171	[p11l1177t1209r1348b1252],
15	only	RB	O	only	advmod	16	SENT_171	[p11l1381t1189r1537b1270],
16	transfected	VBN	O	transfect	rcmod	12	SENT_171	[p11l1568t1189r1962b1252],
17	with	IN	O	with	_	0	SENT_171	[p11l1993t1189r2151b1252],
18	the	DT	O	the	det	22	SENT_171	[p11l7t1300r114b1363],
19	Pgp	NNP	O	Pgp	nn	22	SENT_171	[p11l140t1302r277b1381],
20	reporter	NN	O	reporter	nn	22	SENT_171	[p11l301t1310r587b1381],
21	gene	NN	O	gene	nn	22	SENT_171	[p11l610t1320r777b1381],
22	construct	NN	O	construct	prep_with	16	SENT_171	[p11l803t1310r1132b1363],
23	without	IN	O	without	_	0	SENT_171	[p11l1156t1300r1430b1363],
24	co	NN	O	co	nn	26	SENT_171	[p11l1454t1300r1991b1363],
25	—	NN	O	—	nn	26	SENT_171	[p11l1454t1300r1991b1363],
26	transfection	NN	O	transfection	prep_without	16	SENT_171	[p11l1454t1300r1991b1363],
27	of	IN	O	of	_	0	SENT_171	[p11l2017t1300r2094b1363],
28	a	DT	O	a	det	31	SENT_171	[p11l2115t1320r2152b1363],
29	PXR	NN	O	pxr	nn	31	SENT_171	[p11l7t1413r180b1473],
30	expression	NN	O	expression	nn	31	SENT_171	[p11l215t1411r597b1492],
31	plasmid	NN	O	plasmid	prep_of	26	SENT_171	[p11l630t1411r932b1492],
32	.	.	O	.	_	0	SENT_171	[p11l630t1411r932b1492],

1	In	IN	O	in	_	0	SENT_172	[p11l971t1413r1042b1473],
2	these	DT	O	these	det	3	SENT_172	[p11l1076t1411r1259b1474],
3	cells	NNS	O	cell	prep_in	10	SENT_172	[p11l1295t1411r1476b1485],
4	,	,	O	,	_	0	SENT_172	[p11l1295t1411r1476b1485],
5	none	NN	O	none	nsubj	10	SENT_172	[p11l1514t1431r1685b1474],
6	of	IN	O	of	_	0	SENT_172	[p11l1722t1411r1798b1474],
7	the	DT	O	the	det	8	SENT_172	[p11l1827t1411r1934b1474],
8	compounds	NNS	O	compound	prep_of	5	SENT_172	[p11l1970t1431r2149b1474, p11l6t1522r261b1603],
9	was	VBD	O	be	cop	10	SENT_172	[p11l303t1542r438b1585],
10	able	JJ	O	able	_	0	SENT_172	[p11l480t1522r625b1585],
11	to	TO	O	to	aux	12	SENT_172	[p11l663t1532r730b1585],
12	activate	VB	O	activate	xcomp	10	SENT_172	[p11l771t1522r1047b1585],
13	Pgp	NN	ORGANIZATION	pgp	nn	14	SENT_172	[p11l1085t1524r1222b1603],
14	reporter	NN	O	reporter	dobj	12	SENT_172	[p11l1260t1531r1545b1603],
15	activity	NN	O	activity	nsubj	17	SENT_172	[p11l1583t1522r1850b1603],
16	(	CD	NUMBER	(	num	15	SENT_172	[p11l1891t1522r2149b1600],
17	results	VBZ	O	result	rcmod	14	SENT_172	[p11l1891t1522r2149b1600],
18	not	RB	O	not	neg	17	SENT_172	[p11l7t1643r121b1696],
19	shown	VBN	O	show	dep	17	SENT_172	[p11l148t1633r426b1710],
20	)	NN	O	)	dobj	19	SENT_172	[p11l148t1633r426b1710],
21	.	.	O	.	_	0	SENT_172	[p11l148t1633r426b1710],

1	Induction	NN	O	induction	_	0	SENT_173	[p11l7t1858r350b1921],
2	of	IN	O	of	_	0	SENT_173	[p11l376t1858r454b1921],
3	Pgp	NN	O	pgp	nn	5	SENT_173	[p11l472t1860r608b1939],
4	protein	NN	O	protein	nn	5	SENT_173	[p11l634t1858r888b1939],
5	expression	NN	O	expression	prep_of	1	SENT_173	[p11l914t1858r1296b1939],

1	To	TO	O	to	aux	2	SENT_174	[p11l7t2085r103b2146],
2	evaluate	VB	O	evaluate	purpcl	35	SENT_174	[p11l144t2083r441b2146],
3	whether	IN	O	whether	complm	8	SENT_174	[p11l480t2083r769b2146],
4	Pgp	NNP	ORGANIZATION	Pgp	nn	6	SENT_174	[p11l806t2085r943b2164],
5	reporter	NN	O	reporter	nn	6	SENT_174	[p11l983t2093r1268b2164],
6	activation	NN	O	activation	nsubj	8	SENT_174	[p11l1307t2083r1658b2146],
7	is	VBZ	O	be	cop	8	SENT_174	[p11l1696t2083r1752b2146],
8	predictive	JJ	O	predictive	ccomp	2	SENT_174	[p11l1792t2083r2150b2164],
9	for	IN	O	for	_	0	SENT_174	[p11l7t2193r111b2256],
10	Pgp	NN	ORGANIZATION	pgp	nn	12	SENT_174	[p11l137t2195r273b2274],
11	protein	NN	O	protein	nn	12	SENT_174	[p11l300t2193r554b2274],
12	induction	NN	O	induction	prep_for	8	SENT_174	[p11l581t2193r938b2267],
13	,	,	O	,	_	0	SENT_174	[p11l581t2193r938b2267],
14	the	DT	O	the	det	15	SENT_174	[p11l969t2193r1075b2256],
15	effect	NN	O	effect	nsubjpass	35	SENT_174	[p11l1104t2191r1299b2256],
16	of	IN	O	of	_	0	SENT_174	[p11l1326t2193r1403b2256],
17	the	DT	O	the	det	19	SENT_174	[p11l1425t2193r1531b2256],
18	anticancer	JJ	O	anticancer	amod	19	SENT_174	[p11l1561t2193r1929b2256],
19	drugs	NNS	O	drug	prep_of	15	SENT_174	[p11l1955t2193r2150b2274],
20	on	IN	O	on	_	0	SENT_174	[p11l8t2325r95b2368],
21	the	DT	O	the	det	24	SENT_174	[p11l122t2305r228b2368],
22	protein	NN	O	protein	nn	24	SENT_174	[p11l255t2305r508b2386],
23	expression	NN	O	expression	nn	24	SENT_174	[p11l536t2305r918b2386],
24	levels	NNS	O	level	prep_on	19	SENT_174	[p11l945t2305r1149b2368],
25	of	IN	O	of	_	0	SENT_174	[p11l1180t2305r1258b2368],
26	Pgp	NN	ORGANIZATION	pgp	prep_of	24	SENT_174	[p11l1278t2307r1414b2386],
27	after	IN	O	after	_	0	SENT_174	[p11l1444t2305r1606b2368],
28	48	CD	NUMBER	48	num	30	SENT_174	[p11l1631t2306r1715b2368],
29	h	NN	O	h	nn	30	SENT_174	[p11l1743t2305r1787b2367],
30	treatment	NN	O	treatment	prep_after	26	SENT_174	[p11l1813t2315r2152b2368],
31	in	IN	O	in	_	0	SENT_174	[p11l7t2416r74b2478],
32	LSl8O	NN	O	lsl8o	nn	33	SENT_174	[p11l118t2417r356b2479],
33	cells	NNS	O	cell	prep_in	30	SENT_174	[p11l402t2416r561b2479],
34	was	VBD	O	be	auxpass	35	SENT_174	[p11l608t2436r743b2479],
35	determined	VBN	O	determine	_	0	SENT_174	[p11l790t2416r1210b2479],
36	.	.	O	.	_	0	SENT_174	[p11l790t2416r1210b2479],

1	As	IN	O	as	mark	2	SENT_175	[p11l1258t2417r1354b2479],
2	shown	VBN	O	show	_	0	SENT_175	[p11l1403t2416r1633b2479],
3	in	IN	O	in	_	0	SENT_175	[p11l1677t2416r1744b2478],
4	Fig	NN	O	fig	prep_in	2	SENT_175	[p11l1788t2416r1924b2497],
5	.	.	O	.	_	0	SENT_175	[p11l1788t2416r1924b2497],

1	3	CD	NUMBER	3	nsubj	12	SENT_176	[p11l1956t2417r2016b2490],
2	,	,	O	,	_	0	SENT_176	[p11l1956t2417r2016b2490],
3	all	DT	O	all	det	4	SENT_176	[p11l2065t2416r2150b2479],
4	compounds	NNS	O	compound	appos	1	SENT_176	[p11l8t2527r417b2608],
5	that	WDT	O	that	nsubjpass	7	SENT_176	[p11l444t2527r578b2590],
6	were	VBD	O	be	auxpass	7	SENT_176	[p11l603t2547r774b2590],
7	shown	VBN	O	show	rcmod	4	SENT_176	[p11l803t2527r1033b2590],
8	to	TO	O	to	aux	9	SENT_176	[p11l1058t2537r1125b2590],
9	activate	VB	O	activate	xcomp	7	SENT_176	[p11l1152t2527r1429b2590],
10	PXR	NN	O	pxr	nn	11	SENT_176	[p11l1455t2527r1989b2590],
11	—	NN	O	—	dobj	9	SENT_176	[p11l1455t2527r1989b2590],
12	mediated	VBD	O	mediate	_	0	SENT_176	[p11l1455t2527r1989b2590],
13	Pgp	NNP	ORGANIZATION	Pgp	nn	15	SENT_176	[p11l2013t2529r2150b2608],
14	reporter	NN	O	reporter	nn	15	SENT_176	[p11l6t2648r292b2719],
15	activity	NN	O	activity	dobj	12	SENT_176	[p11l325t2638r589b2719],
16	(	CD	NUMBER	(	num	17	SENT_176	[p11l626t2638r1050b2715],
17	vincristine	NN	O	vincristine	dep	12	SENT_176	[p11l626t2638r1050b2715],
18	,	,	O	,	_	0	SENT_176	[p11l626t2638r1050b2715],
19	tamoxifen	NN	O	tamoxifen	appos	17	SENT_176	[p11l1086t2638r1469b2712],
20	,	,	O	,	_	0	SENT_176	[p11l1086t2638r1469b2712],
21	vinblastine	NN	O	vinblastine	appos	17	SENT_176	[p11l1505t2638r1917b2712],
22	,	,	O	,	_	0	SENT_176	[p11l1505t2638r1917b2712],
23	doce	NN	O	doce	appos	17	SENT_176	[p11l1954t2638r2149b2701],
24	—	CD	NUMBER	—	num	23	SENT_176	[p11l1954t2638r2149b2701],

1	_	NN	O	_	_	0	SENT_177	[p11l251t2985r259b3006],
2	;	:	O	;	_	0	SENT_177	[p11l251t2985r259b3006],
3	-	:	O	-	_	0	SENT_177	[p11l265t2985r280b3006],
4	I3	NN	O	i3	dep	1	SENT_177	[p11l265t2985r280b3006],
5	.5	CD	NUMBER	.5	num	6	SENT_177	[p11l251t3079r259b3100],
6	l	NN	O	l	dep	4	SENT_177	[p11l265t3079r279b3100],
7	\	CD	NUMBER	\	number	8	SENT_177	[p11l265t3079r279b3100],
8	)	CD	NUMBER	)	num	9	SENT_177	[p11l265t3079r279b3100],
9	_	NN	O	_	dep	6	SENT_177	[p11l251t3174r259b3195],
10	.	.	O	.	_	0	SENT_177	[p11l251t3174r259b3195],

1	o	NN	O	o	_	0	SENT_178	[p11l265t3174r280b3195],
2	Relative	JJ	O	relative	amod	3	SENT_178	[p11l199t3338r224b3454],
3	Pgp	NN	O	pgp	dep	1	SENT_178	[p11l199t3269r231b3325],
4	reporter	NN	O	reporter	nn	5	SENT_178	[p11l201t3139r231b3256],
5	activity	NN	O	activity	dep	1	SENT_178	[p11l199t3028r231b3129],

1	G7	NN	O	g7	_	0	SENT_179	[p11l266t3271r281b3292],

1	Fig	NN	O	fig	_	0	SENT_180	[p12l53t27r110b59],
2	.	.	O	.	_	0	SENT_180	[p12l53t27r110b59],

1	2	CD	NUMBER	2	num	4	SENT_181	[p12l122t27r138b52],
2	PXR-mediated	JJ	O	pxr-mediated	amod	4	SENT_181	[p12l164t27r378b52],
3	Pgp	NN	ORGANIZATION	pgp	nn	4	SENT_181	[p12l387t28r441b59],
4	reporter	NN	O	reporter	_	0	SENT_181	[p12l450t31r565b59],
5	gene	NN	O	gene	nn	6	SENT_181	[p12l573t35r639b59],
6	activity	NN	O	activity	dep	4	SENT_181	[p12l649t27r755b59],
7	following	VBG	O	follow	_	0	SENT_181	[p12l765t27r905b59],
8	exposure	NN	O	exposure	nn	10	SENT_181	[p12l914t35r1043b59],
9	exception	NN	O	exception	nn	10	SENT_181	[p12l1116t27r1256b59],
10	ifosfamide	NN	O	ifosfamide	prep_following	4	SENT_181	[p12l1268t27r1422b52],
11	and	CC	O	and	_	0	SENT_181	[p12l1435t28r1486b52],
12	cyclophosphamide	NN	O	cyclophosphamide	conj_and	10	SENT_181	[p12l1498t27r1768b59],
13	(	CD	NUMBER	(	num	12	SENT_181	[p12l1782t28r1909b58],
14	0.3	CD	NUMBER	0.3	num	15	SENT_181	[p12l1782t28r1909b58],
15	—	NN	O	—	dep	12	SENT_181	[p12l1782t28r1909b58],
16	100	CD	NUMBER	100	num	17	SENT_181	[p12l1782t28r1909b58],
17	uM	NN	O	um	dep	12	SENT_181	[p12l1923t28r1981b59],
18	;	:	O	;	_	0	SENT_181	[p12l1923t28r1981b59],
19	dilution	NN	O	dilution	dep	4	SENT_181	[p12l1995t27r2107b52],
20	to	TO	O	to	_	0	SENT_181	[p12l53t72r79b93],
21	anticancer	JJ	O	anticancer	amod	22	SENT_181	[p12l96t68r244b93],
22	drugs	NNS	O	drug	prep_to	19	SENT_181	[p12l259t68r346b100],
23	.	.	O	.	_	0	SENT_181	[p12l259t68r346b100],

1	LS180	NN	O	ls180	nn	2	SENT_182	[p12l363t68r457b93],
2	cells	NNS	O	cell	nsubjpass	4	SENT_182	[p12l473t68r537b93],
3	were	VBD	O	be	auxpass	4	SENT_182	[p12l554t76r622b93],
4	transfected	VBN	O	transfect	_	0	SENT_182	[p12l638t68r797b93],
5	with	IN	O	with	_	0	SENT_182	[p12l812t68r875b93],
6	the	DT	O	the	det	7	SENT_182	[p12l891t68r933b93],
7	pGL3	NN	O	pgl3	prep_with	4	SENT_182	[p12l949t68r1043b100],
8	-	:	O	-	_	0	SENT_182	[p12l949t68r1043b100],
9	factor	NN	O	factor	dep	7	SENT_182	[p12l1116t68r1200b93],
10	3	CD	NUMBER	3	num	11	SENT_182	[p12l1210t68r1245b99],
11	)	NN	O	)	dep	9	SENT_182	[p12l1210t68r1245b99],
12	.	.	O	.	_	0	SENT_182	[p12l1210t68r1245b99],

1	Rifampicin	NNP	O	Rifampicin	nsubjpass	7	SENT_183	[p12l1256t68r1418b100],
2	(	CD	NUMBER	(	num	1	SENT_183	[p12l1428t68r1474b99],
3	10	CD	NUMBER	10	num	5	SENT_183	[p12l1428t68r1474b99],
4	uM	NN	O	um	nn	5	SENT_183	[p12l1485t68r1545b100],
5	)	NN	O	)	dep	1	SENT_183	[p12l1485t68r1545b100],
6	was	VBD	O	be	auxpass	7	SENT_183	[p12l1555t76r1609b93],
7	used	VBN	O	use	_	0	SENT_183	[p12l1619t68r1684b93],
8	as	IN	O	as	_	0	SENT_183	[p12l1694t76r1721b93],
9	positive	JJ	O	positive	amod	10	SENT_183	[p12l1731t68r1844b100],
10	control	NN	O	control	prep_as	7	SENT_183	[p12l1854t68r1963b93],
11	.	.	O	.	_	0	SENT_183	[p12l1854t68r1963b93],

1	These	DT	O	these	det	4	SENT_184	[p12l1973t68r2058b93],
2	reMDR1	NN	O	remdr1	nn	4	SENT_184	[p12l2067t76r2106b93, p12l53t109r148b134],
3	reporter	NN	O	reporter	nn	4	SENT_184	[p12l167t113r282b141],
4	construct	NN	O	construct	nsubj	15	SENT_184	[p12l298t113r437b138],
5	,	,	O	,	_	0	SENT_184	[p12l298t113r437b138],
6	the	DT	O	the	det	9	SENT_184	[p12l455t109r497b134],
7	nuclear	JJ	O	nuclear	amod	9	SENT_184	[p12l514t109r620b134],
8	receptor	NN	O	receptor	nn	9	SENT_184	[p12l635t113r754b141],
9	expression	NN	O	expression	appos	4	SENT_184	[p12l770t109r923b141],
10	vectors	NNS	O	vector	nn	11	SENT_184	[p12l940t113r1043b134],
11	sults	NNS	O	sult	nsubj	14	SENT_184	[p12l1117t109r1180b134],
12	are	VBP	O	be	cop	14	SENT_184	[p12l1194t117r1236b134],
13	the	DT	O	the	det	14	SENT_184	[p12l1249t109r1292b134],
14	means	NNS	O	means	rcmod	9	SENT_184	[p12l1305t117r1394b134],
15	(	VBP	O	(	_	0	SENT_184	[p12l1409t109r1504b140],
16	:	:	O	:	_	0	SENT_184	[p12l1409t109r1504b140],
17	l	NN	O	l	dobj	15	SENT_184	[p12l1409t109r1504b140],
18	:	:	O	:	_	0	SENT_184	[p12l1409t109r1504b140],
19	SD	NN	O	sd	nn	20	SENT_184	[p12l1409t109r1504b140],
20	)	NN	O	)	dep	17	SENT_184	[p12l1409t109r1504b140],
21	of	IN	O	of	_	0	SENT_184	[p12l1518t109r1549b134],
22	three	CD	NUMBER	three	num	24	SENT_184	[p12l1559t109r1630b134],
23	separate	JJ	O	separate	amod	24	SENT_184	[p12l1644t113r1760b141],
24	determinations	NNS	O	determination	prep_of	20	SENT_184	[p12l1774t109r1987b134],
25	and	CC	O	and	_	0	SENT_184	[p12l2002t109r2052b134],
26	are	VBP	O	be	cop	27	SENT_184	[p12l2065t117r2107b134],
27	pCDG-hPXR	NN	O	pcdg-hpxr	conj_and	15	SENT_184	[p12l52t150r253b182],
28	,	,	O	,	_	0	SENT_184	[p12l52t150r253b182],
29	and	CC	O	and	_	0	SENT_184	[p12l265t150r315b175],
30	the	DT	O	the	det	32	SENT_184	[p12l324t150r367b175],
31	pRL-TK	NN	O	prl-tk	nn	32	SENT_184	[p12l376t151r500b182],
32	control	NN	O	control	conj_and	27	SENT_184	[p12l509t150r611b175],
33	Vector	NNP	O	Vector	dep	32	SENT_184	[p12l620t154r717b175],
34	.	.	O	.	_	0	SENT_184	[p12l620t154r717b175],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_185	[p12l729t150r801b175],
2	were	VBD	O	be	auxpass	3	SENT_185	[p12l811t158r880b175],
3	exposed	VBN	O	expose	_	0	SENT_185	[p12l890t150r1007b182],
4	to	TO	O	to	aux	5	SENT_185	[p12l1017t154r1043b175],
5	expressed	VBN	O	express	xcomp	3	SENT_185	[p12l1116t150r1257b182],
6	as	IN	O	as	_	0	SENT_185	[p12l1278t158r1305b175],
7	relative	JJ	O	relative	amod	9	SENT_185	[p12l1326t150r1435b175],
8	fold	JJ	O	fold	amod	9	SENT_185	[p12l1455t150r1512b175],
9	inductions	NNS	O	induction	prep_as	5	SENT_185	[p12l1532t150r1681b175],
10	compared	VBN	O	compare	_	0	SENT_185	[p12l1702t150r1844b182],
11	to	TO	O	to	prepc_compared_to	5	SENT_185	[p12l1864t154r1890b175],
12	0.1	CD	PERCENT	0.1	num	16	SENT_185	[p12l1911t150r1983b175],
13	%	NN	PERCENT	%	nn	16	SENT_185	[p12l1911t150r1983b175],
14	DMSO	NN	O	dmso	nn	16	SENT_185	[p12l2005t150r2106b175],
15	anticancer	JJ	O	anticancer	amod	16	SENT_185	[p12l54t191r202b216],
16	drugs	NNS	O	drug	pobj	5	SENT_185	[p12l222t191r300b223],
17	(	JJ	O	(	amod	18	SENT_185	[p12l322t191r420b223],
18	range	NN	O	range	dep	16	SENT_185	[p12l322t191r420b223],
19	:	:	O	:	_	0	SENT_185	[p12l322t191r420b223],
20	o.	NN	O	o.	nn	21	SENT_185	[p12l443t191r540b216],
21	l	NN	O	l	dep	16	SENT_185	[p12l443t191r540b216],
22	—	CD	NUMBER	—	num	24	SENT_185	[p12l443t191r540b216],
23	lo	NN	O	lo	nn	24	SENT_185	[p12l443t191r540b216],
24	uM	NN	O	um	dep	21	SENT_185	[p12l553t192r611b223],
25	;	:	O	;	_	0	SENT_185	[p12l553t192r611b223],
26	dilution	NN	O	dilution	nn	27	SENT_185	[p12l633t191r744b216],
27	factor	NN	O	factor	dep	16	SENT_185	[p12l765t191r849b216],
28	3	CD	NUMBER	3	num	29	SENT_185	[p12l870t191r897b222],
29	)	NN	O	)	dep	27	SENT_185	[p12l870t191r897b222],
30	with	IN	O	with	_	0	SENT_185	[p12l918t191r981b216],
31	the	DT	O	the	det	37	SENT_185	[p12l1001t191r1044b216],
32	(	CD	NUMBER	(	number	33	SENT_185	[p12l1117t191r1167b222],
33	*	CD	NUMBER	*	num	34	SENT_185	[p12l1117t191r1167b222],
34	P	NN	O	p	npadvmod	35	SENT_185	[p12l1117t191r1167b222],
35	<	JJR	O	<	amod	37	SENT_185	[p12l1178t197r1196b216],
36	0.05	CD	NUMBER	0.05	num	37	SENT_185	[p12l1207t191r1280b222],
37	)	NN	O	)	prep_with	16	SENT_185	[p12l1207t191r1280b222],

1	Q	NNP	O	Q	nn	2	SENT_186	[p12l52t298r88b343],
2	Springer	NNP	O	Springer	_	0	SENT_186	[p12l101t309r223b344],

1	Cancer	NNP	O	Cancer	nn	3	SENT_187	[p12l53t419r152b444],
2	Chemother	NNP	PERSON	Chemother	nn	3	SENT_187	[p12l162t419r318b444],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_187	[p12l328t419r478b444],
4	(	CD	NUMBER	(	num	5	SENT_187	[p12l489t419r581b449],
5	2010	CD	DATE	2010	dep	3	SENT_187	[p12l489t419r581b449],
6	)	CD	NUMBER	)	number	7	SENT_187	[p12l489t419r581b449],
7	66:765	CD	NUMBER	66:765	num	8	SENT_187	[p12l592t419r757b444],
8	—	NN	O	—	dep	5	SENT_187	[p12l592t419r757b444],
9	771	CD	NUMBER	771	number	10	SENT_187	[p12l592t419r757b444],
10	769	CD	NUMBER	769	num	8	SENT_187	[p12l2055t419r2106b444],

1	(	NN	O	(	nn	2	SENT_188	[p12l1043t554r1059b568],
2	D	NN	O	d	_	0	SENT_188	[p12l1043t554r1059b568],
3	C	NN	O	c	dep	2	SENT_188	[p12l1043t571r1059b584],
4	a	DT	O	a	dep	3	SENT_188	[p12l1043t586r1059b601],
5	;	:	O	;	_	0	SENT_188	[p12l1043t586r1059b601],
6	"	``	O	"	punct	8	SENT_188	[p12l1369t580r1385b594],
7	3	CD	NUMBER	3	num	8	SENT_188	[p12l1369t580r1385b594],
8	o	NN	O	o	dep	3	SENT_188	[p12l1550t584r1567b598],

1	G3	NN	O	g3	nn	2	SENT_189	[p12l721t605r737b619],
2	u	NN	O	u	_	0	SENT_189	[p12l821t590r842b619],
3	&	CC	O	&	nsubj	7	SENT_189	[p12l821t590r842b619],
4	+	CC	O	+	cc	7	SENT_189	[p12l821t590r842b619],
5	3	CD	NUMBER	3	num	7	SENT_189	[p12l930t593r947b623],
6	E	NN	O	e	nn	7	SENT_189	[p12l1038t603r1059b623],
7	I	NN	O	i	rcmod	2	SENT_189	[p12l1142t608r1158b621],
8	:	:	O	:	_	0	SENT_189	[p12l1142t608r1158b621],
9	7	CD	NUMBER	7	dep	7	SENT_189	[p12l1245t609r1267b629],
10	,	,	O	,	_	0	SENT_189	[p12l1245t609r1267b629],
11	-	:	O	-	_	0	SENT_189	[p12l1363t597r1385b616],
12	'	''	DATE	'	_	0	SENT_189	[p12l1363t597r1385b616],
13	9	CD	DATE	9	num	14	SENT_189	[p12l1363t597r1385b616],
14	G	NN	O	g	dep	7	SENT_189	[p12l1449t613r1466b628],
15	,	,	O	,	_	0	SENT_189	[p12l1449t613r1466b628],
16	E	NN	O	e	nn	17	SENT_189	[p12l1545t601r1567b621],
17	E	NN	O	e	nsubj	19	SENT_189	[p12l1649t612r1670b632],
18	_	CD	NUMBER	_	num	19	SENT_189	[p12l1754t608r1775b627],
19	g	NN	O	g	xcomp	7	SENT_189	[p12l1754t608r1775b627],
20	-13	CD	NUMBER	-13	advmod	21	SENT_189	[p12l715t622r737b642],
21	E	NN	O	e	dep	19	SENT_189	[p12l821t619r842b640],
22	3	CD	NUMBER	3	dobj	21	SENT_189	[p12l925t627r946b640],
23	:	:	O	:	_	0	SENT_189	[p12l925t627r946b640],
24	‘	CD	NUMBER	‘	dep	22	SENT_189	[p12l1039t625r1059b646],
25	:3	CD	NUMBER	:3	number	26	SENT_189	[p12l1039t625r1059b646],
26	.92	CD	NUMBER	.92	num	27	SENT_189	[p12l1136t623r1158b646],
27	>	JJR	O	>	npadvmod	28	SENT_189	[p12l1251t629r1266b643],
28	<	JJR	O	<	amod	29	SENT_189	[p12l1251t629r1266b643],
29	E	NN	O	e	dep	24	SENT_189	[p12l1369t620r1385b641],
30	'	''	O	'	_	0	SENT_189	[p12l1444t630r1466b644],
31	o	NN	O	o	nn	32	SENT_189	[p12l1444t630r1466b644],
32	E	NN	O	e	dep	22	SENT_189	[p12l1550t624r1566b645],
33	>	JJR	O	>	dep	32	SENT_189	[p12l1654t632r1670b646],
34	<	JJR	O	<	amod	37	SENT_189	[p12l1654t632r1670b646],
35	o	NN	O	o	nn	37	SENT_189	[p12l1759t630r1776b643],
36	tn	NN	O	tn	nn	37	SENT_189	[p12l721t644r737b657],
37	o.	NN	O	o.	dep	32	SENT_189	[p12l826t643r848b657],
38	.9	CD	NUMBER	.9	number	39	SENT_189	[p12l925t641r947b659],
39	(	CD	NUMBER	(	num	40	SENT_189	[p12l1043t648r1059b663],
40	u	NN	O	u	dep	37	SENT_189	[p12l1043t648r1059b663],
41	'	''	O	'	_	0	SENT_189	[p12l1137t648r1158b667],
42	§	CD	NUMBER	§	num	43	SENT_189	[p12l1137t648r1158b667],
43	(	CD	NUMBER	(	dep	22	SENT_189	[p12l1250t644r1267b659],
44	6	CD	NUMBER	6	num	45	SENT_189	[p12l1250t644r1267b659],
45	:6	CD	NUMBER	:6	dep	43	SENT_189	[p12l1369t643r1385b658],
46	--	:	O	--	_	0	SENT_189	[p12l1444t647r1466b650],
47	(	CD	NUMBER	(	number	48	SENT_189	[p12l1550t647r1567b662],
48	5	CD	NUMBER	5	dep	45	SENT_189	[p12l1550t647r1567b662],
49	5	CD	NUMBER	5	dep	48	SENT_189	[p12l1654t647r1670b662],
50	;	:	O	;	_	0	SENT_189	[p12l1654t647r1670b662],
51	'	''	O	'	_	0	SENT_189	[p12l1754t646r1781b665],
52	§	CD	NUMBER	§	dep	53	SENT_189	[p12l1754t646r1781b665],
53	_	NN	O	_	advmod	22	SENT_189	[p12l1754t646r1781b665],

1	o	NN	O	o	_	0	SENT_190	[p12l591t660r613b680],
2	o	NN	O	o	nn	3	SENT_190	[p12l721t659r737b673],
3	o	NN	O	o	dep	1	SENT_190	[p12l826t659r842b673],
4	x	CC	O	x	_	0	SENT_190	[p12l930t661r946b669],
5	—	CD	NUMBER	—	number	6	SENT_190	[p12l930t661r946b669],
6	—	CD	NUMBER	—	dep	1	SENT_190	[p12l1038t665r1059b668],
7	~	NN	O	~	dep	6	SENT_190	[p12l1246t660r1266b668],
8	.	.	O	.	_	0	SENT_190	[p12l1246t660r1266b668],

1	—	NN	O	—	_	0	SENT_191	[p12l1246t660r1266b668],
2	.	.	O	.	_	0	SENT_191	[p12l1246t660r1266b668],
3	'	''	O	'	_	0	SENT_191	[p12l1246t660r1266b668],

1	.	.	O	.	_	0	SENT_192	[p12l1363t660r1385b673],

1	:	:	O	:	_	0	SENT_193	[p12l1363t660r1385b673],
2	E	NN	O	e	_	0	SENT_193	[p12l1449t653r1466b674],
3	-	:	O	-	_	0	SENT_193	[p12l1544t662r1566b670],
4	<	JJR	O	<	dep	2	SENT_193	[p12l1544t662r1566b670],
5	9	CD	NUMBER	9	dep	4	SENT_193	[p12l1649t663r1670b676],
6	;	:	O	;	_	0	SENT_193	[p12l1649t663r1670b676],

1	o.	NN	O	o.	_	0	SENT_194	[p12l721t675r743b689],
2	.	.	O	.	_	0	SENT_194	[p12l821t675r842b689],

1	o	NN	O	o	nn	2	SENT_195	[p12l821t675r842b689],
2	o	NN	O	o	_	0	SENT_195	[p12l930t672r947b685],
3	-	:	O	-	_	0	SENT_195	[p12l1038t670r1059b684],
4	o	NN	O	o	dep	2	SENT_195	[p12l1038t670r1059b684],
5	O	NN	O	o	nn	8	SENT_195	[p12l1142t667r1158b682],
6	‘	NN	O	‘	nn	8	SENT_195	[p12l1250t669r1267b683],
7	D	NN	O	d	nn	8	SENT_195	[p12l1250t669r1267b683],
8	D.	NNP	O	D.	rcmod	4	SENT_195	[p12l1369t676r1391b690],
9	as	IN	O	as	_	0	SENT_195	[p12l1449t676r1466b691],
10	"	``	O	"	punct	12	SENT_195	[p12l1550t671r1567b684],
11	9	CD	NUMBER	9	num	12	SENT_195	[p12l1550t671r1567b684],
12	—	NN	O	—	prep_as	8	SENT_195	[p12l1649t679r1670b682],
13	E	NN	O	e	nn	16	SENT_195	[p12l1759t668r1775b689],
14	‘	CD	NUMBER	‘	num	16	SENT_195	[p12l591t683r613b700],
15	V	NN	O	v	nn	16	SENT_195	[p12l591t683r613b700],
16	’	NN	O	’	dep	12	SENT_195	[p12l591t683r613b700],
17	o	NN	O	o	nn	21	SENT_195	[p12l721t691r737b706],
18	E	NN	O	e	nn	21	SENT_195	[p12l826t690r842b698],
19	E	NN	O	e	nn	21	SENT_195	[p12l925t687r946b707],
20	E	NN	O	e	nn	21	SENT_195	[p12l1038t687r1059b707],
21	E	NN	O	e	rcmod	16	SENT_195	[p12l1142t684r1158b705],
22	°	CD	NUMBER	°	number	23	SENT_195	[p12l1250t685r1267b698],
23	:1	CD	NUMBER	:1	dep	21	SENT_195	[p12l1369t692r1385b705],
24	:	:	O	:	_	0	SENT_195	[p12l1369t692r1385b705],
25	-	:	O	-	_	0	SENT_195	[p12l1446t693r1466b700],
26	'	''	O	'	_	0	SENT_195	[p12l1446t693r1466b700],
27	.9	CD	NUMBER	.9	num	28	SENT_195	[p12l1544t686r1567b708],
28	o	NN	O	o	dep	33	SENT_195	[p12l1654t685r1670b698],
29	as	IN	O	as	_	0	SENT_195	[p12l1759t692r1776b706],
30	E	NN	O	e	prep_as	28	SENT_195	[p12l591t703r613b723],
31	*	CD	NUMBER	*	dep	33	SENT_195	[p12l717t707r737b715],
32	"	``	O	"	punct	33	SENT_195	[p12l717t707r737b715],
33	“	NN	O	“	dep	49	SENT_195	[p12l826t701r842b716],
34	'	''	O	'	_	0	SENT_195	[p12l826t701r842b716],
35	5	CD	NUMBER	5	num	36	SENT_195	[p12l826t701r842b716],
36	>	JJR	O	>	dep	33	SENT_195	[p12l930t709r946b723],
37	>	JJR	O	>	amod	40	SENT_195	[p12l1043t709r1059b723],
38	zu	NN	O	zu	nn	40	SENT_195	[p12l1142t707r1158b722],
39	°	NN	O	°	nn	40	SENT_195	[p12l1250t700r1267b714],
40	o	NN	O	o	dep	36	SENT_195	[p12l1369t707r1385b721],
41	3	CD	NUMBER	3	dep	40	SENT_195	[p12l1450t702r1466b715],
42	-	:	O	-	_	0	SENT_195	[p12l1545t710r1566b713],
43	‘	CD	NUMBER	‘	num	44	SENT_195	[p12l1654t699r1670b714],
44	V	NN	O	v	dep	40	SENT_195	[p12l1654t699r1670b714],
45	2	CD	NUMBER	2	dep	44	SENT_195	[p12l1753t707r1775b719],
46	:	:	O	:	_	0	SENT_195	[p12l1753t707r1775b719],
47	G	NN	O	g	dep	40	SENT_195	[p12l591t727r613b744],
48	<	JJR	O	<	dep	47	SENT_195	[p12l721t716r737b730],
49	1	CD	NUMBER	1	dep	51	SENT_195	[p12l721t716r737b730],
50	:	:	O	:	_	0	SENT_195	[p12l721t716r737b730],
51	o	NN	O	o	dep	2	SENT_195	[p12l826t717r842b731],
52	.	.	O	.	_	0	SENT_195	[p12l1138t724r1158b731],

1	.	.	O	.	_	0	SENT_196	[p12l1138t724r1158b731],

1	1	CD	NUMBER	1	_	0	SENT_197	[p12l1245t716r1267b730],
2	:	:	O	:	_	0	SENT_197	[p12l1245t716r1267b730],
3	E	NN	O	e	dep	1	SENT_197	[p12l1325t725r1346b746],
4	5	CD	NUMBER	5	num	3	SENT_197	[p12l1363t724r1385b737],
5	.	.	O	.	_	0	SENT_197	[p12l1444t718r1466b731],

1	.	.	O	.	_	0	SENT_198	[p12l1444t718r1466b731],

1	.	.	O	.	_	0	SENT_199	[p12l1444t718r1466b731],

1	—	NN	O	—	_	0	SENT_200	[p12l1444t718r1466b731],
2	.	.	O	.	_	0	SENT_200	[p12l1444t718r1466b731],

1	_	NN	O	_	nn	2	SENT_201	[p12l1444t718r1466b731],
2	E	NN	O	e	_	0	SENT_201	[p12l1545t725r1566b746],
3	:2	CD	NUMBER	:2	dep	2	SENT_201	[p12l1654t716r1676b730],
4	.	.	O	.	_	0	SENT_201	[p12l1654t716r1676b730],

1	.	.	O	.	_	0	SENT_202	[p12l1759t721r1775b729],

1	_	NN	O	_	_	0	SENT_203	[p12l1759t721r1775b729],
2	\	NN	O	\	dep	1	SENT_203	[p12l592t756r614b774],
3	,	,	O	,	_	0	SENT_203	[p12l592t756r614b774],
4	2	CD	NUMBER	2	number	5	SENT_203	[p12l715t741r737b762],
5	2	CD	NUMBER	2	appos	2	SENT_203	[p12l821t741r842b762],
6	§	CD	NUMBER	§	num	7	SENT_203	[p12l925t733r953b772],
7	§	NN	O	§	dep	1	SENT_203	[p12l1038t733r1066b772],
8	2	CD	NUMBER	2	number	9	SENT_203	[p12l1137t741r1158b762],
9	2	CD	NUMBER	2	dep	7	SENT_203	[p12l1245t741r1266b762],
10	1	CD	NUMBER	1	num	11	SENT_203	[p12l1331t748r1353b764],
11	g	NN	O	g	dep	1	SENT_203	[p12l1369t739r1391b770],
12	2	CD	NUMBER	2	number	13	SENT_203	[p12l1444t741r1466b762],
13	1	CD	NUMBER	1	dep	11	SENT_203	[p12l1551t748r1573b764],
14	2	CD	NUMBER	2	number	15	SENT_203	[p12l1649t741r1670b762],
15	2	CD	NUMBER	2	dep	1	SENT_203	[p12l1754t741r1775b762],
16	o	NN	O	o	dep	15	SENT_203	[p12l592t770r602b780],
17	1	CD	NUMBER	1	num	16	SENT_203	[p12l722t764r743b780],
18	1	CD	NUMBER	1	number	19	SENT_203	[p12l827t764r848b780],
19	1	CD	NUMBER	1	dep	1	SENT_203	[p12l1143t764r1165b780],
20	1	CD	NUMBER	1	num	21	SENT_203	[p12l1251t764r1273b780],
21	—	NN	O	—	dep	19	SENT_203	[p12l1363t773r1385b776],
22	1	CD	NUMBER	1	number	23	SENT_203	[p12l1450t764r1472b780],
23	1	CD	NUMBER	1	dep	1	SENT_203	[p12l1655t764r1677b780],
24	1	CD	NUMBER	1	num	25	SENT_203	[p12l1760t764r1782b780],
25	—	NN	O	—	dep	23	SENT_203	[p12l592t786r613b794],
26	.	.	O	.	_	0	SENT_203	[p12l925t786r946b794],

1	-	:	O	-	_	0	SENT_204	[p12l925t786r946b794],
2	—	NN	O	—	nn	6	SENT_204	[p12l1038t786r1059b794],
3	o	NN	O	o	nn	6	SENT_204	[p12l1325t774r1347b788],
4	o	NN	O	o	nn	6	SENT_204	[p12l1369t778r1385b791],
5	o	NN	O	o	nn	6	SENT_204	[p12l1545t774r1567b788],
6	o	NN	O	o	dep	26	SENT_204	[p12l592t799r613b821],
7	‘	CD	NUMBER	‘	number	8	SENT_204	[p12l592t799r613b821],
8	9	CD	NUMBER	9	num	12	SENT_204	[p12l716t790r737b819],
9	.9	NN	NUMBER	.9	nn	12	SENT_204	[p12l821t790r843b819],
10	o	NN	O	o	nn	12	SENT_204	[p12l925t799r947b821],
11	‘	CD	NUMBER	‘	num	12	SENT_204	[p12l925t799r947b821],
12	o	NN	O	o	dep	6	SENT_204	[p12l1038t799r1060b821],
13	‘	CD	NUMBER	‘	number	14	SENT_204	[p12l1038t799r1060b821],
14	9	CD	NUMBER	9	num	15	SENT_204	[p12l1137t790r1159b819],
15	.9	NN	NUMBER	.9	dep	12	SENT_204	[p12l1245t790r1267b819],
16	9	CD	NUMBER	9	number	17	SENT_204	[p12l1325t790r1347b819],
17	5	CD	NUMBER	5	amod	15	SENT_204	[p12l1369t792r1391b821],
18	5	LS	NUMBER	5	dep	17	SENT_204	[p12l1444t790r1466b819],
19	-	:	O	-	_	0	SENT_204	[p12l1444t790r1466b819],
20	’	CD	NUMBER	’	number	21	SENT_204	[p12l1444t790r1466b819],
21	9	CD	NUMBER	9	dep	12	SENT_204	[p12l1545t790r1567b819],
22	.9	NN	NUMBER	.9	dep	21	SENT_204	[p12l1649t790r1671b819],
23	9	CD	NUMBER	9	num	22	SENT_204	[p12l1754t790r1776b819],
24	Pgp	NN	O	pgp	dep	26	SENT_204	[p12l363t815r412b843],
25	(	CD	NUMBER	(	num	24	SENT_204	[p12l423t814r527b842],
26	control	NN	O	control	dep	32	SENT_204	[p12l423t814r527b842],
27	)	CD	NUMBER	)	num	26	SENT_204	[p12l423t814r527b842],
28	,	,	O	,	_	0	SENT_204	[p12l1032t835r1035b836],
29	I	PRP	O	I	appos	26	SENT_204	[p12l1268t843r1271b844],
30	,	,	O	,	_	0	SENT_204	[p12l1560t839r1565b840],
31	_	CD	NUMBER	_	appos	26	SENT_204	[p12l1681t839r1685b841],
32	i	FW	O	i	_	0	SENT_204	[p12l1731t835r1807b876],
33	an	DT	O	a	dep	32	SENT_204	[p12l579t847r635b870],
34	in	IN	O	in	dep	32	SENT_204	[p12l693t848r757b869],
35	-3	CD	NUMBER	-3	num	36	SENT_204	[p12l803t839r867b870],
36	3	CD	NUMBER	3	pobj	34	SENT_204	[p12l912t845r978b871],
37	!	.	O	!	_	0	SENT_204	[p12l912t845r978b871],

1	in	IN	O	in	dep	5	SENT_205	[p12l1018t845r1088b871],
2	in	IN	O	in	_	0	SENT_205	[p12l1120t843r1186b872],
3	Zr	NN	O	zr	prep_in	1	SENT_205	[p12l1228t843r1296b874],
4	1	CD	NUMBER	1	num	3	SENT_205	[p12l1326t843r1390b874],
5	1	CD	NUMBER	1	dep	9	SENT_205	[p12l1424t843r1494b872],
6	1	LS	NUMBER	1	dep	5	SENT_205	[p12l1526t841r1599b874],
7	-	:	O	-	_	0	SENT_205	[p12l1526t841r1599b874],
8	1	CD	NUMBER	1	num	9	SENT_205	[p12l1630t839r1707b874],
9	‘	CD	NUMBER	‘	_	0	SENT_205	[p12l1630t839r1707b874],

1	Fig	NN	O	fig	_	0	SENT_206	[p12l7t1184r128b1252],
2	.	.	O	.	_	0	SENT_206	[p12l7t1184r128b1252],

1	3	CD	NUMBER	3	num	3	SENT_207	[p12l152t1184r187b1237],
2	Anticancer	NN	O	anticancer	nn	3	SENT_207	[p12l241t1184r576b1237],
3	drugs	NNS	O	drug	nsubj	4	SENT_207	[p12l610t1184r775b1252],
4	affect	VBP	O	affect	_	0	SENT_207	[p12l813t1182r975b1237],
5	Pgp	NN	O	pgp	nn	7	SENT_207	[p12l1008t1186r1125b1252],
6	protein	NN	O	protein	nn	7	SENT_207	[p12l1158t1184r1374b1252],
7	expression	NN	O	expression	dobj	4	SENT_207	[p12l1408t1184r1749b1252],
8	.	.	O	.	_	0	SENT_207	[p12l1408t1184r1749b1252],

1	Pgp	NN	ORGANIZATION	pgp	nn	3	SENT_208	[p12l1786t1186r1902b1252],
2	protein	NN	O	protein	nn	3	SENT_208	[p12l1935t1184r2152b1252],
3	expression	NN	O	expression	nsubjpass	15	SENT_208	[p12l7t1274r332b1342],
4	after	IN	O	after	_	0	SENT_208	[p12l355t1274r493b1327],
5	exposure	NN	O	exposure	prep_after	3	SENT_208	[p12l514t1291r788b1342],
6	of	IN	O	of	_	0	SENT_208	[p12l812t1274r878b1327],
7	the	DT	O	the	det	8	SENT_208	[p12l895t1274r986b1327],
8	LS180	NN	O	ls180	prep_of	5	SENT_208	[p12l1008t1274r1209b1327],
9	to	TO	O	to	_	0	SENT_208	[p12l1232t1282r1288b1327],
10	the	DT	O	the	det	12	SENT_208	[p12l1311t1274r1403b1327],
11	anticancer	JJ	O	anticancer	amod	12	SENT_208	[p12l1426t1274r1739b1327],
12	drugs	NNS	O	drug	prep_to	8	SENT_208	[p12l1761t1274r1926b1342],
13	as	IN	O	as	amod	12	SENT_208	[p12l1952t1291r2009b1327],
14	was	VBD	O	be	auxpass	15	SENT_208	[p12l2034t1291r2149b1327],
15	determined	VBN	O	determine	_	0	SENT_208	[p12l8t1363r350b1416],
16	with	IN	O	with	_	0	SENT_208	[p12l371t1363r505b1416],
17	immunoblotting	NN	O	immunoblotting	prep_with	15	SENT_208	[p12l526t1363r1016b1431],
18	using	VBG	O	use	xcomp	15	SENT_208	[p12l1039t1363r1201b1431],
19	Pgp	NNP	O	Pgp	dobj	18	SENT_208	[p12l1224t1365r1364b1431],
20	-	:	O	-	_	0	SENT_208	[p12l1224t1365r1364b1431],
21	and	CC	O	and	_	0	SENT_208	[p12l1390t1363r1496b1416],
22	ﬂ-actin-speciﬁc	JJ	O	ﬂ-actin-speciﬁc	amod	23	SENT_208	[p12l1519t1361r1991b1431],
23	antitaxel	NN	O	antitaxel	conj_and	19	SENT_208	[p12l2015t1363r2149b1416, p12l7t1596r199b1670],
24	,	,	O	,	_	0	SENT_208	[p12l2015t1363r2149b1416, p12l7t1596r199b1670],

1	cyclophosphamide	NN	O	cyclophosphamide	nn	8	SENT_209	[p12l234t1596r926b1677],
2	,	,	O	,	_	0	SENT_209	[p12l234t1596r926b1677],
3	ﬂutarnide	NN	O	ﬂutarnide	nn	8	SENT_209	[p12l961t1593r1316b1670],
4	,	,	O	,	_	0	SENT_209	[p12l961t1593r1316b1670],
5	ifosfamide	NN	O	ifosfamide	nn	8	SENT_209	[p12l1350t1596r1733b1659],
6	and	CC	O	and	_	0	SENT_209	[p12l1766t1596r1893b1659],
7	paclitaxel	NN	O	paclitaxel	conj_and	1	SENT_209	[p12l1921t1596r2149b1677, p12l9t1708r182b1785],
8	)	NN	O	)	nsubj	10	SENT_209	[p12l1921t1596r2149b1677, p12l9t1708r182b1785],
9	also	RB	O	also	advmod	10	SENT_209	[p12l229t1708r369b1771],
10	induced	VBD	O	induce	_	0	SENT_209	[p12l412t1708r696b1771],
11	Pgp	NN	O	pgp	nn	13	SENT_209	[p12l736t1710r873b1789],
12	protein	NN	O	protein	nn	13	SENT_209	[p12l915t1708r1170b1789],
13	levels	NNS	O	level	dobj	10	SENT_209	[p12l1211t1708r1417b1771],
14	in	IN	O	in	_	0	SENT_209	[p12l1461t1708r1530b1770],
15	LS180	NN	O	ls180	nn	16	SENT_209	[p12l1571t1709r1808b1771],
16	cells	NNS	O	cell	prep_in	10	SENT_209	[p12l1852t1708r2032b1771],
17	.	.	O	.	_	0	SENT_209	[p12l1852t1708r2032b1771],

1	In	IN	O	in	_	0	SENT_210	[p12l2079t1710r2152b1770],
2	accordance	NN	O	accordance	_	0	SENT_210	[p12l9t1819r410b1882],
3	with	IN	O	with	_	0	SENT_210	[p12l447t1819r605b1882],
4	the	DT	O	the	det	9	SENT_210	[p12l641t1819r748b1882],
5	Pgp	NNP	O	Pgp	nn	9	SENT_210	[p12l785t1821r1240b1900],
6	—	NN	O	—	nn	9	SENT_210	[p12l785t1821r1240b1900],
7	reporter	NN	O	reporter	nn	9	SENT_210	[p12l785t1821r1240b1900],
8	gene	NN	O	gene	nn	9	SENT_210	[p12l1276t1839r1441b1900],
9	assay	NN	O	assay	prep_in_accordance_with	19	SENT_210	[p12l1480t1839r1690b1900],
10	,	,	O	,	_	0	SENT_210	[p12l1480t1839r1690b1900],
11	both	CC	O	both	preconj	14	SENT_210	[p12l1729t1819r1887b1882],
12	etopo	FW	O	etopo	nn	14	SENT_210	[p12l1924t1829r2149b1900],
13	—	FW	O	—	nn	14	SENT_210	[p12l1924t1829r2149b1900],
14	side	NN	O	side	nsubj	19	SENT_210	[p12l10t1930r149b1993],
15	and	CC	O	and	_	0	SENT_210	[p12l178t1930r305b1993],
16	carboplatin	NN	O	carboplatin	nsubj	19	SENT_210	[p12l331t1930r734b2011],
17	did	VBD	O	do	aux	19	SENT_210	[p12l762t1930r874b1993],
18	not	RB	O	not	neg	19	SENT_210	[p12l899t1940r1014b1993],
19	induce	VB	O	induce	_	0	SENT_210	[p12l1039t1930r1276b1993],
20	Pgp	NN	PERSON	pgp	nn	22	SENT_210	[p12l1303t1932r1439b2011],
21	protein	NN	O	protein	nn	22	SENT_210	[p12l1466t1930r1719b2011],
22	expression	NN	O	expression	dobj	19	SENT_210	[p12l1747t1930r2147b2011],
23	.	.	O	.	_	0	SENT_210	[p12l1747t1930r2147b2011],

1	To	TO	O	to	aux	3	SENT_211	[p12l7t2043r103b2104],
2	further	RB	O	further	advmod	3	SENT_211	[p12l131t2041r375b2104],
3	demonstrate	VB	O	demonstrate	purpcl	18	SENT_211	[p12l401t2041r837b2104],
4	that	IN	O	that	complm	6	SENT_211	[p12l864t2041r998b2104],
5	PXR	NN	O	pxr	nsubj	6	SENT_211	[p12l1023t2043r1197b2103],
6	plays	VBZ	O	play	ccomp	3	SENT_211	[p12l1220t2041r1408b2122],
7	an	DT	O	a	det	9	SENT_211	[p12l1438t2061r1518b2104],
8	important	JJ	O	important	amod	9	SENT_211	[p12l1545t2041r1894b2122],
9	role	NN	O	role	dobj	6	SENT_211	[p12l1918t2041r2056b2104],
10	in	IN	O	in	_	0	SENT_211	[p12l2083t2041r2151b2103],
11	the	DT	O	the	det	12	SENT_211	[p12l7t2152r114b2215],
12	upregulation	NN	O	upregulation	prep_in	9	SENT_211	[p12l155t2152r608b2233],
13	of	IN	O	of	_	0	SENT_211	[p12l650t2152r728b2215],
14	Pgp	NNP	ORGANIZATION	Pgp	prep_of	12	SENT_211	[p12l763t2154r919b2233],
15	,	,	O	,	_	0	SENT_211	[p12l763t2154r919b2233],
16	PXR	NNP	O	PXR	nsubjpass	18	SENT_211	[p12l963t2154r1137b2214],
17	was	VBD	O	be	auxpass	18	SENT_211	[p12l1176t2172r1311b2215],
18	knocked	VBN	O	knock	_	0	SENT_211	[p12l1353t2152r1658b2215],
19	down	RB	O	down	advmod	18	SENT_211	[p12l1698t2152r1895b2215],
20	in	IN	O	in	_	0	SENT_211	[p12l1936t2152r2004b2214],
21	the	DT	O	the	det	22	SENT_211	[p12l2044t2152r2150b2215],
22	LS180	NN	O	ls180	prep_in	18	SENT_211	[p12l7t2263r243b2325],
23	cells	NNS	O	cell	nsubj	24	SENT_211	[p12l272t2262r431b2325],
24	(	VBP	O	(	rcmod	22	SENT_211	[p12l462t2262r709b2340],
25	knock	VB	O	knock	csubj	30	SENT_211	[p12l462t2262r709b2340],
26	down	RP	O	down	prt	25	SENT_211	[p12l734t2262r930b2325],
27	efficiency	NN	O	efficiency	dobj	25	SENT_211	[p12l958t2260r1303b2343],
28	was	VBD	O	be	cop	30	SENT_211	[p12l1330t2282r1465b2325],
29	51	CD	PERCENT	51	num	30	SENT_211	[p12l1495t2262r1652b2325],
30	%	NN	PERCENT	%	ccomp	24	SENT_211	[p12l1495t2262r1652b2325],
31	as	IN	O	as	mark	33	SENT_211	[p12l1685t2282r1753b2325],
32	was	VBD	O	be	auxpass	33	SENT_211	[p12l1782t2282r1916b2325],
33	determined	VBN	O	determine	advcl	30	SENT_211	[p12l1945t2262r2150b2325, p12l7t2374r231b2437],
34	48	CD	NUMBER	48	num	35	SENT_211	[p12l288t2375r373b2437],
35	h	NN	O	h	dobj	33	SENT_211	[p12l400t2374r443b2436],
36	after	IN	O	after	mark	43	SENT_211	[p12l504t2374r666b2437],
37	siRNA	NN	O	sirna	nn	38	SENT_211	[p12l726t2374r971b2437],
38	transfection	NN	O	transfection	nsubj	43	SENT_211	[p12l1029t2374r1453b2437],
39	by	IN	O	by	_	0	SENT_211	[p12l1510t2374r1598b2455],
40	Western	NN	MISC	western	nn	41	SENT_211	[p12l1656t2376r1955b2437],
41	blot	NN	O	blot	prep_by	38	SENT_211	[p12l2013t2374r2152b2437],
42	(	CD	NUMBER	(	num	41	SENT_211	[p12l10t2485r268b2562],
43	results	VBZ	O	result	advcl	33	SENT_211	[p12l10t2485r268b2562],
44	not	RB	O	not	neg	43	SENT_211	[p12l309t2495r423b2548],
45	shown	VBN	O	show	dep	43	SENT_211	[p12l462t2485r770b2562],
46	)	NN	O	)	nn	47	SENT_211	[p12l462t2485r770b2562],
47	)	NN	O	)	dobj	45	SENT_211	[p12l462t2485r770b2562],
48	.	.	O	.	_	0	SENT_211	[p12l462t2485r770b2562],

1	The	DT	O	the	det	2	SENT_212	[p12l812t2485r949b2548],
2	cells	NNS	O	cell	nsubjpass	5	SENT_212	[p12l989t2485r1149b2548],
3	were	VBD	O	be	auxpass	5	SENT_212	[p12l1190t2505r1362b2548],
4	subsequently	RB	O	subsequently	advmod	5	SENT_212	[p12l1404t2485r1868b2566],
5	treated	VBN	O	treat	_	0	SENT_212	[p12l1907t2485r2152b2548],
6	with	IN	O	with	_	0	SENT_212	[p12l7t2596r165b2659],
7	the	DT	O	the	det	9	SENT_212	[p12l195t2596r302b2659],
8	anticancer	JJ	O	anticancer	amod	9	SENT_212	[p12l335t2596r704b2659],
9	drugs	NNS	O	drug	prep_with	5	SENT_212	[p12l733t2596r946b2677],
10	.	.	O	.	_	0	SENT_212	[p12l733t2596r946b2677],

1	As	IN	O	as	mark	2	SENT_213	[p12l981t2597r1077b2659],
2	shown	VBN	O	show	_	0	SENT_213	[p12l1112t2596r1342b2659],
3	in	IN	O	in	_	0	SENT_213	[p12l1372t2596r1440b2658],
4	Fig	NN	O	fig	prep_in	2	SENT_213	[p12l1469t2596r1605b2677],
5	.	.	O	.	_	0	SENT_213	[p12l1469t2596r1605b2677],

1	3	CD	NUMBER	3	nsubj	8	SENT_214	[p12l1637t2597r1697b2670],
2	,	,	O	,	_	0	SENT_214	[p12l1637t2597r1697b2670],
3	Pgp	NN	ORGANIZATION	pgp	nn	5	SENT_214	[p12l1730t2598r1867b2677],
4	protein	NN	O	protein	nn	5	SENT_214	[p12l1897t2596r2151b2677],
5	induction	NN	O	induction	appos	1	SENT_214	[p12l7t2706r345b2769],
6	was	VBD	O	be	cop	8	SENT_214	[p12l382t2726r517b2769],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_214	[p12l560t2704r998b2787],
8	lower	JJR	O	lower	_	0	SENT_214	[p12l1037t2706r1241b2769],
9	in	IN	O	in	_	0	SENT_214	[p12l1276t2706r1343b2768],
10	the	DT	O	the	det	14	SENT_214	[p12l1380t2706r1487b2769],
11	PXR	NN	O	pxr	nn	14	SENT_214	[p12l1524t2708r1698b2768],
12	knockdown	NN	O	knockdown	nn	14	SENT_214	[p12l1733t2706r2152b2769],
13	LS180	NN	O	ls180	nn	14	SENT_214	[p12l7t2819r243b2881],
14	cells	NNS	O	cell	prep_in	8	SENT_214	[p12l304t2818r465b2881],
15	after	IN	O	after	mark	26	SENT_214	[p12l527t2818r690b2881],
16	treatment	NN	O	treatment	nsubj	26	SENT_214	[p12l747t2827r1086b2881],
17	with	IN	O	with	_	0	SENT_214	[p12l1145t2818r1303b2881],
18	the	DT	O	the	det	20	SENT_214	[p12l1361t2818r1468b2881],
19	anticancer	JJ	O	anticancer	amod	20	SENT_214	[p12l1530t2818r1897b2881],
20	drugs	NNS	O	drug	prep_with	16	SENT_214	[p12l1955t2818r2150b2899],
21	compared	VBN	O	compare	_	0	SENT_214	[p12l8t2929r360b3010],
22	to	TO	O	to	prepc_compared_to	20	SENT_214	[p12l386t2939r453b2992],
23	the	DT	O	the	det	25	SENT_214	[p12l481t2929r588b2992],
24	control	NN	O	control	nn	25	SENT_214	[p12l617t2929r869b2992],
25	cells	NNS	O	cell	pobj	20	SENT_214	[p12l897t2929r1058b2992],
26	(	VBP	O	(	advcl	8	SENT_214	[p12l1090t2930r1354b3006],
27	LS180	NN	O	ls180	nn	28	SENT_214	[p12l1090t2930r1354b3006],
28	cells	NNS	O	cell	dobj	26	SENT_214	[p12l1383t2929r1543b2992],
29	transfected	VBN	O	transfect	partmod	28	SENT_214	[p12l1573t2929r1966b2992],
30	with	IN	O	with	_	0	SENT_214	[p12l1993t2929r2151b2992],
31	non	JJ	O	non	amod	35	SENT_214	[p12l7t3040r489b3121],
32	—	NN	O	—	nn	35	SENT_214	[p12l7t3040r489b3121],
33	targeting	VBG	O	target	amod	35	SENT_214	[p12l7t3040r489b3121],
34	siRNA	NN	O	sirna	nn	35	SENT_214	[p12l540t3040r833b3118],
35	)	NN	O	)	prep_with	29	SENT_214	[p12l540t3040r833b3118],
36	.	.	O	.	_	0	SENT_214	[p12l540t3040r833b3118],

1	However	RB	O	however	advmod	7	SENT_215	[p12l886t3042r1232b3114],
2	,	,	O	,	_	0	SENT_215	[p12l886t3042r1232b3114],
3	Pgp	NN	ORGANIZATION	pgp	nn	4	SENT_215	[p12l1283t3042r1419b3121],
4	induction	NN	O	induction	nsubj	7	SENT_215	[p12l1468t3040r1807b3103],
5	was	VBD	O	be	cop	7	SENT_215	[p12l1854t3060r1989b3103],
6	not	RB	O	not	neg	7	SENT_215	[p12l2038t3050r2152b3103],
7	completely	RB	O	completely	_	0	SENT_215	[p12l8t3151r403b3232],
8	abolished	VBD	O	abolish	ccomp	7	SENT_215	[p12l436t3151r797b3226],
9	,	,	O	,	_	0	SENT_215	[p12l436t3151r797b3226],
10	most	RBS	O	most	advmod	11	SENT_215	[p12l830t3161r1005b3214],
11	likely	RB	O	likely	dep	8	SENT_215	[p12l1033t3151r1235b3232],
12	as	IN	O	as	dep	11	SENT_215	[p12l1267t3171r1336b3214],
13	a	DT	O	a	det	14	SENT_215	[p12l1370t3171r1407b3214],
14	result	NN	O	result	pobj	12	SENT_215	[p12l1435t3151r1635b3214],
15	of	IN	O	of	_	0	SENT_215	[p12l1664t3151r1742b3214],
16	the	DT	O	the	det	18	SENT_215	[p12l1766t3151r1873b3214],
17	knockdown	JJ	O	knockdown	amod	18	SENT_215	[p12l1902t3151r2149b3214, p12l8t3261r204b3324],
18	elﬁciency	NN	O	elﬁciency	prep_of	14	SENT_215	[p12l231t3259r576b3341],
19	of	IN	O	of	_	0	SENT_215	[p12l604t3261r680b3324],
20	51	CD	PERCENT	51	num	21	SENT_215	[p12l701t3261r880b3324],
21	%	NN	PERCENT	%	prep_of	18	SENT_215	[p12l701t3261r880b3324],
22	.	.	O	.	_	0	SENT_215	[p12l701t3261r880b3324],

1	bodies	NNS	O	body	_	0	SENT_216	[p12l7t3505r221b3558],
2	.	.	O	.	_	0	SENT_216	[p12l7t3505r221b3558],

1	The	DT	O	the	det	2	SENT_217	[p12l249t3505r365b3558],
2	ﬁgure	NN	O	ﬁgure	nsubj	3	SENT_217	[p12l391t3503r565b3573],
3	shows	VBZ	O	show	_	0	SENT_217	[p12l592t3505r777b3558],
4	a	DT	O	a	det	6	SENT_217	[p12l805t3522r836b3558],
5	representative	JJ	O	representative	amod	6	SENT_217	[p12l859t3505r1285b3573],
6	immunoblot	NN	O	immunoblot	nsubj	14	SENT_217	[p12l1310t3505r1684b3558],
7	of	IN	O	of	_	0	SENT_217	[p12l1708t3505r1774b3558],
8	Pgp	NN	ORGANIZATION	pgp	nn	10	SENT_217	[p12l1793t3507r1909b3573],
9	protein	NN	O	protein	nn	10	SENT_217	[p12l1932t3505r2149b3573],
10	expression	NN	O	expression	prep_of	6	SENT_217	[p12l8t3595r332b3663],
11	in	IN	O	in	_	0	SENT_217	[p12l352t3595r410b3647],
12	LS180	NN	O	ls180	nn	13	SENT_217	[p12l429t3595r631b3648],
13	cells	NNS	O	cell	prep_in	10	SENT_217	[p12l651t3595r788b3648],
14	(	VBP	O	(	dep	3	SENT_217	[p12l811t3595r969b3660],
15	both	CC	O	both	advmod	14	SENT_217	[p12l811t3595r969b3660],
16	in	IN	O	in	_	0	SENT_217	[p12l987t3595r1045b3647],
17	control	NN	O	control	prep_in	14	SENT_217	[p12l1065t3595r1278b3648],
18	and	CC	O	and	_	0	SENT_217	[p12l1300t3595r1407b3648],
19	PXR	NN	O	pxr	nsubj	20	SENT_217	[p12l1427t3596r1573b3647],
20	knock	VBP	O	knock	dep	3	SENT_217	[p12l1593t3595r1780b3648],
21	down	IN	O	down	_	0	SENT_217	[p12l1798t3595r1965b3648],
22	cells	NNS	O	cell	prep_down	20	SENT_217	[p12l1986t3595r2147b3660],
23	)	RB	O	)	advmod	22	SENT_217	[p12l1986t3595r2147b3660],
24	following	VBG	O	follow	_	0	SENT_217	[p12l8t3685r302b3753],
25	48	CD	NUMBER	48	num	27	SENT_217	[p12l324t3685r395b3738],
26	h	NN	O	h	nn	27	SENT_217	[p12l420t3685r457b3737],
27	treatment	NN	O	treatment	prep_following	22	SENT_217	[p12l478t3693r764b3738],
28	with	IN	O	with	_	0	SENT_217	[p12l786t3685r919b3738],
29	the	DT	O	the	det	32	SENT_217	[p12l941t3685r1032b3738],
30	indicated	VBN	O	indicate	amod	32	SENT_217	[p12l1053t3685r1332b3738],
31	anticancer	JJ	O	anticancer	amod	32	SENT_217	[p12l1354t3685r1667b3738],
32	drugs	NNS	O	drug	prep_with	27	SENT_217	[p12l1687t3685r1852b3753],

1	Rhodamine	NN	O	rhodamine	_	0	SENT_218	[p13l8t128r419b191],
2	123	CD	NUMBER	123	num	4	SENT_218	[p13l453t129r572b191],
3	accumulation	NN	O	accumulation	nn	4	SENT_218	[p13l604t128r1085b191],
4	assay	NN	O	assay	dep	1	SENT_218	[p13l1112t148r1302b209],

1	To	TO	O	to	aux	2	SENT_219	[p13l8t354r107b415],
2	assess	VB	O	assess	purpcl	22	SENT_219	[p13l147t372r370b415],
3	whether	IN	O	whether	complm	6	SENT_219	[p13l410t352r710b415],
4	PXR	NN	O	pxr	nn	5	SENT_219	[p13l746t352r1303b415],
5	—	NN	O	—	nsubj	6	SENT_219	[p13l746t352r1303b415],
6	mediated	VBD	O	mediate	ccomp	2	SENT_219	[p13l746t352r1303b415],
7	Pgp	NNP	O	Pgp	nn	8	SENT_219	[p13l1340t354r1481b433],
8	induction	NN	O	induction	nsubj	9	SENT_219	[p13l1520t352r1873b415],
9	affects	VBZ	O	affect	ccomp	6	SENT_219	[p13l1913t350r2146b415],
10	the	DT	O	the	det	11	SENT_219	[p13l8t464r118b527],
11	accumulation	NN	O	accumulation	dobj	9	SENT_219	[p13l147t464r653b527],
12	of	IN	O	of	_	0	SENT_219	[p13l680t464r759b527],
13	Pgp	NNP	ORGANIZATION	Pgp	nn	14	SENT_219	[p13l779t466r920b545],
14	substrates	NNS	O	substrate	prep_of	11	SENT_219	[p13l950t464r1338b538],
15	,	,	O	,	_	0	SENT_219	[p13l950t464r1338b538],
16	the	DT	O	the	det	18	SENT_219	[p13l1367t464r1478b527],
17	transport	NN	O	transport	nn	18	SENT_219	[p13l1505t474r1840b545],
18	activity	NN	O	activity	nsubjpass	22	SENT_219	[p13l1867t464r2146b545],
19	of	IN	O	of	_	0	SENT_219	[p13l9t575r88b638],
20	Pgp	NNP	ORGANIZATION	Pgp	prep_of	18	SENT_219	[p13l107t577r246b656],
21	was	VBD	O	be	auxpass	22	SENT_219	[p13l273t595r410b638],
22	analyzed	VBN	O	analyze	_	0	SENT_219	[p13l441t575r764b656],
23	using	VBG	O	use	xcomp	22	SENT_219	[p13l789t575r984b656],
24	a	DT	O	a	det	28	SENT_219	[p13l1013t595r1051b638],
25	rhodamine	NN	O	rhodamine	nn	28	SENT_219	[p13l1074t575r1466b638],
26	123	CD	NUMBER	123	num	28	SENT_219	[p13l1501t576r1621b638],
27	accumulation	NN	O	accumulation	nn	28	SENT_219	[p13l1654t575r2149b638],
28	assay	NN	O	assay	dobj	23	SENT_219	[p13l10t706r218b767],
29	.	.	O	.	_	0	SENT_219	[p13l10t706r218b767],

1	Following	VBG	O	follow	_	0	SENT_220	[p13l276t686r642b767],
2	48	CD	NUMBER	48	num	4	SENT_220	[p13l697t687r780b749],
3	h	NN	O	h	nn	4	SENT_220	[p13l809t686r852b748],
4	pretreatment	NN	O	pretreatment	prep_following	12	SENT_220	[p13l903t695r1358b767],
5	with	IN	O	with	_	0	SENT_220	[p13l1410t686r1568b749],
6	the	DT	O	the	det	8	SENT_220	[p13l1620t686r1728b749],
7	anticancer	JJ	O	anticancer	amod	8	SENT_220	[p13l1783t686r2151b749],
8	drugs	NNS	O	drug	prep_with	4	SENT_220	[p13l9t797r224b878],
9	,	,	O	,	_	0	SENT_220	[p13l9t797r224b878],
10	cells	NNS	O	cell	nsubjpass	12	SENT_220	[p13l257t797r417b860],
11	were	VBD	O	be	auxpass	12	SENT_220	[p13l447t817r619b860],
12	exposed	VBN	O	expose	_	0	SENT_220	[p13l648t797r940b878],
13	to	TO	O	to	_	0	SENT_220	[p13l968t807r1034b860],
14	rhodamine	NN	O	rhodamine	prep_to	12	SENT_220	[p13l1063t797r1446b860],
15	123	CD	NUMBER	123	num	14	SENT_220	[p13l1483t798r1602b860],
16	in	IN	O	in	_	0	SENT_220	[p13l1634t797r1703b859],
17	the	DT	O	the	det	18	SENT_220	[p13l1731t797r1838b860],
18	absence	NN	O	absence	prep_in	12	SENT_220	[p13l1869t797r2148b860],
19	or	CC	O	or	_	0	SENT_220	[p13l9t927r82b970],
20	presence	NN	O	presence	conj_or	18	SENT_220	[p13l151t927r465b988],
21	of	IN	O	of	_	0	SENT_220	[p13l538t907r615b970],
22	the	DT	O	the	det	27	SENT_220	[p13l681t907r788b970],
23	Pgp-speciﬁc	JJ	MISC	pgp-speciﬁc	amod	27	SENT_220	[p13l862t905r1303b988],
24	inhibitor	NN	O	inhibitor	nn	27	SENT_220	[p13l1378t907r1687b970],
25	zosuquidar	NN	O	zosuquidar	nn	27	SENT_220	[p13l1759t907r2152b988],
26	(	CD	NUMBER	(	num	27	SENT_220	[p13l11t1019r447b1097],
27	LY335979	NN	O	ly335979	prep_of	18	SENT_220	[p13l11t1019r447b1097],
28	;	:	O	;	_	0	SENT_220	[p13l11t1019r447b1097],
29	ICSO	NN	O	icso	nn	31	SENT_220	[p13l509t1019r686b1082],
30	=	JJ	O	=	amod	31	SENT_220	[p13l712t1046r758b1070],
31	4nM	NN	O	4nm	dep	27	SENT_220	[p13l784t1020r979b1097],
32	)	CD	NUMBER	)	number	33	SENT_220	[p13l784t1020r979b1097],
33	[	CD	NUMBER	[	dep	31	SENT_220	[p13l1047t1019r1206b1095],
34	16	CD	NUMBER	16	num	35	SENT_220	[p13l1047t1019r1206b1095],
35	]	NN	O	]	dep	33	SENT_220	[p13l1047t1019r1206b1095],
36	.	.	O	.	_	0	SENT_220	[p13l1047t1019r1206b1095],

1	The	DT	O	the	det	2	SENT_221	[p13l1268t1019r1405b1082],
2	ratio	NN	O	ratio	nsubj	18	SENT_221	[p13l1464t1019r1626b1082],
3	between	IN	O	between	_	0	SENT_221	[p13l1684t1019r1983b1082],
4	the	DT	O	the	det	6	SENT_221	[p13l2041t1019r2148b1082],
5	intracellular	JJ	O	intracellular	amod	6	SENT_221	[p13l8t1130r442b1193],
6	ﬂuorescence	NN	O	ﬂuorescence	prep_between	2	SENT_221	[p13l468t1127r913b1193],
7	of	IN	O	of	_	0	SENT_221	[p13l941t1130r1019b1193],
8	rhodamine	NN	O	rhodamine	prep_of	6	SENT_221	[p13l1038t1130r1422b1193],
9	123	CD	NUMBER	123	num	8	SENT_221	[p13l1457t1131r1576b1193],
10	in	IN	O	in	_	0	SENT_221	[p13l1607t1130r1676b1192],
11	the	DT	O	the	det	12	SENT_221	[p13l1702t1130r1810b1193],
12	presence	NN	O	presence	prep_in	8	SENT_221	[p13l1835t1150r2148b1211],
13	and	CC	O	and	_	0	SENT_221	[p13l10t1242r136b1305],
14	absence	NN	O	absence	prep_in	8	SENT_221	[p13l172t1242r451b1305],
15	of	IN	O	of	_	0	SENT_221	[p13l486t1242r564b1305],
16	zosuquidar	NN	O	zosuquidar	prep_of	12	SENT_221	[p13l593t1242r986b1323],
17	is	VBZ	O	be	cop	18	SENT_221	[p13l1018t1242r1073b1305],
18	indicative	JJ	O	indicative	_	0	SENT_221	[p13l1111t1242r1462b1305],
19	for	IN	O	for	_	0	SENT_221	[p13l1497t1242r1601b1305],
20	the	DT	O	the	det	23	SENT_221	[p13l1633t1242r1740b1305],
21	Pgp	NNP	O	Pgp	nn	23	SENT_221	[p13l1775t1244r1911b1323],
22	transport	NN	O	transport	nn	23	SENT_221	[p13l1946t1252r2147b1305, p13l7t1363r152b1434],
23	activity	NN	O	activity	prep_for	18	SENT_221	[p13l187t1353r452b1434],
24	in	IN	O	in	mark	29	SENT_221	[p13l488t1353r555b1415],
25	the	DT	O	the	det	28	SENT_221	[p13l589t1353r696b1416],
26	treated	VBN	O	treat	amod	28	SENT_221	[p13l732t1353r975b1416],
27	LSl8O	NN	O	lsl8o	nn	28	SENT_221	[p13l1008t1354r1245b1416],
28	cells	NNS	O	cell	nsubj	29	SENT_221	[p13l1281t1353r1440b1416],
29	[	VBP	O	[	advcl	18	SENT_221	[p13l1484t1354r1642b1429],
30	11	CD	NUMBER	11	num	31	SENT_221	[p13l1484t1354r1642b1429],
31	]	CD	NUMBER	]	dobj	29	SENT_221	[p13l1484t1354r1642b1429],
32	.	.	O	.	_	0	SENT_221	[p13l1484t1354r1642b1429],

1	As	IN	O	as	mark	2	SENT_222	[p13l1682t1354r1777b1416],
2	shown	VBN	O	show	_	0	SENT_222	[p13l1817t1353r2046b1416],
3	in	IN	O	in	_	0	SENT_222	[p13l2082t1353r2149b1415],
4	Fig	NN	O	fig	prep_in	2	SENT_222	[p13l8t1464r143b1545],
5	.	.	O	.	_	0	SENT_222	[p13l8t1464r143b1545],

1	4	CD	NUMBER	4	nsubj	6	SENT_223	[p13l173t1465r235b1538],
2	,	,	O	,	_	0	SENT_223	[p13l173t1465r235b1538],
3	rhodamine	NN	O	rhodamine	appos	1	SENT_223	[p13l269t1464r652b1527],
4	123	CD	NUMBER	123	num	5	SENT_223	[p13l692t1465r811b1527],
5	accumulation	NN	O	accumulation	dep	3	SENT_223	[p13l848t1464r1330b1527],
6	corresponds	VBZ	O	correspond	_	0	SENT_223	[p13l1361t1464r1790b1545],
7	with	IN	O	with	_	0	SENT_223	[p13l1824t1464r1983b1527],
8	Pgp	NN	ORGANIZATION	pgp	nn	11	SENT_223	[p13l2013t1466r2150b1545],
9	protein	NN	O	protein	nn	11	SENT_223	[p13l7t1575r260b1656],
10	expression	NN	O	expression	nn	11	SENT_223	[p13l294t1575r675b1656],
11	data	NNS	O	datum	prep_with	6	SENT_223	[p13l709t1575r876b1649],
12	;	:	O	;	_	0	SENT_223	[p13l709t1575r876b1649],
13	low	JJ	O	low	amod	15	SENT_223	[p13l912t1575r1044b1638],
14	cellular	JJ	O	cellular	amod	15	SENT_223	[p13l1078t1575r1348b1638],
15	rhodamine	NN	O	rhodamine	nsubjpass	19	SENT_223	[p13l1377t1575r1760b1638],
16	123	CD	NUMBER	123	num	17	SENT_223	[p13l1801t1576r1920b1638],
17	accumulation	NN	O	accumulation	dep	15	SENT_223	[p13l1959t1595r2147b1638, p13l8t1685r326b1748],
18	was	VBD	O	be	auxpass	19	SENT_223	[p13l350t1705r485b1748],
19	observed	VBN	O	observe	parataxis	6	SENT_223	[p13l512t1685r833b1748],
20	for	IN	O	for	_	0	SENT_223	[p13l856t1685r959b1748],
21	paclitaxel	NN	O	paclitaxel	prep_for	19	SENT_223	[p13l980t1685r1348b1766],
22	,	,	O	,	_	0	SENT_223	[p13l980t1685r1348b1766],
23	docetaxel	NN	O	docetaxel	conj_and	21	SENT_223	[p13l1376t1685r1718b1748],
24	and	CC	O	and	_	0	SENT_223	[p13l1743t1685r1869b1748],
25	ﬂutamide	NN	O	ﬂutamide	conj_and	21	SENT_223	[p13l1893t1682r2147b1748, p13l8t1797r135b1871],
26	,	,	O	,	_	0	SENT_223	[p13l1893t1682r2147b1748, p13l8t1797r135b1871],
27	which	WDT	O	which	nsubjpass	29	SENT_223	[p13l175t1797r393b1860],
28	were	VBD	O	be	auxpass	29	SENT_223	[p13l429t1817r599b1860],
29	shown	VBN	O	show	rcmod	21	SENT_223	[p13l640t1797r869b1860],
30	to	TO	O	to	aux	31	SENT_223	[p13l904t1807r971b1860],
31	induce	VB	O	induce	xcomp	29	SENT_223	[p13l1008t1797r1245b1860],
32	Pgp	NN	O	pgp	nn	34	SENT_223	[p13l1282t1799r1418b1878],
33	protein	NN	O	protein	nn	34	SENT_223	[p13l1454t1797r1708b1878],
34	expression	NN	O	expression	dobj	31	SENT_223	[p13l1745t1797r2146b1878],
35	,	,	O	,	_	0	SENT_223	[p13l1745t1797r2146b1878],

1	_	NN	O	_	_	0	SENT_224	[p13l483t1953r491b1973],
2	;	:	O	;	_	0	SENT_224	[p13l483t1953r491b1973],
3	l	NN	O	l	nn	6	SENT_224	[p13l505t1953r519b1973],
4	\	CD	NUMBER	\	num	6	SENT_224	[p13l505t1953r519b1973],
5	J	NN	O	j	nn	6	SENT_224	[p13l505t1953r519b1973],
6	_	NN	O	_	dep	1	SENT_224	[p13l483t2029r491b2049],
7	.	.	O	.	_	0	SENT_224	[p13l483t2029r491b2049],
8	"	''	O	"	punct	1	SENT_224	[p13l499t2029r519b2049],

1	o	NN	O	o	nn	2	SENT_225	[p13l499t2029r519b2049],
2	P	NN	O	p	_	0	SENT_225	[p13l482t2106r502b2126],
3	on	IN	O	on	_	0	SENT_225	[p13l505t2106r519b2126],
4	S3	NN	O	s3	nn	5	SENT_225	[p13l482t2257r502b2278],
5	A	NN	O	a	prep_on	2	SENT_225	[p13l505t2257r519b2277],

1	relative	JJ	O	relative	amod	3	SENT_226	[p13l435t2327r460b2430],
2	rhodamine	NN	O	rhodamine	nn	3	SENT_226	[p13l435t2160r460b2314],
3	accumulation	NN	O	accumulation	_	0	SENT_226	[p13l435t1956r460b2149],
4	5	CD	NUMBER	5	dep	3	SENT_226	[p13l482t2334r502b2355],
5	:	:	O	:	_	0	SENT_226	[p13l482t2334r502b2355],
6	)	CD	NUMBER	)	num	7	SENT_226	[p13l482t2334r502b2355],
7	C	NN	O	c	dep	3	SENT_226	[p13l482t2181r495b2202],
8	)	CD	NUMBER	)	number	9	SENT_226	[p13l482t2181r495b2202],
9	|	CD	NUMBER	|	num	10	SENT_226	[p13l505t2334r519b2355],
10	\	NN	O	\	dep	7	SENT_226	[p13l505t2334r519b2355],
11	)	CD	NUMBER	)	number	12	SENT_226	[p13l505t2334r519b2355],
12	03	CD	NUMBER	03	dep	3	SENT_226	[p13l505t2181r519b2202],
13	P	NN	O	p	nn	14	SENT_226	[p13l482t2410r502b2430],
14	o	NN	O	o	dep	12	SENT_226	[p13l505t2410r519b2430],

1	U	NNP	O	U	nn	2	SENT_227	[p13l579t2460r601b2478],
2	E	NNP	O	E	_	0	SENT_227	[p13l579t2481r601b2502],
3	(	NN	O	(	nn	11	SENT_227	[p13l579t2505r601b2522],
4	D	NN	O	d	nn	11	SENT_227	[p13l579t2505r601b2522],
5	O	NN	O	o	nn	11	SENT_227	[p13l579t2524r601b2545],
6	epgsodoie	NN	O	epgsodoie	nn	11	SENT_227	[p13l672t2459r699b2584],
7	ug1e	NN	O	ug1e	nn	11	SENT_227	[p13l772t2459r799b2599],
8	|	CD	NUMBER	|	num	11	SENT_227	[p13l772t2459r799b2599],
9	doqJeo	NN	O	doqjeo	nn	11	SENT_227	[p13l772t2459r799b2599],
10	eunsuouyx	NN	O	eunsuouyx	nn	11	SENT_227	[p13l876t2458r898b2587],
11	eu	NN	O	eu	dep	2	SENT_227	[p13l974t2458r996b2594],
12	!	.	O	!	_	0	SENT_227	[p13l974t2458r996b2594],

1	1se	JJ	O	1se	amod	5	SENT_228	[p13l974t2458r996b2594],
2	|	NN	O	|	nn	5	SENT_228	[p13l974t2458r996b2594],
3	qugA	NN	O	quga	nn	5	SENT_228	[p13l974t2458r996b2594],
4	ueuxowei	NN	O	ueuxoweus	nn	5	SENT_228	[p13l1072t2458r1094b2581],
5	epguieudoudolo	NN	O	epguieudoudolo	_	0	SENT_228	[p13l1167t2459r1195b2684],
6	/	:	O	/	punct	8	SENT_228	[p13l1167t2459r1195b2684],
7	(	CD	NUMBER	(	num	8	SENT_228	[p13l1167t2459r1195b2684],
8	o	NN	O	o	dep	5	SENT_228	[p13l1167t2459r1195b2684],

1	|	NN	O	|	_	0	SENT_229	[p13l1271t2459r1293b2580],
2	exe1eoop	NN	O	exe1eoop	nn	3	SENT_229	[p13l1271t2459r1293b2580],
3	epIu	NN	O	epiu	dep	1	SENT_229	[p13l1369t2458r1391b2575],
4	.	.	O	.	_	0	SENT_229	[p13l1369t2458r1391b2575],

1	ne1n	NN	O	ne1n	nn	2	SENT_230	[p13l1369t2458r1391b2575],
2	|	NN	O	|	_	0	SENT_230	[p13l1369t2458r1391b2575],
3	;	:	O	;	_	0	SENT_230	[p13l1369t2458r1391b2575],
4	9P	NN	O	9p	dep	2	SENT_230	[p13l1467t2460r1489b2588],
5	!	.	O	!	_	0	SENT_230	[p13l1467t2460r1489b2588],

1	UJ9JS0J	NN	O	uj9js0j	_	0	SENT_231	[p13l1467t2460r1489b2588],
2	!	.	O	!	_	0	SENT_231	[p13l1467t2460r1489b2588],

1	|	NN	O	|	nn	2	SENT_232	[p13l1562t2459r1590b2577],
2	eXe1I	NN	O	exe1us	nsubj	4	SENT_232	[p13l1562t2459r1590b2577],
3	|	CD	NUMBER	|	dep	2	SENT_232	[p13l1562t2459r1590b2577],
4	oed	VBD	O	oe	_	0	SENT_232	[p13l1562t2459r1590b2577],
5	uI3	NN	O	ui3	nn	7	SENT_232	[p13l1660t2460r1688b2581],
6	|	CD	NUMBER	|	num	7	SENT_232	[p13l1660t2460r1688b2581],
7	dUJ9	NN	O	duj9	dobj	4	SENT_232	[p13l1660t2460r1688b2581],
8	;	:	O	;	_	0	SENT_232	[p13l1660t2460r1688b2581],
9	l.I	NN	O	l.i	dep	7	SENT_232	[p13l1660t2460r1688b2581],

1	Fig	NN	O	fig	_	0	SENT_233	[p13l52t2726r108b2758],
2	.	.	O	.	_	0	SENT_233	[p13l52t2726r108b2758],

1	4	LS	NUMBER	4	dep	5	SENT_234	[p13l119t2726r136b2751],
2	Anticancer	NN	O	anticancer	nn	5	SENT_234	[p13l161t2726r316b2751],
3	drug	NN	O	drug	nn	5	SENT_234	[p13l328t2726r390b2758],
4	pretreatment	NN	O	pretreatment	nn	5	SENT_234	[p13l403t2730r582b2758],
5	aﬂects	NNS	O	aﬂects	_	0	SENT_234	[p13l594t2725r682b2751],
6	Pgp	NNP	O	Pgp	nn	8	SENT_234	[p13l694t2727r748b2758],
7	substrate	NN	O	substrate	nn	8	SENT_234	[p13l762t2726r885b2751],
8	accumula	NN	O	accumulum	dep	5	SENT_234	[p13l898t2726r1043b2751],
9	-	:	O	-	_	0	SENT_234	[p13l898t2726r1043b2751],
10	of	IN	O	of	_	0	SENT_234	[p13l1116t2726r1146b2751],
11	intracellular	JJ	O	intracellular	amod	14	SENT_234	[p13l1153t2726r1324b2751],
12	rhodamine	NN	O	rhodamine	nn	14	SENT_234	[p13l1332t2726r1482b2751],
13	123	CD	NUMBER	123	num	14	SENT_234	[p13l1495t2726r1542b2751],
14	ﬂuorescence	NN	O	ﬂuorescence	prep_of	8	SENT_234	[p13l1554t2725r1729b2751],
15	in	IN	O	in	_	0	SENT_234	[p13l1738t2726r1765b2751],
16	the	DT	O	the	det	20	SENT_234	[p13l1774t2726r1816b2751],
17	absence	NN	O	absence	nn	20	SENT_234	[p13l1826t2726r1936b2751],
18	or	CC	O	or	_	0	SENT_234	[p13l1946t2734r1975b2751],
19	presence	NN	O	presence	nn	20	SENT_234	[p13l1983t2734r2106b2758],
20	tion	NN	O	tion	prep_in	5	SENT_234	[p13l52t2767r113b2792],
21	.	.	O	.	_	0	SENT_234	[p13l52t2767r113b2792],

1	LS180	NN	O	ls180	nn	2	SENT_235	[p13l128t2767r221b2792],
2	cells	NNS	O	cell	nsubjpass	4	SENT_235	[p13l235t2767r297b2792],
3	were	VBD	O	be	auxpass	4	SENT_235	[p13l311t2775r378b2792],
4	exposed	VBN	O	expose	_	0	SENT_235	[p13l392t2767r507b2799],
5	to	TO	O	to	_	0	SENT_235	[p13l519t2771r546b2792],
6	the	DT	O	the	det	9	SENT_235	[p13l559t2767r601b2792],
7	indicated	VBN	O	indicate	amod	9	SENT_235	[p13l614t2767r743b2792],
8	anticancer	JJ	O	anticancer	amod	9	SENT_235	[p13l756t2767r900b2792],
9	drugs	NNS	O	drug	prep_to	4	SENT_235	[p13l913t2767r989b2799],
10	for	IN	O	for	dep	9	SENT_235	[p13l1003t2767r1044b2792],
11	of	IN	O	of	_	0	SENT_235	[p13l1116t2767r1146b2792],
12	zosuquidar	NN	O	zosuquidar	prep_of	9	SENT_235	[p13l1157t2767r1311b2799],
13	is	VBZ	O	be	cop	14	SENT_235	[p13l1324t2767r1345b2792],
14	indicative	JJ	O	indicative	rcmod	12	SENT_235	[p13l1358t2767r1497b2792],
15	for	IN	O	for	_	0	SENT_235	[p13l1510t2767r1551b2792],
16	the	DT	O	the	det	17	SENT_235	[p13l1563t2767r1605b2792],
17	functionality	NN	O	functionality	prep_for	14	SENT_235	[p13l1618t2767r1797b2799],
18	of	IN	O	of	_	0	SENT_235	[p13l1811t2767r1841b2792],
19	Pgp	NNP	O	Pgp	prep_of	17	SENT_235	[p13l1851t2768r1912b2799],
20	.	.	O	.	_	0	SENT_235	[p13l1851t2768r1912b2799],

1	The	DT	O	the	det	2	SENT_236	[p13l1927t2767r1981b2792],
2	data	NNS	O	datum	nsubj	5	SENT_236	[p13l1994t2767r2052b2792],
3	are	VBP	O	be	cop	5	SENT_236	[p13l2065t2775r2106b2792],
4	48	CD	NUMBER	48	num	5	SENT_236	[p13l52t2808r85b2833],
5	h	NN	O	h	_	0	SENT_236	[p13l96t2808r121b2837],
6	,	,	O	,	_	0	SENT_236	[p13l96t2808r121b2837],
7	after	IN	O	after	_	0	SENT_236	[p13l134t2808r197b2833],
8	which	WDT	O	which	rel	13	SENT_236	[p13l208t2808r294b2833],
9	rhodamine	NN	O	rhodamine	nsubjpass	13	SENT_236	[p13l304t2808r454b2833],
10	123	CD	NUMBER	123	num	11	SENT_236	[p13l469t2808r516b2833],
11	accumulation	NN	O	accumulation	dep	9	SENT_236	[p13l530t2808r718b2833],
12	was	VBD	O	be	auxpass	13	SENT_236	[p13l729t2816r783b2833],
13	determined	VBN	O	determine	rcmod	5	SENT_236	[p13l795t2808r953b2833],
14	in	IN	O	in	_	0	SENT_236	[p13l964t2808r990b2833],
15	the	DT	O	the	prep_in	13	SENT_236	[p13l1001t2808r1043b2833],
16	normalized	VBN	O	normalize	dep	15	SENT_236	[p13l1115t2808r1274b2833],
17	to	TO	O	to	_	0	SENT_236	[p13l1290t2812r1316b2833],
18	the	DT	O	the	det	20	SENT_236	[p13l1332t2808r1374b2833],
19	DMSO	NN	ORGANIZATION	dmso	nn	20	SENT_236	[p13l1390t2808r1491b2833],
20	controls	NNS	O	control	prep_to	16	SENT_236	[p13l1508t2808r1620b2833],
21	and	CC	O	and	_	0	SENT_236	[p13l1638t2808r1687b2833],
22	are	VBP	O	be	auxpass	23	SENT_236	[p13l1704t2816r1745b2833],
23	presented	VBN	O	present	conj_and	16	SENT_236	[p13l1761t2808r1896b2840],
24	as	IN	O	as	_	0	SENT_236	[p13l1913t2816r1940b2833],
25	mean	JJ	O	mean	amod	26	SENT_236	[p13l1957t2816r2032b2833],
26	data	NNS	O	datum	prep_as	23	SENT_236	[p13l2049t2808r2107b2833],
27	absence	NN	O	absence	dobj	16	SENT_236	[p13l53t2850r163b2875],
28	or	CC	O	or	_	0	SENT_236	[p13l173t2858r202b2875],
29	presence	NN	O	presence	dobj	16	SENT_236	[p13l209t2858r333b2882],
30	of	IN	O	of	_	0	SENT_236	[p13l342t2850r373b2875],
31	the	DT	O	the	det	34	SENT_236	[p13l379t2850r421b2875],
32	Pgp-speciﬁc	JJ	MISC	pgp-speciﬁc	amod	34	SENT_236	[p13l431t2849r604b2882],
33	inhibitor	NN	O	inhibitor	nn	34	SENT_236	[p13l614t2850r736b2875],
34	zosuquidar	NN	O	zosuquidar	prep_of	27	SENT_236	[p13l745t2850r906b2882],
35	.	.	O	.	_	0	SENT_236	[p13l745t2850r906b2882],

1	The	DT	O	the	det	2	SENT_237	[p13l917t2850r971b2875],
2	ratio	NN	O	ratio	dep	13	SENT_237	[p13l980t2850r1044b2875],
3	(	CD	NUMBER	(	num	5	SENT_237	[p13l1116t2850r1210b2881],
4	:	:	O	:	_	0	SENT_237	[p13l1116t2850r1210b2881],
5	|	CD	NUMBER	|	dep	2	SENT_237	[p13l1116t2850r1210b2881],
6	:	:	O	:	_	0	SENT_237	[p13l1116t2850r1210b2881],
7	SD	NN	O	sd	nn	8	SENT_237	[p13l1116t2850r1210b2881],
8	)	NN	O	)	dep	2	SENT_237	[p13l1116t2850r1210b2881],
9	of	IN	O	of	_	0	SENT_237	[p13l1221t2850r1252b2875],
10	three	CD	NUMBER	three	num	12	SENT_237	[p13l1259t2850r1328b2875],
11	different	JJ	O	different	amod	12	SENT_237	[p13l1339t2849r1456b2875],
12	experiments	NNS	O	experiment	prep_of	8	SENT_237	[p13l1466t2850r1637b2882],
13	(	VBP	O	(	_	0	SENT_237	[p13l1648t2850r1698b2881],
14	*	CD	NUMBER	*	num	15	SENT_237	[p13l1648t2850r1698b2881],
15	P	NN	O	p	nsubj	16	SENT_237	[p13l1648t2850r1698b2881],
16	<	JJR	O	<	xcomp	13	SENT_237	[p13l1708t2856r1726b2875],
17	0.05	CD	NUMBER	0.05	num	18	SENT_237	[p13l1737t2850r1808b2881],
18	)	NN	O	)	nsubj	13	SENT_237	[p13l1737t2850r1808b2881],

1	‘	NN	O	‘	_	0	SENT_238	[p13l1931t2957r1968b3002],
2	E	NN	O	e	nn	3	SENT_238	[p13l1931t2957r1968b3002],
3	Springer	NN	PERSON	springer	dep	1	SENT_238	[p13l1981t2968r2103b3003],

1	770	CD	NUMBER	770	num	4	SENT_239	[p13l52t3078r104b3103],
2	Cancer	NN	O	cancer	nn	4	SENT_239	[p13l1400t3078r1500b3103],
3	Chemother	NN	PERSON	chemother	nn	4	SENT_239	[p13l1509t3078r1666b3103],
4	Pharmacol	NN	PERSON	pharmacol	_	0	SENT_239	[p13l1675t3078r1826b3103],
5	(	CD	NUMBER	(	num	6	SENT_239	[p13l1836t3078r1928b3108],
6	2010	CD	DATE	2010	dep	4	SENT_239	[p13l1836t3078r1928b3108],
7	)	CD	NUMBER	)	number	8	SENT_239	[p13l1836t3078r1928b3108],
8	66:765	CD	NUMBER	66:765	num	9	SENT_239	[p13l1939t3078r2104b3103],
9	—	NN	O	—	dep	6	SENT_239	[p13l1939t3078r2104b3103],
10	771	CD	NUMBER	771	dep	4	SENT_239	[p13l1939t3078r2104b3103],

1	while	IN	O	while	_	0	SENT_240	[p13l9t3247r206b3310],
2	etoposide	NN	O	etoposide	prep_while	7	SENT_240	[p13l246t3247r586b3328],
3	and	CC	O	and	_	0	SENT_240	[p13l628t3247r753b3310],
4	carboplatin	NN	O	carboplatin	prep_while	7	SENT_240	[p13l793t3247r1194b3328],
5	did	VBD	O	do	aux	7	SENT_240	[p13l1233t3247r1345b3310],
6	not	RB	O	not	neg	7	SENT_240	[p13l1383t3257r1497b3310],
7	affect	VB	O	affect	_	0	SENT_240	[p13l1536t3245r1728b3310],
8	rhodamine	NN	O	rhodamine	dobj	7	SENT_240	[p13l1766t3247r2147b3310],
9	123	CD	NUMBER	123	num	10	SENT_240	[p13l18t3360r136b3422],
10	accumulation	NN	O	accumulation	nsubj	7	SENT_240	[p13l175t3359r674b3421],
11	.	.	O	.	_	0	SENT_240	[p13l175t3359r674b3421],

1	In	IN	O	in	_	0	SENT_241	[p13l711t3361r784b3420],
2	contrast	NN	O	contrast	prep_in	27	SENT_241	[p13l818t3369r1118b3433],
3	,	,	O	,	_	0	SENT_241	[p13l818t3369r1118b3433],
4	the	DT	O	the	det	5	SENT_241	[p13l1154t3359r1261b3421],
5	accumulation	NN	O	accumulation	nsubj	27	SENT_241	[p13l1297t3359r1778b3421],
6	of	IN	O	of	_	0	SENT_241	[p13l1811t3359r1889b3421],
7	rhodamine	NN	O	rhodamine	prep_of	5	SENT_241	[p13l1914t3359r2145b3421, p13l9t3470r186b3533],
8	123	CD	NUMBER	123	num	7	SENT_241	[p13l221t3471r341b3533],
9	in	IN	O	in	_	0	SENT_241	[p13l372t3470r440b3532],
10	the	DT	O	the	det	11	SENT_241	[p13l466t3470r573b3533],
11	cells	NNS	O	cell	prep_in	7	SENT_241	[p13l602t3470r761b3533],
12	that	WDT	O	that	nsubjpass	14	SENT_241	[p13l790t3470r924b3533],
13	were	VBD	O	be	auxpass	14	SENT_241	[p13l950t3490r1121b3533],
14	treated	VBN	O	treat	rcmod	11	SENT_241	[p13l1148t3470r1390b3533],
15	with	IN	O	with	_	0	SENT_241	[p13l1417t3470r1574b3533],
16	the	DT	O	the	det	18	SENT_241	[p13l1601t3470r1708b3533],
17	Vinca	NNP	LOCATION	Vinca	nn	18	SENT_241	[p13l1741t3473r1941b3534],
18	alkaloids	NNS	O	alkaloid	prep_with	14	SENT_241	[p13l1972t3470r2144b3533, p13l9t3582r200b3656],
19	,	,	O	,	_	0	SENT_241	[p13l1972t3470r2144b3533, p13l9t3582r200b3656],
20	cyclophosphamide	NN	O	cyclophosphamide	appos	18	SENT_241	[p13l230t3582r920b3663],
21	,	,	O	,	_	0	SENT_241	[p13l230t3582r920b3663],
22	ifosfamide	NN	O	ifosfamide	appos	18	SENT_241	[p13l949t3582r1329b3645],
23	and	CC	O	and	_	0	SENT_241	[p13l1358t3582r1485b3645],
24	tamoxifen	NN	O	tamoxifen	conj_and	20	SENT_241	[p13l1509t3582r1872b3645],
25	did	VBD	O	do	aux	27	SENT_241	[p13l1898t3582r2010b3645],
26	not	RB	O	not	neg	27	SENT_241	[p13l2035t3591r2149b3645],
27	correspond	VB	O	correspond	_	0	SENT_241	[p13l10t3693r406b3774],
28	with	IN	O	with	_	0	SENT_241	[p13l431t3693r588b3756],
29	Pgp	NN	ORGANIZATION	pgp	nn	31	SENT_241	[p13l613t3695r749b3774],
30	protein	NN	O	protein	nn	31	SENT_241	[p13l774t3693r1028b3774],
31	expression	NN	O	expression	prep_with	27	SENT_241	[p13l1053t3693r1451b3774],
32	.	.	O	.	_	0	SENT_241	[p13l1053t3693r1451b3774],

1	Effect	NN	O	effect	_	0	SENT_242	[p14l9t119r217b184],
2	of	IN	O	of	_	0	SENT_242	[p14l242t121r319b184],
3	PXR	NN	O	pxr	nn	4	SENT_242	[p14l338t123r511b183],
4	activation	NN	O	activation	prep_of	1	SENT_242	[p14l537t121r887b184],
5	on	IN	O	on	_	0	SENT_242	[p14l913t141r999b184],
6	doxorubicin	NN	O	doxorubicin	nn	7	SENT_242	[p14l1025t121r1456b184],
7	cytotoxicity	NN	O	cytotoxicity	prep_on	1	SENT_242	[p14l1482t121r1907b202],

1	To	TO	O	to	aux	2	SENT_243	[p14l9t347r104b408],
2	study	VB	O	study	purpcl	29	SENT_243	[p14l135t345r322b426],
3	whether	IN	O	whether	complm	7	SENT_243	[p14l350t345r635b408],
4	activation	NN	O	activation	nsubj	7	SENT_243	[p14l661t345r1006b408],
5	of	IN	O	of	_	0	SENT_243	[p14l1034t345r1111b408],
6	PXR	NN	O	pxr	prep_of	4	SENT_243	[p14l1132t347r1302b407],
7	affects	VBZ	O	affect	ccomp	2	SENT_243	[p14l1330t343r1551b408],
8	the	DT	O	the	det	9	SENT_243	[p14l1580t345r1686b408],
9	efficacy	NN	O	efficacy	dobj	7	SENT_243	[p14l1714t343r1983b426],
10	of	IN	O	of	_	0	SENT_243	[p14l2012t345r2089b408],
11	a	DT	O	a	det	14	SENT_243	[p14l2112t365r2149b408],
12	cytotoxic	JJ	O	cytotoxic	amod	14	SENT_243	[p14l10t456r334b537],
13	Pgp	NN	O	pgp	nn	14	SENT_243	[p14l365t458r500b537],
14	substrate	NN	O	substrate	prep_of	9	SENT_243	[p14l534t456r861b530],
15	,	,	O	,	_	0	SENT_243	[p14l534t456r861b530],
16	the	DT	O	the	det	17	SENT_243	[p14l893t456r999b519],
17	effect	NN	O	effect	nsubjpass	29	SENT_243	[p14l1030t454r1220b519],
18	of	IN	O	of	_	0	SENT_243	[p14l1249t456r1325b519],
19	PXR	NN	O	pxr	nn	20	SENT_243	[p14l1349t458r1520b518],
20	activation	NN	O	activation	prep_of	17	SENT_243	[p14l1552t456r1895b519],
21	on	IN	O	on	_	0	SENT_243	[p14l1925t476r2012b519],
22	the	DT	O	the	det	23	SENT_243	[p14l2041t456r2147b519],
23	cytotoxicity	NN	O	cytotoxicity	prep_on	20	SENT_243	[p14l10t568r428b649],
24	of	IN	O	of	_	0	SENT_243	[p14l463t568r539b631],
25	doxorubicin	NN	O	doxorubicin	prep_of	23	SENT_243	[p14l567t568r992b631],
26	in	IN	O	in	_	0	SENT_243	[p14l1024t568r1091b630],
27	LS180	NN	O	ls180	prep_in	25	SENT_243	[p14l1123t569r1358b631],
28	was	VBD	O	be	auxpass	29	SENT_243	[p14l1391t588r1524b631],
29	assessed	VBN	O	assess	_	0	SENT_243	[p14l1561t568r1874b631],
30	.	.	O	.	_	0	SENT_243	[p14l1561t568r1874b631],

1	Therefore	RB	O	therefore	advmod	11	SENT_244	[p14l1911t568r2144b631, p14l9t679r169b753],
2	,	,	O	,	_	0	SENT_244	[p14l1911t568r2144b631, p14l9t679r169b753],
3	prior	RB	O	prior	_	0	SENT_244	[p14l204t679r377b760],
4	to	TO	O	to	_	0	SENT_244	[p14l409t689r475b742],
5	doxorubicin	NN	O	doxorubicin	nn	6	SENT_244	[p14l510t679r935b742],
6	exposure	NN	O	exposure	prep_prior_to	11	SENT_244	[p14l969t699r1304b760],
7	,	,	O	,	_	0	SENT_244	[p14l969t699r1304b760],
8	LS180	NN	O	ls180	nn	9	SENT_244	[p14l1340t680r1575b742],
9	cells	NNS	O	cell	nsubjpass	11	SENT_244	[p14l1609t679r1767b742],
10	were	VBD	O	be	auxpass	11	SENT_244	[p14l1803t699r1972b742],
11	pretreated	VBN	O	pretreat	_	0	SENT_244	[p14l2006t699r2145b760, p14l9t790r248b853],
12	with	IN	O	with	_	0	SENT_244	[p14l276t790r431b853],
13	the	DT	O	the	det	19	SENT_244	[p14l458t790r564b853],
14	prototypical	JJ	O	prototypical	amod	19	SENT_244	[p14l589t790r1014b871],
15	PXR	NN	O	pxr	nn	19	SENT_244	[p14l1042t792r1213b852],
16	agonist	NN	O	agonist	nn	19	SENT_244	[p14l1240t790r1493b871],
17	10	CD	NUMBER	10	num	19	SENT_244	[p14l1527t791r1605b853],
18	uM	NN	O	um	nn	19	SENT_244	[p14l1633t792r1755b870],
19	rifampicin	NN	O	rifampicin	prep_with	11	SENT_244	[p14l1782t790r2148b871],
20	or	CC	O	or	_	0	SENT_244	[p14l10t921r82b964],
21	0.1	CD	PERCENT	0.1	number	22	SENT_244	[p14l109t902r287b964],
22	%	NN	PERCENT	%	amod	26	SENT_244	[p14l109t902r287b964],
23	DMSO	NN	O	dmso	npadvmod	25	SENT_244	[p14l317t902r571b964],
24	(	CD	NUMBER	(	num	23	SENT_244	[p14l602t901r909b979],
25	solvent	JJ	O	solvent	amod	26	SENT_244	[p14l602t901r909b979],
26	)	NN	O	)	prep_with	11	SENT_244	[p14l602t901r909b979],
27	for	IN	O	for	_	0	SENT_244	[p14l939t901r1042b964],
28	48	CD	NUMBER	48	num	29	SENT_244	[p14l1067t902r1150b964],
29	h.	NN	O	h.	prep_for	26	SENT_244	[p14l1178t901r1238b964],
30	As	IN	O	as	mark	31	SENT_244	[p14l1270t902r1364b964],
31	shown	VBN	O	show	dep	11	SENT_244	[p14l1396t901r1623b964],
32	in	IN	O	in	_	0	SENT_244	[p14l1649t901r1717b963],
33	Fig	NN	O	fig	prep_in	31	SENT_244	[p14l1744t901r1877b982],
34	.	.	O	.	_	0	SENT_244	[p14l1744t901r1877b982],

1	5a	NN	O	5a	nn	4	SENT_245	[p14l1907t901r2006b975],
2	,	,	O	,	_	0	SENT_245	[p14l1907t901r2006b975],
3	rifampicin	NN	O	rifampicin	dep	4	SENT_245	[p14l2036t901r2144b963, p14l11t1011r292b1092],
4	pretreatment	NN	O	pretreatment	nsubj	5	SENT_245	[p14l328t1021r775b1092],
5	affects	VBZ	O	affect	_	0	SENT_245	[p14l812t1009r1031b1074],
6	the	DT	O	the	det	8	SENT_245	[p14l1070t1011r1175b1074],
7	intracellular	JJ	O	intracellular	amod	8	SENT_245	[p14l1213t1011r1638b1074],
8	accumulation	NN	O	accumulation	dobj	5	SENT_245	[p14l1675t1011r2146b1074],
9	of	IN	O	of	_	0	SENT_245	[p14l10t1123r87b1186],
10	doxorubicin	NN	O	doxorubicin	prep_of	8	SENT_245	[p14l104t1123r545b1186],
11	.	.	O	.	_	0	SENT_245	[p14l104t1123r545b1186],

1	To	TO	O	to	aux	2	SENT_246	[p14l572t1125r668b1186],
2	determine	VB	O	determine	_	0	SENT_246	[p14l693t1123r1042b1186],
3	whether	IN	O	whether	complm	9	SENT_246	[p14l1066t1123r1352b1186],
4	reduced	VBN	O	reduce	amod	5	SENT_246	[p14l1371t1123r1651b1186],
5	accumulation	NN	O	accumulation	nsubj	9	SENT_246	[p14l1675t1123r2147b1186],
6	of	IN	O	of	_	0	SENT_246	[p14l10t1234r87b1297],
7	doxorubicin	NN	O	doxorubicin	prep_of	5	SENT_246	[p14l104t1234r528b1297],
8	also	RB	O	also	advmod	9	SENT_246	[p14l552t1234r690b1297],
9	affects	VBZ	O	affect	ccomp	2	SENT_246	[p14l715t1232r936b1297],
10	the	DT	O	the	det	11	SENT_246	[p14l960t1234r1065b1297],
11	efficacy	NN	O	efficacy	dobj	9	SENT_246	[p14l1089t1232r1360b1315],
12	of	IN	O	of	_	0	SENT_246	[p14l1384t1234r1461b1297],
13	this	DT	O	this	det	14	SENT_246	[p14l1478t1234r1601b1297],
14	agent	NN	O	agent	prep_of	11	SENT_246	[p14l1628t1244r1834b1315],
15	,	,	O	,	_	0	SENT_246	[p14l1628t1244r1834b1315],
16	rifampicin	NN	O	rifampicin	appos	14	SENT_246	[p14l1859t1234r2144b1315, p14l10t1345r143b1408],
17	—	CD	NUMBER	—	num	16	SENT_246	[p14l1859t1234r2144b1315, p14l10t1345r143b1408],
18	or	CC	O	or	_	0	SENT_246	[p14l186t1365r258b1408],
19	solvent	JJ	O	solvent	appos	14	SENT_246	[p14l300t1345r576b1408],
20	-	:	O	-	_	0	SENT_246	[p14l300t1345r576b1408],
21	pretreated	JJ	O	pretreated	amod	22	SENT_246	[p14l617t1345r971b1426],
22	cells	NNS	O	cell	dep	2	SENT_246	[p14l1010t1345r1168b1408],
23	were	VBD	O	be	auxpass	24	SENT_246	[p14l1210t1365r1380b1408],
24	exposed	VBN	O	expose	rcmod	22	SENT_246	[p14l1422t1345r1709b1426],
25	to	TO	O	to	_	0	SENT_246	[p14l1749t1355r1814b1408],
26	different	JJ	O	different	amod	28	SENT_246	[p14l1857t1343r2149b1408],
27	doxorubicin	NN	O	doxorubicin	nn	28	SENT_246	[p14l10t1457r433b1520],
28	concentrations	NNS	O	concentration	prep_to	24	SENT_246	[p14l483t1457r994b1520],
29	(	VBP	O	(	rcmod	28	SENT_246	[p14l1048t1457r1341b1538],
30	ranging	VBG	O	range	xcomp	29	SENT_246	[p14l1048t1457r1341b1538],
31	from	IN	O	from	_	0	SENT_246	[p14l1392t1457r1563b1520],
32	0.3	CD	NUMBER	0.3	prep_from	30	SENT_246	[p14l1612t1458r1715b1520],
33	to	TO	NUMBER	to	_	0	SENT_246	[p14l1769t1467r1835b1520],
34	20	CD	NUMBER	20	num	35	SENT_246	[p14l1887t1458r1971b1520],
35	uM	NN	O	um	prep_to	30	SENT_246	[p14l2001t1459r2144b1537],
36	;	:	O	;	_	0	SENT_246	[p14l2001t1459r2144b1537],
37	dilution	NN	O	dilution	nn	38	SENT_246	[p14l10t1568r282b1631],
38	factor	NN	O	factor	dep	22	SENT_246	[p14l309t1568r514b1631],
39	2	CD	NUMBER	2	num	40	SENT_246	[p14l541t1569r628b1646],
40	)	NN	O	)	dep	38	SENT_246	[p14l541t1569r628b1646],
41	.	.	O	.	_	0	SENT_246	[p14l541t1569r628b1646],

1	As	IN	O	as	mark	2	SENT_247	[p14l661t1569r755b1631],
2	shown	VBN	O	show	_	0	SENT_247	[p14l787t1568r1013b1631],
3	in	IN	O	in	_	0	SENT_247	[p14l1041t1568r1107b1630],
4	Fig	NN	O	fig	prep_in	2	SENT_247	[p14l1135t1568r1268b1649],
5	.	.	O	.	_	0	SENT_247	[p14l1135t1568r1268b1649],

1	5b	NN	O	5b	nsubj	12	SENT_248	[p14l1298t1568r1402b1642],
2	,	,	O	,	_	0	SENT_248	[p14l1298t1568r1402b1642],
3	following	VBG	O	follow	_	0	SENT_248	[p14l1433t1568r1773b1649],
4	doxorubicin	NN	O	doxorubicin	nn	7	SENT_248	[p14l1801t1568r2144b1631, p14l10t1678r116b1741],
5	exposure	NN	O	exposure	nn	7	SENT_248	[p14l178t1698r494b1759],
6	cell	NN	O	cell	nn	7	SENT_248	[p14l557t1678r681b1741],
7	viability	NN	O	viability	prep_following	1	SENT_248	[p14l743t1678r1034b1759],
8	was	VBD	O	be	cop	12	SENT_248	[p14l1096t1698r1230b1741],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_248	[p14l1296t1676r1725b1759],
10	(	CD	NUMBER	(	num	11	SENT_248	[p14l1790t1679r1870b1755],
11	P	NN	O	p	npadvmod	12	SENT_248	[p14l1790t1679r1870b1755],
12	<	JJR	O	<	dep	22	SENT_248	[p14l1894t1694r1940b1740],
13	0.05	CD	NUMBER	0.05	num	14	SENT_248	[p14l1966t1678r2146b1756],
14	)	CD	NUMBER	)	npadvmod	15	SENT_248	[p14l1966t1678r2146b1756],
15	higher	JJR	O	higher	advmod	12	SENT_248	[p14l8t1790r235b1871],
16	in	IN	O	in	_	0	SENT_248	[p14l278t1790r346b1852],
17	the	DT	O	the	det	21	SENT_248	[p14l390t1790r496b1853],
18	rifampicin	NN	O	rifampicin	nn	21	SENT_248	[p14l542t1790r934b1871],
19	—	NN	O	—	nn	21	SENT_248	[p14l542t1790r934b1871],
20	pretreated	JJ	O	pretreated	amod	21	SENT_248	[p14l982t1790r1335b1871],
21	cells	NNS	O	cell	prep_in	12	SENT_248	[p14l1379t1790r1537b1853],
22	(	VBP	O	(	_	0	SENT_248	[p14l1588t1791r1763b1875],
23	IC50	NN	O	ic50	dobj	22	SENT_248	[p14l1588t1791r1763b1875],
24	=	JJ	O	=	advmod	22	SENT_248	[p14l1788t1817r1834b1841],
25	2.5	CD	NUMBER	2.5	num	27	SENT_248	[p14l1861t1790r1965b1853],
26	uM	NN	O	um	nn	27	SENT_248	[p14l1995t1791r2144b1870],
27	)	NN	O	)	dep	24	SENT_248	[p14l1995t1791r2144b1870],
28	compared	VBN	O	compare	_	0	SENT_248	[p14l10t1901r357b1982],
29	to	TO	O	to	prepc_compared_to	22	SENT_248	[p14l407t1911r473b1964],
30	the	DT	O	the	det	35	SENT_248	[p14l525t1901r630b1964],
31	solvent	JJ	O	solvent	amod	35	SENT_248	[p14l685t1901r937b1964],
32	(	NN	O	(	nn	35	SENT_248	[p14l989t1902r1194b1979],
33	0.1	CD	PERCENT	0.1	num	35	SENT_248	[p14l989t1902r1194b1979],
34	%	NN	PERCENT	%	nn	35	SENT_248	[p14l989t1902r1194b1979],
35	DMSO	NN	O	dmso	pobj	22	SENT_248	[p14l1249t1902r1532b1979],
36	)	CD	NUMBER	)	num	38	SENT_248	[p14l1249t1902r1532b1979],
37	pretreated	JJ	O	pretreated	amod	38	SENT_248	[p14l1584t1901r1937b1982],
38	cells	NNS	O	cell	nsubj	39	SENT_248	[p14l1988t1901r2144b1964],
39	(	VBP	O	(	rcmod	35	SENT_248	[p14l12t2013r188b2096],
40	IC50	NN	O	ic50	nsubj	41	SENT_248	[p14l12t2013r188b2096],
41	=	JJ	O	=	xcomp	39	SENT_248	[p14l213t2039r259b2063],
42	1.5	CD	NUMBER	1.5	num	44	SENT_248	[p14l293t2012r389b2075],
43	uM	NN	O	um	nn	44	SENT_248	[p14l420t2013r588b2092],
44	)	NN	O	)	nsubj	22	SENT_248	[p14l420t2013r588b2092],
45	.	.	O	.	_	0	SENT_248	[p14l420t2013r588b2092],

1	This	DT	O	this	nsubj	2	SENT_249	[p14l627t2012r780b2075],
2	indicates	VBZ	O	indicate	_	0	SENT_249	[p14l816t2012r1126b2075],
3	that	IN	O	that	complm	8	SENT_249	[p14l1163t2012r1295b2075],
4	PXR	NN	O	pxr	nn	5	SENT_249	[p14l1328t2014r1499b2074],
5	activation	NN	O	activation	nsubj	8	SENT_249	[p14l1535t2012r1878b2075],
6	indeed	RB	O	indeed	advmod	8	SENT_249	[p14l1912t2012r2148b2075],
7	can	MD	O	can	aux	8	SENT_249	[p14l10t2143r130b2186],
8	reduce	VB	O	reduce	ccomp	2	SENT_249	[p14l151t2123r386b2186],
9	the	DT	O	the	det	10	SENT_249	[p14l409t2123r515b2186],
10	activity	NN	O	activity	dobj	8	SENT_249	[p14l541t2123r801b2204],
11	of	IN	O	of	_	0	SENT_249	[p14l825t2123r903b2186],
12	cytotoxic	JJ	O	cytotoxic	amod	14	SENT_249	[p14l920t2123r1244b2204],
13	Pgp	NNP	O	Pgp	nn	14	SENT_249	[p14l1269t2125r1405b2204],
14	substrates	NNS	O	substrate	prep_of	10	SENT_249	[p14l1431t2123r1772b2186],
15	as	IN	O	as	_	0	SENT_249	[p14l1800t2143r1867b2186],
16	a	DT	O	a	det	17	SENT_249	[p14l1894t2143r1930b2186],
17	result	NN	O	result	prep_as	8	SENT_249	[p14l1951t2123r2149b2186],
18	of	IN	O	of	_	0	SENT_249	[p14l10t2234r86b2297],
19	decreased	VBN	O	decrease	amod	21	SENT_249	[p14l105t2234r452b2297],
20	intracellular	JJ	O	intracellular	amod	21	SENT_249	[p14l475t2234r901b2297],
21	accumulation	NN	O	accumulation	prep_of	17	SENT_249	[p14l926t2234r1414b2297],
22	.	.	O	.	_	0	SENT_249	[p14l926t2234r1414b2297],

1	Discussion	NN	O	discussion	_	0	SENT_250	[p14l9t2459r411b2523],

1	The	DT	O	the	det	2	SENT_251	[p14l9t2685r145b2748],
2	development	NN	O	development	nsubj	13	SENT_251	[p14l180t2685r642b2766],
3	of	IN	O	of	_	0	SENT_251	[p14l674t2685r752b2748],
4	MDR	NN	ORGANIZATION	mdr	prep_of	2	SENT_251	[p14l779t2687r981b2747],
5	in	IN	O	in	_	0	SENT_251	[p14l1014t2685r1081b2747],
6	response	NN	O	response	prep_in	4	SENT_251	[p14l1113t2705r1425b2766],
7	to	TO	O	to	_	0	SENT_251	[p14l1458t2695r1525b2748],
8	anticancer	JJ	O	anticancer	amod	9	SENT_251	[p14l1561t2685r1928b2748],
9	treatment	NN	O	treatment	prep_to	6	SENT_251	[p14l1959t2695r2144b2748, p14l9t2806r187b2859],
10	is	VBZ	O	be	cop	13	SENT_251	[p14l223t2796r278b2859],
11	a	DT	O	a	det	13	SENT_251	[p14l318t2816r355b2859],
12	major	JJ	O	major	amod	13	SENT_251	[p14l390t2796r598b2877],
13	problem	NN	O	problem	_	0	SENT_251	[p14l631t2796r931b2877],
14	in	IN	O	in	_	0	SENT_251	[p14l966t2796r1033b2858],
15	the	DT	O	the	det	16	SENT_251	[p14l1069t2796r1176b2859],
16	clinic	NN	O	clinic	prep_in	13	SENT_251	[p14l1214t2796r1428b2859],
17	.	.	O	.	_	0	SENT_251	[p14l1214t2796r1428b2859],

1	Since	IN	O	since	mark	6	SENT_252	[p14l1471t2796r1665b2859],
2	induction	NN	O	induction	nsubj	6	SENT_252	[p14l1701t2796r2039b2859],
3	of	IN	O	of	_	0	SENT_252	[p14l2076t2796r2153b2859],
4	Pgp	NNP	ORGANIZATION	Pgp	prep_of	2	SENT_252	[p14l9t2909r145b2988],
5	is	VBZ	O	be	cop	6	SENT_252	[p14l187t2907r242b2970],
6	one	CD	NUMBER	one	advcl	16	SENT_252	[p14l287t2927r412b2970],
7	of	IN	O	of	_	0	SENT_252	[p14l454t2907r531b2970],
8	the	DT	O	the	det	10	SENT_252	[p14l565t2907r672b2970],
9	main	JJ	O	main	amod	10	SENT_252	[p14l714t2907r891b2970],
10	mechanisms	NNS	O	mechanism	prep_of	6	SENT_252	[p14l931t2907r1370b2970],
11	underlying	VBG	O	underlie	partmod	10	SENT_252	[p14l1412t2907r1798b2988],
12	acquired	VBN	O	acquire	dep	11	SENT_252	[p14l1842t2907r2147b2988],
13	MDR	NNP	ORGANIZATION	MDR	dobj	12	SENT_252	[p14l9t3020r231b3092],
14	,	,	O	,	_	0	SENT_252	[p14l9t3020r231b3092],
15	we	PRP	O	we	nsubj	16	SENT_252	[p14l257t3038r358b3081],
16	evaluated	VBD	O	evaluate	dep	24	SENT_252	[p14l382t3018r724b3081],
17	whether	IN	O	whether	complm	20	SENT_252	[p14l746t3018r1035b3081],
18	several	JJ	O	several	nsubj	20	SENT_252	[p14l1058t3018r1306b3081],
19	widely	RB	O	widely	advmod	20	SENT_252	[p14l1330t3018r1571b3099],
20	used	VBN	O	use	ccomp	16	SENT_252	[p14l1594t3018r1758b3081],
21	anticancer	JJ	O	anticancer	amod	22	SENT_252	[p14l1781t3018r2148b3081],
22	drugs	NNS	O	drug	dobj	20	SENT_252	[p14l10t3129r204b3210],
23	can	MD	O	can	aux	24	SENT_252	[p14l240t3149r361b3192],
24	induce	VB	O	induce	_	0	SENT_252	[p14l395t3129r631b3192],
25	Pgp	NN	O	pgp	nn	26	SENT_252	[p14l665t3131r801b3210],
26	expression	NN	O	expression	dobj	24	SENT_252	[p14l836t3129r1217b3210],
27	via	IN	O	via	_	0	SENT_252	[p14l1250t3129r1359b3192],
28	activation	NN	O	activation	prep_via	26	SENT_252	[p14l1392t3129r1743b3192],
29	of	IN	O	of	_	0	SENT_252	[p14l1777t3129r1854b3192],
30	PXR	NN	O	pxr	prep_of	28	SENT_252	[p14l1881t3131r2072b3203],
31	,	,	O	,	_	0	SENT_252	[p14l1881t3131r2072b3203],
32	a	DT	O	a	det	34	SENT_252	[p14l2111t3149r2148b3192],
33	nuclear	JJ	O	nuclear	amod	34	SENT_252	[p14l9t3240r272b3303],
34	receptor	NN	O	receptor	appos	30	SENT_252	[p14l342t3250r636b3321],
35	that	WDT	O	that	nsubjpass	38	SENT_252	[p14l706t3240r840b3303],
36	is	VBZ	O	be	auxpass	38	SENT_252	[p14l912t3240r967b3303],
37	increasingly	RB	O	increasingly	advmod	38	SENT_252	[p14l1041t3240r1477b3321],
38	associated	VBN	O	associate	rcmod	34	SENT_252	[p14l1551t3240r1917b3303],
39	with	IN	O	with	_	0	SENT_252	[p14l1989t3240r2147b3303],
40	acquired	VBN	O	acquire	amod	41	SENT_252	[p14l11t3351r317b3432],
41	MDR	NNP	ORGANIZATION	MDR	prep_with	38	SENT_252	[p14l341t3353r544b3413],
42	[	CD	NUMBER	[	num	43	SENT_252	[p14l574t3352r660b3427],
43	9	CD	NUMBER	9	nsubj	24	SENT_252	[p14l574t3352r660b3427],
44	,	,	O	,	_	0	SENT_252	[p14l574t3352r660b3427],
45	17	CD	NUMBER	17	num	46	SENT_252	[p14l696t3352r823b3427],
46	]	NN	O	]	appos	43	SENT_252	[p14l696t3352r823b3427],
47	.	.	O	.	_	0	SENT_252	[p14l696t3352r823b3427],

1	Indeed	RB	O	indeed	advmod	6	SENT_253	[p14l111t3462r373b3536],
2	,	,	O	,	_	0	SENT_253	[p14l111t3462r373b3536],
3	several	JJ	O	several	amod	5	SENT_253	[p14l427t3462r675b3525],
4	anticancer	JJ	O	anticancer	amod	5	SENT_253	[p14l725t3462r1093b3525],
5	drugs	NNS	O	drug	nsubj	6	SENT_253	[p14l1139t3462r1333b3543],
6	(	VBP	O	(	_	0	SENT_253	[p14l1387t3462r1809b3540],
7	vincristine	NN	O	vincristine	nsubjpass	24	SENT_253	[p14l1387t3462r1809b3540],
8	,	,	O	,	_	0	SENT_253	[p14l1387t3462r1809b3540],
9	vinblas	NN	O	vinbla	nn	22	SENT_253	[p14l1861t3462r2145b3525],
10	—	NN	O	—	nn	22	SENT_253	[p14l1861t3462r2145b3525],
11	tine	NN	O	tine	nn	22	SENT_253	[p14l9t3572r161b3646],
12	,	,	O	,	_	0	SENT_253	[p14l9t3572r161b3646],
13	cyclophosphamide	NN	O	cyclophosphamide	nn	22	SENT_253	[p14l211t3572r900b3653],
14	,	,	O	,	_	0	SENT_253	[p14l211t3572r900b3653],
15	ifosfamide	NN	O	ifosfamide	nn	22	SENT_253	[p14l950t3572r1350b3646],
16	,	,	O	,	_	0	SENT_253	[p14l950t3572r1350b3646],
17	docetaxel	NN	O	docetaxel	nn	22	SENT_253	[p14l1401t3572r1762b3646],
18	,	,	O	,	_	0	SENT_253	[p14l1401t3572r1762b3646],
19	ﬂutamide	NN	O	ﬂutamide	nn	22	SENT_253	[p14l1811t3569r2146b3635],
20	and	CC	O	and	_	0	SENT_253	[p14l11t3684r137b3747],
21	tamoxifen	NN	O	tamoxifen	conj_and	11	SENT_253	[p14l165t3684r554b3761],
22	)	NN	O	)	appos	7	SENT_253	[p14l165t3684r554b3761],
23	were	VBD	O	be	auxpass	24	SENT_253	[p14l586t3704r757b3747],
24	shown	VBN	O	show	ccomp	6	SENT_253	[p14l790t3684r1019b3747],
25	to	TO	O	to	aux	26	SENT_253	[p14l1048t3694r1115b3747],
26	increase	VB	O	increase	xcomp	24	SENT_253	[p14l1145t3684r1436b3747],
27	Pgp	NNP	O	Pgp	nn	29	SENT_253	[p14l1467t3686r1603b3765],
28	reporter	NN	O	reporter	nn	29	SENT_253	[p14l1632t3693r1917b3765],
29	activity	NN	O	activity	dobj	26	SENT_253	[p14l1946t3684r2145b3747, p15l9t22r101b103],

1	in	IN	O	in	_	0	SENT_254	[p15l133t22r201b84],
2	cells	NNS	O	cell	pobj	1	SENT_254	[p15l234t22r393b85],
3	co-transfected	VBN	O	co-transfect	partmod	2	SENT_254	[p15l428t22r935b85],
4	with	IN	O	with	_	0	SENT_254	[p15l966t22r1123b85],
5	a	DT	O	a	det	8	SENT_254	[p15l1156t42r1193b85],
6	PXR	NN	O	pxr	nn	8	SENT_254	[p15l1224t24r1398b84],
7	expression	NN	O	expression	nn	8	SENT_254	[p15l1430t22r1810b103],
8	plasmid	NN	O	plasmid	prep_with	3	SENT_254	[p15l1841t22r2141b103],
9	.	.	O	.	_	0	SENT_254	[p15l1841t22r2141b103],

1	In	IN	O	in	_	0	SENT_255	[p15l9t135r82b195],
2	accordance	NN	O	accordance	prep_in	8	SENT_255	[p15l111t133r530b208],
3	,	,	O	,	_	0	SENT_255	[p15l111t133r530b208],
4	the	DT	O	the	det	7	SENT_255	[p15l561t133r668b196],
5	same	JJ	O	same	amod	7	SENT_255	[p15l700t153r878b196],
6	anticancer	JJ	O	anticancer	amod	7	SENT_255	[p15l908t133r1276b196],
7	drugs	NNS	O	drug	nsubj	8	SENT_255	[p15l1302t133r1496b214],
8	induced	VBD	O	induce	_	0	SENT_255	[p15l1525t133r1807b196],
9	Pgp	NN	O	pgp	nn	11	SENT_255	[p15l1835t135r1971b214],
10	protein	NN	O	protein	nn	11	SENT_255	[p15l1999t153r2145b214, p15l9t244r141b307],
11	expression	NN	O	expression	dobj	8	SENT_255	[p15l177t244r558b325],
12	in	IN	O	in	_	0	SENT_255	[p15l593t244r661b306],
13	LSl8O	NN	O	lsl8o	nn	14	SENT_255	[p15l696t245r933b307],
14	cells	NNS	O	cell	prep_in	11	SENT_255	[p15l969t244r1149b307],
15	.	.	O	.	_	0	SENT_255	[p15l969t244r1149b307],

1	However	RB	O	however	advmod	19	SENT_256	[p15l1190t246r1535b318],
2	,	,	O	,	_	0	SENT_256	[p15l1190t246r1535b318],
3	when	WRB	O	when	advmod	6	SENT_256	[p15l1575t244r1767b307],
4	PXR	NN	O	pxr	nsubjpass	6	SENT_256	[p15l1801t246r1975b306],
5	was	VBD	O	be	auxpass	6	SENT_256	[p15l2010t264r2145b307],
6	knocked	VBN	O	knock	advcl	19	SENT_256	[p15l8t355r311b418],
7	down	RB	O	down	advmod	6	SENT_256	[p15l348t355r544b418],
8	in	IN	O	in	_	0	SENT_256	[p15l581t355r649b417],
9	these	DT	O	these	det	11	SENT_256	[p15l685t355r867b418],
10	cells	NNS	O	cell	nn	11	SENT_256	[p15l905t355r1066b418],
11	treatment	NN	O	treatment	prep_in	7	SENT_256	[p15l1104t365r1444b418],
12	with	IN	O	with	_	0	SENT_256	[p15l1479t355r1638b418],
13	the	DT	O	the	det	16	SENT_256	[p15l1674t355r1781b418],
14	indicated	VBN	O	indicate	amod	16	SENT_256	[p15l1819t355r2148b418],
15	anticancer	JJ	O	anticancer	amod	16	SENT_256	[p15l11t467r377b530],
16	drugs	NNS	O	drug	prep_with	6	SENT_256	[p15l419t467r613b548],
17	did	VBD	O	do	aux	19	SENT_256	[p15l658t467r770b530],
18	not	RB	O	not	neg	19	SENT_256	[p15l811t476r925b530],
19	result	VB	O	result	_	0	SENT_256	[p15l965t467r1165b530],
20	in	IN	O	in	_	0	SENT_256	[p15l1204t467r1273b529],
21	Pgp	NNP	O	Pgp	nn	23	SENT_256	[p15l1314t469r1450b548],
22	protein	NN	O	protein	nn	23	SENT_256	[p15l1492t467r1746b548],
23	induction	NN	O	induction	prep_in	19	SENT_256	[p15l1787t467r2141b530],
24	.	.	O	.	_	0	SENT_256	[p15l1787t467r2141b530],

1	Together	RB	O	together	advmod	4	SENT_257	[p15l9t578r332b659],
2	these	DT	O	these	det	3	SENT_257	[p15l356t578r539b641],
3	results	NNS	O	result	nsubj	4	SENT_257	[p15l564t578r795b641],
4	indicate	VBP	O	indicate	_	0	SENT_257	[p15l823t578r1105b641],
5	that	IN	O	that	complm	7	SENT_257	[p15l1132t578r1265b641],
6	PXR	NN	O	pxr	nsubj	7	SENT_257	[p15l1289t580r1463b640],
7	plays	VBZ	O	play	ccomp	4	SENT_257	[p15l1486t578r1673b659],
8	a	DT	O	a	det	10	SENT_257	[p15l1703t598r1740b641],
9	substantial	JJ	O	substantial	amod	10	SENT_257	[p15l1768t578r2146b641],
10	role	NN	O	role	dobj	7	SENT_257	[p15l8t689r145b752],
11	in	IN	O	in	_	0	SENT_257	[p15l171t689r238b751],
12	anticancer	JJ	O	anticancer	amod	15	SENT_257	[p15l266t689r632b752],
13	drug-related	JJ	O	drug-related	amod	15	SENT_257	[p15l656t689r1092b770],
14	Pgp	NN	O	pgp	nn	15	SENT_257	[p15l1116t691r1253b770],
15	induction	NN	O	induction	prep_in	10	SENT_257	[p15l1278t689r1634b752],
16	.	.	O	.	_	0	SENT_257	[p15l1278t689r1634b752],

1	Furthermore	RB	O	furthermore	advmod	47	SENT_258	[p15l111t799r578b873],
2	,	,	O	,	_	0	SENT_258	[p15l111t799r578b873],
3	since	IN	O	since	mark	9	SENT_258	[p15l608t799r786b862],
4	Pgp	NNP	ORGANIZATION	Pgp	nsubj	9	SENT_258	[p15l811t801r947b880],
5	is	VBZ	O	be	cop	9	SENT_258	[p15l971t799r1026b862],
6	a	DT	O	a	det	9	SENT_258	[p15l1054t819r1091b862],
7	drug	NN	O	drug	nn	9	SENT_258	[p15l1115t799r1275b880],
8	eﬂlux	NN	O	eﬂlux	nn	9	SENT_258	[p15l1300t797r1498b862],
9	transporter	NN	O	transporter	advcl	47	SENT_258	[p15l1523t809r1912b880],
10	that	WDT	O	that	nsubjpass	12	SENT_258	[p15l1933t799r2067b862],
11	is	VBZ	O	be	auxpass	12	SENT_258	[p15l2089t799r2145b862],
12	involved	VBN	O	involve	rcmod	9	SENT_258	[p15l9t911r322b974],
13	in	IN	O	in	_	0	SENT_258	[p15l362t911r429b973],
14	the	DT	O	the	det	15	SENT_258	[p15l469t911r577b974],
15	extrusion	NN	O	extrusion	prep_in	12	SENT_258	[p15l618t911r950b974],
16	of	IN	O	of	_	0	SENT_258	[p15l991t911r1068b974],
17	a	DT	O	a	det	19	SENT_258	[p15l1106t931r1143b974],
18	wide	JJ	O	wide	amod	19	SENT_258	[p15l1181t911r1353b974],
19	variety	NN	O	variety	prep_of	15	SENT_258	[p15l1394t911r1640b992],
20	of	IN	O	of	_	0	SENT_258	[p15l1683t911r1760b974],
21	substrates	NNS	O	substrate	prep_of	19	SENT_258	[p15l1798t911r2145b974],
22	from	IN	O	from	_	0	SENT_258	[p15l9t1021r182b1084],
23	the	DT	O	the	det	24	SENT_258	[p15l210t1021r317b1084],
24	cell	NN	O	cell	prep_from	12	SENT_258	[p15l347t1021r494b1095],
25	,	,	O	,	_	0	SENT_258	[p15l347t1021r494b1095],
26	the	DT	O	the	det	27	SENT_258	[p15l525t1021r633b1084],
27	eﬂect	NN	O	eﬂect	nsubjpass	47	SENT_258	[p15l663t1019r857b1084],
28	of	IN	O	of	_	0	SENT_258	[p15l885t1021r963b1084],
29	Pgp	NN	ORGANIZATION	pgp	nn	31	SENT_258	[p15l985t1023r1121b1102],
30	protein	NN	O	protein	nn	31	SENT_258	[p15l1151t1021r1404b1102],
31	induction	NN	O	induction	prep_of	27	SENT_258	[p15l1434t1021r1771b1084],
32	following	VBG	O	follow	_	0	SENT_258	[p15l1800t1021r2146b1102],
33	treatment	NN	O	treatment	prep_following	31	SENT_258	[p15l9t1142r347b1196],
34	with	IN	O	with	_	0	SENT_258	[p15l379t1133r537b1196],
35	the	DT	O	the	det	38	SENT_258	[p15l568t1133r675b1196],
36	indicated	VBN	O	indicate	amod	38	SENT_258	[p15l709t1133r1036b1196],
37	anticancer	JJ	O	anticancer	amod	38	SENT_258	[p15l1069t1133r1436b1196],
38	drugs	NNS	O	drug	prep_with	33	SENT_258	[p15l1468t1133r1661b1214],
39	on	IN	O	on	_	0	SENT_258	[p15l1696t1153r1782b1196],
40	the	DT	O	the	det	42	SENT_258	[p15l1814t1133r1921b1196],
41	intracellular	JJ	O	intracellular	amod	42	SENT_258	[p15l1954t1133r2144b1196, p15l10t1244r279b1307],
42	accumulation	NN	O	accumulation	prep_on	38	SENT_258	[p15l333t1244r813b1307],
43	of	IN	O	of	_	0	SENT_258	[p15l868t1244r945b1307],
44	Pgp	NNP	ORGANIZATION	Pgp	nn	45	SENT_258	[p15l993t1246r1130b1325],
45	substrates	NNS	O	substrate	prep_of	42	SENT_258	[p15l1188t1244r1534b1307],
46	was	VBD	O	be	auxpass	47	SENT_258	[p15l1592t1264r1727b1307],
47	evaluated	VBN	O	evaluate	_	0	SENT_258	[p15l1783t1244r2142b1307],
48	.	.	O	.	_	0	SENT_258	[p15l1783t1244r2142b1307],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_259	[p15l9t1354r390b1428],
2	,	,	O	,	_	0	SENT_259	[p15l9t1354r390b1428],
3	ﬂutamide	NN	O	ﬂutamide	conj_and	1	SENT_259	[p15l419t1351r774b1429],
4	,	,	O	,	_	0	SENT_259	[p15l419t1351r774b1429],
5	paclitaxel	NN	O	paclitaxel	conj_and	1	SENT_259	[p15l799t1354r1147b1435],
6	and	CC	O	and	_	0	SENT_259	[p15l1173t1354r1300b1417],
7	the	DT	O	the	det	9	SENT_259	[p15l1322t1354r1430b1417],
8	positive	JJ	O	positive	amod	9	SENT_259	[p15l1453t1354r1735b1435],
9	control	NN	O	control	conj_and	1	SENT_259	[p15l1760t1354r2011b1417],
10	rif	NN	O	rif	dep	1	SENT_259	[p15l2035t1354r2146b1416, p15l7t1594r86b1690],
11	@	IN	O	@	amod	10	SENT_259	[p15l2035t1354r2146b1416, p15l7t1594r86b1690],

1	Springer	NNP	PERSON	Springer	_	0	SENT_260	[p15l113t1617r376b1692],

1	_	NN	O	_	nn	2	SENT_261	[p15l207t1942r225b1987],
2	L	NN	O	l	_	0	SENT_261	[p15l207t1942r225b1987],
3	[	CD	NUMBER	[	num	6	SENT_261	[p15l256t1942r287b1987],
4	U	NNP	O	U	nn	6	SENT_261	[p15l256t1942r287b1987],
5	_	NNP	O	_	nn	6	SENT_261	[p15l207t2114r225b2160],
6	L	NN	O	l	dep	2	SENT_261	[p15l207t2114r225b2160],

1	C	NN	O	c	_	0	SENT_262	[p15l257t2114r288b2161],

1	o	NN	O	o	_	0	SENT_263	[p15l203t2286r250b2333],
2	oo	NN	O	oo	dep	1	SENT_263	[p15l257t2286r288b2333],
3	.	.	O	.	_	0	SENT_263	[p15l203t2459r250b2506],

1	o	NN	O	o	_	0	SENT_264	[p15l203t2459r250b2506],
2	on	IN	O	on	prep	1	SENT_264	[p15l257t2459r288b2506],
3	.	.	O	.	_	0	SENT_264	[p15l204t2626r250b2673],

1	o	NN	O	o	_	0	SENT_265	[p15l204t2626r250b2673],
2	4	CD	NUMBER	4	num	1	SENT_265	[p15l256t2626r289b2671, p15l105t2791r160b3017],
3	:	:	O	:	_	0	SENT_265	[p15l256t2626r289b2671, p15l105t2791r160b3017],
4	relative	JJ	O	relative	amod	6	SENT_265	[p15l256t2626r289b2671, p15l105t2791r160b3017],
5	doxorubicin	NN	O	doxorubicin	nn	6	SENT_265	[p15l105t2401r160b2767],
6	accumulation	NN	O	accumulation	dep	1	SENT_265	[p15l105t1951r160b2374],

1	.	.	O	.	_	0	SENT_266	[p15l204t2799r250b2845],

1	o	NN	O	o	nn	2	SENT_267	[p15l204t2799r250b2845],
2	N	NN	O	n	_	0	SENT_267	[p15l256t2799r287b2844],

1	.	.	O	.	_	0	SENT_268	[p15l203t2971r250b3018],

1	o	NN	O	o	nn	2	SENT_269	[p15l203t2971r250b3018],
2	o	NN	O	o	_	0	SENT_269	[p15l257t2971r288b3018],

1	0.1	CD	PERCENT	0.1	num	2	SENT_270	[p15l591t3084r732b3131],
2	%	NN	PERCENT	%	_	0	SENT_270	[p15l591t3084r732b3131],
3	DMSO	NN	O	dmso	nn	6	SENT_270	[p15l757t3082r942b3131],
4	10	CD	NUMBER	10	num	6	SENT_270	[p15l1371t3084r1434b3131],
5	uM	NN	O	um	nn	6	SENT_270	[p15l1455t3083r1539b3144],
6	rifampicin	NN	O	rifampicin	dep	2	SENT_270	[p15l1565t3083r1830b3143],

1	P	NN	O	p	_	0	SENT_271	[p15l78t3273r478b3333],
2	'	''	O	'	_	0	SENT_271	[p15l78t3273r478b3333],
3	9	CD	NUMBER	9	num	5	SENT_271	[p15l78t3273r478b3333],
4	|	NN	O	|	nn	5	SENT_271	[p15l78t3273r478b3333],
5	YC0pr0t9in	NN	O	yc0pr0t9in	dep	1	SENT_271	[p15l78t3273r478b3333],
6	;	:	O	;	_	0	SENT_271	[p15l618t3297r1087b3330],
7	*	CD	NUMBER	*	dep	5	SENT_271	[p15l618t3297r1087b3330],

1	B-actin	NN	O	b-actin	_	0	SENT_272	[p15l286t3368r469b3430],
2	.	.	O	.	_	0	SENT_272	[p15l1212t3407r1215b3410],

1	o	NN	O	o	nn	2	SENT_273	[p15l1289t3368r1292b3369],
2	o	NN	O	o	_	0	SENT_273	[p15l1329t3368r1334b3369],

1	cell	NN	O	cell	nn	2	SENT_274	[p16l56t881r110b984],
2	Viability	NN	O	viability	_	0	SENT_274	[p16l56t618r125b856],

1	25	CD	NUMBER	25	_	0	SENT_275	[p16l166t1049r290b1095],
2	°	CD	NUMBER	°	dep	1	SENT_275	[p16l166t1049r290b1095],
3	/	:	O	/	punct	1	SENT_275	[p16l166t1049r290b1095],
4	o	NN	O	o	nn	5	SENT_275	[p16l166t1049r290b1095],
5	log	NN	O	log	dep	1	SENT_275	[p16l889t1539r978b1607],
6	[	CD	NUMBER	[	num	8	SENT_275	[p16l1006t1538r1411b1606],
7	doxorubicin	NN	O	doxorubicin	nn	8	SENT_275	[p16l1006t1538r1411b1606],
8	]	NN	O	]	dep	5	SENT_275	[p16l1006t1538r1411b1606],
9	in	IN	O	in	_	0	SENT_275	[p16l1440t1539r1488b1591],
10	uM	NN	O	um	prep_in	5	SENT_275	[p16l1515t1539r1618b1610],

1	Fig	NN	O	fig	_	0	SENT_276	[p16l7t1705r128b1774],
2	.	.	O	.	_	0	SENT_276	[p16l7t1705r128b1774],

1	5	CD	NUMBER	5	nsubj	5	SENT_277	[p16l152t1706r187b1759],
2	a	DT	O	a	det	4	SENT_277	[p16l241t1722r276b1759],
3	Rifampicin	NN	MISC	rifampicin	nn	4	SENT_277	[p16l311t1706r653b1774],
4	pretreatment	NN	O	pretreatment	dep	1	SENT_277	[p16l686t1714r1073b1774],
5	decreases	VBZ	O	decrease	_	0	SENT_277	[p16l1108t1706r1396b1759],
6	doxorubicin	NN	O	doxorubicin	nn	7	SENT_277	[p16l1432t1706r1800b1759],
7	accumulation	NN	O	accumulation	dobj	5	SENT_277	[p16l1835t1706r2148b1759, p16l7t1795r124b1848],
8	in	IN	O	in	_	0	SENT_277	[p16l143t1795r201b1847],
9	LSl80	NN	O	lsl80	nn	10	SENT_277	[p16l220t1795r423b1848],
10	cells	NNS	O	cell	prep_in	7	SENT_277	[p16l444t1795r597b1848],
11	.	.	O	.	_	0	SENT_277	[p16l444t1795r597b1848],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_278	[p16l621t1795r1006b1848],
2	accumulation	NN	O	accumulation	nsubjpass	4	SENT_278	[p16l1028t1795r1436b1848],
3	was	VBD	O	be	auxpass	4	SENT_278	[p16l1457t1812r1572b1848],
4	assessed	VBN	O	assess	_	0	SENT_278	[p16l1596t1795r1852b1848],
5	in	IN	O	in	_	0	SENT_278	[p16l1872t1795r1928b1847],
6	LS	NN	O	l	nn	8	SENT_278	[p16l1948t1796r2032b1848],
7	180	CD	NUMBER	180	num	8	SENT_278	[p16l2046t1796r2151b1848],
8	cells	NNS	O	cell	prep_in	4	SENT_278	[p16l7t1884r143b1937],
9	after	IN	O	after	_	0	SENT_278	[p16l164t1884r302b1937],
10	48	CD	NUMBER	48	num	12	SENT_278	[p16l317t1884r389b1937],
11	h	NN	O	h	nn	12	SENT_278	[p16l413t1884r450b1936],
12	pretreatment	NN	O	pretreatment	prep_after	4	SENT_278	[p16l465t1892r852b1952],
13	with	IN	O	with	_	0	SENT_278	[p16l869t1884r1004b1937],
14	rifampicin	NN	O	rifampicin	prep_with	4	SENT_278	[p16l1019t1884r1338b1952],
15	(	CD	NUMBER	(	number	16	SENT_278	[p16l1357t1885r1454b1949],
16	10	CD	NUMBER	10	num	18	SENT_278	[p16l1357t1885r1454b1949],
17	uM	NN	O	um	nn	18	SENT_278	[p16l1480t1885r1626b1952],
18	)	NN	O	)	dep	4	SENT_278	[p16l1480t1885r1626b1952],
19	.	.	O	.	_	0	SENT_278	[p16l1480t1885r1626b1952],

1	These	DT	O	these	det	2	SENT_279	[p16l1648t1884r1827b1937],
2	results	NNS	O	result	nsubjpass	4	SENT_279	[p16l1845t1884r2041b1937],
3	are	VBP	O	be	auxpass	4	SENT_279	[p16l2062t1901r2152b1937],
4	derived	VBN	O	derive	dep	13	SENT_279	[p16l8t1973r235b2026],
5	from	IN	O	from	_	0	SENT_279	[p16l274t1973r421b2026],
6	a	DT	O	a	det	8	SENT_279	[p16l462t1990r493b2026],
7	representative	JJ	O	representative	amod	8	SENT_279	[p16l531t1973r959b2041],
8	experiment	NN	O	experiment	prep_from	4	SENT_279	[p16l1000t1973r1342b2041],
9	and	CC	O	and	_	0	SENT_279	[p16l1383t1973r1490b2026],
10	data	NNS	O	datum	prep_from	4	SENT_279	[p16l1531t1973r1656b2026],
11	are	VBP	O	be	cop	13	SENT_279	[p16l1697t1990r1786b2026],
12	the	DT	O	the	det	13	SENT_279	[p16l1826t1973r1917b2026],
13	means	NNS	O	means	_	0	SENT_279	[p16l1957t1990r2149b2026],
14	(	CD	NUMBER	(	num	16	SENT_279	[p16l9t2062r211b2127],
15	:	:	O	:	_	0	SENT_279	[p16l9t2062r211b2127],
16	|	CD	NUMBER	|	dep	13	SENT_279	[p16l9t2062r211b2127],
17	:	:	O	:	_	0	SENT_279	[p16l9t2062r211b2127],
18	SD	NN	O	sd	dep	13	SENT_279	[p16l9t2062r211b2127],
19	)	CD	NUMBER	)	num	18	SENT_279	[p16l9t2062r211b2127],
20	from	IN	O	from	_	0	SENT_279	[p16l246t2062r394b2115],
21	three	CD	NUMBER	three	num	23	SENT_279	[p16l427t2062r577b2115],
22	separate	JJ	O	separate	amod	23	SENT_279	[p16l613t2070r858b2130],
23	determinations	NNS	O	determination	prep_from	18	SENT_279	[p16l893t2062r1344b2115],
24	and	CC	O	and	_	0	SENT_279	[p16l1380t2062r1487b2115],
25	is	VBZ	O	be	auxpass	26	SENT_279	[p16l1520t2062r1566b2115],
26	expressed	VBN	O	express	conj_and	13	SENT_279	[p16l1603t2062r1901b2130],
27	as	IN	O	as	_	0	SENT_279	[p16l1936t2079r1994b2115],
28	fold	JJ	O	fold	amod	29	SENT_279	[p16l2030t2062r2151b2115],
29	decrease	NN	O	decrease	prep_as	26	SENT_279	[p16l8t2151r268b2204],
30	in	IN	O	in	_	0	SENT_279	[p16l313t2151r371b2203],
31	doxorubicin	NN	O	doxorubicin	nn	32	SENT_279	[p16l416t2151r783b2204],
32	accumulation	NN	O	accumulation	prep_in	29	SENT_279	[p16l830t2151r1238b2204],
33	compared	VBN	O	compare	_	0	SENT_279	[p16l1284t2151r1584b2219],
34	to	TO	O	to	prepc_compared_to	26	SENT_279	[p16l1627t2159r1684b2204],
35	0.1	CD	PERCENT	0.1	number	36	SENT_279	[p16l1731t2151r1883b2204],
36	%	NN	PERCENT	%	amod	37	SENT_279	[p16l1731t2151r1883b2204],
37	DMSO	NN	O	dmso	pobj	26	SENT_279	[p16l1931t2151r2149b2204],
38	(	CD	NUMBER	(	number	39	SENT_279	[p16l9t2241r154b2305],
39	**	CD	NUMBER	**	num	40	SENT_279	[p16l9t2241r154b2305],
40	P	NN	O	p	npadvmod	41	SENT_279	[p16l9t2241r154b2305],
41	<	JJR	O	<	amod	37	SENT_279	[p16l176t2253r216b2292],
42	0.01	CD	NUMBER	0.01	num	43	SENT_279	[p16l239t2240r410b2305],
43	)	NN	O	)	nsubj	13	SENT_279	[p16l239t2240r410b2305],
44	.	.	O	.	_	0	SENT_279	[p16l239t2240r410b2305],

1	b	NN	O	b	nn	3	SENT_280	[p16l446t2240r484b2293],
2	Rifampicin	NN	MISC	rifampicin	nn	3	SENT_280	[p16l517t2240r860b2308],
3	pretreatment	NN	O	pretreatment	nsubj	4	SENT_280	[p16l889t2248r1277b2308],
4	reduces	VBZ	O	reduce	_	0	SENT_280	[p16l1307t2240r1537b2293],
5	the	DT	O	the	det	6	SENT_280	[p16l1571t2240r1662b2293],
6	cytotoxicity	NN	O	cytotoxicity	dobj	4	SENT_280	[p16l1695t2240r2057b2308],
7	of	IN	O	of	_	0	SENT_280	[p16l2090t2240r2153b2293],
8	doxorubicin	NN	O	doxorubicin	prep_of	6	SENT_280	[p16l8t2328r375b2381],
9	in	IN	O	in	_	0	SENT_280	[p16l395t2328r453b2380],
10	LS	NN	O	l	nn	11	SENT_280	[p16l472t2328r556b2381],
11	l	NN	O	l	prep_in	4	SENT_280	[p16l569t2329r591b2380],
12	80	CD	NUMBER	80	num	13	SENT_280	[p16l604t2329r674b2381],
13	cells	NNS	O	cell	dep	11	SENT_280	[p16l695t2328r848b2381],
14	.	.	O	.	_	0	SENT_280	[p16l695t2328r848b2381],

1	The	DT	O	the	det	2	SENT_281	[p16l873t2328r990b2381],
2	effect	NN	O	effect	nsubjpass	16	SENT_281	[p16l1011t2326r1175b2381],
3	of	IN	O	of	_	0	SENT_281	[p16l1197t2328r1262b2381],
4	96	CD	NUMBER	96	num	7	SENT_281	[p16l1278t2328r1351b2382],
5	h	NN	O	h	nn	7	SENT_281	[p16l1372t2328r1409b2380],
6	rifampicin	NN	O	rifampicin	nn	7	SENT_281	[p16l1428t2328r1747b2396],
7	pretreatment	NN	O	pretreatment	prep_of	2	SENT_281	[p16l1766t2336r2152b2396],
8	on	IN	O	on	_	0	SENT_281	[p16l8t2434r81b2470],
9	the	DT	O	the	det	10	SENT_281	[p16l111t2417r201b2470],
10	cytotoxicity	NN	O	cytotoxicity	prep_on	7	SENT_281	[p16l233t2417r596b2485],
11	of	IN	O	of	_	0	SENT_281	[p16l628t2417r693b2470],
12	doxorubicin	NN	O	doxorubicin	prep_of	10	SENT_281	[p16l718t2417r1086b2470],
13	in	IN	O	in	_	0	SENT_281	[p16l1115t2417r1173b2469],
14	LSl80	NN	O	lsl80	prep_in	12	SENT_281	[p16l1202t2417r1405b2470],
15	was	VBD	O	be	auxpass	16	SENT_281	[p16l1436t2434r1550b2470],
16	determined	VBN	O	determine	_	0	SENT_281	[p16l1583t2417r1925b2470],
17	with	IN	O	with	_	0	SENT_281	[p16l1955t2417r2089b2470],
18	a	DT	O	a	det	21	SENT_281	[p16l2121t2434r2152b2470],
19	neutral	JJ	O	neutral	amod	21	SENT_281	[p16l7t2506r217b2559],
20	red	JJ	O	red	amod	21	SENT_281	[p16l238t2506r335b2559],
21	assay	NN	O	assay	prep_with	16	SENT_281	[p16l360t2523r537b2574],
22	.	.	O	.	_	0	SENT_281	[p16l360t2523r537b2574],

1	The	DT	O	the	det	2	SENT_282	[p16l564t2506r679b2559],
2	results	NNS	O	result	nsubjpass	16	SENT_282	[p16l701t2506r899b2559],
3	are	VBP	O	be	auxpass	4	SENT_282	[p16l925t2523r1014b2559],
4	presented	VBN	O	present	dep	21	SENT_282	[p16l1037t2506r1329b2574],
5	as	IN	O	as	_	0	SENT_282	[p16l1353t2523r1410b2559],
6	mean	JJ	O	mean	amod	7	SENT_282	[p16l1436t2523r1599b2559],
7	Viabilities	NNPS	O	Viabilities	prep_as	4	SENT_282	[p16l1622t2506r1920b2559],
8	(	CD	NUMBER	(	num	10	SENT_282	[p16l1946t2506r2149b2571],
9	:	:	O	:	_	0	SENT_282	[p16l1946t2506r2149b2571],
10	|	CD	NUMBER	|	dep	7	SENT_282	[p16l1946t2506r2149b2571],
11	:	:	O	:	_	0	SENT_282	[p16l1946t2506r2149b2571],
12	SD	NN	O	sd	nn	13	SENT_282	[p16l1946t2506r2149b2571],
13	)	NN	O	)	dep	7	SENT_282	[p16l1946t2506r2149b2571],
14	and	CC	O	and	_	0	SENT_282	[p16l8t2595r115b2648],
15	are	VBP	O	be	auxpass	16	SENT_282	[p16l138t2612r227b2648],
16	derived	VBN	O	derive	conj_and	4	SENT_282	[p16l250t2595r477b2648],
17	from	IN	O	from	_	0	SENT_282	[p16l498t2595r646b2648],
18	four	CD	NUMBER	four	num	20	SENT_282	[p16l666t2595r793b2648],
19	separate	JJ	O	separate	amod	20	SENT_282	[p16l815t2603r1061b2663],
20	determinations	NNS	O	determination	prep_from	16	SENT_282	[p16l1084t2595r1534b2648],
21	(	VBP	O	(	_	0	SENT_282	[p16l1560t2596r1629b2660],
22	P	NN	O	p	dep	23	SENT_282	[p16l1560t2596r1629b2660],
23	<	JJR	O	<	dobj	21	SENT_282	[p16l1651t2608r1690b2647],
24	0.05	CD	NUMBER	0.05	num	25	SENT_282	[p16l1713t2595r1868b2660],
25	)	NN	O	)	nsubj	21	SENT_282	[p16l1713t2595r1868b2660],

1	ampicin	NN	O	ampicin	nsubj	8	SENT_283	[p16l9t2825r296b2906],
2	that	WDT	O	that	nsubj	3	SENT_283	[p16l366t2825r501b2888],
3	induced	VBD	O	induce	rcmod	1	SENT_283	[p16l572t2825r855b2888],
4	Pgp	NN	ORGANIZATION	pgp	nn	6	SENT_283	[p16l926t2827r1063b2906],
5	protein	NN	O	protein	nn	6	SENT_283	[p16l1134t2825r1388b2906],
6	expression	NN	O	expression	dobj	3	SENT_283	[p16l1460t2825r1842b2906],
7	indeed	RB	O	indeed	advmod	3	SENT_283	[p16l1913t2825r2152b2888],
8	affected	VBD	O	affect	_	0	SENT_283	[p16l9t2933r285b2998],
9	the	DT	O	the	det	11	SENT_283	[p16l314t2935r421b2998],
10	intracellular	JJ	O	intracellular	amod	11	SENT_283	[p16l451t2935r886b2998],
11	accumulation	NN	O	accumulation	dobj	8	SENT_283	[p16l915t2935r1396b2998],
12	of	IN	O	of	_	0	SENT_283	[p16l1427t2935r1504b2998],
13	the	DT	O	the	det	16	SENT_283	[p16l1528t2935r1635b2998],
14	Pgp	NNP	O	Pgp	nn	16	SENT_283	[p16l1666t2937r1803b3016],
15	substrate	NN	O	substrate	nn	16	SENT_283	[p16l1836t2935r2150b2998],
16	rhodamine	NN	O	rhodamine	prep_of	11	SENT_283	[p16l6t3047r389b3110],
17	123	CD	NUMBER	123	dep	16	SENT_283	[p16l453t3048r595b3110],
18	.	.	O	.	_	0	SENT_283	[p16l453t3048r595b3110],

1	In	IN	O	in	_	0	SENT_284	[p16l653t3049r724b3109],
2	addition	NN	O	addition	prep_in	19	SENT_284	[p16l780t3047r1090b3122],
3	,	,	O	,	_	0	SENT_284	[p16l780t3047r1090b3122],
4	carboplatin	NN	O	carboplatin	nsubj	19	SENT_284	[p16l1149t3047r1551b3128],
5	and	CC	O	and	_	0	SENT_284	[p16l1607t3047r1732b3110],
6	etoposide	NN	O	etoposide	nsubj	19	SENT_284	[p16l1786t3047r2148b3128],
7	,	,	O	,	_	0	SENT_284	[p16l1786t3047r2148b3128],
8	which	WDT	O	which	nsubj	9	SENT_284	[p16l7t3157r225b3220],
9	had	VBD	O	have	rcmod	4	SENT_284	[p16l269t3157r399b3220],
10	no	DT	O	no	det	11	SENT_284	[p16l443t3177r530b3220],
11	effect	NN	O	effect	dobj	9	SENT_284	[p16l578t3155r771b3220],
12	on	IN	O	on	_	0	SENT_284	[p16l816t3177r902b3220],
13	Pgp	NN	ORGANIZATION	pgp	nn	15	SENT_284	[p16l948t3159r1085b3238],
14	protein	NN	O	protein	nn	15	SENT_284	[p16l1130t3157r1384b3238],
15	expression	NN	O	expression	prep_on	11	SENT_284	[p16l1430t3157r1831b3238],
16	,	,	O	,	_	0	SENT_284	[p16l1430t3157r1831b3238],
17	did	VBD	O	do	aux	19	SENT_284	[p16l1882t3157r1993b3220],
18	not	RB	O	not	neg	19	SENT_284	[p16l2038t3167r2152b3220],
19	affect	VB	O	affect	_	0	SENT_284	[p16l9t3267r201b3332],
20	rhodamine	NN	O	rhodamine	nn	22	SENT_284	[p16l242t3269r625b3332],
21	123	CD	NUMBER	123	num	22	SENT_284	[p16l677t3270r796b3332],
22	accumulation	NN	O	accumulation	dobj	19	SENT_284	[p16l847t3269r1346b3332],
23	.	.	O	.	_	0	SENT_284	[p16l847t3269r1346b3332],

1	However	RB	O	however	advmod	5	SENT_285	[p16l1395t3271r1741b3344],
2	,	,	O	,	_	0	SENT_285	[p16l1395t3271r1741b3344],
3	tamoxifen	NN	O	tamoxifen	nsubjpass	5	SENT_285	[p16l1788t3269r2152b3332],
4	was	VBD	O	be	auxpass	5	SENT_285	[p16l7t3401r142b3444],
5	shown	VBN	O	show	_	0	SENT_285	[p16l188t3381r417b3444],
6	to	TO	O	to	aux	7	SENT_285	[p16l457t3391r523b3444],
7	activate	VB	O	activate	xcomp	5	SENT_285	[p16l566t3381r841b3444],
8	PXR	NN	O	pxr	nn	9	SENT_285	[p16l882t3381r1415b3444],
9	—	NN	O	—	nsubj	18	SENT_285	[p16l882t3381r1415b3444],
10	mediated	VBD	O	mediate	ccomp	7	SENT_285	[p16l882t3381r1415b3444],
11	Pgp	NNP	O	Pgp	nn	13	SENT_285	[p16l1454t3383r1591b3462],
12	protein	NN	O	protein	nn	13	SENT_285	[p16l1630t3381r1884b3462],
13	induction	NN	O	induction	dobj	10	SENT_285	[p16l1924t3381r2148b3444, p16l7t3492r164b3567],
14	,	,	O	,	_	0	SENT_285	[p16l1924t3381r2148b3444, p16l7t3492r164b3567],
15	but	CC	O	but	_	0	SENT_285	[p16l194t3492r309b3555],
16	did	VBD	O	do	aux	18	SENT_285	[p16l337t3492r449b3555],
17	not	RB	O	not	neg	18	SENT_285	[p16l476t3502r590b3555],
18	affect	VB	O	affect	conj_but	10	SENT_285	[p16l619t3490r812b3555],
19	the	DT	O	the	det	20	SENT_285	[p16l839t3492r947b3555],
20	accumulation	NN	O	accumulation	dobj	18	SENT_285	[p16l977t3492r1459b3555],
21	of	IN	O	of	_	0	SENT_285	[p16l1488t3492r1565b3555],
22	rhodamine	NN	O	rhodamine	prep_of	20	SENT_285	[p16l1586t3492r1969b3555],
23	123	CD	NUMBER	123	num	22	SENT_285	[p16l2007t3493r2148b3555],
24	.	.	O	.	_	0	SENT_285	[p16l2007t3493r2148b3555],

1	This	DT	O	this	nsubjpass	4	SENT_286	[p16l7t3604r163b3667],
2	can	MD	O	can	aux	4	SENT_286	[p16l199t3624r321b3667],
3	be	VB	O	be	auxpass	4	SENT_286	[p16l354t3604r436b3667],
4	explained	VBN	O	explain	dep	23	SENT_286	[p16l471t3604r820b3685],
5	by	IN	O	by	_	0	SENT_286	[p16l851t3604r939b3685],
6	the	DT	O	the	det	7	SENT_286	[p16l973t3604r1080b3667],
7	fact	NN	O	fact	agent	4	SENT_286	[p16l1115t3604r1249b3667],
8	that	IN	O	that	complm	14	SENT_286	[p16l1282t3604r1416b3667],
9	tamoxifen	NN	O	tamoxifen	nsubj	14	SENT_286	[p16l1449t3604r1811b3667],
10	is	VBZ	O	be	cop	14	SENT_286	[p16l1845t3604r1901b3667],
11	also	RB	O	also	advmod	14	SENT_286	[p16l1938t3604r2079b3667],
12	a	DT	O	a	det	14	SENT_286	[p16l2115t3624r2152b3667],
13	known	JJ	O	known	amod	14	SENT_286	[p16l6t3715r249b3778],
14	inhibitor	NN	O	inhibitor	ccomp	4	SENT_286	[p16l274t3715r584b3778],
15	of	IN	O	of	_	0	SENT_286	[p16l608t3715r685b3778],
16	Pgp	NNP	ORGANIZATION	Pgp	prep_of	14	SENT_286	[p16l704t3717r840b3796],
17	and	CC	O	and	_	0	SENT_286	[p16l869t3715r995b3778],
18	thus	RB	O	thus	advmod	19	SENT_286	[p16l1019t3715r1164b3778],
19	prevents	VBZ	O	prevent	conj_and	4	SENT_286	[p16l1190t3725r1492b3796],
20	the	DT	O	the	det	22	SENT_286	[p16l1519t3715r1626b3778],
21	Pgp	NNP	O	Pgp	nn	22	SENT_286	[p16l1652t3715r2152b3796],
22	—	NN	O	—	dobj	19	SENT_286	[p16l1652t3715r2152b3796],
23	mediated	VBD	O	mediate	_	0	SENT_286	[p16l1652t3715r2152b3796],
24	extrusion	NN	O	extrusion	dobj	23	SENT_286	[p17l8t22r339b85],
25	of	IN	O	of	_	0	SENT_286	[p17l364t22r442b85],
26	rhodamine	NN	O	rhodamine	prep_of	24	SENT_286	[p17l458t22r842b85],
27	123	CD	NUMBER	123	number	28	SENT_286	[p17l874t23r994b85],
28	[	CD	NUMBER	[	num	26	SENT_286	[p17l1028t23r1188b98],
29	18	CD	NUMBER	18	num	30	SENT_286	[p17l1028t23r1188b98],
30	]	NN	O	]	nsubj	23	SENT_286	[p17l1028t23r1188b98],
31	.	.	O	.	_	0	SENT_286	[p17l1028t23r1188b98],

1	The	DT	O	the	det	3	SENT_287	[p17l1216t22r1354b85],
2	observed	VBN	O	observe	amod	3	SENT_287	[p17l1379t22r1701b85],
3	discrepancy	NN	O	discrepancy	_	0	SENT_287	[p17l1726t22r2151b103],
4	between	IN	O	between	_	0	SENT_287	[p17l6t133r306b196],
5	the	DT	O	the	det	8	SENT_287	[p17l339t133r447b196],
6	Pgp	NN	O	pgp	nn	8	SENT_287	[p17l483t135r619b214],
7	protein	NN	O	protein	nn	8	SENT_287	[p17l654t133r907b214],
8	expression	NN	O	expression	prep_between	3	SENT_287	[p17l943t133r1325b214],
9	and	CC	O	and	_	0	SENT_287	[p17l1361t133r1488b196],
10	Pgp	NN	O	pgp	nn	11	SENT_287	[p17l1521t135r1657b214],
11	functionality	NN	O	functionality	conj_and	8	SENT_287	[p17l1694t133r2151b214],

1	Cancer	NNP	O	Cancer	nn	3	SENT_288	[p17l53t289r152b314],
2	Chemother	NNP	PERSON	Chemother	nn	3	SENT_288	[p17l162t289r318b314],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_288	[p17l328t289r478b314],
4	(	CD	NUMBER	(	num	5	SENT_288	[p17l489t289r581b319],
5	2010	CD	DATE	2010	dep	3	SENT_288	[p17l489t289r581b319],
6	)	CD	NUMBER	)	number	7	SENT_288	[p17l489t289r581b319],
7	66:765	CD	NUMBER	66:765	num	8	SENT_288	[p17l592t289r757b314],
8	—	NN	O	—	dep	5	SENT_288	[p17l592t289r757b314],
9	771	CD	NUMBER	771	number	10	SENT_288	[p17l592t289r757b314],
10	771	CD	NUMBER	771	num	8	SENT_288	[p17l2055t289r2104b314],

1	after	IN	O	after	_	0	SENT_289	[p17l10t458r172b521],
2	treatment	NN	O	treatment	prep_after	8	SENT_289	[p17l226t468r563b521],
3	with	IN	O	with	_	0	SENT_289	[p17l618t458r775b521],
4	the	DT	O	the	det	5	SENT_289	[p17l831t458r938b521],
5	Vinca	NNP	O	Vinca	prep_with	2	SENT_289	[p17l999t461r1199b522],
6	alkaloids	NNS	O	alkaloid	nsubj	12	SENT_289	[p17l1258t458r1576b521],
7	is	VBZ	O	be	cop	8	SENT_289	[p17l1633t458r1688b521],
8	difficult	JJ	O	difficult	_	0	SENT_289	[p17l1747t456r2025b521],
9	to	TO	O	to	aux	10	SENT_289	[p17l2078t468r2146b521],
10	explain	VB	O	explain	xcomp	8	SENT_289	[p17l9t570r270b651],
11	and	CC	O	and	_	0	SENT_289	[p17l297t570r423b633],
12	requires	VBZ	O	require	conj_and	8	SENT_289	[p17l446t570r732b651],
13	further	JJ	O	further	amod	14	SENT_289	[p17l759t570r1001b633],
14	investigation	NN	O	investigation	dobj	12	SENT_289	[p17l1025t570r1505b651],
15	.	.	O	.	_	0	SENT_289	[p17l1025t570r1505b651],

1	Since	IN	O	since	mark	9	SENT_290	[p17l113t681r305b744],
2	activation	NN	O	activation	nsubjpass	9	SENT_290	[p17l339t681r683b744],
3	of	IN	O	of	_	0	SENT_290	[p17l714t681r792b744],
4	PXR	NN	O	pxr	prep_of	2	SENT_290	[p17l816t683r988b743],
5	by	IN	O	by	_	0	SENT_290	[p17l1015t681r1103b762],
6	anticancer	JJ	O	anticancer	amod	7	SENT_290	[p17l1136t681r1497b744],
7	drugs	NNS	O	drug	prep_by	4	SENT_290	[p17l1527t681r1719b762],
8	was	VBD	O	be	auxpass	9	SENT_290	[p17l1752t701r1886b744],
9	shown	VBN	O	show	advcl	20	SENT_290	[p17l1921t681r2147b744],
10	to	TO	O	to	aux	11	SENT_290	[p17l8t801r74b854],
11	affect	VB	O	affect	xcomp	9	SENT_290	[p17l125t789r314b854],
12	the	DT	O	the	det	13	SENT_290	[p17l360t791r467b854],
13	accumulation	NN	O	accumulation	dobj	11	SENT_290	[p17l517t791r989b854],
14	of	IN	O	of	_	0	SENT_290	[p17l1038t791r1114b854],
15	Pgp	NNP	ORGANIZATION	Pgp	nn	16	SENT_290	[p17l1157t793r1293b872],
16	substrates	NNS	O	substrate	prep_of	13	SENT_290	[p17l1345t791r1707b865],
17	,	,	O	,	_	0	SENT_290	[p17l1345t791r1707b865],
18	we	PRP	O	we	nsubj	20	SENT_290	[p17l1759t811r1859b854],
19	further	RB	O	further	advmod	20	SENT_290	[p17l1909t791r2148b854],
20	assessed	VBD	O	assess	_	0	SENT_290	[p17l10t903r306b966],
21	whether	IN	O	whether	complm	26	SENT_290	[p17l347t903r631b966],
22	PXR	NN	O	pxr	nn	23	SENT_290	[p17l670t905r841b965],
23	activation	NN	O	activation	nsubj	26	SENT_290	[p17l882t903r1227b966],
24	could	MD	O	could	aux	26	SENT_290	[p17l1268t903r1463b966],
25	also	RB	O	also	advmod	26	SENT_290	[p17l1504t903r1642b966],
26	attenuate	VB	O	attenuate	ccomp	20	SENT_290	[p17l1685t913r1999b966],
27	the	DT	O	the	det	29	SENT_290	[p17l2040t903r2146b966],
28	cytotoxic	JJ	O	cytotoxic	amod	29	SENT_290	[p17l9t1014r333b1095],
29	effects	NNS	O	effect	dobj	26	SENT_290	[p17l358t1012r579b1077],
30	of	IN	O	of	_	0	SENT_290	[p17l605t1014r681b1077],
31	doxorubicin	NN	O	doxorubicin	prep_of	29	SENT_290	[p17l698t1014r1141b1088],
32	,	,	O	,	_	0	SENT_290	[p17l698t1014r1141b1088],
33	a	DT	O	a	det	37	SENT_290	[p17l1168t1034r1205b1077],
34	known	JJ	O	known	amod	37	SENT_290	[p17l1225t1014r1466b1077],
35	cytotoxic	JJ	O	cytotoxic	amod	37	SENT_290	[p17l1489t1014r1814b1095],
36	Pgp	NN	O	pgp	nn	37	SENT_290	[p17l1838t1016r1972b1095],
37	substrate	NN	O	substrate	appos	31	SENT_290	[p17l1999t1014r2142b1077, p17l11t1136r215b1189],
38	.	.	O	.	_	0	SENT_290	[p17l1999t1014r2142b1077, p17l11t1136r215b1189],

1	However	RB	O	however	advmod	23	SENT_291	[p17l249t1128r590b1200],
2	,	,	O	,	_	0	SENT_291	[p17l249t1128r590b1200],
3	to	TO	O	to	aux	4	SENT_291	[p17l621t1136r688b1189],
4	avoid	VB	O	avoid	purpcl	23	SENT_291	[p17l720t1126r912b1189],
5	potential	JJ	O	potential	amod	7	SENT_291	[p17l940t1126r1248b1207],
6	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_291	[p17l1276t1126r1928b1207],
7	interactions	NNS	O	interaction	dobj	4	SENT_291	[p17l1958t1126r2144b1189, p17l10t1237r255b1300],
8	between	IN	O	between	_	0	SENT_291	[p17l343t1237r638b1300],
9	the	DT	O	the	det	12	SENT_291	[p17l725t1237r831b1300],
10	selected	VBN	O	select	amod	12	SENT_291	[p17l922t1237r1203b1300],
11	anticancer	JJ	O	anticancer	amod	12	SENT_291	[p17l1292t1237r1653b1300],
12	drugs	NNS	O	drug	prep_between	7	SENT_291	[p17l1739t1237r1931b1318],
13	and	CC	O	and	_	0	SENT_291	[p17l2023t1237r2148b1300],
14	doxorubicin	NN	O	doxorubicin	conj_and	12	SENT_291	[p17l9t1348r432b1411],
15	that	WDT	O	that	nsubj	17	SENT_291	[p17l475t1348r608b1411],
16	could	MD	O	could	aux	17	SENT_291	[p17l649t1348r844b1411],
17	lead	VB	O	lead	rcmod	14	SENT_291	[p17l887t1348r1033b1411],
18	to	TO	O	to	_	0	SENT_291	[p17l1075t1358r1140b1411],
19	increased	VBN	O	increase	amod	20	SENT_291	[p17l1184t1348r1517b1411],
20	cytotoxicity	NN	O	cytotoxicity	prep_to	17	SENT_291	[p17l1560t1348r1998b1429],
21	,	,	O	,	_	0	SENT_291	[p17l1560t1348r1998b1429],
22	we	PRP	O	we	nsubj	23	SENT_291	[p17l2044t1368r2146b1411],
23	chose	VBD	O	choose	_	0	SENT_291	[p17l9t1459r208b1522],
24	to	TO	O	to	aux	25	SENT_291	[p17l233t1469r298b1522],
25	pretreat	VB	O	pretreat	xcomp	23	SENT_291	[p17l324t1469r595b1540],
26	the	DT	O	the	det	27	SENT_291	[p17l619t1459r725b1522],
27	cells	NNS	O	cell	dobj	25	SENT_291	[p17l752t1459r909b1522],
28	with	IN	O	with	_	0	SENT_291	[p17l937t1459r1093b1522],
29	the	DT	O	the	det	33	SENT_291	[p17l1117t1459r1223b1522],
30	prototypical	JJ	O	prototypical	amod	33	SENT_291	[p17l1247t1459r1671b1540],
31	PXR	NN	O	pxr	nn	33	SENT_291	[p17l1697t1461r1868b1521],
32	agonist	NN	O	agonist	nn	33	SENT_291	[p17l1895t1459r2148b1540],
33	rifampicin	NN	O	rifampicin	prep_with	25	SENT_291	[p17l7t1570r390b1651],
34	.	.	O	.	_	0	SENT_291	[p17l7t1570r390b1651],

1	Indeed	RB	O	indeed	advmod	9	SENT_292	[p17l465t1570r723b1644],
2	,	,	O	,	_	0	SENT_292	[p17l465t1570r723b1644],
3	pretreatment	NN	O	pretreatment	nsubj	22	SENT_292	[p17l796t1580r1243b1651],
4	of	IN	O	of	_	0	SENT_292	[p17l1313t1570r1390b1633],
5	LSl80	NN	O	lsl80	nn	6	SENT_292	[p17l1454t1571r1689b1633],
6	cells	NNS	O	cell	prep_of	3	SENT_292	[p17l1760t1570r1918b1633],
7	with	IN	O	with	_	0	SENT_292	[p17l1990t1570r2146b1633],
8	rifampicin	NN	O	rifampicin	prep_with	6	SENT_292	[p17l7t1681r373b1762],
9	decreased	VBD	O	decrease	_	0	SENT_292	[p17l415t1681r762b1744],
10	the	DT	O	the	det	12	SENT_292	[p17l802t1681r908b1744],
11	intracellular	JJ	O	intracellular	amod	12	SENT_292	[p17l948t1681r1373b1744],
12	accumulation	NN	O	accumulation	dobj	9	SENT_292	[p17l1414t1681r1887b1744],
13	of	IN	O	of	_	0	SENT_292	[p17l1929t1681r2005b1744],
14	the	DT	O	the	det	18	SENT_292	[p17l2040t1681r2146b1744],
15	cytotoxic	JJ	O	cytotoxic	amod	18	SENT_292	[p17l9t1791r333b1872],
16	Pgp	NN	O	pgp	nn	18	SENT_292	[p17l359t1793r493b1872],
17	substrate	NN	O	substrate	nn	18	SENT_292	[p17l522t1791r830b1854],
18	doxorubicin	NN	O	doxorubicin	prep_of	12	SENT_292	[p17l856t1791r1279b1854],
19	and	CC	O	and	_	0	SENT_292	[p17l1305t1791r1430b1854],
20	additionally	RB	O	additionally	advmod	9	SENT_292	[p17l1456t1791r1873b1872],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_292	[p17l1901t1789r2143b1872, p17l9t1902r222b1983],
22	reduced	VBD	O	reduce	conj_and	9	SENT_292	[p17l261t1902r542b1965],
23	the	DT	O	the	det	25	SENT_292	[p17l582t1902r688b1965],
24	cytotoxic	JJ	O	cytotoxic	amod	25	SENT_292	[p17l729t1902r1053b1983],
25	efficacy	NN	O	efficacy	dobj	22	SENT_292	[p17l1096t1900r1366b1983],
26	of	IN	O	of	_	0	SENT_292	[p17l1408t1902r1484b1965],
27	this	DT	O	this	det	28	SENT_292	[p17l1518t1902r1641b1965],
28	agent	NN	O	agent	prep_of	25	SENT_292	[p17l1685t1912r1891b1983],
29	.	.	O	.	_	0	SENT_292	[p17l1685t1912r1891b1983],

1	These	DT	O	these	det	2	SENT_293	[p17l1936t1902r2145b1965],
2	results	NNS	O	result	nsubj	3	SENT_293	[p17l7t2014r235b2077],
3	indicate	VBP	O	indicate	_	0	SENT_293	[p17l265t2014r542b2077],
4	that	IN	O	that	complm	9	SENT_293	[p17l571t2014r703b2077],
5	activation	NN	O	activation	nsubj	9	SENT_293	[p17l733t2014r1077b2077],
6	of	IN	O	of	_	0	SENT_293	[p17l1106t2014r1183b2077],
7	PXR	NN	O	pxr	nn	8	SENT_293	[p17l1205t2014r1730b2077],
8	—	NN	O	—	prep_of	5	SENT_293	[p17l1205t2014r1730b2077],
9	mediated	VBD	O	mediate	ccomp	3	SENT_293	[p17l1205t2014r1730b2077],
10	Pgp	NNP	O	Pgp	nn	11	SENT_293	[p17l1758t2016r1893b2095],
11	induction	NN	O	induction	nsubj	16	SENT_293	[p17l1921t2014r2143b2077, p17l8t2125r144b2188],
12	by	IN	O	by	_	0	SENT_293	[p17l183t2125r269b2206],
13	anticancer	JJ	O	anticancer	amod	14	SENT_293	[p17l313t2125r674b2188],
14	drugs	NNS	O	drug	prep_by	11	SENT_293	[p17l712t2125r904b2206],
15	can	MD	O	can	aux	16	SENT_293	[p17l947t2145r1068b2188],
16	underlie	VB	O	underlie	ccomp	9	SENT_293	[p17l1107t2125r1394b2188],
17	the	DT	O	the	det	18	SENT_293	[p17l1435t2125r1540b2188],
18	development	NN	O	development	dobj	16	SENT_293	[p17l1581t2125r2037b2206],
19	of	IN	O	of	_	0	SENT_293	[p17l2077t2125r2153b2188],
20	acquired	VBN	O	acquire	amod	21	SENT_293	[p17l10t2236r312b2317],
21	resistance	NN	O	resistance	prep_of	18	SENT_293	[p17l344t2236r708b2299],
22	.	.	O	.	_	0	SENT_293	[p17l344t2236r708b2299],

1	This	DT	O	this	nsubj	3	SENT_294	[p17l746t2236r900b2299],
2	is	VBZ	O	be	cop	3	SENT_294	[p17l936t2236r990b2299],
3	further	JJ	O	further	_	0	SENT_294	[p17l1026t2236r1266b2299],
4	supported	VBN	O	support	ccomp	3	SENT_294	[p17l1300t2236r1645b2317],
5	by	IN	O	by	_	0	SENT_294	[p17l1676t2236r1764b2317],
6	studies	NNS	O	study	prep_by	4	SENT_294	[p17l1800t2236r2039b2299],
7	of	IN	O	of	_	0	SENT_294	[p17l2075t2236r2152b2299],
8	Chen	NNP	LOCATION	Chen	dep	11	SENT_294	[p17l9t2347r194b2410],
9	et	FW	O	et	nn	11	SENT_294	[p17l227t2357r290b2410],
10	al.	FW	O	al.	nn	11	SENT_294	[p17l314t2347r391b2410],
11	[	FW	O	[	prepc_of	6	SENT_294	[p17l435t2348r523b2423],
12	9	CD	NUMBER	9	num	13	SENT_294	[p17l435t2348r523b2423],
13	]	NN	O	]	dep	6	SENT_294	[p17l435t2348r523b2423],
14	and	CC	O	and	_	0	SENT_294	[p17l564t2347r688b2410],
15	Gupta	NNP	PERSON	Gupta	dep	18	SENT_294	[p17l722t2348r937b2428],
16	et	FW	O	et	nn	18	SENT_294	[p17l969t2357r1032b2410],
17	al.	FW	O	al.	nn	18	SENT_294	[p17l1056t2347r1133b2410],
18	[	FW	O	[	conj_and	4	SENT_294	[p17l1177t2348r1335b2423],
19	17	CD	NUMBER	17	num	20	SENT_294	[p17l1177t2348r1335b2423],
20	]	NN	O	]	dep	3	SENT_294	[p17l1177t2348r1335b2423],
21	,	,	O	,	_	0	SENT_294	[p17l1177t2348r1335b2423],
22	who	WP	O	who	nsubj	24	SENT_294	[p17l1372t2347r1520b2410],
23	have	VBP	O	have	aux	24	SENT_294	[p17l1554t2347r1720b2410],
24	shown	VBN	O	show	rcmod	20	SENT_294	[p17l1757t2347r1983b2410],
25	that	IN	O	that	complm	29	SENT_294	[p17l2015t2347r2148b2410],
26	activation	NN	O	activation	nsubj	29	SENT_294	[p17l10t2458r354b2521],
27	of	IN	O	of	_	0	SENT_294	[p17l389t2458r465b2521],
28	PXR	NN	O	pxr	prep_of	26	SENT_294	[p17l493t2460r664b2520],
29	promotes	VBZ	O	promote	ccomp	24	SENT_294	[p17l696t2468r1022b2539],
30	the	DT	O	the	det	33	SENT_294	[p17l1057t2458r1163b2521],
31	multidrug	JJ	O	multidrug	amod	32	SENT_294	[p17l1197t2458r1543b2539],
32	resistant	JJ	O	resistant	amod	33	SENT_294	[p17l1576t2458r1871b2521],
33	phenotype	NN	O	phenotype	dobj	29	SENT_294	[p17l1901t2458r2143b2539, p17l8t2579r158b2650],
34	of	IN	O	of	_	0	SENT_294	[p17l184t2569r260b2632],
35	prostate	NN	O	prostate	nn	40	SENT_294	[p17l277t2579r555b2650],
36	and	CC	O	and	_	0	SENT_294	[p17l580t2569r705b2632],
37	ovarian	JJ	O	ovarian	conj_and	35	SENT_294	[p17l730t2569r992b2632],
38	cancer	NN	O	cancer	nn	40	SENT_294	[p17l1016t2589r1246b2632],
39	cell	NN	O	cell	nn	40	SENT_294	[p17l1270t2569r1393b2632],
40	lines	NNS	O	line	prep_of	33	SENT_294	[p17l1418t2569r1601b2643],
41	,	,	O	,	_	0	SENT_294	[p17l1418t2569r1601b2643],
42	respectively	RB	O	respectively	advmod	3	SENT_294	[p17l1628t2569r2072b2650],
43	.	.	O	.	_	0	SENT_294	[p17l1628t2569r2072b2650],

1	Since	IN	O	since	mark	5	SENT_295	[p17l113t2680r308b2743],
2	Pgp	NNP	ORGANIZATION	Pgp	nsubj	5	SENT_295	[p17l332t2682r469b2761],
3	is	VBZ	O	be	cop	5	SENT_295	[p17l494t2680r549b2743],
4	co	NN	O	co	nn	5	SENT_295	[p17l577t2680r1043b2761],
5	—	NN	O	—	advcl	26	SENT_295	[p17l577t2680r1043b2761],
6	expressed	VBN	O	express	partmod	5	SENT_295	[p17l577t2680r1043b2761],
7	with	IN	O	with	_	0	SENT_295	[p17l1067t2680r1225b2743],
8	PXR	NN	O	pxr	prep_with	6	SENT_295	[p17l1249t2682r1423b2742],
9	in	IN	O	in	_	0	SENT_295	[p17l1447t2680r1514b2742],
10	important	JJ	O	important	amod	12	SENT_295	[p17l1539t2680r1887b2761],
11	barrier	NN	O	barrier	nn	12	SENT_295	[p17l1908t2680r2149b2743],
12	tissues	NNS	O	tissue	prep_in	8	SENT_295	[p17l8t2791r265b2865],
13	,	,	O	,	_	0	SENT_295	[p17l8t2791r265b2865],
14	such	JJ	O	such	_	0	SENT_295	[p17l310t2791r470b2853],
15	as	IN	O	as	_	0	SENT_295	[p17l511t2811r579b2853],
16	the	DT	O	the	det	17	SENT_295	[p17l621t2791r728b2853],
17	intestines	NNS	O	intestine	prep_such_as	8	SENT_295	[p17l767t2791r1103b2853],
18	and	CC	O	and	_	0	SENT_295	[p17l1146t2791r1272b2853],
19	the	DT	O	the	det	20	SENT_295	[p17l1311t2791r1418b2853],
20	liver	NN	O	liver	prep_such_as	8	SENT_295	[p17l1458t2791r1639b2865],
21	,	,	O	,	_	0	SENT_295	[p17l1458t2791r1639b2865],
22	activation	NN	O	activation	nsubj	26	SENT_295	[p17l1684t2791r2034b2853],
23	of	IN	O	of	_	0	SENT_295	[p17l2074t2791r2152b2853],
24	PXR	NN	O	pxr	nn	25	SENT_295	[p17l8t2901r540b2964],
25	—	NN	O	—	prep_of	22	SENT_295	[p17l8t2901r540b2964],
26	mediated	VBD	O	mediate	_	0	SENT_295	[p17l8t2901r540b2964],
27	Pgp	NNP	ORGANIZATION	Pgp	nn	28	SENT_295	[p17l570t2903r706b2982],
28	induction	NN	O	induction	nsubj	30	SENT_295	[p17l738t2901r1075b2964],
29	could	MD	O	could	aux	30	SENT_295	[p17l1107t2901r1303b2964],
30	affect	VB	O	affect	ccomp	26	SENT_295	[p17l1335t2899r1527b2964],
31	the	DT	O	the	det	33	SENT_295	[p17l1556t2901r1663b2964],
32	pharmacokinetic	JJ	O	pharmacokinetic	amod	33	SENT_295	[p17l1693t2901r2143b2982, p17l8t3012r179b3075],
33	proﬁle	NN	O	proﬁle	dobj	30	SENT_295	[p17l216t3010r448b3093],
34	of	IN	O	of	_	0	SENT_295	[p17l488t3012r564b3075],
35	(	CD	NUMBER	(	num	39	SENT_295	[p17l598t3012r790b3089],
36	oral	JJ	O	oral	amod	39	SENT_295	[p17l598t3012r790b3089],
37	)	NN	O	)	nn	39	SENT_295	[p17l598t3012r790b3089],
38	anticancer	JJ	O	anticancer	amod	39	SENT_295	[p17l830t3012r1198b3075],
39	drugs	NNS	O	drug	prep_of	33	SENT_295	[p17l1233t3012r1447b3093],
40	.	.	O	.	_	0	SENT_295	[p17l1233t3012r1447b3093],

1	Indeed	RB	O	indeed	advmod	11	SENT_296	[p17l1489t3012r1750b3086],
2	,	,	O	,	_	0	SENT_296	[p17l1489t3012r1750b3086],
3	drug-drug	JJ	O	drug-drug	amod	4	SENT_296	[p17l1790t3012r2145b3093],
4	interactions	NNS	O	interaction	nsubj	11	SENT_296	[p17l8t3124r422b3187],
5	as	IN	O	as	_	0	SENT_296	[p17l474t3144r543b3187],
6	a	DT	O	a	det	7	SENT_296	[p17l594t3144r631b3187],
7	result	NN	O	result	prep_as	4	SENT_296	[p17l678t3124r877b3187],
8	of	IN	O	of	_	0	SENT_296	[p17l925t3124r1002b3187],
9	PXR	NN	O	pxr	nn	10	SENT_296	[p17l1044t3124r1575b3187],
10	—	NN	O	—	prep_of	7	SENT_296	[p17l1044t3124r1575b3187],
11	mediated	VBD	O	mediate	_	0	SENT_296	[p17l1044t3124r1575b3187],
12	Pgp	NNP	O	Pgp	nn	13	SENT_296	[p17l1623t3126r1759b3205],
13	induction	NN	O	induction	nsubjpass	16	SENT_296	[p17l1809t3124r2146b3187],
14	have	VBP	O	have	aux	16	SENT_296	[p17l7t3235r174b3298],
15	been	VBN	O	be	auxpass	16	SENT_296	[p17l201t3235r370b3298],
16	reported	VBN	O	report	ccomp	11	SENT_296	[p17l397t3235r712b3316],
17	.	.	O	.	_	0	SENT_296	[p17l397t3235r712b3316],

1	For	IN	O	for	_	0	SENT_297	[p17l743t3237r868b3298],
2	instance	NN	O	instance	prep_for	21	SENT_297	[p17l894t3235r1205b3309],
3	,	,	O	,	_	0	SENT_297	[p17l894t3235r1205b3309],
4	intake	NN	O	intake	nsubj	21	SENT_297	[p17l1236t3235r1452b3298],
5	of	IN	O	of	_	0	SENT_297	[p17l1481t3235r1559b3298],
6	St.	NNP	O	St.	nn	7	SENT_297	[p17l1583t3236r1670b3298],
7	John	NNP	PERSON	John	poss	9	SENT_297	[p17l1702t3235r1932b3298],
8	’s	POS	O	’s	_	0	SENT_297	[p17l1702t3235r1932b3298],
9	wort	NN	O	wort	prep_of	4	SENT_297	[p17l1962t3244r2142b3309],
10	,	,	O	,	_	0	SENT_297	[p17l1962t3244r2142b3309],
11	which	WDT	O	which	nsubj	12	SENT_297	[p17l8t3346r225b3409],
12	contains	VBZ	O	contain	rcmod	9	SENT_297	[p17l250t3346r544b3409],
13	the	DT	O	the	det	16	SENT_297	[p17l571t3346r678b3409],
14	PXR	NN	O	pxr	nn	16	SENT_297	[p17l703t3348r876b3408],
15	agonist	NN	O	agonist	nn	16	SENT_297	[p17l902t3346r1158b3427],
16	hyperforin	NN	O	hyperforin	dobj	12	SENT_297	[p17l1181t3346r1576b3427],
17	,	,	O	,	_	0	SENT_297	[p17l1181t3346r1576b3427],
18	by	IN	O	by	_	0	SENT_297	[p17l1604t3346r1691b3427],
19	healthy	JJ	O	healthy	amod	20	SENT_297	[p17l1716t3346r1978b3427],
20	volunteers	NNS	O	volunteer	prep_by	12	SENT_297	[p17l2003t3346r2143b3409, p17l7t3467r262b3520],
21	resulted	VBD	O	result	_	0	SENT_297	[p17l294t3457r577b3520],
22	in	IN	O	in	_	0	SENT_297	[p17l606t3457r674b3519],
23	a	DT	O	a	det	25	SENT_297	[p17l706t3477r742b3520],
24	1.9-fold	JJ	O	1.9-fold	amod	25	SENT_297	[p17l780t3457r1056b3521],
25	increase	NN	O	increase	prep_in	21	SENT_297	[p17l1085t3457r1377b3520],
26	in	IN	O	in	_	0	SENT_297	[p17l1407t3457r1475b3519],
27	the	DT	O	the	det	29	SENT_297	[p17l1505t3457r1612b3520],
28	oral	JJ	O	oral	amod	29	SENT_297	[p17l1643t3457r1778b3520],
29	clearance	NN	O	clearance	prep_in	25	SENT_297	[p17l1810t3457r2145b3520],
30	of	IN	O	of	_	0	SENT_297	[p17l9t3569r87b3632],
31	the	DT	O	the	det	34	SENT_297	[p17l123t3569r229b3632],
32	Pgp	NNP	O	Pgp	nn	34	SENT_297	[p17l273t3571r409b3650],
33	substrate	NN	O	substrate	nn	34	SENT_297	[p17l457t3569r769b3632],
34	fexofenadine	NN	O	fexofenadine	prep_of	29	SENT_297	[p17l812t3569r1278b3632],
35	[	CD	NUMBER	[	number	36	SENT_297	[p17l1328t3570r1488b3645],
36	19	CD	NUMBER	19	num	37	SENT_297	[p17l1328t3570r1488b3645],
37	]	NN	O	]	dobj	21	SENT_297	[p17l1328t3570r1488b3645],
38	,	,	O	,	_	0	SENT_297	[p17l1328t3570r1488b3645],
39	while	IN	O	while	mark	42	SENT_297	[p17l1535t3569r1730b3632],
40	rifampicin	NN	O	rifampicin	nn	41	SENT_297	[p17l1772t3569r2146b3650],
41	pretreatment	NN	O	pretreatment	nsubj	42	SENT_297	[p17l7t3690r461b3761],
42	resulted	VBD	O	result	dep	37	SENT_297	[p17l497t3680r780b3743],
43	in	IN	O	in	_	0	SENT_297	[p17l818t3680r885b3742],
44	a	DT	O	a	quantmod	45	SENT_297	[p17l925t3700r962b3743],
45	1.3	CD	NUMBER	1.3	prep_in	42	SENT_297	[p17l1007t3681r1135b3743],
46	-	:	O	-	_	0	SENT_297	[p17l1007t3681r1135b3743],
47	to	TO	O	to	_	0	SENT_297	[p17l1176t3690r1242b3743],
48	5.3	CD	NUMBER	5.3	number	49	SENT_297	[p17l1282t3680r1566b3743],
49	—	CD	NUMBER	—	num	51	SENT_297	[p17l1282t3680r1566b3743],
50	fold	JJ	O	fold	amod	51	SENT_297	[p17l1282t3680r1566b3743],
51	increase	NN	O	increase	prep_to	45	SENT_297	[p17l1603t3680r1894b3743],
52	in	IN	O	in	_	0	SENT_297	[p17l1933t3680r2000b3742],
53	the	DT	O	the	det	55	SENT_297	[p17l2038t3680r2144b3743],
54	oral	JJ	O	oral	amod	55	SENT_297	[p18l9t21r144b83],
55	clearance	NN	O	clearance	prep_in	42	SENT_297	[p18l184t21r520b83],
56	of	IN	O	of	_	0	SENT_297	[p18l560t21r636b83],
57	fexofenadine	NN	O	fexofenadine	prep_of	55	SENT_297	[p18l669t21r1134b83],
58	[	CD	NUMBER	[	number	59	SENT_297	[p18l1179t22r1338b96],
59	20	CD	NUMBER	20	num	60	SENT_297	[p18l1179t22r1338b96],
60	]	NN	O	]	dep	42	SENT_297	[p18l1179t22r1338b96],
61	.	.	O	.	_	0	SENT_297	[p18l1179t22r1338b96],

1	In	IN	O	in	_	0	SENT_298	[p18l1380t23r1452b82],
2	the	DT	O	the	det	4	SENT_298	[p18l1491t21r1598b83],
3	same	JJ	O	same	amod	4	SENT_298	[p18l1639t41r1818b83],
4	manner	NN	O	manner	prep_in	12	SENT_298	[p18l1856t41r2141b95],
5	,	,	O	,	_	0	SENT_298	[p18l1856t41r2141b95],
6	anticancer	JJ	O	anticancer	amod	7	SENT_298	[p18l10t131r376b194],
7	drugs	NNS	O	drug	nsubj	12	SENT_298	[p18l410t131r604b212],
8	that	WDT	O	that	nsubj	9	SENT_298	[p18l640t131r774b194],
9	activate	VBP	O	activate	rcmod	7	SENT_298	[p18l809t131r1085b194],
10	PXR	NN	O	pxr	dobj	9	SENT_298	[p18l1120t133r1294b193],
11	might	MD	O	might	aux	12	SENT_298	[p18l1328t131r1536b212],
12	affect	VB	O	affect	_	0	SENT_298	[p18l1571t129r1763b194],
13	their	PRP$	O	they	poss	15	SENT_298	[p18l1796t131r1960b194],
14	own	JJ	O	own	amod	15	SENT_298	[p18l1995t151r2146b194],
15	pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_298	[p18l7t243r657b324],
16	,	,	O	,	_	0	SENT_298	[p18l7t243r657b324],
17	but	CC	O	but	_	0	SENT_298	[p18l715t243r830b306],
18	also	RB	O	also	_	0	SENT_298	[p18l886t243r1025b306],
19	that	DT	O	that	dobj	12	SENT_298	[p18l1082t243r1215b306],
20	of	IN	O	of	_	0	SENT_298	[p18l1270t243r1347b306],
21	other	JJ	O	other	prep_of	19	SENT_298	[p18l1398t243r1580b306],
22	concomitantly	RB	O	concomitantly	advmod	23	SENT_298	[p18l1635t243r2145b324],
23	administered	VBN	O	administer	partmod	21	SENT_298	[p18l10t354r471b417],
24	(	NN	O	(	nn	27	SENT_298	[p18l497t354r918b431],
25	anticancer	JJ	O	anticancer	amod	27	SENT_298	[p18l497t354r918b431],
26	)	NN	O	)	nn	27	SENT_298	[p18l497t354r918b431],
27	drugs	NNS	O	drug	dobj	23	SENT_298	[p18l948t354r1161b435],
28	.	.	O	.	_	0	SENT_298	[p18l948t354r1161b435],

1	In	IN	O	in	_	0	SENT_299	[p18l110t467r183b527],
2	conclusion	NN	O	conclusion	prep_in	10	SENT_299	[p18l207t465r612b539],
3	,	,	O	,	_	0	SENT_299	[p18l207t465r612b539],
4	several	JJ	O	several	nsubjpass	10	SENT_299	[p18l641t465r890b528],
5	widely	RB	O	widely	advmod	6	SENT_299	[p18l914t465r1155b546],
6	used	VBN	O	use	partmod	4	SENT_299	[p18l1179t465r1342b528],
7	anticancer	JJ	O	anticancer	amod	8	SENT_299	[p18l1366t465r1733b528],
8	drugs	NNS	O	drug	dobj	6	SENT_299	[p18l1755t465r1949b546],
9	were	VBD	O	be	auxpass	10	SENT_299	[p18l1974t485r2145b528],
10	shown	VBN	O	show	_	0	SENT_299	[p18l11t576r240b639],
11	to	TO	O	to	aux	12	SENT_299	[p18l276t586r343b639],
12	activate	VB	O	activate	xcomp	10	SENT_299	[p18l382t576r657b639],
13	PXR	NN	O	pxr	nn	14	SENT_299	[p18l695t576r1228b639],
14	—	NN	O	—	nsubj	15	SENT_299	[p18l695t576r1228b639],
15	mediated	VBD	O	mediate	dep	12	SENT_299	[p18l695t576r1228b639],
16	Pgp	NNP	O	Pgp	nn	17	SENT_299	[p18l1263t578r1399b657],
17	induction	NN	O	induction	dobj	15	SENT_299	[p18l1438t576r1794b651],
18	,	,	O	,	_	0	SENT_299	[p18l1438t576r1794b651],
19	and	CC	O	and	_	0	SENT_299	[p18l1836t576r1962b639],
20	as	IN	O	as	mark	23	SENT_299	[p18l2001t596r2069b639],
21	a	DT	O	a	det	22	SENT_299	[p18l2110t596r2147b639],
22	result	NN	O	result	nsubj	23	SENT_299	[p18l7t686r207b749],
23	affect	VB	O	affect	dep	12	SENT_299	[p18l252t684r444b749],
24	the	DT	O	the	det	26	SENT_299	[p18l488t686r595b749],
25	intracellular	JJ	O	intracellular	amod	26	SENT_299	[p18l640t686r1074b749],
26	accumulation	NN	O	accumulation	dobj	23	SENT_299	[p18l1119t686r1598b749],
27	and	CC	O	and	_	0	SENT_299	[p18l1645t686r1770b749],
28	cytotoxic	JJ	O	cytotoxic	amod	29	SENT_299	[p18l1815t686r2145b767],
29	activity	NN	O	activity	dobj	23	SENT_299	[p18l10t798r274b879],
30	of	IN	O	of	_	0	SENT_299	[p18l301t798r378b861],
31	Pgp	NNP	O	Pgp	nn	32	SENT_299	[p18l397t800r534b879],
32	substrates	NNS	O	substrate	prep_of	26	SENT_299	[p18l562t798r929b861],
33	.	.	O	.	_	0	SENT_299	[p18l562t798r929b861],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	5	SENT_300	[p18l7t1008r602b1077],
2	The	DT	O	the	det	3	SENT_300	[p18l683t1009r799b1062],
3	authors	NNS	O	author	dep	1	SENT_300	[p18l822t1009r1041b1062],
4	would	MD	O	would	aux	5	SENT_300	[p18l1063t1009r1252b1062],
5	like	VB	O	like	_	0	SENT_300	[p18l1272t1009r1384b1062],
6	to	TO	O	to	aux	7	SENT_300	[p18l1405t1017r1461b1062],
7	thank	VB	O	thank	xcomp	5	SENT_300	[p18l1482t1009r1652b1062],
8	the	DT	O	the	det	9	SENT_300	[p18l1670t1009r1761b1062],
9	Maurits	NNP	PERSON	Maurits	dobj	7	SENT_300	[p18l1782t1009r2016b1062],
10	and	CC	O	and	_	0	SENT_300	[p18l2039t1009r2146b1062],
11	Anna	NNP	PERSON	Anna	nn	13	SENT_300	[p18l8t1100r172b1152],
12	de	IN	PERSON	de	amod	13	SENT_300	[p18l207t1099r275b1152],
13	Kock	NNP	PERSON	Kock	dobj	7	SENT_300	[p18l312t1099r475b1152],
14	foundation	NN	O	foundation	tmod	7	SENT_300	[p18l508t1099r837b1152],
15	and	CC	O	and	_	0	SENT_300	[p18l873t1099r980b1152],
16	the	DT	O	the	det	18	SENT_300	[p18l1014t1099r1105b1152],
17	Nijbakker-Morra	NNP	LOCATION	Nijbakker-Morra	nn	18	SENT_300	[p18l1140t1099r1661b1167],
18	foundation	NN	O	foundation	tmod	7	SENT_300	[p18l1695t1099r2023b1152],
19	for	IN	O	for	_	0	SENT_300	[p18l2059t1099r2147b1152],
20	ﬁnancially	RB	O	ﬁnancially	advmod	21	SENT_300	[p18l9t1185r326b1255],
21	supporting	VBG	O	support	prepc_for	5	SENT_300	[p18l351t1187r672b1255],
22	this	DT	O	this	det	23	SENT_300	[p18l695t1187r801b1240],
23	study	NN	O	study	dobj	21	SENT_300	[p18l827t1187r1003b1255],
24	.	.	O	.	_	0	SENT_300	[p18l827t1187r1003b1255],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_301	[p18l10t1373r265b1429],
2	of	IN	O	of	_	0	SENT_301	[p18l286t1374r352b1428],
3	interest	NN	O	interest	nn	5	SENT_301	[p18l368t1374r613b1428],
4	statement	NN	O	statement	nn	5	SENT_301	[p18l634t1379r950b1428],
5	None	NN	O	none	prep_of	1	SENT_301	[p18l1027t1376r1206b1428],
6	.	.	O	.	_	0	SENT_301	[p18l1027t1376r1206b1428],

1	Open	NNP	O	Open	nn	2	SENT_302	[p18l9t1554r184b1623],
2	Access	NN	O	access	nsubj	31	SENT_302	[p18l209t1555r422b1608],
3	This	DT	O	this	det	4	SENT_302	[p18l503t1555r635b1608],
4	article	NN	O	article	nsubjpass	6	SENT_302	[p18l664t1555r852b1608],
5	is	VBZ	O	be	auxpass	6	SENT_302	[p18l877t1555r925b1608],
6	distributed	VBN	O	distribute	parataxis	31	SENT_302	[p18l953t1555r1277b1608],
7	under	IN	O	under	_	0	SENT_302	[p18l1302t1555r1474b1608],
8	the	DT	O	the	det	9	SENT_302	[p18l1499t1555r1590b1608],
9	terms	NNS	O	term	prep_under	6	SENT_302	[p18l1616t1563r1782b1608],
10	of	IN	O	of	_	0	SENT_302	[p18l1810t1555r1876b1608],
11	the	DT	O	the	det	16	SENT_302	[p18l1896t1555r1987b1608],
12	Creative	NNP	O	Creative	nn	16	SENT_302	[p18l2014t1556r2145b1608, p18l9t1644r153b1697],
13	Commons	NNPS	O	Commons	nn	16	SENT_302	[p18l189t1645r498b1697],
14	Attribution	NNP	O	Attribution	nn	16	SENT_302	[p18l534t1644r872b1697],
15	Noncommercial	NNP	O	Noncommercial	nn	16	SENT_302	[p18l905t1644r1396b1697],
16	License	NNP	O	License	prep_of	9	SENT_302	[p18l1430t1644r1666b1697],
17	which	WDT	O	which	nsubj	18	SENT_302	[p18l1700t1644r1885b1697],
18	permits	VBZ	O	permit	rcmod	16	SENT_302	[p18l1918t1644r2144b1712],
19	any	DT	O	any	det	21	SENT_302	[p18l9t1751r115b1802],
20	noncommercial	JJ	O	noncommercial	amod	21	SENT_302	[p18l133t1734r606b1787],
21	use	NN	O	use	dobj	18	SENT_302	[p18l623t1751r740b1797],
22	,	,	O	,	_	0	SENT_302	[p18l623t1751r740b1797],
23	distribution	NN	O	distribution	conj_and	21	SENT_302	[p18l761t1734r1127b1797],
24	,	,	O	,	_	0	SENT_302	[p18l761t1734r1127b1797],
25	and	CC	O	and	_	0	SENT_302	[p18l1149t1734r1256b1787],
26	reproduction	NN	O	reproduction	conj_and	21	SENT_302	[p18l1272t1734r1660b1802],
27	in	IN	O	in	_	0	SENT_302	[p18l1678t1734r1735b1786],
28	any	DT	O	any	det	29	SENT_302	[p18l1754t1751r1860b1802],
29	medium	NN	O	medium	prep_in	26	SENT_302	[p18l1878t1734r2143b1797],
30	,	,	O	,	_	0	SENT_302	[p18l1878t1734r2143b1797],
31	provided	VBD	O	provide	_	0	SENT_302	[p18l7t1823r277b1891],
32	the	DT	O	the	det	34	SENT_302	[p18l298t1823r389b1876],
33	original	JJ	O	original	amod	34	SENT_302	[p18l412t1823r646b1891],
34	author	NN	O	author	iobj	31	SENT_302	[p18l669t1823r939b1888],
35	(	CD	NUMBER	(	num	36	SENT_302	[p18l669t1823r939b1888],
36	s	NNS	O	s	dobj	31	SENT_302	[p18l669t1823r939b1888],
37	)	CD	NUMBER	)	nsubjpass	41	SENT_302	[p18l669t1823r939b1888],
38	and	CC	O	and	_	0	SENT_302	[p18l964t1823r1071b1876],
39	source	NN	O	source	nsubjpass	41	SENT_302	[p18l1094t1840r1289b1876],
40	are	VBP	O	be	auxpass	41	SENT_302	[p18l1312t1840r1401b1876],
41	credited	VBN	O	credit	rcmod	36	SENT_302	[p18l1424t1823r1682b1876],
42	.	.	O	.	_	0	SENT_302	[p18l1424t1823r1682b1876],

1	References	NNS	O	reference	_	0	SENT_303	[p18l9t2053r423b2117],

1	1	LS	NUMBER	1	_	0	SENT_304	[p18l54t2267r98b2319],
2	.	.	O	.	_	0	SENT_304	[p18l54t2267r98b2319],

1	Sinicrope	JJ	O	sinicrope	amod	2	SENT_305	[p18l140t2266r428b2334],
2	FA	NN	O	fa	nsubj	5	SENT_305	[p18l450t2267r546b2318],
3	et	FW	O	et	nn	5	SENT_305	[p18l568t2274r622b2319],
4	al	FW	O	al	nn	5	SENT_305	[p18l643t2266r694b2319],
5	(	FW	O	(	_	0	SENT_305	[p18l719t2266r915b2331],
6	1994	CD	DATE	1994	num	8	SENT_305	[p18l719t2266r915b2331],
7	)	NNP	O	)	nn	8	SENT_305	[p18l719t2266r915b2331],
8	Relationship	NN	O	relationship	dobj	5	SENT_305	[p18l940t2266r1321b2334],
9	of	IN	O	of	_	0	SENT_305	[p18l1345t2266r1410b2319],
10	P-glycoprotein	NN	O	p-glycoprotein	nn	14	SENT_305	[p18l1427t2266r1879b2334],
11	and	CC	O	and	_	0	SENT_305	[p18l1902t2266r2009b2319],
12	carcinoembryonic	JJ	O	carcinoembryonic	nn	14	SENT_305	[p18l2030t2283r2145b2319, p18l139t2355r593b2423],
13	antigen	NN	O	antigen	nn	14	SENT_305	[p18l625t2355r846b2423],
14	expression	NN	O	expression	prep_of	8	SENT_305	[p18l875t2355r1200b2423],
15	in	IN	O	in	_	0	SENT_305	[p18l1229t2355r1285b2407],
16	human	JJ	O	human	amod	18	SENT_305	[p18l1313t2355r1520b2408],
17	colon	NN	O	colon	nn	18	SENT_305	[p18l1549t2355r1716b2408],
18	carcinoma	NN	O	carcinoma	prep_in	14	SENT_305	[p18l1746t2355r2061b2408],
19	to	TO	O	to	_	0	SENT_305	[p18l2089t2363r2146b2408],
20	local	JJ	O	local	amod	21	SENT_305	[p18l132t2444r278b2497],
21	invasion	NN	O	invasion	prep_to	5	SENT_305	[p18l340t2444r614b2507],
22	,	,	O	,	_	0	SENT_305	[p18l340t2444r614b2507],
23	DNA	NN	O	dna	nn	24	SENT_305	[p18l681t2445r844b2497],
24	ploidy	NN	O	ploidy	prep_to	5	SENT_305	[p18l906t2444r1117b2512],
25	,	,	O	,	_	0	SENT_305	[p18l906t2444r1117b2512],
26	and	CC	O	and	_	0	SENT_305	[p18l1184t2444r1291b2497],
27	disease	NN	O	disease	nn	28	SENT_305	[p18l1354t2444r1572b2497],
28	relapse	NN	O	relapse	conj_and	21	SENT_305	[p18l1635t2444r1866b2512],
29	.	.	O	.	_	0	SENT_305	[p18l1635t2444r1866b2512],

1	Cancer	NNP	O	Cancer	_	0	SENT_306	[p18l1934t2444r2149b2497],
2	74	CD	NUMBER	74	num	1	SENT_306	[p18l132t2533r696b2598],
3	(	CD	NUMBER	(	number	4	SENT_306	[p18l132t2533r696b2598],
4	11	CD	NUMBER	11	num	5	SENT_306	[p18l132t2533r696b2598],
5	)	NN	O	)	dep	1	SENT_306	[p18l132t2533r696b2598],
6	:2908	CD	NUMBER	:2908	number	7	SENT_306	[p18l132t2533r696b2598],
7	—	CD	NUMBER	—	dep	1	SENT_306	[p18l132t2533r696b2598],
8	2917	CD	DATE	2917	dep	7	SENT_306	[p18l132t2533r696b2598],

1	2	LS	NUMBER	2	_	0	SENT_307	[p18l40t2623r91b2675],
2	.	.	O	.	_	0	SENT_307	[p18l40t2623r91b2675],

1	Sonneveld	JJ	O	sonneveld	amod	7	SENT_308	[p18l133t2622r453b2675],
2	P	NN	O	p	nn	7	SENT_308	[p18l469t2623r510b2674],
3	(	CD	NUMBER	(	num	7	SENT_308	[p18l530t2622r727b2687],
4	2000	CD	DATE	2000	num	7	SENT_308	[p18l530t2622r727b2687],
5	)	CD	NUMBER	)	num	7	SENT_308	[p18l530t2622r727b2687],
6	Multidrug	JJ	O	multidrug	amod	7	SENT_308	[p18l746t2622r1055b2690],
7	resistance	NN	O	resistance	_	0	SENT_308	[p18l1073t2622r1373b2675],
8	in	IN	O	in	dep	7	SENT_308	[p18l1391t2622r1448b2674],
9	haematological	JJ	O	haematological	amod	10	SENT_308	[p18l1465t2622r1932b2690],
10	malignancies	NNS	O	malignancy	pobj	8	SENT_308	[p18l1949t2622r2146b2690, p18l131t2711r374b2764],
11	.	.	O	.	_	0	SENT_308	[p18l1949t2622r2146b2690, p18l131t2711r374b2764],

1	J	NNP	O	J	nn	2	SENT_309	[p18l398t2712r426b2764],
2	Intern	NNP	O	Intern	nsubj	3	SENT_309	[p18l449t2712r630b2764],
3	Med	VBD	O	med	_	0	SENT_309	[p18l650t2711r790b2764],
4	247	CD	NUMBER	247	number	5	SENT_309	[p18l812t2711r1302b2776],
5	(	CD	NUMBER	(	dobj	3	SENT_309	[p18l812t2711r1302b2776],
6	5	CD	NUMBER	5	num	7	SENT_309	[p18l812t2711r1302b2776],
7	)	NN	O	)	dep	5	SENT_309	[p18l812t2711r1302b2776],
8	:52	CD	NUMBER	:52	num	9	SENT_309	[p18l812t2711r1302b2776],
9	l	NN	O	l	tmod	3	SENT_309	[p18l812t2711r1302b2776],
10	—	NN	O	—	dep	9	SENT_309	[p18l812t2711r1302b2776],
11	534	CD	NUMBER	534	num	10	SENT_309	[p18l812t2711r1302b2776],

1	3	LS	NUMBER	3	_	0	SENT_310	[p18l41t2801r91b2853],
2	.	.	O	.	_	0	SENT_310	[p18l41t2801r91b2853],

1	Punyammalee	NN	O	punyammalee	nn	2	SENT_311	[p18l131t2800r562b2868],
2	B	NN	O	b	nsubj	5	SENT_311	[p18l583t2801r627b2852],
3	et	FW	O	et	nn	5	SENT_311	[p18l651t2808r705b2853],
4	al	FW	O	al	nn	5	SENT_311	[p18l727t2800r778b2853],
5	(	FW	O	(	_	0	SENT_311	[p18l801t2800r998b2865],
6	1997	CD	DATE	1997	num	8	SENT_311	[p18l801t2800r998b2865],
7	)	NNP	O	)	nn	8	SENT_311	[p18l801t2800r998b2865],
8	Association	NNP	O	Association	dobj	5	SENT_311	[p18l1020t2800r1380b2853],
9	of	IN	O	of	_	0	SENT_311	[p18l1401t2800r1466b2853],
10	mdrl	NN	O	mdrl	nn	12	SENT_311	[p18l1480t2800r1634b2853],
11	gene	NN	O	gene	nn	12	SENT_311	[p18l1661t2817r1802b2868],
12	expression	NN	O	expression	prep_of	8	SENT_311	[p18l1822t2800r2148b2868],
13	with	IN	O	with	_	0	SENT_311	[p18l132t2889r265b2942],
14	other	JJ	O	other	amod	16	SENT_311	[p18l284t2889r440b2942],
15	prognostic	JJ	O	prognostic	amod	16	SENT_311	[p18l455t2889r776b2957],
16	factors	NNS	O	factor	prep_with	12	SENT_311	[p18l795t2889r1000b2942],
17	and	CC	O	and	_	0	SENT_311	[p18l1021t2889r1129b2942],
18	clinical	JJ	O	clinical	amod	19	SENT_311	[p18l1147t2889r1369b2942],
19	outcome	NN	O	outcome	conj_and	16	SENT_311	[p18l1388t2897r1649b2942],
20	in	IN	O	in	_	0	SENT_311	[p18l1667t2889r1724b2941],
21	human	JJ	O	human	amod	23	SENT_311	[p18l1742t2889r1948b2942],
22	breast	NN	O	breast	nn	23	SENT_311	[p18l1966t2889r2149b2942],
23	cancer	NN	O	cancer	prep_in	5	SENT_311	[p18l132t2995r344b3031],
24	.	.	O	.	_	0	SENT_311	[p18l132t2995r344b3031],

1	J	NNP	O	J	nn	4	SENT_312	[p18l369t2979r397b3031],
2	Med	NNP	O	Med	nn	4	SENT_312	[p18l418t2978r557b3031],
3	Assoc	NNP	O	Assoc	nn	4	SENT_312	[p18l579t2979r762b3031],
4	Thai	NNP	O	Thai	_	0	SENT_312	[p18l785t2978r923b3031],
5	80	CD	NUMBER	80	number	6	SENT_312	[p18l948t2978r1224b3046],
6	(	CD	NUMBER	(	num	7	SENT_312	[p18l948t2978r1224b3046],
7	Suppl	NN	O	suppl	dep	4	SENT_312	[p18l948t2978r1224b3046],
8	l	NN	O	l	tmod	7	SENT_312	[p18l1253t2978r1678b3043],
9	)	CD	NUMBER	)	dep	4	SENT_312	[p18l1253t2978r1678b3043],
10	:	:	O	:	_	0	SENT_312	[p18l1253t2978r1678b3043],
11	Sl62	NN	O	sl62	dep	9	SENT_312	[p18l1253t2978r1678b3043],
12	.	.	O	.	_	0	SENT_312	[p18l1253t2978r1678b3043],

1	—	NN	O	—	_	0	SENT_313	[p18l1253t2978r1678b3043],
2	.	.	O	.	_	0	SENT_313	[p18l1253t2978r1678b3043],

1	Sl73	NN	O	sl73	_	0	SENT_314	[p18l1253t2978r1678b3043],

1	4	LS	NUMBER	4	_	0	SENT_315	[p18l39t3067r91b3120],
2	.	.	O	.	_	0	SENT_315	[p18l39t3067r91b3120],

1	Synold	JJ	O	synold	amod	2	SENT_316	[p18l133t3067r346b3135],
2	TW	NNP	O	TW	nsubj	18	SENT_316	[p18l374t3068r507b3130],
3	,	,	O	,	_	0	SENT_316	[p18l374t3068r507b3130],
4	Dussault	NNP	PERSON	Dussault	dep	11	SENT_316	[p18l537t3067r805b3120],
5	I	PRP	O	I	dep	4	SENT_316	[p18l831t3068r871b3130],
6	,	,	O	,	_	0	SENT_316	[p18l831t3068r871b3130],
7	Forman	NNP	PERSON	Forman	appos	5	SENT_316	[p18l901t3068r1138b3120],
8	BM	NN	O	bm	dep	11	SENT_316	[p18l1166t3068r1281b3119],
9	(	CD	NUMBER	(	num	8	SENT_316	[p18l1313t3068r1511b3132],
10	2001	CD	DATE	2001	num	11	SENT_316	[p18l1313t3068r1511b3132],
11	)	CD	NUMBER	)	dep	18	SENT_316	[p18l1313t3068r1511b3132],
12	The	DT	O	the	det	13	SENT_316	[p18l1541t3067r1658b3120],
13	orphan	NN	O	orphan	dep	11	SENT_316	[p18l1687t3067r1896b3135],
14	nuclear	JJ	O	nuclear	amod	16	SENT_316	[p18l1924t3067r2149b3120],
15	receptor	NN	O	receptor	nn	16	SENT_316	[p18l130t3163r382b3223],
16	SXR	NN	O	sxr	nsubj	18	SENT_316	[p18l406t3155r552b3208],
17	coordinately	RB	O	coordinately	advmod	18	SENT_316	[p18l576t3155r957b3223],
18	regulates	VBZ	O	regulate	_	0	SENT_316	[p18l981t3155r1255b3223],
19	drug	NN	O	drug	nn	20	SENT_316	[p18l1282t3155r1418b3223],
20	metabolism	NN	O	metabolism	dobj	18	SENT_316	[p18l1443t3155r1800b3208],
21	and	CC	O	and	_	0	SENT_316	[p18l1825t3155r1932b3208],
22	eﬂlux	NN	O	eﬂlux	dobj	18	SENT_316	[p18l1957t3153r2144b3208],
23	.	.	O	.	_	0	SENT_316	[p18l1957t3153r2144b3208],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_317	[p18l131t3245r240b3297],
2	Med	NNP	O	Med	_	0	SENT_317	[p18l260t3244r400b3297],
3	7	CD	NUMBER	7	number	4	SENT_317	[p18l421t3244r835b3309],
4	(	CD	NUMBER	(	dep	2	SENT_317	[p18l421t3244r835b3309],
5	5	CD	NUMBER	5	num	6	SENT_317	[p18l421t3244r835b3309],
6	)	NN	O	)	dep	4	SENT_317	[p18l421t3244r835b3309],
7	:584	CD	NUMBER	:584	num	8	SENT_317	[p18l421t3244r835b3309],
8	—	NN	O	—	dep	4	SENT_317	[p18l421t3244r835b3309],
9	590	CD	NUMBER	590	dep	2	SENT_317	[p18l421t3244r835b3309],

1	5	CD	NUMBER	5	_	0	SENT_318	[p18l37t3333r87b3386],
2	.	.	O	.	_	0	SENT_318	[p18l37t3333r87b3386],

1	Pfrunder	NN	O	pfrunder	_	0	SENT_319	[p18l131t3333r411b3386],
2	A	NN	O	a	dep	1	SENT_319	[p18l445t3334r498b3385],
3	et	FW	O	et	nn	2	SENT_319	[p18l534t3341r589b3386],
4	al	FW	O	al	nn	2	SENT_319	[p18l614t3333r667b3386],
5	(	FW	O	(	dep	2	SENT_319	[p18l703t3333r910b3398],
6	2003	CD	DATE	2003	dep	2	SENT_319	[p18l703t3333r910b3398],
7	)	CD	NUMBER	)	num	9	SENT_319	[p18l703t3333r910b3398],
8	Gene	NN	O	gene	nn	9	SENT_319	[p18l947t3333r1110b3386],
9	expression	NN	O	expression	dep	1	SENT_319	[p18l1146t3333r1486b3401],
10	of	IN	O	of	_	0	SENT_319	[p18l1521t3333r1589b3386],
11	CYP3A4	NN	O	cyp3a4	nn	15	SENT_319	[p18l1620t3333r1923b3396],
12	,	,	O	,	_	0	SENT_319	[p18l1620t3333r1923b3396],
13	ABCtransporters	NN	O	abctransporter	dep	15	SENT_319	[p18l1960t3333r2143b3386, p18l131t3429r479b3489],
14	(	CD	NUMBER	(	num	15	SENT_319	[p18l501t3422r726b3486],
15	MDRI	NN	ORGANIZATION	mdrus	prep_of	9	SENT_319	[p18l501t3422r726b3486],
16	and	CC	O	and	_	0	SENT_319	[p18l752t3421r857b3474],
17	MRPl-MRP5	NN	O	mrpl-mrp5	nn	18	SENT_319	[p18l875t3421r1315b3486],
18	)	NN	O	)	dep	1	SENT_319	[p18l875t3421r1315b3486],
19	and	CC	O	and	_	0	SENT_319	[p18l1337t3421r1443b3474],
20	hPXR	NN	O	hpxr	conj_and	18	SENT_319	[p18l1460t3421r1643b3473],
21	in	IN	O	in	_	0	SENT_319	[p18l1661t3421r1718b3473],
22	three	CD	NUMBER	three	num	28	SENT_319	[p18l1736t3421r1883b3474],
23	different	JJ	O	different	amod	28	SENT_319	[p18l1903t3419r2149b3474],
24	human	JJ	O	human	amod	28	SENT_319	[p18l131t3510r335b3563],
25	colon	NN	O	colon	nn	28	SENT_319	[p18l355t3510r520b3563],
26	carcinoma	NN	O	carcinoma	nn	28	SENT_319	[p18l540t3510r850b3563],
27	cell	NN	O	cell	nn	28	SENT_319	[p18l869t3510r975b3563],
28	lines	NNS	O	line	prep_in	18	SENT_319	[p18l995t3510r1150b3563],
29	.	.	O	.	_	0	SENT_319	[p18l995t3510r1150b3563],

1	J	NNP	O	J	nn	3	SENT_320	[p18l1173t3511r1201b3563],
2	Pharm	NNP	O	Pharm	nn	3	SENT_320	[p18l1220t3510r1416b3563],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_320	[p18l1436t3510r1754b3563],
4	55	CD	NUMBER	55	num	6	SENT_320	[p18l1775t3510r2142b3575],
5	(	CD	NUMBER	(	num	6	SENT_320	[p18l1775t3510r2142b3575],
6	l	NN	O	l	dep	3	SENT_320	[p18l1775t3510r2142b3575],
7	)	CD	NUMBER	)	number	8	SENT_320	[p18l1775t3510r2142b3575],
8	:59	CD	NUMBER	:59	num	9	SENT_320	[p18l1775t3510r2142b3575],
9	—	NN	O	—	dep	6	SENT_320	[p18l1775t3510r2142b3575],
10	66	CD	NUMBER	66	number	11	SENT_320	[p18l1775t3510r2142b3575],
11	6	CD	NUMBER	6	num	9	SENT_320	[p18l41t3599r92b3652],
12	.	.	O	.	_	0	SENT_320	[p18l41t3599r92b3652],

1	Masuyama	NN	O	masuyama	nn	2	SENT_321	[p18l131t3600r467b3667],
2	H	NN	O	h	nsubj	5	SENT_321	[p18l490t3600r543b3651],
3	et	FW	O	et	nn	5	SENT_321	[p18l568t3607r621b3652],
4	al	FW	O	al	nn	5	SENT_321	[p18l644t3599r694b3652],
5	(	FW	O	(	_	0	SENT_321	[p18l721t3599r918b3664],
6	2003	CD	DATE	2003	num	8	SENT_321	[p18l721t3599r918b3664],
7	)	CD	NUMBER	)	num	8	SENT_321	[p18l721t3599r918b3664],
8	Expression	NN	O	expression	dobj	5	SENT_321	[p18l945t3599r1284b3667],
9	and	CC	O	and	_	0	SENT_321	[p18l1309t3599r1417b3652],
10	potential	JJ	O	potential	amod	11	SENT_321	[p18l1440t3599r1707b3667],
11	roles	NNS	O	role	conj_and	8	SENT_321	[p18l1730t3599r1876b3652],
12	of	IN	O	of	_	0	SENT_321	[p18l1904t3599r1969b3652],
13	pregnane	NN	O	pregnane	nn	15	SENT_321	[p18l1987t3616r2146b3667, p18l132t3705r274b3741],
14	X	NN	O	x	nn	15	SENT_321	[p18l300t3689r353b3740],
15	receptor	NN	O	receptor	prep_of	11	SENT_321	[p18l380t3696r631b3756],
16	in	IN	O	in	_	0	SENT_321	[p18l657t3688r715b3740],
17	endometrial	JJ	O	endometrial	amod	18	SENT_321	[p18l742t3688r1106b3741],
18	cancer	NN	O	cancer	prep_in	5	SENT_321	[p18l1133t3705r1346b3741],
19	.	.	O	.	_	0	SENT_321	[p18l1133t3705r1346b3741],

1	J	NNP	O	J	nn	4	SENT_322	[p18l1376t3689r1404b3741],
2	Clin	NNP	O	Clin	nn	4	SENT_322	[p18l1432t3688r1562b3741],
3	Endocrinol	NNP	O	Endocrinol	nn	4	SENT_322	[p18l1588t3688r1928b3741],
4	Metab	NNP	O	Metab	_	0	SENT_322	[p18l1954t3688r2147b3741],

1	.	.	O	.	_	0	SENT_323	[p19l83t153r92b162],

1	Mensah-Osman	NN	O	mensah-osman	nn	2	SENT_324	[p19l131t109r615b162],
2	E	NN	O	e	nsubj	10	SENT_324	[p19l632t110r677b161],
3	(	CD	NUMBER	(	num	4	SENT_324	[p19l697t109r894b174],
4	2005	CD	DATE	2005	dep	2	SENT_324	[p19l697t109r894b174],
5	)	CD	NUMBER	)	num	6	SENT_324	[p19l697t109r894b174],
6	Ecteinascidin-743	NN	O	ecteinascidin-743	dep	2	SENT_324	[p19l914t109r1462b162],
7	is	VBZ	O	be	cop	10	SENT_324	[p19l1483t109r1530b162],
8	a	DT	O	a	det	10	SENT_324	[p19l1551t126r1582b162],
9	potent	JJ	O	potent	amod	10	SENT_324	[p19l1598t117r1789b177],
10	inhibitor	NN	O	inhibitor	_	0	SENT_324	[p19l1806t109r2070b162],
11	of	IN	O	of	_	0	SENT_324	[p19l2087t109r2153b162],
12	P450	NN	O	p450	nn	14	SENT_324	[p19l131t198r286b251],
13	3A4	NN	O	3a4	nn	14	SENT_324	[p19l319t198r445b251],
14	enzyme	NN	O	enzyme	prep_of	10	SENT_324	[p19l477t215r712b266],
15	and	CC	O	and	_	0	SENT_324	[p19l744t198r851b251],
16	accumulates	VBZ	O	accumulate	conj_and	10	SENT_324	[p19l881t198r1255b251],
17	cytoplasmic	JJ	O	cytoplasmic	amod	18	SENT_324	[p19l1288t198r1654b266],
18	PXR	NN	O	pxr	dobj	16	SENT_324	[p19l1686t199r1833b250],
19	to	TO	O	to	aux	20	SENT_324	[p19l1863t206r1919b251],
20	inhibit	VB	O	inhibit	xcomp	16	SENT_324	[p19l1949t198r2149b251],
21	transcription	NN	O	transcription	dobj	20	SENT_324	[p19l132t287r517b355],
22	of	IN	O	of	_	0	SENT_324	[p19l566t287r632b340],
23	P450	NN	O	p450	nn	24	SENT_324	[p19l675t287r830b340],
24	3A4	NN	O	3a4	prep_of	21	SENT_324	[p19l881t287r1008b340],
25	and	CC	O	and	_	0	SENT_324	[p19l1059t287r1166b340],
26	MDR1	NN	O	mdr1	prep_of	21	SENT_324	[p19l1214t288r1440b340],
27	:	:	O	:	_	0	SENT_324	[p19l1214t288r1440b340],
28	implications	NNS	O	implication	dep	21	SENT_324	[p19l1494t287r1869b355],
29	for	IN	O	for	_	0	SENT_324	[p19l1920t287r2009b340],
30	the	DT	O	the	det	31	SENT_324	[p19l2056t287r2147b340],
31	enhancement	NN	O	enhancement	prep_for	28	SENT_324	[p19l132t376r535b429],
32	of	IN	O	of	_	0	SENT_324	[p19l556t376r621b429],
33	cytotoxicity	NN	O	cytotoxicity	prep_of	31	SENT_324	[p19l639t376r1002b444],
34	to	TO	O	to	_	0	SENT_324	[p19l1024t384r1081b429],
35	chemotherapeutic	JJ	O	chemotherapeutic	amod	36	SENT_324	[p19l1104t376r1645b444],
36	agents	NNS	O	agent	prep_to	20	SENT_324	[p19l1669t384r1860b444],
37	in	IN	O	in	_	0	SENT_324	[p19l1883t376r1941b428],
38	osteosarcoma	NN	O	osteosarcoma	prep_in	36	SENT_324	[p19l1963t384r2146b429, p19l134t482r400b518],
39	.	.	O	.	_	0	SENT_324	[p19l1963t384r2146b429, p19l134t482r400b518],

1	2005	CD	DATE	2005	_	0	SENT_325	[p19l426t465r573b518],
2	ASCO	NNP	ORGANIZATION	ASCO	dep	1	SENT_325	[p19l597t465r798b518],
3	annual	JJ	SET	annual	amod	4	SENT_325	[p19l823t465r1023b518],
4	meeting	NN	O	meeting	dep	1	SENT_325	[p19l1045t465r1289b533],

1	.	.	O	.	_	0	SENT_326	[p19l83t598r92b607],

1	Dotzlaw	NN	MISC	dotzlaw	nsubjpass	16	SENT_327	[p19l131t554r387b607],
2	H	NN	O	h	dep	1	SENT_327	[p19l411t555r463b606],
3	et	FW	O	et	nn	2	SENT_327	[p19l487t562r539b607],
4	al	FW	O	al	nn	2	SENT_327	[p19l562t554r613b607],
5	(	FW	O	(	dep	2	SENT_327	[p19l637t555r835b619],
6	1999	CD	DATE	1999	num	7	SENT_327	[p19l637t555r835b619],
7	)	CD	NUMBER	)	dep	1	SENT_327	[p19l637t555r835b619],
8	The	DT	O	the	det	14	SENT_327	[p19l860t554r976b607],
9	human	JJ	O	human	amod	14	SENT_327	[p19l997t554r1204b607],
10	orphan	NN	O	orphan	nn	14	SENT_327	[p19l1228t554r1437b622],
11	receptor	NN	O	receptor	nn	14	SENT_327	[p19l1457t562r1709b622],
12	PXR	NN	O	pxr	nn	14	SENT_327	[p19l1729t555r1877b606],
13	messenger	NN	O	messenger	nn	14	SENT_327	[p19l1897t571r2146b607, p19l133t660r228b711],
14	RNA	NN	O	rna	dep	7	SENT_327	[p19l248t644r408b696],
15	is	VBZ	O	be	auxpass	16	SENT_327	[p19l430t643r477b696],
16	expressed	VBN	O	express	_	0	SENT_327	[p19l501t643r800b711],
17	in	IN	O	in	_	0	SENT_327	[p19l821t643r879b695],
18	both	CC	O	both	preconj	19	SENT_327	[p19l900t643r1036b696],
19	normal	JJ	O	normal	amod	23	SENT_327	[p19l1057t643r1272b696],
20	and	CC	O	and	_	0	SENT_327	[p19l1295t643r1402b696],
21	neoplastic	JJ	O	neoplastic	conj_and	19	SENT_327	[p19l1423t643r1731b711],
22	breast	NN	O	breast	nn	23	SENT_327	[p19l1752t643r1935b696],
23	tissue	NN	O	tissue	prep_in	16	SENT_327	[p19l1956t643r2144b696],
24	.	.	O	.	_	0	SENT_327	[p19l1956t643r2144b696],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_328	[p19l133t732r261b785],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_328	[p19l282t733r498b785],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_328	[p19l519t733r629b785],
4	5	CD	NUMBER	5	num	3	SENT_328	[p19l653t732r1143b797],
5	(	CD	NUMBER	(	number	6	SENT_328	[p19l653t732r1143b797],
6	8	CD	NUMBER	8	num	7	SENT_328	[p19l653t732r1143b797],
7	)	NN	O	)	dep	3	SENT_328	[p19l653t732r1143b797],
8	:2103	CD	NUMBER	:2103	number	9	SENT_328	[p19l653t732r1143b797],
9	—	CD	NUMBER	—	dep	3	SENT_328	[p19l653t732r1143b797],
10	2107	CD	DATE	2107	dep	9	SENT_328	[p19l653t732r1143b797],

1	.	.	O	.	_	0	SENT_329	[p19l83t865r92b874],

1	Chen	NNP	O	Chen	nsubj	7	SENT_330	[p19l133t821r291b874],
2	Y	NN	O	y	dep	1	SENT_330	[p19l311t822r364b873],
3	et	FW	O	et	nn	2	SENT_330	[p19l384t829r438b874],
4	al	FW	O	al	nn	2	SENT_330	[p19l460t821r512b874],
5	(	FW	O	(	dep	2	SENT_330	[p19l534t822r731b886],
6	2007	CD	DATE	2007	num	7	SENT_330	[p19l534t822r731b886],
7	)	CD	NUMBER	)	_	0	SENT_330	[p19l534t822r731b886],
8	Human	JJ	O	human	amod	11	SENT_330	[p19l755t822r978b874],
9	pregnane	NN	O	pregnane	nn	11	SENT_330	[p19l997t838r1277b889],
10	X	NN	O	x	nn	11	SENT_330	[p19l1297t822r1350b873],
11	receptor	NN	O	receptor	dobj	7	SENT_330	[p19l1370t829r1621b889],
12	and	CC	O	and	_	0	SENT_330	[p19l1641t821r1749b874],
13	resistance	NN	O	resistance	conj_and	11	SENT_330	[p19l1768t821r2069b874],
14	to	TO	O	to	_	0	SENT_330	[p19l2090t829r2147b874],
15	chemotherapy	NN	O	chemotherapy	prep_to	11	SENT_330	[p19l132t910r562b978],
16	in	IN	O	in	_	0	SENT_330	[p19l611t910r669b962],
17	prostate	NN	O	prostate	nn	18	SENT_330	[p19l715t918r957b978],
18	cancer	NN	O	cancer	prep_in	7	SENT_330	[p19l1006t927r1218b963],
19	.	.	O	.	_	0	SENT_330	[p19l1006t927r1218b963],

1	Cancer	NN	O	cancer	nn	2	SENT_331	[p19l1271t911r1486b963],
2	Res	NNP	O	Res	_	0	SENT_331	[p19l1533t911r1644b963],
3	67	CD	NUMBER	67	number	4	SENT_331	[p19l1695t910r1912b975],
4	(	CD	NUMBER	(	dep	2	SENT_331	[p19l1695t910r1912b975],
5	21	CD	NUMBER	21	num	6	SENT_331	[p19l1695t910r1912b975],
6	)	NN	O	)	dep	4	SENT_331	[p19l1695t910r1912b975],
7	:	:	O	:	_	0	SENT_331	[p19l1695t910r1912b975],
8	1036110367	CD	NUMBER	1036110367	dep	4	SENT_331	[p19l1927t910r2149b963, p19l139t999r318b1052],

1	Harmsen	NNP	PERSON	Harmsen	nn	2	SENT_332	[p19l132t1089r406b1141],
2	S	NNP	O	S	_	0	SENT_332	[p19l431t1088r466b1141],
3	et	FW	O	et	nn	5	SENT_332	[p19l495t1096r548b1141],
4	al.	FW	O	al.	nn	5	SENT_332	[p19l570t1088r638b1141],
5	(	FW	O	(	dep	2	SENT_332	[p19l667t1088r865b1153],
6	2008	CD	DATE	2008	num	8	SENT_332	[p19l667t1088r865b1153],
7	)	CD	NUMBER	)	num	8	SENT_332	[p19l667t1088r865b1153],
8	Comparison	NN	O	comparison	dobj	5	SENT_332	[p19l892t1088r1264b1156],
9	of	IN	O	of	_	0	SENT_332	[p19l1289t1088r1355b1141],
10	two	CD	NUMBER	two	prep_of	8	SENT_332	[p19l1374t1096r1485b1141],
11	immortalized	VBN	O	immortalize	dep	5	SENT_332	[p19l1510t1088r1917b1141],
12	human	JJ	O	human	amod	14	SENT_332	[p19l1941t1088r2148b1141],
13	cell	NN	O	cell	nn	14	SENT_332	[p19l132t1177r239b1230],
14	lines	NNS	O	line	nsubj	16	SENT_332	[p19l270t1177r411b1230],
15	to	TO	O	to	aux	16	SENT_332	[p19l444t1185r501b1230],
16	study	VB	O	study	xcomp	11	SENT_332	[p19l536t1177r696b1245],
17	nuclear	JJ	O	nuclear	amod	18	SENT_332	[p19l728t1177r953b1230],
18	receptor	NN	O	receptor	dobj	16	SENT_332	[p19l982t1185r1232b1245],
19	mediated	VBN	O	mediate	partmod	18	SENT_332	[p19l1263t1177r1542b1230],
20	Cyp3a4	NN	O	cyp3a4	nn	21	SENT_332	[p19l1574t1177r1809b1245],
21	induction	NN	O	induction	dobj	19	SENT_332	[p19l1841t1177r2144b1230],
22	.	.	O	.	_	0	SENT_332	[p19l1841t1177r2144b1230],

1	Drug	NN	O	drug	nn	3	SENT_333	[p19l131t1267r286b1334],
2	Metab	NNP	O	Metab	nn	3	SENT_333	[p19l308t1266r500b1319],
3	Dispos	NNP	O	Dispos	_	0	SENT_333	[p19l523t1266r732b1334],
4	36	CD	NUMBER	36	number	5	SENT_333	[p19l758t1266r935b1331],
5	(	CD	NUMBER	(	num	13	SENT_333	[p19l758t1266r935b1331],
6	6	CD	NUMBER	6	num	7	SENT_333	[p19l758t1266r935b1331],
7	)	NN	O	)	dep	13	SENT_333	[p19l758t1266r935b1331],
8	:	:	O	:	_	0	SENT_333	[p19l758t1266r935b1331],
9	1	CD	NUMBER	1	num	13	SENT_333	[p19l950t1267r972b1318],
10	166-1	CD	NUMBER	166-1	num	13	SENT_333	[p19l988t1266r1164b1319],
11	171	CD	NUMBER	171	num	13	SENT_333	[p19l1181t1267r1279b1319],
12	Collett	NNP	O	Collett	nn	13	SENT_333	[p19l132t1355r339b1408],
13	A	NNP	O	A	nsubj	20	SENT_333	[p19l358t1356r427b1418],
14	,	,	O	,	_	0	SENT_333	[p19l358t1356r427b1418],
15	Tanianis-Hughes	NNP	O	Tanianis-Hughes	nn	16	SENT_333	[p19l450t1355r970b1423],
16	J	NNP	O	J	appos	13	SENT_333	[p19l992t1356r1036b1418],
17	,	,	O	,	_	0	SENT_333	[p19l992t1356r1036b1418],
18	Warhurst	NNP	O	Warhurst	nn	19	SENT_333	[p19l1059t1355r1344b1408],
19	G	NNP	O	G	appos	13	SENT_333	[p19l1364t1355r1416b1408],
20	(	VBD	O	(	rcmod	3	SENT_333	[p19l1439t1355r1636b1420],
21	2004	CD	DATE	2004	num	22	SENT_333	[p19l1439t1355r1636b1420],
22	)	CD	NUMBER	)	dobj	20	SENT_333	[p19l1439t1355r1636b1420],
23	Rapid	JJ	O	rapid	amod	24	SENT_333	[p19l1659t1355r1840b1423],
24	induction	NN	O	induction	dep	3	SENT_333	[p19l1860t1355r2148b1408],
25	of	IN	O	of	_	0	SENT_333	[p19l133t1444r198b1497],
26	P-glycoprotein	NN	O	p-glycoprotein	nn	27	SENT_333	[p19l217t1444r671b1512],
27	expression	NN	O	expression	prep_of	24	SENT_333	[p19l697t1444r1021b1512],
28	by	IN	O	by	_	0	SENT_333	[p19l1045t1444r1120b1512],
29	high	JJ	O	high	amod	31	SENT_333	[p19l1145t1444r1279b1512],
30	permeability	NN	O	permeability	nn	31	SENT_333	[p19l1302t1444r1688b1512],
31	compounds	NNS	O	compound	prep_by	27	SENT_333	[p19l1714t1444r2063b1512],
32	in	IN	O	in	_	0	SENT_333	[p19l2090t1444r2148b1496],
33	colonic	JJ	O	colonic	amod	34	SENT_333	[p19l132t1533r354b1586],
34	cells	NNS	O	cell	prep_in	31	SENT_333	[p19l387t1533r522b1586],
35	in	IN	O	in	_	0	SENT_333	[p19l556t1533r614b1585],
36	Vitro	NNP	O	Vitro	prep_in	34	SENT_333	[p19l645t1533r804b1586],
37	:	:	O	:	_	0	SENT_333	[p19l645t1533r804b1586],
38	a	DT	O	a	det	40	SENT_333	[p19l841t1550r873b1586],
39	possible	JJ	O	possible	amod	40	SENT_333	[p19l903t1533r1153b1601],
40	source	NN	O	source	dep	3	SENT_333	[p19l1187t1550r1381b1586],
41	of	IN	O	of	_	0	SENT_333	[p19l1415t1533r1480b1586],
42	transporter	NN	O	transporter	prep_of	40	SENT_333	[p19l1507t1541r1838b1601],
43	mediated	VBN	O	mediate	partmod	42	SENT_333	[p19l1869t1533r2148b1586],
44	drug	NN	O	drug	nn	45	SENT_333	[p19l132t1622r268b1690],
45	interactions	NNS	O	interaction	dobj	43	SENT_333	[p19l291t1622r680b1675],
46	?	.	O	?	_	0	SENT_333	[p19l291t1622r680b1675],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_334	[p19l702t1622r977b1675],
2	Pharmacol	NNP	ORGANIZATION	Pharmacol	_	0	SENT_334	[p19l997t1622r1323b1675],
3	68	CD	NUMBER	68	number	4	SENT_334	[p19l1347t1622r1798b1687],
4	(	CD	NUMBER	(	dep	2	SENT_334	[p19l1347t1622r1798b1687],
5	4	CD	NUMBER	4	num	6	SENT_334	[p19l1347t1622r1798b1687],
6	)	NN	O	)	dep	4	SENT_334	[p19l1347t1622r1798b1687],
7	:783	CD	NUMBER	:783	num	8	SENT_334	[p19l1347t1622r1798b1687],
8	—	NN	O	—	dep	2	SENT_334	[p19l1347t1622r1798b1687],
9	790	CD	NUMBER	790	dep	8	SENT_334	[p19l1347t1622r1798b1687],
10	Shepard	NNP	O	Shepard	nn	11	SENT_334	[p19l133t1711r381b1779],
11	RL	NNP	O	RL	dep	2	SENT_334	[p19l415t1712r511b1763],
12	et	FW	O	et	nn	14	SENT_334	[p19l545t1719r600b1764],
13	al	FW	O	al	nn	14	SENT_334	[p19l621t1711r673b1764],
14	(	FW	O	(	rcmod	11	SENT_334	[p19l710t1711r908b1776],
15	2003	CD	DATE	2003	num	17	SENT_334	[p19l710t1711r908b1776],
16	)	CD	NUMBER	)	num	17	SENT_334	[p19l710t1711r908b1776],
17	Modulation	NN	O	modulation	dobj	14	SENT_334	[p19l944t1711r1301b1764],
18	of	IN	O	of	_	0	SENT_334	[p19l1337t1711r1402b1764],
19	P-glycoprotein	NN	O	p-glycoprotein	prep_of	17	SENT_334	[p19l1432t1711r1887b1779],
20	but	CC	O	but	_	0	SENT_334	[p19l1920t1711r2018b1764],
21	not	RB	O	not	_	0	SENT_334	[p19l2052t1719r2149b1764],
22	MRP1	NN	O	mrp1	conj_negcc	19	SENT_334	[p19l131t1801r353b1852],
23	-	:	O	-	_	0	SENT_334	[p19l131t1801r353b1852],
24	or	CC	O	or	_	0	SENT_334	[p19l397t1817r459b1853],
25	BCRP-mediated	JJ	O	bcrp-mediated	amod	27	SENT_334	[p19l498t1800r998b1853],
26	drug	NN	O	drug	nn	27	SENT_334	[p19l1039t1800r1176b1868],
27	resistance	NN	O	resistance	conj_or	17	SENT_334	[p19l1217t1800r1518b1853],
28	by	IN	O	by	_	0	SENT_334	[p19l1558t1800r1633b1868],
29	LY335979	NN	O	ly335979	prep_by	14	SENT_334	[p19l1675t1800r2020b1854],
30	.	.	O	.	_	0	SENT_334	[p19l1675t1800r2020b1854],

1	Int	NN	O	int	nn	3	SENT_335	[p19l2065t1801r2149b1853],
2	J	NN	O	j	nn	3	SENT_335	[p19l131t1890r159b1942],
3	Cancer	NN	O	cancer	dep	13	SENT_335	[p19l181t1890r397b1942],
4	103	CD	NUMBER	103	num	5	SENT_335	[p19l424t1889r905b1954],
5	(	NN	O	(	dep	3	SENT_335	[p19l424t1889r905b1954],
6	1	CD	NUMBER	1	number	7	SENT_335	[p19l424t1889r905b1954],
7	)	CD	NUMBER	)	num	8	SENT_335	[p19l424t1889r905b1954],
8	:121	CD	NUMBER	:121	dep	5	SENT_335	[p19l424t1889r905b1954],
9	—	NN	O	—	dep	13	SENT_335	[p19l424t1889r905b1954],
10	125	CD	NUMBER	125	num	9	SENT_335	[p19l424t1889r905b1954],
11	Van	NNP	PERSON	Van	nn	13	SENT_335	[p19l132t1995r239b2031],
12	Asperen	NNP	PERSON	Asperen	nn	13	SENT_335	[p19l258t1979r512b2046],
13	J	NNP	PERSON	J	dep	22	SENT_335	[p19l530t1979r576b2041],
14	,	,	O	,	_	0	SENT_335	[p19l530t1979r576b2041],
15	Van	NNP	PERSON	Van	nn	17	SENT_335	[p19l597t1995r706b2031],
16	Tellingen	NNP	PERSON	Tellingen	nn	17	SENT_335	[p19l725t1978r1016b2046],
17	O	NNP	O	O	appos	13	SENT_335	[p19l1036t1978r1105b2041],
18	,	,	O	,	_	0	SENT_335	[p19l1036t1978r1105b2041],
19	Beijnen	NNP	PERSON	Beijnen	nn	21	SENT_335	[p19l1126t1978r1363b2046],
20	J	NNP	PERSON	J	nn	21	SENT_335	[p19l1381t1979r1409b2031],
21	H	NNP	PERSON	H	appos	13	SENT_335	[p19l1412t1979r1464b2030],
22	(	VBD	O	(	_	0	SENT_335	[p19l1487t1978r1684b2043],
23	1998	CD	DATE	1998	num	25	SENT_335	[p19l1487t1978r1684b2043],
24	)	CD	NUMBER	)	num	25	SENT_335	[p19l1487t1978r1684b2043],
25	Determination	NN	O	determination	dobj	22	SENT_335	[p19l1705t1978r2147b2031],
26	of	IN	O	of	_	0	SENT_335	[p19l133t2067r199b2120],
27	doxorubicin	NN	O	doxorubicin	prep_of	25	SENT_335	[p19l223t2067r611b2120],
28	and	CC	O	and	_	0	SENT_335	[p19l641t2067r751b2120],
29	metabolites	NNS	O	metabolite	prep_of	25	SENT_335	[p19l779t2067r1148b2120],
30	in	IN	O	in	_	0	SENT_335	[p19l1177t2067r1236b2119],
31	murine	JJ	O	murine	amod	32	SENT_335	[p19l1265t2067r1487b2120],
32	specimens	NNS	O	specimen	prep_in	22	SENT_335	[p19l1518t2067r1846b2135],
33	by	IN	O	by	_	0	SENT_335	[p19l1876t2067r1951b2135],
34	highperformance	NN	O	highperformance	nn	36	SENT_335	[p19l1980t2067r2143b2135, p19l130t2156r520b2224],
35	liquid	JJ	O	liquid	amod	36	SENT_335	[p19l542t2156r719b2224],
36	chromatography	NN	O	chromatography	prep_by	22	SENT_335	[p19l740t2156r1255b2224],
37	.	.	O	.	_	0	SENT_335	[p19l740t2156r1255b2224],

1	J	NN	O	j	nn	3	SENT_336	[p19l1281t2157r1309b2209],
2	Chromatogr	NN	O	chromatogr	nn	3	SENT_336	[p19l1331t2156r1700b2224],
3	B	NN	O	b	_	0	SENT_336	[p19l1720t2157r1764b2208],
4	Biomed	NNP	O	Biomed	nn	6	SENT_336	[p19l1791t2156r2032b2209],
5	Sci	NNP	O	Sci	nn	6	SENT_336	[p19l2055t2156r2149b2209],
6	Appl	NNP	O	Appl	dep	3	SENT_336	[p19l131t2245r281b2313],
7	712	CD	NUMBER	712	num	8	SENT_336	[p19l304t2245r869b2310],
8	(	NN	O	(	dep	6	SENT_336	[p19l304t2245r869b2310],
9	1	CD	NUMBER	1	num	10	SENT_336	[p19l304t2245r869b2310],
10	—	NN	O	—	dep	3	SENT_336	[p19l304t2245r869b2310],
11	2	CD	NUMBER	2	dep	10	SENT_336	[p19l304t2245r869b2310],
12	)	CD	NUMBER	)	number	13	SENT_336	[p19l304t2245r869b2310],
13	:129	CD	NUMBER	:129	dep	3	SENT_336	[p19l304t2245r869b2310],
14	—	NN	O	—	dep	13	SENT_336	[p19l304t2245r869b2310],
15	143	CD	NUMBER	143	num	14	SENT_336	[p19l304t2245r869b2310],
16	DeGregorio	NNP	O	DeGregorio	nn	17	SENT_336	[p19l131t2334r494b2402],
17	MW	NNP	O	MW	dep	3	SENT_336	[p19l517t2335r655b2387],
18	et	FW	O	et	nn	20	SENT_336	[p19l678t2342r731b2387],
19	al	FW	O	al	nn	20	SENT_336	[p19l754t2334r805b2387],
20	(	FW	O	(	rcmod	17	SENT_336	[p19l829t2334r1027b2399],
21	1984	CD	DATE	1984	num	23	SENT_336	[p19l829t2334r1027b2399],
22	)	NNP	O	)	nn	23	SENT_336	[p19l829t2334r1027b2399],
23	Uptake	NNP	O	Uptake	dobj	20	SENT_336	[p19l1051t2334r1288b2402],
24	,	,	O	,	_	0	SENT_336	[p19l1051t2334r1288b2402],
25	metabolism	NN	O	metabolism	conj_and	23	SENT_336	[p19l1311t2334r1684b2397],
26	,	,	O	,	_	0	SENT_336	[p19l1311t2334r1684b2397],
27	and	CC	O	and	_	0	SENT_336	[p19l1710t2334r1818b2387],
28	cytotoxicity	NN	O	cytotoxicity	conj_and	23	SENT_336	[p19l1840t2334r2146b2402, p19l131t2423r209b2491],
29	of	IN	O	of	_	0	SENT_336	[p19l231t2423r297b2476],
30	doxorubicin	NN	O	doxorubicin	prep_of	28	SENT_336	[p19l313t2423r681b2476],
31	in	IN	O	in	_	0	SENT_336	[p19l702t2423r760b2475],
32	human	JJ	O	human	amod	33	SENT_336	[p19l779t2423r986b2476],
33	Ewing	NNP	PERSON	Ewing	poss	35	SENT_336	[p19l1007t2423r1258b2491],
34	’s	POS	O	’s	_	0	SENT_336	[p19l1007t2423r1258b2491],
35	sarcoma	NN	O	sarcoma	prep_in	20	SENT_336	[p19l1284t2440r1537b2476],
36	and	CC	O	and	_	0	SENT_336	[p19l1558t2423r1665b2476],
37	rhabdomyosarcoma	NN	O	rhabdomyosarcoma	nn	38	SENT_336	[p19l1685t2423r2146b2491, p19l132t2529r295b2565],
38	cells	NNS	O	cell	prep_in	20	SENT_336	[p19l318t2512r469b2565],
39	.	.	O	.	_	0	SENT_336	[p19l318t2512r469b2565],

1	Cancer	NNP	O	Cancer	nn	3	SENT_337	[p19l496t2512r712b2565],
2	Chemother	NNP	O	Chemother	nn	3	SENT_337	[p19l732t2512r1071b2565],
3	Pharmacol	NNP	O	Pharmacol	dep	12	SENT_337	[p19l1092t2512r1418b2565],
4	12	CD	NUMBER	12	num	5	SENT_337	[p19l1446t2512r1812b2577],
5	(	CD	NUMBER	(	dep	3	SENT_337	[p19l1446t2512r1812b2577],
6	1	CD	NUMBER	1	num	7	SENT_337	[p19l1446t2512r1812b2577],
7	)	NN	O	)	dep	12	SENT_337	[p19l1446t2512r1812b2577],
8	:59	CD	NUMBER	:59	num	12	SENT_337	[p19l1446t2512r1812b2577],
9	—	CD	NUMBER	—	num	12	SENT_337	[p19l1446t2512r1812b2577],
10	63	CD	NUMBER	63	num	12	SENT_337	[p19l1446t2512r1812b2577],
11	Repetto	NNP	O	Repetto	nn	12	SENT_337	[p19l131t2602r366b2669],
12	G	NNP	O	G	dep	20	SENT_337	[p19l386t2602r454b2664],
13	,	,	O	,	_	0	SENT_337	[p19l386t2602r454b2664],
14	del	FW	O	del	nn	16	SENT_337	[p19l476t2601r566b2654],
15	Peso	FW	O	peso	nn	16	SENT_337	[p19l583t2602r725b2654],
16	A	NN	O	a	appos	12	SENT_337	[p19l743t2602r813b2663],
17	,	,	O	,	_	0	SENT_337	[p19l743t2602r813b2663],
18	Zurita	NNP	PERSON	Zurita	nn	19	SENT_337	[p19l833t2601r1020b2654],
19	J	NNP	PERSON	J	appos	12	SENT_337	[p19l1035t2602r1063b2654],
20	(	VBD	O	(	_	0	SENT_337	[p19l1084t2601r1281b2666],
21	2008	CD	DATE	2008	dobj	20	SENT_337	[p19l1084t2601r1281b2666],
22	)	CD	NUMBER	)	num	26	SENT_337	[p19l1084t2601r1281b2666],
23	Neutral	NNP	O	Neutral	nn	26	SENT_337	[p19l1301t2601r1528b2654],
24	red	JJ	O	red	amod	26	SENT_337	[p19l1545t2601r1642b2654],
25	uptake	NN	O	uptake	nn	26	SENT_337	[p19l1658t2601r1861b2669],
26	assay	NN	O	assay	dep	20	SENT_337	[p19l1880t2618r2042b2669],
27	for	IN	O	for	_	0	SENT_337	[p19l2061t2601r2150b2654],
28	the	DT	O	the	det	29	SENT_337	[p19l132t2690r223b2743],
29	estimation	NN	O	estimation	prep_for	20	SENT_337	[p19l255t2690r572b2743],
30	of	IN	O	of	_	0	SENT_337	[p19l604t2690r670b2743],
31	cell	NN	O	cell	nn	32	SENT_337	[p19l696t2690r805b2743],
32	Viability/cytotoxicity	NN	O	viability/cytotoxicity	prep_of	29	SENT_337	[p19l837t2690r1493b2758],
33	.	.	O	.	_	0	SENT_337	[p19l837t2690r1493b2758],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_338	[p19l1528t2691r1638b2743],
2	Protoc	NNP	PERSON	Protoc	_	0	SENT_338	[p19l1669t2691r1866b2743],
3	3:1125	CD	NUMBER	3:1125	dep	2	SENT_338	[p19l1900t2690r2149b2743],
4	—	CD	NUMBER	—	number	5	SENT_338	[p19l1900t2690r2149b2743],
5	1	CD	NUMBER	1	num	7	SENT_338	[p19l139t2780r161b2831],
6	13	CD	NUMBER	13	number	7	SENT_338	[p19l177t2779r239b2832],
7	1	CD	NUMBER	1	dep	3	SENT_338	[p19l254t2780r276b2831],

1	Dantzig	NNP	PERSON	Dantzig	nn	2	SENT_339	[p19l131t2868r370b2936],
2	AH	NNP	O	AH	nsubj	5	SENT_339	[p19l403t2869r512b2920],
3	et	FW	O	et	nn	5	SENT_339	[p19l545t2876r599b2921],
4	al	FW	O	al	nn	5	SENT_339	[p19l621t2868r672b2921],
5	(	FW	O	(	_	0	SENT_339	[p19l707t2868r904b2933],
6	1999	CD	DATE	1999	num	8	SENT_339	[p19l707t2868r904b2933],
7	)	CD	NUMBER	)	num	8	SENT_339	[p19l707t2868r904b2933],
8	Selectivity	NN	O	selectivity	dobj	5	SENT_339	[p19l940t2868r1264b2936],
9	of	IN	O	of	_	0	SENT_339	[p19l1298t2868r1364b2921],
10	the	DT	O	the	det	13	SENT_339	[p19l1391t2868r1482b2921],
11	multidrug	JJ	O	multidrug	amod	13	SENT_339	[p19l1515t2868r1814b2936],
12	resistance	NN	O	resistance	nn	13	SENT_339	[p19l1846t2868r2148b2921],
13	modulator	NN	O	modulator	prep_of	8	SENT_339	[p19l131t2956r461b3019],
14	,	,	O	,	_	0	SENT_339	[p19l131t2956r461b3019],
15	LY335979	NN	O	ly335979	appos	13	SENT_339	[p19l504t2956r851b3019],
16	,	,	O	,	_	0	SENT_339	[p19l504t2956r851b3019],
17	for	IN	O	for	_	0	SENT_339	[p19l896t2956r984b3009],
18	P-glycoprotein	NN	O	p-glycoprotein	prep_for	8	SENT_339	[p19l1025t2956r1478b3024],
19	and	CC	O	and	_	0	SENT_339	[p19l1522t2956r1629b3009],
20	eﬂect	NN	O	eﬂect	prep_for	8	SENT_339	[p19l1672t2954r1835b3009],
21	on	IN	O	on	_	0	SENT_339	[p19l1878t2973r1951b3009],
22	cytochrome	NN	O	cytochrome	nn	24	SENT_339	[p19l1993t2964r2146b3024, p19l132t3045r358b3098],
23	P-450	NN	MISC	p-450	nn	24	SENT_339	[p19l381t3045r560b3098],
24	activities	NNS	O	activity	prep_on	5	SENT_339	[p19l584t3045r873b3098],
25	.	.	O	.	_	0	SENT_339	[p19l584t3045r873b3098],

1	J	NNP	O	J	nn	4	SENT_340	[p19l898t3046r926b3098],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_340	[p19l947t3045r1273b3098],
3	Exp	NNP	O	Exp	nn	4	SENT_340	[p19l1295t3046r1414b3113],
4	Ther	NNP	O	Ther	_	0	SENT_340	[p19l1437t3045r1581b3098],
5	290	CD	NUMBER	290	num	6	SENT_340	[p19l1602t3045r2093b3110],
6	(	NN	O	(	dep	4	SENT_340	[p19l1602t3045r2093b3110],
7	2	CD	NUMBER	2	number	8	SENT_340	[p19l1602t3045r2093b3110],
8	)	CD	NUMBER	)	num	9	SENT_340	[p19l1602t3045r2093b3110],
9	:854	CD	NUMBER	:854	dep	6	SENT_340	[p19l1602t3045r2093b3110],
10	—	NN	O	—	nn	13	SENT_340	[p19l1602t3045r2093b3110],
11	862	CD	NUMBER	862	num	13	SENT_340	[p19l1602t3045r2093b3110],
12	Gupta	NNP	PERSON	Gupta	nn	13	SENT_340	[p19l133t3134r317b3202],
13	D	NNP	O	D	dep	6	SENT_340	[p19l337t3135r388b3186],
14	et	FW	O	et	dep	13	SENT_340	[p19l412t3142r465b3187],
15	al	FW	O	al	nn	18	SENT_340	[p19l487t3134r539b3187],
16	(	FW	O	(	dep	18	SENT_340	[p19l563t3134r760b3199],
17	2008	CD	DATE	2008	num	18	SENT_340	[p19l563t3134r760b3199],
18	)	CD	NUMBER	)	advmod	19	SENT_340	[p19l563t3134r760b3199],
19	Expanding	VBG	O	expand	partmod	4	SENT_340	[p19l783t3134r1112b3202],
20	the	DT	O	the	det	21	SENT_340	[p19l1135t3134r1226b3187],
21	roles	NNS	O	role	dobj	19	SENT_340	[p19l1246t3134r1393b3187],
22	for	IN	O	for	_	0	SENT_340	[p19l1416t3134r1504b3187],
23	pregnane	NN	O	pregnane	nn	25	SENT_340	[p19l1523t3151r1802b3202],
24	X	NN	O	x	nn	25	SENT_340	[p19l1824t3135r1877b3186],
25	receptor	NN	O	receptor	prep_for	21	SENT_340	[p19l1897t3142r2149b3202],
26	in	IN	O	in	_	0	SENT_340	[p19l131t3223r188b3275],
27	cancer	NN	O	cancer	prep_in	25	SENT_340	[p19l209t3240r422b3276],
28	:	:	O	:	_	0	SENT_340	[p19l209t3240r422b3276],
29	proliferation	NN	O	proliferation	nn	32	SENT_340	[p19l447t3223r828b3291],
30	and	CC	O	and	_	0	SENT_340	[p19l850t3223r957b3276],
31	drug	NN	O	drug	nn	32	SENT_340	[p19l978t3223r1114b3291],
32	resistance	NN	O	resistance	dep	4	SENT_340	[p19l1134t3223r1435b3276],
33	in	IN	O	in	_	0	SENT_340	[p19l1455t3223r1513b3275],
34	ovarian	JJ	O	ovarian	amod	35	SENT_340	[p19l1534t3223r1761b3276],
35	cancer	NN	O	cancer	prep_in	32	SENT_340	[p19l1781t3240r1993b3276],
36	.	.	O	.	_	0	SENT_340	[p19l1781t3240r1993b3276],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_341	[p19l2018t3223r2148b3276],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_341	[p19l132t3312r347b3365],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_341	[p19l367t3313r477b3365],
4	14	CD	NUMBER	14	number	5	SENT_341	[p19l509t3312r1070b3377],
5	(	CD	NUMBER	(	dep	3	SENT_341	[p19l509t3312r1070b3377],
6	17	CD	NUMBER	17	num	7	SENT_341	[p19l509t3312r1070b3377],
7	)	NN	O	)	dep	5	SENT_341	[p19l509t3312r1070b3377],
8	:5332	CD	NUMBER	:5332	num	12	SENT_341	[p19l509t3312r1070b3377],
9	—	CD	NUMBER	—	num	12	SENT_341	[p19l509t3312r1070b3377],
10	5340	CD	NUMBER	5340	num	12	SENT_341	[p19l509t3312r1070b3377],
11	Rao	NNP	O	Rao	nn	12	SENT_341	[p19l131t3402r251b3454],
12	US	NNP	LOCATION	US	dep	3	SENT_341	[p19l273t3401r385b3464],
13	,	,	O	,	_	0	SENT_341	[p19l273t3401r385b3464],
14	Fine	NNP	ORGANIZATION	Fine	nn	15	SENT_341	[p19l409t3401r543b3454],
15	RL	NNP	ORGANIZATION	RL	appos	12	SENT_341	[p19l565t3402r676b3464],
16	,	,	O	,	_	0	SENT_341	[p19l565t3402r676b3464],
17	Scarborough	NNP	ORGANIZATION	Scarborough	nn	18	SENT_341	[p19l702t3401r1091b3469],
18	GA	NNP	ORGANIZATION	GA	appos	3	SENT_341	[p19l1113t3401r1220b3454],
19	(	CD	NUMBER	(	num	20	SENT_341	[p19l1243t3401r1441b3466],
20	1994	CD	DATE	1994	dep	18	SENT_341	[p19l1243t3401r1441b3466],
21	)	NNP	O	)	nn	22	SENT_341	[p19l1243t3401r1441b3466],
22	Antiestrogens	NNPS	O	Antiestrogens	dep	3	SENT_341	[p19l1465t3401r1887b3469],
23	and	CC	O	and	_	0	SENT_341	[p19l1910t3401r2018b3454],
24	steroid	NN	O	steroid	nn	25	SENT_341	[p19l2041t3409r2146b3454, p19l130t3490r253b3543],
25	hormones	NNS	O	hormone	conj_and	22	SENT_341	[p19l275t3490r593b3543],
26	:	:	O	:	_	0	SENT_341	[p19l275t3490r593b3543],
27	substrates	NNS	O	substrate	dep	22	SENT_341	[p19l624t3490r920b3543],
28	of	IN	O	of	_	0	SENT_341	[p19l946t3490r1013b3543],
29	the	DT	O	the	det	31	SENT_341	[p19l1031t3490r1122b3543],
30	human	JJ	O	human	amod	31	SENT_341	[p19l1146t3490r1353b3543],
31	P-glycoprotein	NN	O	p-glycoprotein	prep_of	27	SENT_341	[p19l1376t3490r1845b3558],
32	.	.	O	.	_	0	SENT_341	[p19l1376t3490r1845b3558],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_342	[p19l1873t3490r2148b3543],
2	Pharmacol	NNP	ORGANIZATION	Pharmacol	dep	9	SENT_342	[p19l131t3579r457b3632],
3	48	CD	NUMBER	48	num	4	SENT_342	[p19l477t3579r931b3644],
4	(	NN	O	(	dep	2	SENT_342	[p19l477t3579r931b3644],
5	2	CD	NUMBER	2	number	6	SENT_342	[p19l477t3579r931b3644],
6	)	CD	NUMBER	)	dep	4	SENT_342	[p19l477t3579r931b3644],
7	:287	CD	NUMBER	:287	num	8	SENT_342	[p19l477t3579r931b3644],
8	—	NN	O	—	dep	9	SENT_342	[p19l477t3579r931b3644],
9	292	CD	NUMBER	292	_	0	SENT_342	[p19l477t3579r931b3644],
10	Dresser	NNP	O	Dresser	nn	11	SENT_342	[p19l131t3669r364b3721],
11	GK	NNP	O	GK	dep	9	SENT_342	[p19l385t3668r494b3721],
12	et	FW	O	et	nn	14	SENT_342	[p19l514t3676r566b3721],
13	al	FW	O	al	nn	14	SENT_342	[p19l589t3668r640b3721],
14	(	FW	O	(	rcmod	11	SENT_342	[p19l663t3668r861b3733],
15	2003	CD	DATE	2003	num	16	SENT_342	[p19l663t3668r861b3733],
16	)	CD	NUMBER	)	nn	18	SENT_342	[p19l663t3668r861b3733],
17	Coordinate	JJ	O	coordinate	amod	18	SENT_342	[p19l884t3668r1222b3721],
18	induction	NN	O	induction	dobj	14	SENT_342	[p19l1243t3668r1530b3721],
19	of	IN	O	of	prep	18	SENT_342	[p19l1551t3668r1617b3721],
20	both	CC	O	both	prep	14	SENT_342	[p19l1632t3668r1767b3721],
21	cytochrome	NN	O	cytochrome	dep	20	SENT_342	[p19l1788t3668r2147b3736],

1	P4503A	NN	O	p4503a	_	0	SENT_343	[p20l131t17r380b70],
2	and	CC	O	and	_	0	SENT_343	[p20l411t17r519b70],
3	MDR1	NN	O	mdr1	conj_and	1	SENT_343	[p20l548t18r753b69],
4	by	IN	O	by	_	0	SENT_343	[p20l789t17r863b85],
5	St	NNP	PERSON	St	nn	6	SENT_343	[p20l896t18r956b70],
6	John	NNP	PERSON	John	poss	8	SENT_343	[p20l985t17r1182b70],
7	’s	POS	O	’s	_	0	SENT_343	[p20l985t17r1182b70],
8	wort	NN	O	wort	prep_by	1	SENT_343	[p20l1214t25r1354b70],
9	in	IN	O	in	_	0	SENT_343	[p20l1383t17r1440b69],
10	healthy	JJ	O	healthy	amod	11	SENT_343	[p20l1469t17r1693b85],
11	subjects	NNS	O	subject	prep_in	1	SENT_343	[p20l1726t17r1983b85],
12	.	.	O	.	_	0	SENT_343	[p20l1726t17r1983b85],

1	Clin	NNP	O	Clin	nn	3	SENT_344	[p20l2018t17r2148b70],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_344	[p20l131t106r457b159],
3	Ther	NNP	O	Ther	_	0	SENT_344	[p20l478t106r622b159],
4	73	CD	NUMBER	73	number	5	SENT_344	[p20l643t106r1018b171],
5	(	CD	NUMBER	(	dep	3	SENT_344	[p20l643t106r1018b171],
6	1	CD	NUMBER	1	num	7	SENT_344	[p20l643t106r1018b171],
7	)	NN	O	)	dep	5	SENT_344	[p20l643t106r1018b171],
8	:41	CD	NUMBER	:41	num	10	SENT_344	[p20l643t106r1018b171],
9	—	CD	NUMBER	—	num	10	SENT_344	[p20l643t106r1018b171],
10	5O	NN	O	5o	dep	3	SENT_344	[p20l643t106r1018b171],

1	20	CD	NUMBER	20	_	0	SENT_345	[p20l6t195r92b247],
2	.	.	O	.	_	0	SENT_345	[p20l6t195r92b247],

1	Hamman	NNP	PERSON	Hamman	nn	2	SENT_346	[p20l131t196r403b247],
2	MA	NNP	O	MA	nsubj	5	SENT_346	[p20l428t195r548b246],
3	et	FW	O	et	nn	5	SENT_346	[p20l573t202r626b247],
4	al	FW	O	al	nn	5	SENT_346	[p20l645t194r695b247],
5	(	FW	O	(	_	0	SENT_346	[p20l723t195r915b259],
6	2001	CD	DATE	2001	number	7	SENT_346	[p20l723t195r915b259],
7	)	CD	NUMBER	)	num	9	SENT_346	[p20l723t195r915b259],
8	The	DT	O	the	det	9	SENT_346	[p20l942t194r1056b247],
9	effect	NN	O	effect	dobj	5	SENT_346	[p20l1082t192r1242b247],
10	of	IN	O	of	_	0	SENT_346	[p20l1268t194r1332b247],
11	rifampin	NN	O	rifampin	nn	12	SENT_346	[p20l1350t194r1604b262],
12	administration	NN	O	administration	prep_of	9	SENT_346	[p20l1631t194r2051b247],
13	on	IN	O	on	_	0	SENT_346	[p20l2078t211r2150b247],
14	the	DT	O	the	det	15	SENT_346	[p20l132t283r219b336],
15	disposition	NN	O	disposition	prep_on	5	SENT_346	[p20l240t283r559b351],
16	of	IN	O	of	_	0	SENT_346	[p20l578t283r642b336],
17	fexofenadine	NN	O	fexofenadine	prep_of	15	SENT_346	[p20l656t283r1052b336],
18	.	.	O	.	_	0	SENT_346	[p20l656t283r1052b336],

1	Clin	NNP	O	Clin	nn	3	SENT_347	[p20l1076t283r1201b336],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_347	[p20l1219t283r1534b336],
3	Ther	NNP	O	Ther	_	0	SENT_347	[p20l1553t283r1693b336],
4	69	CD	NUMBER	69	num	3	SENT_347	[p20l1711t283r1884b348],
5	(	CD	NUMBER	(	number	6	SENT_347	[p20l1711t283r1884b348],
6	3	CD	NUMBER	3	num	7	SENT_347	[p20l1711t283r1884b348],
7	)	NN	O	)	dep	3	SENT_347	[p20l1711t283r1884b348],
8	:	:	O	:	_	0	SENT_347	[p20l1711t283r1884b348],
9	1	CD	NUMBER	1	number	10	SENT_347	[p20l1898t284r1920b335],
10	14-121	CD	NUMBER	14-121	dep	7	SENT_347	[p20l1935t283r2143b335],

1	@	IN	O	@	_	0	SENT_348	[p20l1768t514r1847b611],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_348	[p20l1875t538r2139b613],

